Sentence,class,file
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dc/bb/main.PMC5477063.pdf
Article No~e00323 14 http://dx.doi.org/10.1016/j.heliyon.2017.e00323 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dc/bb/main.PMC5477063.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dc/bb/main.PMC5477063.pdf
Article No~e00323 15 http://dx.doi.org/10.1016/j.heliyon.2017.e00323 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dc/bb/main.PMC5477063.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dc/bb/main.PMC5477063.pdf
Article No~e00323 16 http://dx.doi.org/10.1016/j.heliyon.2017.e00323 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dc/bb/main.PMC5477063.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dc/bb/main.PMC5477063.pdf
UG proposal Unfair Fair Hyperfair Age group (yrs) Response type N % p N % p N % p 6 Accept 18 47 34 100 0.00 30 88 0.00 Refuse 16 53 0.86 0 - 4 12 8 Accept 10 33 0.10 30 100 0.00 25 83 0.00 Refuse 20 67 0 - 5 17 10 Accept 8 27 29 97 19 63 0.20 Refuse 22 73 0.02 1 3 0.00 11 37 Article No~e00323 17 http://dx.doi.org/10.1016/j.heliyon.2017.e00323 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dc/bb/main.PMC5477063.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dc/bb/main.PMC5477063.pdf
"Our data showed that, as children ’s ability to delay gratification improves with age, the correlation between fairness and altruism becomes Article No~e00323 18 http://dx.doi.org/10.1016/j.heliyon.2017.e00323 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/dc/bb/main.PMC5477063.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dc/bb/main.PMC5477063.pdf
"’s (2010) observation on nearly 900 children and adolescents aged eight to seventeen years, according to which true propensity to inequality aversion is Article No~e00323 19 http://dx.doi.org/10.1016/j.heliyon.2017.e00323 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/dc/bb/main.PMC5477063.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dc/bb/main.PMC5477063.pdf
"As a matter of fact, even in consideration of these Article No~e00323 20 http://dx.doi.org/10.1016/j.heliyon.2017.e00323 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/dc/bb/main.PMC5477063.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dc/bb/main.PMC5477063.pdf
Article No~e00323 21 http://dx.doi.org/10.1016/j.heliyon.2017.e00323 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dc/bb/main.PMC5477063.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dc/bb/main.PMC5477063.pdf
Article No~e00323 22 http://dx.doi.org/10.1016/j.heliyon.2017.e00323 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dc/bb/main.PMC5477063.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dc/bb/main.PMC5477063.pdf
Article No~e00323 23 http://dx.doi.org/10.1016/j.heliyon.2017.e00323 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dc/bb/main.PMC5477063.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dc/bb/main.PMC5477063.pdf
Article No~e00323 24 http://dx.doi.org/10.1016/j.heliyon.2017.e00323 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dc/bb/main.PMC5477063.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dc/bb/main.PMC5477063.pdf
Article No~e00323 25 http://dx.doi.org/10.1016/j.heliyon.2017.e00323 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dc/bb/main.PMC5477063.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dc/bb/main.PMC5477063.pdf
Article No~e00323 26 http://dx.doi.org/10.1016/j.heliyon.2017.e00323 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dc/bb/main.PMC5477063.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dc/bb/main.PMC5477063.pdf
Article No~e00323 27 http://dx.doi.org/10.1016/j.heliyon.2017.e00323 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dc/bb/main.PMC5477063.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dc/bb/main.PMC5477063.pdf
Article No~e00323 28 http://dx.doi.org/10.1016/j.heliyon.2017.e00323 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dc/bb/main.PMC5477063.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dc/bb/main.PMC5477063.pdf
Strain Mt14Twasﬁrst isolated after a 7-day pre-incubation in an anaerobic blood culture bottle supplemented with rumen and sheep blood and seeding on 5% sheep-blood- enriched Columbia agar at 37°C in an anaerobic New Microbe and New Infect 2017; 19:1–7 © 2017 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2017.02.002,Non-OADS,/arxiv_data1/oa_pdf/3c/2c/main.PMC5477064.pdf
"Scale bar indicates 2% nucleotide sequence divergence.2 New Microbes and New Infections , Volume 19 Number C, September 2017 NMNI © 2017 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,19,1–7 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/3c/2c/main.PMC5477064.pdf
"New bacteria from the gut of healthy infants 3 © 2017 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,19,1–7 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/3c/2c/main.PMC5477064.pdf
"Scale bar indicates 0.5% nucleotide sequence divergence.4 New Microbes and New Infections , Volume 19 Number C, September 2017 NMNI © 2017 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,19,1–7 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/3c/2c/main.PMC5477064.pdf
"MALDI-TOF MS spectra The MALDI-TOF MS spectra of ‘Khelai ﬁella massiliensis ’,‘Nia- meybacter massiliensis ’,‘Enterobacter massiliensis ’,‘Brachybacte- rium massiliense ’and ‘Massilibacillus massiliensis ’are available at http://www.mediterraneeinfection.com/article.php?",Non-OADS,/arxiv_data1/oa_pdf/3c/2c/main.PMC5477064.pdf
"New bacteria from the gut of healthy infants 5 © 2017 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,19,1–7 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/3c/2c/main.PMC5477064.pdf
"Scale bar indicates 1% nucleotide sequence divergence.6 New Microbes and New Infections , Volume 19 Number C, September 2017 NMNI © 2017 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,19,1–7 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/3c/2c/main.PMC5477064.pdf
Research- Gate 2015;35. http://dx.doi.org/10.1099/ijsem.0.000824 .,OADS,/arxiv_data1/oa_pdf/3c/2c/main.PMC5477064.pdf
"New bacteria from the gut of healthy infants 7 © 2017 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,19,1–7 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/3c/2c/main.PMC5477064.pdf
This is an open a ccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Baseline characteristics ChildParentsAfrican AmericanObesity preventionFruits and vegetables 1.,Non-OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.05.011 2211-3355/Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
35:25 –41.http://dx.doi.org/10.1006/pmed.2002.1028 .,Non-OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://dx.doi.org/10.1016/j.jada.2006.06.021 .,OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://dx.doi.org/10.1111/j.1365-277X.2005.00648.x .,OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://dx.doi.org/10.1016/j.jada.2010.07.001 .,OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
169:86 –90.http://dx.doi.org/10.1001/jamapediatrics.2014.2220 .,Non-OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://dx.doi.org/10.1016/j.maturitas.2011.08.005 .,OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://dx.doi.org/10.1016/ 1047-2797(95)00033-4 .,OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://dx.doi.org/10.1017/ S1368980000000392 .,Non-OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://dx.doi.org/ 10.1177/1090198103257254 .,Non-OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://dx.doi.org/10.1038/oby.2004.265 .,OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://dx.doi.org/10.1016/j.ypmed.2003.05.001 .,OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://dx.doi.org/10.1016/j.ypmed.2003.05.002 .,OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://dx.doi.org/10.1016/j.pmedr.2015.05.007 .,OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://dx.doi.org/10.1056/NEJMcp043052 .,OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://dx.doi.org/10.1006/pmed.1993.1078 .,Non-OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://dx.doi.org/10.1093/her/11.3.299 .,OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://dx.doi.org/10.1001/archpediatrics.2011.204 .,Non-OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://dx.doi.org/10.1017/s136898001200290x .,Non-OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://dx.doi.org/10.1016/S0031-3955(05)70349-7 .,OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://dx.doi.org/10.1016/j.jneb.2009.05.007 .,OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
Nurs.69:16 –30.http://dx.doi.org/10.1111/j.1365-2648.2012.06086.x .,OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
29:26 –32.http://dx.doi.org/10.1080/10556699.,Non-OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://www.houstonfoodbank.org/aboutus/more- about-us/ .,Non-OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://www.houstonfoodbank.org/programs/backpack-buddy/ .,Non-OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://www.houstonfoodbank.org/programs/kids-cafe/ .,Non-OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://dx.doi.org/10.1016/j.jneb.2014.08.007 .,OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
Trials 29:42–55.http://dx.doi.org/10.1016/j.cct.2007.05.001 .,OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
42:85 –95.http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
8:112. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
"http://dx.doi.org/10.1038/oby.2005.251 .Kumanyika, S.K., Swank, M., Stachecki, J., Whitt-Glover, M.C., Brennan, L.K., 2014.",Non-OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://dx.doi.org/10.1111/obr.12206 .,Non-OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://dx.doi.org/10.4162/nrp.2015.9.3.278 .,Non-OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://dx.doi.org/10.1001/jama.2012.40 .,Non-OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://dx.doi.org/10.1016/j.jada.2007.06.015 .,OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
Trials 29:56 –69.http://dx.doi.org/10.1016/j.cct.2007.,OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
Pediatrics 110:307 –314.http://dx.doi.org/ 10.1542/peds.110.2.307 .,Non-OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://dx.doi.org/10.1111/j.1467-789X.2008.00475.x .,Non-OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://www.pewinternet.org/2014/01/06/african-americans-and-technology-use/ .,Non-OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://dx.doi.org/10.2196/resprot.2348 .,Non-OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://dx.doi.org/10.2196/jmir.1889 .,Non-OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
Butter ﬂy girls; promoting healthy diet and physical activity to young African American girls online: rationale and design.BMC Public Health 13:709. http://dx.doi.org/10.1186/1471-2458-13-709 .,Non-OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
12:39. http://dx.doi.org/10.1186/s12966-015-0199-z .,Non-OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
http://dx.doi.org/10.1016/j.jneb.2006.02.011 .115 C. Callender et al.,OADS,/arxiv_data1/oa_pdf/e9/91/main.PMC5477066.pdf
"Initial in utero DTI studies have revealed how commissural, projection and association ﬁbers emerge in the living human fetus http://dx.doi.org/10.1016/j.nicl.2017.06.013 Received 28 November 2016; Received in revised form 25 January 2017; Accepted 8 June 2017⁎Corresponding author at: Center for MR-Research, University Children's Hospital, Steinwiesstrasse 75, CH-8032 Zürich, Switzerland.",Non-OADS,/arxiv_data1/oa_pdf/10/9d/main.PMC5477067.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/10/9d/main.PMC5477067.pdf
"Academic Press, pp.1–17.http://dx.doi.org/10.1016/B978-0-12-179060-8.50006-2 .",Non-OADS,/arxiv_data1/oa_pdf/10/9d/main.PMC5477067.pdf
"11While mTORC1 signaling is relatively well understood, the functions of mTORC2 have not been widely investigated, andonly recently has its critical roles in cytoskeletal organization, regu-lation of cell survival, and promotion of neovascularization been Received 8 February 2017; accepted 29 May 2017; http://dx.doi.org/10.1016/j.omtn.2017.05.012 .",OADS,/arxiv_data1/oa_pdf/0f/55/main.PMC5477068.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0f/55/main.PMC5477068.pdf
The synergy  between percutaneous coronary intervention with TAXUS and cardiac surgery (SYNTAX) score of the patients were calculated using a web-based computer program (http://www.syntaxscore.,OADS,/arxiv_data1/oa_pdf/7c/8f/AJC-17-483.PMC5477082.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/3/e1602811/DC1section S1.,Non-OADS,/arxiv_data1/oa_pdf/a7/37/1602811.PMC5477090.pdf
"Further, the ﬁndings are inconsistent across studies ( Pan et al., 2012 ), which is likely explained by the clin- ical heterogeneity of PD and the current insensitivity of imaging http://dx.doi.org/10.1016/j.nicl.2017.05.012 Received 28 February 2017; Received in revised form 20 April 2017; Accepted 20 May 2017⁎Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/36/71/main.PMC5477092.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/36/71/main.PMC5477092.pdf
http://dx.doi.org/10.1002/mds.26605 .,Non-OADS,/arxiv_data1/oa_pdf/36/71/main.PMC5477092.pdf
http://dx.doi.org/10.1523/JNEUROSCI.3554-12.2013 .,Non-OADS,/arxiv_data1/oa_pdf/36/71/main.PMC5477092.pdf
http://dx.doi.org/10.1007/s00401-009-0538-8 .,Non-OADS,/arxiv_data1/oa_pdf/36/71/main.PMC5477092.pdf
http://dx.doi.org/10.1098/rstb.2005.1634 .,OADS,/arxiv_data1/oa_pdf/36/71/main.PMC5477092.pdf
http://dx.doi.org/10.1152/ physrev.00032.2011 .,Non-OADS,/arxiv_data1/oa_pdf/36/71/main.PMC5477092.pdf
http://dx.doi.org/10.1002/ana.24323 .,Non-OADS,/arxiv_data1/oa_pdf/36/71/main.PMC5477092.pdf
http://dx.doi.org/10.1093/brain/awm184 .,Non-OADS,/arxiv_data1/oa_pdf/36/71/main.PMC5477092.pdf
http://dx.doi.org/10.1016/j.parkreldis.,OADS,/arxiv_data1/oa_pdf/36/71/main.PMC5477092.pdf
http://dx.doi.org/10.1002/mds.22340 .L.J.,Non-OADS,/arxiv_data1/oa_pdf/36/71/main.PMC5477092.pdf
"NeuroImage 14, 21 –36.http://dx.doi.org/10.1006/nimg.2001.0786 .",OADS,/arxiv_data1/oa_pdf/36/71/main.PMC5477092.pdf
http://dx.doi.org/10.1093/brain/ awv104 .,Non-OADS,/arxiv_data1/oa_pdf/36/71/main.PMC5477092.pdf
http://dx.doi.org/10.1111/acel.12271 .,Non-OADS,/arxiv_data1/oa_pdf/36/71/main.PMC5477092.pdf
http://dx.doi.org/10.1002/ hbm.23081 .,Non-OADS,/arxiv_data1/oa_pdf/36/71/main.PMC5477092.pdf
"27, 8 –30.http://dx.doi.org/10.1002/mds.23795 .",Non-OADS,/arxiv_data1/oa_pdf/36/71/main.PMC5477092.pdf
http://dx.doi.org/10.1007/s00415-011-6187-6 .,Non-OADS,/arxiv_data1/oa_pdf/36/71/main.PMC5477092.pdf
"Brain 137, 12 –32.http://dx.doi.org/10.1093/brain/awt162 .",Non-OADS,/arxiv_data1/oa_pdf/36/71/main.PMC5477092.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/36/71/main.PMC5477092.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/36/71/main.PMC5477092.pdf
http://dx.doi.org/10.1007/s00401-010-0711-0 .,Non-OADS,/arxiv_data1/oa_pdf/36/71/main.PMC5477092.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/36/71/main.PMC5477092.pdf
"6, 10. http://dx.doi.org/10.3389/fninf.2012.00010 .",Non-OADS,/arxiv_data1/oa_pdf/36/71/main.PMC5477092.pdf
"NeuroImage 44, 83 –98.http://dx.doi.org/10.1016/j.neuroimage.2008.03.061 .",OADS,/arxiv_data1/oa_pdf/36/71/main.PMC5477092.pdf
http://dx.doi.org/10.1016/j.neuroimage.2004.07.,OADS,/arxiv_data1/oa_pdf/36/71/main.PMC5477092.pdf
http://dx.doi.org/10.1523/ JNEUROSCI.2261-13.2013 .,Non-OADS,/arxiv_data1/oa_pdf/36/71/main.PMC5477092.pdf
http://dx.doi.org/10.1212/WNL.0000000000001737 .,Non-OADS,/arxiv_data1/oa_pdf/36/71/main.PMC5477092.pdf
http://dx.doi.org/10.1002/mds.23429 .,Non-OADS,/arxiv_data1/oa_pdf/36/71/main.PMC5477092.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/71/main.PMC5477092.pdf
http://dx.doi.org/10.1212/WNL.0000000000000087 .,Non-OADS,/arxiv_data1/oa_pdf/36/71/main.PMC5477092.pdf
"25, 39 –44.http://dx.doi.org/10.1016/j.parkreldis.2016 .",OADS,/arxiv_data1/oa_pdf/36/71/main.PMC5477092.pdf
http://dx.doi.org/10.1111/j.1600-0447.1983.,Non-OADS,/arxiv_data1/oa_pdf/36/71/main.PMC5477092.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d1/2f/ccide-9-039.PMC5477166.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d1/2f/ccide-9-039.PMC5477166.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).",Non-OADS,/arxiv_data1/oa_pdf/d1/2f/ccide-9-039.PMC5477166.pdf
"6 Quartz–tungsten–halogen (QTH) curing  unit has been extensively used for a long time; however, light-emitting diode (LED) Correspondence: Flávio henrique Baggio  aguiarDepartment of restorative Dentistry, Piracicaba Dental school, University of Campinas, avenida limeira, 901, areião, PO Box 52, 13414-903 Piracicaba, sP, BrazilTel +55 19 2106 5337Fax +55 19 3421 0144email aguiar@fop.unicamp.brJournal name:  Clinical, Cosmetic and Investigational Dentistry Article Designation: Original ResearchY ear: 2017V olume: 9Running head verso: Theobaldo et alRunning head recto: Preheating of bulk fill compositeDOI: http://dx.doi.org/10.2147/CCIDE.S130803",Non-OADS,/arxiv_data1/oa_pdf/d1/2f/ccide-9-039.PMC5477166.pdf
" Clinical, Cosmetic and Investigational Dentistry 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress  Clinical, Cosmetic and Investigational Dentistry Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-cosmetic-and-investigational-dentistry-journalClinical, Cosmetic and Investigational Dentistry is an international,   peer-reviewed, open access, online journal focusing on the latest clini- cal and experimental research in dentistry with specific emphasis on cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/d1/2f/ccide-9-039.PMC5477166.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/d1/2f/ccide-9-039.PMC5477166.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/41/9e/ccide-9-027.PMC5477167.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/41/9e/ccide-9-027.PMC5477167.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).",Non-OADS,/arxiv_data1/oa_pdf/41/9e/ccide-9-027.PMC5477167.pdf
"10,11 Direct resin materials are the materials of first choice to restore  anterior and posterior teeth.11,12 The present case report discusses the management of asymmetric smile associated  with unsatisfactory extensive composite restorations and describes a clinical protocol Correspondence: Flávio Henrique Baggio  AguiarDepartment of Restorative Dentistry, Piracicaba Dental School, PO Box 52, University of Campinas – UNICAMP, 13414-13903, Piracicaba, SP, BrazilTel +55 19 2101 5340Email aguiar@fop.unicamp.brJournal name:  Clinical, Cosmetic and Investigational Dentistry Article Designation: CASE REPORTY ear: 2017V olume: 9Running head verso: Gouveia et alRunning head recto: Esthetic smile rehabilitation: a case reportDOI: http://dx.doi.org/10.2147/CCIDE.S130698",Non-OADS,/arxiv_data1/oa_pdf/41/9e/ccide-9-027.PMC5477167.pdf
" Clinical, Cosmetic and Investigational Dentistry 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress  Clinical, Cosmetic and Investigational Dentistry Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-cosmetic-and-investigational-dentistry-journalClinical, Cosmetic and Investigational Dentistry is an international,   peer-reviewed, open access, online journal focusing on the latest clini- cal and experimental research in dentistry with specific emphasis on cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/41/9e/ccide-9-027.PMC5477167.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/41/9e/ccide-9-027.PMC5477167.pdf
Graphical abstract This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/c6/nihms868519.PMC5477225.pdf
*Correspondence: erk5@columbia.edu.6Co-first author Supplemental Information: Supplemental Information includes Supplemental Experimental Procedures and four figures and can be  found with this article online at http://dx.doi.org/10.1016/j.celrep.2015.04.061 .,Non-OADS,/arxiv_data1/oa_pdf/dd/c6/nihms868519.PMC5477225.pdf
Available from: https://www.nytimes.com/2015/06/02/ upshot/to-be-sued-less-doctors-should-talk-to-patients-more.html?_ r=0.,Non-OADS,/arxiv_data1/oa_pdf/21/cd/IJEM-21-489.PMC5477430.pdf
Available from: http://www.rchiips.org/NFHS/ districtfactsheet_NFHS-4.shtml.,Non-OADS,/arxiv_data1/oa_pdf/06/58/IJEM-21-492.PMC5477431.pdf
Available from: http://www.omicsgroup.com/conferences/ nursing-emergencymedicine-2013.,Non-OADS,/arxiv_data1/oa_pdf/e4/f0/IJEM-21-524.PMC5477438.pdf
Available from: http://www.who.int/chp/topics/ Osteoporosis.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c9/73/IJEM-21-535.PMC5477440.pdf
Available from: http://www.mmatsuda.,Non-OADS,/arxiv_data1/oa_pdf/14/fd/IJEM-21-540.PMC5477441.pdf
Available from: http://www.who.int/mental_ health/media/en/76.pdf?ua=1.,Non-OADS,/arxiv_data1/oa_pdf/b1/51/IJEM-21-564.PMC5477445.pdf
Available from: http://www.who.int/healthinfo/global_ burden_disease/estimates_regional_2002_revised/en/.,Non-OADS,/arxiv_data1/oa_pdf/b1/51/IJEM-21-564.PMC5477445.pdf
Available from: http://www.tbcindia.nic.in/pdfs/ TB%20India%202012-%20Annual%20Report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6f/d1/IJEM-21-570.PMC5477446.pdf
Available from: http://www.un.org/esa/population/ publications/wpp2006/WPP2006-Highlights-rev.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6f/d1/IJEM-21-570.PMC5477446.pdf
Available from:  http://www.thelancet.com/diabetes-endocrinology.,Non-OADS,/arxiv_data1/oa_pdf/6f/d1/IJEM-21-570.PMC5477446.pdf
Available from: http://www.uttarkashi.nic.in/Dept/ Health/RNTCP/RNTCP.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6f/d1/IJEM-21-570.PMC5477446.pdf
Available from: http://www.who.int/mediacentre/ factsheets/fs104/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/6f/d1/IJEM-21-570.PMC5477446.pdf
Available from:   https://www.psoriasis.org/document.doc?id=354.,Non-OADS,/arxiv_data1/oa_pdf/1f/41/IJEM-21-581.PMC5477448.pdf
Available from: http://www.accessdata.fda.gov/drugsatfda_docs/ label/2016/008085s066lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1f/41/IJEM-21-581.PMC5477448.pdf
Available from: http://www.wpro.who.int/nutrition/documents/docs/ Redefiningobesity.pdf.,Non-OADS,/arxiv_data1/oa_pdf/14/4a/IJEM-21-588.PMC5477449.pdf
Available from:   http://www.who.int/mediacentre/factsheets/fs363/en/.,Non-OADS,/arxiv_data1/oa_pdf/14/4a/IJEM-21-588.PMC5477449.pdf
Available from: http://www.apps.who.,Non-OADS,/arxiv_data1/oa_pdf/e9/ea/IJEM-21-600.PMC5477451.pdf
Available from: http://www.bd.com/us/diabetes/page.,Non-OADS,/arxiv_data1/oa_pdf/e9/ea/IJEM-21-600.PMC5477451.pdf
Available from:  http://www.bit.ly/2bmZKu7.,Non-OADS,/arxiv_data1/oa_pdf/e9/ea/IJEM-21-600.PMC5477451.pdf
Available from: http://www.fit4diabetes.com.,Non-OADS,/arxiv_data1/oa_pdf/e9/ea/IJEM-21-600.PMC5477451.pdf
Available from: http://www.bd.com/ us/diabetes/page.aspx?cat=7001 and id=7253.,Non-OADS,/arxiv_data1/oa_pdf/e9/ea/IJEM-21-600.PMC5477451.pdf
Available from: http://www.bd.com/ us/diabetes/page.aspx?cat=7001 and id=32371.,Non-OADS,/arxiv_data1/oa_pdf/e9/ea/IJEM-21-600.PMC5477451.pdf
Available from: http://www.products.,Non-OADS,/arxiv_data1/oa_pdf/e9/ea/IJEM-21-600.PMC5477451.pdf
Available  from: http://www.fit4diabetes.com/files/1413/4727/6994/BD4224_ FIT_Safety_STG07_AW2_PP.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e9/ea/IJEM-21-600.PMC5477451.pdf
Available  from: http://www.nacoonline.org/upload/NGO%20 and %20Targeted/ waste%20disposal%20recommendations%20for%20IDU%20TI.,Non-OADS,/arxiv_data1/oa_pdf/e9/ea/IJEM-21-600.PMC5477451.pdf
Available from:  https://www.va.gov/oig/pubs/V AOIG-13-01320-200.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e9/ea/IJEM-21-600.PMC5477451.pdf
Available from: http://www.apiindia.org/medicine_update_2013/ chap51.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c0/62/IJEM-21-618.PMC5477452.pdf
Available from:  http://www.healio.com/cardiology/diabetes/news/print/ cardiology-today/%7B35b140d2-5a1f-4cbc-a6fb-b4f1114df4b4%7D/ use-of-metformin-in-patients-with-diabetes-and-hf.,Non-OADS,/arxiv_data1/oa_pdf/c0/62/IJEM-21-618.PMC5477452.pdf
Available from: http://icmr.nic.in/guidelines_ diabetes/guide_diabetes.htm.,Non-OADS,/arxiv_data1/oa_pdf/c0/62/IJEM-21-618.PMC5477452.pdf
"Available from: http://www.accessdata.fda.gov/drugsatfda_docs/ label/2008/020357s031,021202s016lbl.pdf.",Non-OADS,/arxiv_data1/oa_pdf/c0/62/IJEM-21-618.PMC5477452.pdf
Available from: http://www.accessdata.fda.,OADS,/arxiv_data1/oa_pdf/c0/62/IJEM-21-618.PMC5477452.pdf
Available from: http://www.accessdata.fda.,OADS,/arxiv_data1/oa_pdf/c0/62/IJEM-21-618.PMC5477452.pdf
Available from: http://www.accessdata.fda.gov/ drugsatfda_docs/label/2013/017532Orig1s034lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c0/62/IJEM-21-618.PMC5477452.pdf
Available from: http://www.accessdata.fda.gov/drugsatfda_docs/ label/2011/021073s043s044lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c0/62/IJEM-21-618.PMC5477452.pdf
Available from:  https://www.clinicaltrials.gov/ct2/show/NCT00829660.,Non-OADS,/arxiv_data1/oa_pdf/c0/62/IJEM-21-618.PMC5477452.pdf
Available  from: https://www.clinicaltrials.gov/ct2/show/NCT01897532.,Non-OADS,/arxiv_data1/oa_pdf/c0/62/IJEM-21-618.PMC5477452.pdf
Available from: http://www.fda.gov/downloads/Drugs/ DevelopmentApprovalProcess/UCM071436.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c0/62/IJEM-21-618.PMC5477452.pdf
Available from: http://www.ema.europa.eu/docs/en_GB/document_ library/EPAR_-_Product_Information/human/002677/WC500168592.,Non-OADS,/arxiv_data1/oa_pdf/c0/62/IJEM-21-618.PMC5477452.pdf
Available  from: https://www.clinicaltrials.gov/ct2/show/NCT01730534.,Non-OADS,/arxiv_data1/oa_pdf/c0/62/IJEM-21-618.PMC5477452.pdf
Available from: https://www.clinicaltrials.gov/ct2/show/ NCT02065791.,Non-OADS,/arxiv_data1/oa_pdf/c0/62/IJEM-21-618.PMC5477452.pdf
Available from: https://www.clinicaltrials.gov/ct2/ show/NCT01032629.,Non-OADS,/arxiv_data1/oa_pdf/c0/62/IJEM-21-618.PMC5477452.pdf
Available from: https://www.clinicaltrials.gov/ ct2/show/NCT01989754.,Non-OADS,/arxiv_data1/oa_pdf/c0/62/IJEM-21-618.PMC5477452.pdf
Available  from: https://www.novonordisk.com/bin/getPDF.1991879.pdf.,OADS,/arxiv_data1/oa_pdf/c0/62/IJEM-21-618.PMC5477452.pdf
Available from: https://www.clinicaltrials.gov/ ct2/show/NCT01394952.,Non-OADS,/arxiv_data1/oa_pdf/c0/62/IJEM-21-618.PMC5477452.pdf
Available from: https://www.clinicaltrials.gov/ct2/show/ NCT01144338.,Non-OADS,/arxiv_data1/oa_pdf/c0/62/IJEM-21-618.PMC5477452.pdf
Available from: https://www.clinicaltrials.,Non-OADS,/arxiv_data1/oa_pdf/c0/62/IJEM-21-618.PMC5477452.pdf
Available from: http://www.accessdata.fda.gov/drugsatfda_docs/ label/2015/020986s082lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c0/62/IJEM-21-618.PMC5477452.pdf
Available from: http://www.accessdata.fda.gov/drugsatfda_docs/ label/2015/203313lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c0/62/IJEM-21-618.PMC5477452.pdf
Available from:  http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/203314lbl.,Non-OADS,/arxiv_data1/oa_pdf/c0/62/IJEM-21-618.PMC5477452.pdf
Available from: http://www.emedicine.medscape.com/Pandora’s Box: Neurological Manifestations of  Hypoparathyroidism,Non-OADS,/arxiv_data1/oa_pdf/82/47/IJEM-21-638.PMC5477458.pdf
Available  from: https://www.idf.org/sites/default/files/Diabetes%20in%20the%20 Young_1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4a/55/IJEM-21-642.PMC5477462.pdf
Available  from: https://www.idf.org/sites/default/files/Diabetes%20in%20the%20 Young_1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e9/b4/IJEM-21-643.PMC5477463.pdf
The national plan for preventing Flu pandemics (1430-2009) Available from: http://www.health.moh.gov.sa/swine/na tionalplan.pdf 16.,Non-OADS,/arxiv_data1/oa_pdf/93/82/idr-9-2-6930.PMC5477470.pdf
Available from: http://www.gulfnews.com/nation/Healt h/10347706.html 17.,Non-OADS,/arxiv_data1/oa_pdf/93/82/idr-9-2-6930.PMC5477470.pdf
Available from: http://www.msal.gob.ar/sida/index.php/ publicaciones/boletines-sobre-vih-sida.,Non-OADS,/arxiv_data1/oa_pdf/28/69/idr-9-2-7017.PMC5477474.pdf
Available from: http://www.APRegistry.com.,Non-OADS,/arxiv_data1/oa_pdf/28/69/idr-9-2-7017.PMC5477474.pdf
Available from: http://aidsinfo.nih.gov/content- files/lvguidelines/PerinatalGL.pdf.,OADS,/arxiv_data1/oa_pdf/28/69/idr-9-2-7017.PMC5477474.pdf
Available from: http://sadi.org.ar/publicaciones-de-las- comisiones/item/233-consenso-argenti- no-tarv-2014-draft.,Non-OADS,/arxiv_data1/oa_pdf/28/69/idr-9-2-7017.PMC5477474.pdf
Available from: http://www.euro.who.int/en/health-topics/Health-systems/pub- lic-health-services.,Non-OADS,/arxiv_data1/oa_pdf/a7/da/jphr-6-1-819.PMC5477476.pdf
Use of published material is allowed under the following terms and conditions:  https://creativecommons.org/licenses/by-nc/4.0/legalcode.,Non-OADS,/arxiv_data1/oa_pdf/e1/0e/1020809.PMC5477599.pdf
"Sharing published material for non-commercial pur-poses is subject to the following conditions:  https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect.",Non-OADS,/arxiv_data1/oa_pdf/e1/0e/1020809.PMC5477599.pdf
Use of published material is allowed under the following terms and conditions:  https://creativecommons.org/licenses/by-nc/4.0/legalcode.,Non-OADS,/arxiv_data1/oa_pdf/41/76/1020826.PMC5477601.pdf
"Sharing published material for non-commercial pur-poses is subject to the following conditions: https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect.",Non-OADS,/arxiv_data1/oa_pdf/41/76/1020826.PMC5477601.pdf
Use of published material is allowed under the following terms and conditions:  https://creativecommons.org/licenses/by-nc/4.0/legalcode.,Non-OADS,/arxiv_data1/oa_pdf/8a/8c/1020835.PMC5477602.pdf
"Sharing published material for non-commercial pur-poses is subject to the following conditions:  https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect.",Non-OADS,/arxiv_data1/oa_pdf/8a/8c/1020835.PMC5477602.pdf
Use of published material is allowed under the following terms and conditions:  https://creativecommons.org/licenses/by-nc/4.0/legalcode.,Non-OADS,/arxiv_data1/oa_pdf/c8/b8/1020843.PMC5477603.pdf
"Sharing published material for non-commercial pur-poses is subject to the following conditions:  https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect.",Non-OADS,/arxiv_data1/oa_pdf/c8/b8/1020843.PMC5477603.pdf
Use of published material is allowed under the following terms and conditions:  https://creativecommons.org/licenses/by-nc/4.0/legalcode.,Non-OADS,/arxiv_data1/oa_pdf/76/34/1020854.PMC5477604.pdf
"Sharing published material for non-commercial pur-poses is subject to the following conditions: https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect.",Non-OADS,/arxiv_data1/oa_pdf/76/34/1020854.PMC5477604.pdf
Use of published material is allowed under the following terms and conditions:  https://creativecommons.org/licenses/by-nc/4.0/legalcode.,Non-OADS,/arxiv_data1/oa_pdf/02/04/1020865.PMC5477605.pdf
"Sharing published material for non-commercial pur-poses is subject to the following conditions:  https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect.",Non-OADS,/arxiv_data1/oa_pdf/02/04/1020865.PMC5477605.pdf
Use of published material is allowed under the following terms and conditions:  https://creativecommons.org/licenses/by-nc/4.0/legalcode.,Non-OADS,/arxiv_data1/oa_pdf/b2/24/1020874.PMC5477606.pdf
"Sharing published material for non-commercial pur-poses is subject to the following conditions: https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect.",Non-OADS,/arxiv_data1/oa_pdf/b2/24/1020874.PMC5477606.pdf
Use of published material is allowed under the following terms and conditions:  https://creativecommons.org/licenses/by-nc/4.0/legalcode.,Non-OADS,/arxiv_data1/oa_pdf/a3/e3/1020895.PMC5477608.pdf
"Sharing published material for non-commercial pur-poses is subject to the following conditions:  https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect.",Non-OADS,/arxiv_data1/oa_pdf/a3/e3/1020895.PMC5477608.pdf
Available at: http://seer.cancer.gov/csr/1975_2012/(Accessed July 2015).,Non-OADS,/arxiv_data1/oa_pdf/a3/e3/1020895.PMC5477608.pdf
"October 2014, Revision 17.Available at: http://www.velcade.com/files/ PDFs/VELCADE_PRESCRIBING_INFOR- MATION.pdf  (Accessed July 2015).",Non-OADS,/arxiv_data1/oa_pdf/a3/e3/1020895.PMC5477608.pdf
List of approved products FY 2015. https://www.pmda.go.jp/ files/000208993.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a3/e3/1020895.PMC5477608.pdf
Use of  published material is allowed under the following terms and  conditions:  https://creativecommons.org/licenses/by-nc/4.0/legalcode.,Non-OADS,/arxiv_data1/oa_pdf/94/24/1020903.PMC5477609.pdf
"Sharing published material for non-commercial pur - poses is subject to the following conditions:  https://creativecommons.org/licenses/by-nc/4.0/legalcode,  sect.",Non-OADS,/arxiv_data1/oa_pdf/94/24/1020903.PMC5477609.pdf
Use of published material is allowed under the following terms and conditions:  https://creativecommons.org/licenses/by-nc/4.0/legalcode.,Non-OADS,/arxiv_data1/oa_pdf/12/1e/1020910.PMC5477610.pdf
"Sharing published material for non-commercial pur-poses is subject to the following conditions: https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect.",Non-OADS,/arxiv_data1/oa_pdf/12/1e/1020910.PMC5477610.pdf
Available from: http://www.myeloma- comorbidityindex.org/de_main.html 35.,Non-OADS,/arxiv_data1/oa_pdf/12/1e/1020910.PMC5477610.pdf
Use of  published material is allowed under the following terms and  conditions:  https://creativecommons.org/licenses/by-nc/4.0/legalcode.,Non-OADS,/arxiv_data1/oa_pdf/26/51/1020922.PMC5477611.pdf
"Sharing published material for non-commercial pur - poses is subject to the following conditions:  https://creativecommons.org/licenses/by-nc/4.0/legalcode,  sect.",Non-OADS,/arxiv_data1/oa_pdf/26/51/1020922.PMC5477611.pdf
Use of published material is allowed under the following terms and conditions:  https://creativecommons.org/licenses/by-nc/4.0/legalcode.,Non-OADS,/arxiv_data1/oa_pdf/ad/20/1020932.PMC5477612.pdf
"Sharing published material for non-commercial pur-poses is subject to the following conditions: https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect.",Non-OADS,/arxiv_data1/oa_pdf/ad/20/1020932.PMC5477612.pdf
Use of  published material is allowed under the following terms and  conditions:  https://creativecommons.org/licenses/by-nc/4.0/legalcode.,Non-OADS,/arxiv_data1/oa_pdf/34/43/1020941.PMC5477613.pdf
"Sharing published material for non-commercial pur - poses is subject to the following conditions:  https://creativecommons.org/licenses/by-nc/4.0/legalcode,  sect.",Non-OADS,/arxiv_data1/oa_pdf/34/43/1020941.PMC5477613.pdf
Use of  published material is allowed under the following terms and  conditions:  https://creativecommons.org/licenses/by-nc/4.0/legalcode.,Non-OADS,/arxiv_data1/oa_pdf/27/8e/1020948.PMC5477614.pdf
"Sharing published material for non-commercial pur - poses is subject to the following conditions:  https://creativecommons.org/licenses/by-nc/4.0/legalcode,  sect.",Non-OADS,/arxiv_data1/oa_pdf/27/8e/1020948.PMC5477614.pdf
Use of  published material is allowed under the following terms and  conditions:  https://creativecommons.org/licenses/by-nc/4.0/legalcode.,Non-OADS,/arxiv_data1/oa_pdf/cf/4a/1020958.PMC5477615.pdf
"Sharing published material for non-commercial pur - poses is subject to the following conditions:  https://creativecommons.org/licenses/by-nc/4.0/legalcode,  sect.",Non-OADS,/arxiv_data1/oa_pdf/cf/4a/1020958.PMC5477615.pdf
Nuisance variables for motion were computed with the Artifact Detection Tool (http://www.nitrc.org/projects/ artifact_detect/ ) and entered in the general linear model (see what follows).,OADS,/arxiv_data1/oa_pdf/a4/63/i1534-7362-17-6-10.PMC5477629.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by- nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/77/9f/main.PMC5477635.pdf
A complete listing of ADNI inves- tigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/ how_to_apply/ADNI_Acknowledgement_List.pdf .,OADS,/arxiv_data1/oa_pdf/77/9f/main.PMC5477635.pdf
E-mail address: dmatthews@admdx.com http://dx.doi.org/10.1016/j.trci.2016.02.004 2352-8737/ /C2112016 ADM Diagnostics.,OADS,/arxiv_data1/oa_pdf/77/9f/main.PMC5477635.pdf
This is an open access article under the CC BY-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/77/9f/main.PMC5477635.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.trci.2016.02.004 .,OADS,/arxiv_data1/oa_pdf/77/9f/main.PMC5477635.pdf
Available at: https://www.researchgate.,Non-OADS,/arxiv_data1/oa_pdf/77/9f/main.PMC5477635.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Clemens T , Michelsen K, Brand H. Supporting health systems in Europe: added value of EU actions?",Non-OADS,/arxiv_data1/oa_pdf/2c/8a/bmjqs-2016-005567.PMC5477662.pdf
http://www.gov.uk/government/news/nursing-associate-role-offers-new-route-into-nursing(accessed 25 Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/2c/8a/bmjqs-2016-005567.PMC5477662.pdf
"http://webarchive.nationalarchives.gov.uk/ 20150407084003/; http://www.midstaffspublicinquiry .com/report (accessed 25 Jan 2016), 2013.",Non-OADS,/arxiv_data1/oa_pdf/2c/8a/bmjqs-2016-005567.PMC5477662.pdf
"http://www.nhs.uk/nhsengland/bruce-keogh-review/documents/outcomes/keogh-review-final-report.pdf (accessed 25 Jan 2016),2013.",Non-OADS,/arxiv_data1/oa_pdf/2c/8a/bmjqs-2016-005567.PMC5477662.pdf
http://health.gov.ie/future-health/office-of-chief-nursing-officer/taskforce-on-staffing-and-skill-mix-for-nursing/ (accessed 15 Oct 2014).,Non-OADS,/arxiv_data1/oa_pdf/2c/8a/bmjqs-2016-005567.PMC5477662.pdf
"NICE, 2014: http://www.nice.org.uk/guidance/sg1 (accessed 19Aug 2015).",Non-OADS,/arxiv_data1/oa_pdf/2c/8a/bmjqs-2016-005567.PMC5477662.pdf
"http://www.euro.who.int/en/health-topics/Health-systems/nursing-and-midwifery/data-and-statistics (accessed 25 Jan 2016), 2016.",Non-OADS,/arxiv_data1/oa_pdf/2c/8a/bmjqs-2016-005567.PMC5477662.pdf
"NHS Surveys: UK http://www.nhssurveys.org/survey/1017 (accessed 31 Jan 2016], 2011.",Non-OADS,/arxiv_data1/oa_pdf/2c/8a/bmjqs-2016-005567.PMC5477662.pdf
"https://www.cms.gov/ Medicare/Quality-Initiatives-Patient-Assessment-instruments/ HospitalQualityInits/HospitalHCAHPS.html (accessed29 Jan 2016), 2014.",Non-OADS,/arxiv_data1/oa_pdf/2c/8a/bmjqs-2016-005567.PMC5477662.pdf
"Leuven: KU Leuven.http://www.nivel.nl/en/cc4hca (accessed 10 Jul 2016), 2014.46 Lake ET .",Non-OADS,/arxiv_data1/oa_pdf/2c/8a/bmjqs-2016-005567.PMC5477662.pdf
"London: BBC, 2016. http://www.bbc.com/news/ uk-england-london-35242993 (accessed 25 Jan 2016).",Non-OADS,/arxiv_data1/oa_pdf/2c/8a/bmjqs-2016-005567.PMC5477662.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/6b/main.PMC5477669.pdf
Production and Hosting by Elsevier on behalf of KeAi http://dx.doi.org/10.1016/j.wjorl.2016.05.007 2095-8811/Copyright ª2016 Chinese Medical Association.,Non-OADS,/arxiv_data1/oa_pdf/04/6b/main.PMC5477669.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/6b/main.PMC5477669.pdf
"Published with license by Taylor & Francis This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not alter ed, transformed, or built upon in any way.ADIPOCYTE 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/c2/e9/kadi-06-02-1304870.PMC5477704.pdf
"2, 102 –111 https://doi.org/10.1080/21623945.2017.1304870",Non-OADS,/arxiv_data1/oa_pdf/c2/e9/kadi-06-02-1304870.PMC5477704.pdf
Metabolism 1980; 29:333-9; PMID:7374443; https://doi.org/10.1016/0026- 0495(80)90006-2110 E. D. TESTROET ET AL.,OADS,/arxiv_data1/oa_pdf/c2/e9/kadi-06-02-1304870.PMC5477704.pdf
"J Anim Sci 1986; 62:980-91; PMID:3519556; https://doi.org/10.2527/jas1986.624980x [6] Jo J, Gavrilova O, Pack S, Jou W, Mullen W, Sumner A E ,C u s h m a nS W ,P e r i w a lV .H y p e r t r o p h ya n d / o rhyperplasia: dynamics of adipose tissue growth.",Non-OADS,/arxiv_data1/oa_pdf/c2/e9/kadi-06-02-1304870.PMC5477704.pdf
"Plos Comp Biol 2009; 5:1-11; https://doi.org/10.1371/ journal.pcbi.1000324 [7] Rogers KL, Etherton TD, Kris-Etherton PM.",OADS,/arxiv_data1/oa_pdf/c2/e9/kadi-06-02-1304870.PMC5477704.pdf
"Br J Clin Pharmac 1989; 28:655-62; https://doi.org/10.1111/j.1365- 2125.1989.tb03558.x [11] Hirsch J, Gallian E. Methods for the determination of adipose cell size in man and animals.",Non-OADS,/arxiv_data1/oa_pdf/c2/e9/kadi-06-02-1304870.PMC5477704.pdf
"Ann Stat 1985; 13:70-84; https://doi.org/10.1214/aos/1176346577 [15] Hausman GJ, Dodson MV, Ajuwon K, Azain M, Barnes KM, Guan LL, Jiang Z, Poulous SP, Sainz RD, Smith S,et al.",OADS,/arxiv_data1/oa_pdf/c2/e9/kadi-06-02-1304870.PMC5477704.pdf
"J Anim Sci 2009; 87:1218-46; PMID:18849378; https://doi.org/10.2527/jas.2008-1427 [16] Wang QA, Scherer PE, Gupta RK.",OADS,/arxiv_data1/oa_pdf/c2/e9/kadi-06-02-1304870.PMC5477704.pdf
"J Lipid Res 2014; 55:605-20;PMID:24532650; https://doi.org/10.1194/jlr.R046441 [17] Sun K, Kusminski CM, Scherer PE.",OADS,/arxiv_data1/oa_pdf/c2/e9/kadi-06-02-1304870.PMC5477704.pdf
"J Clin Invest 2011; 121:2094-101;PMID:21633177; https://doi.org/10.1172/JCI45887[18] Kim JA, van de Wall E, Laplante M, Azzara A, Trujillo ME, Hoffman SM, Schraw T, Durand JL, Li H, Li G, et al.",OADS,/arxiv_data1/oa_pdf/c2/e9/kadi-06-02-1304870.PMC5477704.pdf
"J Clin Invest 2007; 117:2621- 37; PMID:17717599; https://doi.org/10.1172/JCI31021 [19] Kusminski CM, Holland WL, Sun K, Park J, Spurgin SB, Lin Y, Askew GR, Simcox JA, McClain DA, Lai C, et al.",OADS,/arxiv_data1/oa_pdf/c2/e9/kadi-06-02-1304870.PMC5477704.pdf
"Anim Sci J2011; 82:144-9; PMID:21269373; https://doi.org/10.1111/j.1740-0929.2010.00810.x [22] Spalding KL, Arner E, Westermark PO, Bernard S, Bucholz BA, Bergmann O, Blomqvist L, Hoffstedt J,N€aslund E, Britton T, et al.",OADS,/arxiv_data1/oa_pdf/c2/e9/kadi-06-02-1304870.PMC5477704.pdf
"Nature 2008; 435:783-7; https://doi.org/ 10.1038/nature06902 [23] Hirsch J, Han PW.",Non-OADS,/arxiv_data1/oa_pdf/c2/e9/kadi-06-02-1304870.PMC5477704.pdf
Biochem Biphys Res Commun 2013; 430:43-8; https://doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c2/e9/kadi-06-02-1304870.PMC5477704.pdf
"Nature Cell Biol 2015; 17:376-85; PMID:25730471; https://doi.org/10.1038/ncb3122 [27] Kruglikov IL, Scherer PE.",OADS,/arxiv_data1/oa_pdf/c2/e9/kadi-06-02-1304870.PMC5477704.pdf
Exp Dermatol 2016; 25:258-62;PMID:26781768; https://doi.org/10.1111/exd.12941ADIPOCYTE 111,Non-OADS,/arxiv_data1/oa_pdf/c2/e9/kadi-06-02-1304870.PMC5477704.pdf
http://dx.doi.org/10.1016/j.ajur.2016.08.001 2214-3882/ ª2016 Editorial Ofﬁce of Asian Journal of Urology.,Non-OADS,/arxiv_data1/oa_pdf/d7/c0/main.PMC5477778.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/c0/main.PMC5477778.pdf
Oncotarget 2016. http://dx.doi.org/10.18632/onco- target.8493 [Epub ahead of print].,Non-OADS,/arxiv_data1/oa_pdf/d7/c0/main.PMC5477778.pdf
Mol Oncol 2014. http://dx.doi.org/10.1016/j.mo- lonc.2014.10.014 .,OADS,/arxiv_data1/oa_pdf/d7/c0/main.PMC5477778.pdf
"https://doi.org/10.1177/1745499917696425Research in Comparative &   International Education 2017, Vol.",Non-OADS,/arxiv_data1/oa_pdf/08/4a/10.1177_1745499917696425.PMC5477834.pdf
Available at: http://documents.worldbank.org/curated/en/2011/09/15556498/promotion-social- cohesion-through-education-sri-lanka (accessed 1 March 2015).,Non-OADS,/arxiv_data1/oa_pdf/08/4a/10.1177_1745499917696425.PMC5477834.pdf
[E-book] Available at:  http://booksgoogle.com (accessed 12 November  2014).,Non-OADS,/arxiv_data1/oa_pdf/08/4a/10.1177_1745499917696425.PMC5477834.pdf
Available  at: http://www.statistics.gov.lk/PopHouSat/CPH2011/index.php?fileName=pop42&gp=Activities& tpl=3 (accessed 12 January 2015).,OADS,/arxiv_data1/oa_pdf/08/4a/10.1177_1745499917696425.PMC5477834.pdf
Available at: https://educationanddevelopment.wordpress.com/research-projects/sri-lanka-studying- education-for-peacebuilding/ Fraser N (1995) From redistribution to recognition?,Non-OADS,/arxiv_data1/oa_pdf/08/4a/10.1177_1745499917696425.PMC5477834.pdf
"Available at: http://www.oecd.org/countries/srilanka/48885009.pdf  Helbardt S, Hellmann-Rajanayagam D and Korff R (2010) War’s dark glamour: Ethics of research in war and  conflict zones.",Non-OADS,/arxiv_data1/oa_pdf/08/4a/10.1177_1745499917696425.PMC5477834.pdf
Available at: http://educationanddevelopment.files.wordpress.com/2008/04/master-these-ids-sri-lankan-teachers-as-agents-of-peace-cc3a9line-hoeks.pdf Lessons Learnt and Reconciliation Commission (LLRC) (2011) Report on the commission of inquiry on les- sons learnt and reconciliation.,Non-OADS,/arxiv_data1/oa_pdf/08/4a/10.1177_1745499917696425.PMC5477834.pdf
Available at: https://educationanddevelopment.wordpress.com/rp/research-consortium-education-and-peacebuilding/ Novelli M and Smith A (2011) The Role of Education in Peacebuilding: Methodological Framework for  Three Country Case Studies.,Non-OADS,/arxiv_data1/oa_pdf/08/4a/10.1177_1745499917696425.PMC5477834.pdf
Available at:  http://old.himalmag.com/component/content/article/948.html (accessed 12 November 2014).,Non-OADS,/arxiv_data1/oa_pdf/08/4a/10.1177_1745499917696425.PMC5477834.pdf
Available at: http://booksgoogle.com (accessed 23 January 2014).,Non-OADS,/arxiv_data1/oa_pdf/08/4a/10.1177_1745499917696425.PMC5477834.pdf
Available at: http://unesdoc.unesco.org/images/0019/001907/190743e.pdf (accessed 23 February 2017).,Non-OADS,/arxiv_data1/oa_pdf/08/4a/10.1177_1745499917696425.PMC5477834.pdf
Available at: http://www.un.org/News/dh/infocus/Sri_Lanka/The_Internal_Review_Panel_report_on_Sri_Lanka.pdf (accessed 14 January 2014).,Non-OADS,/arxiv_data1/oa_pdf/08/4a/10.1177_1745499917696425.PMC5477834.pdf
Available at: https://www.brookings.edu/wp-content/uploads/2016/06/08- education-agenda-fragile-states-winthrop.pdf World Bank (2014) World Bank Open Data.,Non-OADS,/arxiv_data1/oa_pdf/08/4a/10.1177_1745499917696425.PMC5477834.pdf
"Available at: http://data.worldbank.org  Author biographies Ross Duncan has a postgraduate MSc in International Development with a specialization in Education from the University of Amsterdam, and an undergraduate MA Honours degree in Human Geography and Political Science from the University of Glasgow.",Non-OADS,/arxiv_data1/oa_pdf/08/4a/10.1177_1745499917696425.PMC5477834.pdf
2008. http://www.who.int/csr/mass_gathering/en/print.html (accessed 15 Jul 2016).,Non-OADS,/arxiv_data1/oa_pdf/ea/59/bmjopen-2016-013563.PMC5477837.pdf
23. http://www.moh.gov.sa/Pages/Default.aspx (accessed 20 Sep 2016).24. https://www.srca.org.sa/ (accessed 20 Sep 2016).25.,OADS,/arxiv_data1/oa_pdf/ea/59/bmjopen-2016-013563.PMC5477837.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/77/main.PMC5477840.pdf
Contents lists available at ScienceDirect Contemporary Clinical Trials Communications journal homepage: www.elsevier.com/locate/conctc http://dx.doi.org/10.1016/j.conctc.2017.02.003 2451-8654/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/77/main.PMC5477840.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Contemporary Clinical Trials Communications 6 (2017) 1 e8,Non-OADS,/arxiv_data1/oa_pdf/c1/77/main.PMC5477840.pdf
http://www.genetests.org Received for publication: 12.9.07 Accepted in revised form: 27.9.07 C/circlecopyrtThe Author [2008].,OADS,/arxiv_data1/oa_pdf/2f/c9/sfm005.PMC5477856.pdf
"http://www.cdc.gov/brfss/ (11 August, 2008) 2.",Non-OADS,/arxiv_data1/oa_pdf/8d/a9/sfn131.PMC5477869.pdf
http://www.fosrenol.com Received for publication: 22.7.08 Accepted in revised form: 1.8.08,Non-OADS,/arxiv_data1/oa_pdf/61/94/sfn137.PMC5477872.pdf
UK Renal Registry Report 2006 (Chapter 4) [http://www.renalreg.,Non-OADS,/arxiv_data1/oa_pdf/01/e9/sfm046.PMC5477906.pdf
"[http://www.dh.gov.uk/assetRoot/04/10/26/80/ 04102680.pdf], 2005 7.",Non-OADS,/arxiv_data1/oa_pdf/01/e9/sfm046.PMC5477906.pdf
"[http://www.dh.gov.uk/en/Publicationsandstatistics/ Publications/PublicationsPolicyAndGuidance/DH_4006522], 1999 10.",Non-OADS,/arxiv_data1/oa_pdf/01/e9/sfm046.PMC5477906.pdf
http://www.dailytimes.com.pk/default.asp?page=2007\05\23\story_23-5-2007_pg3_1 (Accessed on 24 May 2007) 4.,Non-OADS,/arxiv_data1/oa_pdf/f6/70/sfn009.PMC5477914.pdf
http://www.heartfile.org/pdf/OTB.pdf (Accessed on 10 September 2007) 6.,Non-OADS,/arxiv_data1/oa_pdf/f6/70/sfn009.PMC5477914.pdf
The ERA-EDTA Registry (http://www.era-edta-reg.org) collects individual and aggregated data from national and/or regional renal registries in Europe and countries border- ing the Mediterranean Sea.,OADS,/arxiv_data1/oa_pdf/c0/3d/sfp127.PMC5477935.pdf
Indicators on these goals are currently being monitored (http://www.ep.niddk.nih.gov/Divisions/kuh/kidneyHP2010.,Non-OADS,/arxiv_data1/oa_pdf/c0/3d/sfp127.PMC5477935.pdf
"Available at: http://epp.eurostat.ec.europa.eu/portal/ page/portal/population/data/main_tables (1 February 2010, datelast accessed).",OADS,/arxiv_data1/oa_pdf/1f/c8/sfq059.PMC5477971.pdf
"Concentrations and associated summary statistics for the most fre- quently sampled job categories (process technician,pipefitter/welder, machinist, and laboratory techni- cian) are shown in Table 3; data for all non-task sam- ples are shown in Supplemental Table 1 (Available online at: http://tih.sagepub.com/content/by/supple- mental-data).",OADS,/arxiv_data1/oa_pdf/12/86/10.1177_0748233715619072.PMC5477978.pdf
Complete task data and summary statistics for task samples representing 24 separate task bins are summarized in Supplemental Table 2 (Avaliable online at: http://tih.sagepub.com/ content/by/supplemental-data).,OADS,/arxiv_data1/oa_pdf/12/86/10.1177_0748233715619072.PMC5477978.pdf
Analysis of the non-task benzene samples indi- cated that 57 %had benzene air concentrations below the limit of detection (Table 3; Supplemental Table 1 (Available online at: http://tih.sagepub.com/content/ by/supplemental-data)).,OADS,/arxiv_data1/oa_pdf/12/86/10.1177_0748233715619072.PMC5477978.pdf
"Overall, the results from the analysis of the task-level data indicate that tasks that require opening of equipment containing liquid process streams, such as blinding and breaking, equipment cleaning and repair, and equipment preparation gener- ally have higher air concentrations than those where direct contact is minimal (Table 4; Supplemental Table 2 (Available online at: http://tih.sagepub.com/ content/by/supplemental-data)).",OADS,/arxiv_data1/oa_pdf/12/86/10.1177_0748233715619072.PMC5477978.pdf
"creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Journal of the Royal Society of Medicine Cardiovascular Disease 6: 1–11 !The Author(s) 2017 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/2048004017712862 journals.sagepub.com/home/cvd",Non-OADS,/arxiv_data1/oa_pdf/20/e5/10.1177_2048004017712862.PMC5477995.pdf
Supplemental Material The supplemental materials are available at http://journals.sagepub .com/doi/suppl/10.1177/1932296816668877.,Non-OADS,/arxiv_data1/oa_pdf/5f/98/10.1177_1932296816668877.PMC5478028.pdf
Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206538s000lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5f/98/10.1177_1932296816668877.PMC5478028.pdf
Available at http://www.hc-sc.gc.ca/dhp-mps/prodpharma/rds- sdr/drug-med/rds_sdr_toujeo_173316-eng.php.,Non-OADS,/arxiv_data1/oa_pdf/5f/98/10.1177_1932296816668877.PMC5478028.pdf
Available at: https://www.tga.gov.au/artg/artg- id-223457.,Non-OADS,/arxiv_data1/oa_pdf/5f/98/10.1177_1932296816668877.PMC5478028.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.ASTROBIOLOGY Volume 17, Number 4, 2017Mary Ann Liebert, Inc.DOI: 10.1089/ast.2016.1627 363",Non-OADS,/arxiv_data1/oa_pdf/33/e3/ast.2016.1627.PMC5478115.pdf
"Ad- ditionally, all attendees at the workshop (complete abstractauthor list available at http://www.hou.usra.edu/meetings/ biosignature2016/authorindex.cfm) provided signiﬁcant mate- rial and discussion that have formed the basis of this work.",Non-OADS,/arxiv_data1/oa_pdf/33/e3/ast.2016.1627.PMC5478115.pdf
"Available online at http://astrobiology.nasa.gov/uploads/ ﬁler_public/01/28/01283266-e401-4dcb-8e05-3918b21edb79/ nasa_astrobiology_strategy_2015_151008.pdf Hecht, M.H., Kounaves, S.P., Quinn, R.C., West, S.J., Young, S.M., Ming, D.W., Catling, D.C., Clark, B.C., Boynton, W.V., Hoff- man, J., Deﬂores, L.P., Gospodinova, K., Kapit, J., and Smith, P.H.",Non-OADS,/arxiv_data1/oa_pdf/33/e3/ast.2016.1627.PMC5478115.pdf
"(2013) Report of the Mars 2020 Science Deﬁnition Team, posted July 1, 2013, by the Mars Exploration Program Analysis Group (MEPAG) at http://mepag.jpl.nasa.gov/reports/ MEP/Mars_2020_SDT_Report_Final.pdf Naeem, S., Hahn, D.R., and Schuurman, G. (2000) Producer- decomposer co-dependency inﬂuences biodiversity effects.",OADS,/arxiv_data1/oa_pdf/33/e3/ast.2016.1627.PMC5478115.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/91/25/ccid-10-195.PMC5478159.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/91/25/ccid-10-195.PMC5478159.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical, Cosmetic and Investigational Dermatology 2017:10 195–198Clinical, Cosmetic and Investigational Dermatology Dovepress submit your manuscript | www.dovepress.com Dovepress 195 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S133966 Severe atypical herpes zoster as an initial  symptom of fatal myelodysplastic syndrome with  refractory anemia and blast excess (RAEB II) Uwe Wollina1  Gesina Hansel1  Anja Baunacke1  Georgi Tchernev2 1Department of Dermatology and  Allergology, Academic T eaching  Hospital Dresden-Friedrichstadt,  Dresden, Germany;  2Department  of Dermatology and Dermatologic Surgery, Medical Institute of Ministry of Interior (MVR), Sofia, BulgariaAbstract:  Herpes zoster is a common disease caused due to varicella zoster virus (VZV)  infection with increasing incidence by age.",Non-OADS,/arxiv_data1/oa_pdf/91/25/ccid-10-195.PMC5478159.pdf
"His medical history was positive for diabetes mellitus type 2 treated by diet and an arterial hypertension controlled by 160 mg valsartan 160 mg/d.Correspondence: Uwe Wollina   Department of Dermatology and  Allergology, Academic Teaching Hospital Dresden-Friedrichstadt, Friedrichstrasse 41, 01067 Dresden, Germany   Email wollina-uw@khdf.deJournal name: Clinical, Cosmetic and Investigational Dermatology Article Designation: CASE REPORTY ear: 2017V olume: 10Running head verso: Wollina et alRunning head recto: Severe atypical herpes zoster as an initial symptom of fatal MDSDOI: http://dx.doi.org/10.2147/CCID.S133966",Non-OADS,/arxiv_data1/oa_pdf/91/25/ccid-10-195.PMC5478159.pdf
"Clinical, Cosmetic and Investigational Dermatology 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journal Clinical, Cosmetic and Investigational Dermatology is an interna- tional, peer-reviewed, open access, online journal that focuses on   the latest clinical and experimental research in all aspects of skin   disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/91/25/ccid-10-195.PMC5478159.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authorsDovepress 198 Wollina et al MDS with RAEB is characterized by an increased mor - tality.,Non-OADS,/arxiv_data1/oa_pdf/91/25/ccid-10-195.PMC5478159.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Viral miRNAsKSHV HHV8 EBVHHV4Infection prevalence 1.,Non-OADS,/arxiv_data1/oa_pdf/52/11/main.PMC5478184.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.04.018 2352-3964/© 2017 Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/52/11/main.PMC5478184.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/52/11/main.PMC5478184.pdf
"The Fisher's exact test, Shapiro-Wilk test, Mann-Whitney-Wilcoxon nonparametric test, Kruskal-Wallis test, and Dunn's post hoc test analyses were performed in R (version 3.0.1) ( http://www.r-project.org /).",Non-OADS,/arxiv_data1/oa_pdf/52/11/main.PMC5478184.pdf
This method is suitable to the detection inhuman body ﬂuids (and not only plasma) of any virus codifying miRNAs (29 viruses according to miRBase at http://www.mirbase.org /).,Non-OADS,/arxiv_data1/oa_pdf/52/11/main.PMC5478184.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Atypical kinaseRIOK1RAS Three-dimensional (3D) tissue culture XenograftsBioluminescence imaging 1.,Non-OADS,/arxiv_data1/oa_pdf/6e/48/main.PMC5478185.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.04.015 2352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6e/48/main.PMC5478185.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6e/48/main.PMC5478185.pdf
S11) ( https://portals.broadinstitute.org/ achilles ).,Non-OADS,/arxiv_data1/oa_pdf/6e/48/main.PMC5478185.pdf
"   Case Rep Ophthalmol 2017;8:137 –143  DOI: 10.1159/000458517   Published online: March 7, 2017  © 2017 The Author(s)Published by S.  Karger AG, Basel   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/a3/7c/cop-0008-0137.PMC5478186.pdf
"   Case Rep Gastroenterol 2017;11:155 –161  DOI: 10.1159/000463378   Published online: March 21, 2017  © 2017 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/78/fb/crg-0011-0155.PMC5478187.pdf
"   Case Rep Oncol 2017;10:239 –243  DOI: 10.1159/000463381   Published online: March 9, 2017  © 2017 The Author(s)Published by S.  Karger AG, Basel   www.karger.com/cro   This article is licensed  under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/a6/42/cro-0010-0239.PMC5478188.pdf
DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2017.04.031 .,OADS,/arxiv_data1/oa_pdf/32/4e/main.PMC5478199.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.05.007 2352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/32/4e/main.PMC5478199.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/4e/main.PMC5478199.pdf
"The results were restricted to patients with type 2 diabetes of Caucasian ethnicity, and future studies should examineEBioMedicine 20 (2017) 17 –18 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2017.03.036 .",Non-OADS,/arxiv_data1/oa_pdf/a6/ce/main.PMC5478200.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.05.009 2352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a6/ce/main.PMC5478200.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/ce/main.PMC5478200.pdf
Biomedical research needs to continue to combine fundamental approaches and ﬁndings in waysEBioMedicine 20 (2017) 15 –16 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2017.03.037 .,Non-OADS,/arxiv_data1/oa_pdf/0a/62/main.PMC5478202.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.05.004 2352-3964/© 2017 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/0a/62/main.PMC5478202.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0a/62/main.PMC5478202.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/0a/62/main.PMC5478202.pdf
What are the spatial and temporal kinetics of viral infection and immune response in this congenitallyEBioMedicine 20 (2017) 11 –12 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2017.04.029 .,Non-OADS,/arxiv_data1/oa_pdf/3e/a2/main.PMC5478203.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.05.005 2352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3e/a2/main.PMC5478203.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3e/a2/main.PMC5478203.pdf
EBioMedicine http://dx.doi.org/10.1016/j.ebiom.2017.04.029 .,OADS,/arxiv_data1/oa_pdf/3e/a2/main.PMC5478203.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/a2/main.PMC5478203.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Restrictive lung disease Ferroportin Hereditary hemochromatosisIron OverloadHepcidin resistance 1.,Non-OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.04.036 2352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
http://dx.doi.org/10.1016/j.cmet.,OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
http://dx.doi.org/10.1016/j.bbamcr.2012.05.010 .,OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
http://dx.doi.org/10.1164/rccm.200211-1292OC .,Non-OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
Rep. 6:39172. http://dx.doi.org/10.1038/srep39172 .,Non-OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
http://dx.doi.org/10.1261/rna.7220704 .,Non-OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
http://dx.doi.org/10.1016/j.bbagen.2008.11.004 .,OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
http://dx.doi.org/10.1097/01.CCM.,Non-OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
9:10. http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
http://dx.doi.org/10.1016/j.jcf.2012.10.010 .,OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
http://dx.doi.org/10.1016/j.jcf.2012.10.010 .238 J. Neves et al.,OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
http://dx.doi.org/10.1113/ EP085166 .,Non-OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
http://dx.doi.org/ 10.1111/bjh.14396 .,Non-OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
299:F1 –13.http://dx.doi.org/10.1152/ajprenal.00174.2010 .,Non-OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
10:34. http://dx.doi.org/10.1186/s40248-015-0031-2 .,Non-OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
12:87.http://dx.doi.org/10.1186/1465-9921-12-87 .,Non-OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
http://dx.doi.org/10.1006/meth.2001.1262 .,OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
http://dx.doi.org/10.1164/rccm.200708-1233OC .,Non-OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
http://dx.doi.org/10.1165/rcmb.2013- 0086MA .,OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
http://dx.doi.org/10.1146/annurev.nutr.28.061807.,Non-OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
http://dx.doi.org/10.1016/j.cell.2016.12.034 .,OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
http://dx.doi.org/10.1007/978-1-62703-056-4_18 .,Non-OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
http://dx.doi.org/10.1126/ science.1104742 .,Non-OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
"http://dx.doi.org/10.1016/j.taap.2004.06.021 .Parakh, A., Dubey, A.P., Chowdhury, V., Sethi, G.R., Jain, S., Hira, H.S., 2007.",OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
http://dx.doi.org/10.1097/MPH.0b013e318033a73d .,Non-OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
http://dx.doi.org/10.1183/09031936.00154006 .,Non-OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
http://dx.doi.org/10.1529/ biophysj.105.073106 .,Non-OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
http://dx.doi.org/10.1038/nsmb1222 .,Non-OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
http://dx.doi.org/10.1182/blood-2009- 04-216226 .,Non-OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
http://dx.doi.org/10.1165/rcmb.2008- 0487OC .,Non-OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
http://dx.doi.org/10.1182/blood-2015-08-663245 .,Non-OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
http://dx.doi.org/10.1152/ajplung.00253.2001 .239 J. Neves et al.,OADS,/arxiv_data1/oa_pdf/ab/69/main.PMC5478206.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: TendonsTenomodulin Knockout mouse model Running testsAtomic force microscopyCollagen I crosslinking 1.,Non-OADS,/arxiv_data1/oa_pdf/a6/54/main.PMC5478207.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.05.003 2352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a6/54/main.PMC5478207.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/54/main.PMC5478207.pdf
"These spe- ciﬁc viral miRNAs have likewise been explored as potential diagnostic platforms ( Lagatie et al., 2014; Zhu et al., 2017; Takahashi et al., 2013;EBioMedicine 20 (2017) 9 –10 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2017.04.018 .",Non-OADS,/arxiv_data1/oa_pdf/c4/86/main.PMC5478208.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.05.008 2352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/86/main.PMC5478208.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c4/86/main.PMC5478208.pdf
http://dx.doi.org/10.1111/liv.,Non-OADS,/arxiv_data1/oa_pdf/c4/86/main.PMC5478208.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Branched-chain amino acids catabolismColorectal cancerBCKDKTumorigenesisMEK Phenyl butyrate 1.,Non-OADS,/arxiv_data1/oa_pdf/2a/82/main.PMC5478211.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.05.0012352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2a/82/main.PMC5478211.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2a/82/main.PMC5478211.pdf
http://dx.doi.org/10.1038/nature18600 .,Non-OADS,/arxiv_data1/oa_pdf/2a/82/main.PMC5478211.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: MUTYH-associated polyposisColorectal cancer8-OxoguanineBase excision repairExome sequencingMutational signature 1.,Non-OADS,/arxiv_data1/oa_pdf/06/0a/main.PMC5478212.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.04.022 2352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/06/0a/main.PMC5478212.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/06/0a/main.PMC5478212.pdf
"The names of mutational signatures used in this manuscript are consistent with the ones on the COSMIC website, http://cancer.sanger.ac.uk/cosmic/signatures .",Non-OADS,/arxiv_data1/oa_pdf/06/0a/main.PMC5478212.pdf
"frameshift, stop gained, initiator codon, inframe insertion or deletion, splice and missense with deleteri- ous (SIFT) or damaging (Polyphen) prediction; synonymous, intronic, 5′- and 3 ′- UTR and missense variants with tolerated (SIFT) and benign (Polyphen) prediction were ﬁltered out, unless they were reported in the Catalogue of somatic mutations in cancer (Cosmic) database (http://cancer.sanger.ac.uk/cosmic ).",Non-OADS,/arxiv_data1/oa_pdf/06/0a/main.PMC5478212.pdf
"Protein recovery was evaluated by gel analysis by ImageJ software, available free online at the NIH website ( http://rsb.info.nih.gov /).",OADS,/arxiv_data1/oa_pdf/06/0a/main.PMC5478212.pdf
4:18. http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/06/0a/main.PMC5478212.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Human Immunode ﬁciency Virus (HIV) Single cell quanti ﬁcation Digital PCRHIV reservoirs HIV reactivation Histone deacetylase inhibitors 1.,Non-OADS,/arxiv_data1/oa_pdf/94/cf/main.PMC5478213.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.05.0062352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/94/cf/main.PMC5478213.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/94/cf/main.PMC5478213.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Dengue virus Immunocompetent mouse modelSecondary infectionImmune responseCD8 +Tl y m p h o c y t e s 1.,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.04.033 2352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
Virology 487:41 –49.http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1016/j.chom.2010.10.007 (pii).,OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.176/5/2817 (pii).,OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1089/ vim.2008.0089 .,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1038/nature12060nature12060 (pii).,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1186/1471-2334-4-39 .,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1128/ JCM.39.11.4119-4124.2001 .,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
2014:901276. http://dx.doi.org/10.1155/2014/901276 .,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1002/jmv.20108 .,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1093/ infdis/jiv258 (jiv258 [pii]).,OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
2015:917143. http://dx.doi.org/10.1155/2015/917143 .,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1016/j.jcv.2014.04.002S1386- 6532(14)00134-6 (pii).,OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
15:34 –41.http://dx.doi.org/10.1038/nm.,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.10.006 (S2352-3964(16)30461-3 [pii]).,OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1016/j.yexmp.2010.07.007S0014-4800(10)00104-8 (pii).,OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
1:51. http://dx.doi.org/10.1038/srep00051 .,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1038/icb.2010.61icb201061 (pii).,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.4269/ajtmh.2012.12-015786/5/743 (pii).,OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1016/ S0140-6736(14)60572-9S0140-6736(14)60572-9 (pii).,OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
8:S7 –16.http://dx.doi.org/10.1038/nrmicro2460nrmicro2460 (pii).,OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1006/viro.1997.8500 (S0042-6822(97)98500-7 [pii]).,OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1086/ 340365 (JID011089 [pii]).,OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1128/CMR.00035-0922/ 4/564 (pii).,OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1128/JVI.01826-10JVI.01826-10 (pii).,OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1038/nm887nm887 (pii).,OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.176/6/3821 (pii).,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.4161/jkst.277152013JAKS0148R (pii).,OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1086/380762 (JID30900 [pii]).,OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
2010:164878. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1099/vir.0.045088-0vir.0.045088-0 (pii).,OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1016/ j.virol.2005.04.042 (S0042-6822(05)00270-9 [pii]).,OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
85:43 –45.http://dx.doi.org/10.1038/sj.icb.7100008 (7100008 [pii]).,OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
Methods 410:34 –38.http://dx.doi.org/10.1016/j.jim.2014.01.001S0022- 1759(14)00003-9 (pii).,OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1038/nm918nm918 (pii).,OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1128/JVI.06743-11JVI.06743-11 (pii).,OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1128/JVI.02675-12JVI.02675-12 (pii).,OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1111/j.,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1038/ nri3014nri3014 (pii).,OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1371/journal.pntd.0002194PNTD-D-12-00967 (pii).,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
"http://dx.doi.org/10.1371/journal.ppat.1004541PPATHOGENS-D-14- 01538 (pii).Shresta, S., Sharar, K.L., Prigozhin, D.M., Beatty, P.R., Harris, E., 2006.",OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1128/JVI.00062-06 (80/20/10208 [pii]).,OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1016/j.cellimm.2010.02.005S0008-8749(10)00035-3 (pii).,OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1371/journal.pone.0046292PONE-D-12-16090 (pii).,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1086/315215 (JID990867 [pii]).,OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1128/JVI.00216-15JVI.00216-15 (pii).,OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/ 10.1073/pnas.13052271101305227110 (pii).,OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1182/blood-2002-05- 1470 .,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1097/QCO.0b013e32835fb938 .,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.4049/jimmunol.0801974182/ 8/4865 (pii).,OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.4049/jimmunol.1001709jimmunol.,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
5:151. http://dx.doi.org/10.3389/ ﬁmmu.2014.00151 .,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1016/j.chom.2010.01.004S1931- 3128(10)00030-2 (pii).,OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.4049/jimmunol.,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.1128/JVI.00036-15JVI.00036-15 (pii).,OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.3390/v4010062viruses-04-00062 (pii).,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
http://dx.doi.org/10.4049/jimmunol.1102124jimmunol.,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC5478214.pdf
"MeSH Keywords:  Barotrauma • Embolism, Air • Stroke  Full-text PDF: http://www.amjcaserep.com/abstract/index/idArt/903354Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Medicine, University of Toronto, Toronto, ON, Canada 2 Department of Anesthesiology, University of Toronto, Toronto, ON, Canada 3 Interdepartmental Division of Critical Care, University of Toronto, Toronto, ON,  CanadaISSN 1941-5923 © Am J Case Rep, 2017; 18: 660-664 DOI: 10.12659/AJCR.903354 660 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)",Non-OADS,/arxiv_data1/oa_pdf/19/12/amjcaserep-18-660.PMC5478217.pdf
"MeSH Keywords:  Abdominal Pain • Multidetector Computed Tomography • Pancreatectomy • Pancreatic Neoplasms  Full-text PDF: http://www.amjcaserep.com/abstract/index/idArt/902867Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Radiology, University of Puerto Rico School of Medicine, San Juan,  Puerto Rico 2 Department of Pathology, University of Puerto Rico School of Medicine, San Juan,  Puerto Rico 3 Department of Surgery, University of Puerto Rico School of Medicine, San Juan  Puerto RicoISSN 1941-5923 © Am J Case Rep, 2017; 18: 656-659 DOI: 10.12659/AJCR.902867 656 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)",Non-OADS,/arxiv_data1/oa_pdf/07/cb/amjcaserep-18-656.PMC5478218.pdf
"MeSH Keywords:  Cadaver • Compressive Strength • Decompression, Surgical • Prosthesis Design • Spinal FusionX  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/905466Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Orthopedics, Second Affiliated Hospital of Xi’an Jiaotong  University, Xi’an, Shaanxi, P.R.",Non-OADS,/arxiv_data1/oa_pdf/e5/2a/medscimonit-23-2863.PMC5478219.pdf
"MeSH Keywords:  Endocarditis • Heart Failure • Hemodynamics  Full-text PDF: http://www.amjcaserep.com/abstract/index/idArt/903071Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection GDepartment of Cardiology, Providence Hospital and Medical Centers, Michigan  State University, Southfield, MI, U.S.AISSN 1941-5923 © Am J Case Rep, 2017; 18: 665-668  DOI: 10.12659/AJCR.903071 665 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)",Non-OADS,/arxiv_data1/oa_pdf/80/21/amjcaserep-18-665.PMC5478220.pdf
Available from URL: https://www.hcup-us.ahrq.gov/reports/statbriefs/sb172- Conditions-Readmissions-Payer.jsp  5.,OADS,/arxiv_data1/oa_pdf/80/21/amjcaserep-18-665.PMC5478220.pdf
"MeSH Keywords:  Congenital Abnormalities • Hernia, Diaphragmatic • Testicular Diseases • Genetic Diseases, X-Linked  Full-text PDF: http://www.amjcaserep.com/abstract/index/idArt/903964Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Pathology, University of Cincinnati, College of Medicine,  Cincinnati, OH, U.S.A. 2 Division of Allergy and Immunology, Cincinnati Children’s Hospital, Cincinnati,  OH, U.S.A. 3 Division of Pathology, Cincinnati Children’s Hospital, Cincinnati, OH, U.S.A.ISSN 1941-5923 © Am J Case Rep, 2017; 18: 649-655 DOI: 10.12659/AJCR.903964 649 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)",Non-OADS,/arxiv_data1/oa_pdf/c2/b1/amjcaserep-18-649.PMC5478221.pdf
"These accumulating data combined with the recent work by Kobayashi et al., the “mislocalization ”of tau to theEBioMedicine 20 (2017) 3 –4 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2017.05.012 .",OADS,/arxiv_data1/oa_pdf/fd/d9/main.PMC5478231.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.05.013 2352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/fd/d9/main.PMC5478231.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fd/d9/main.PMC5478231.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: MMEJCRISPR/Cas9In vivo targeted integration Fah −/−mice Gene therapy 1.,Non-OADS,/arxiv_data1/oa_pdf/5f/95/main.PMC5478232.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.05.0152352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5f/95/main.PMC5478232.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5f/95/main.PMC5478232.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: LenalidomideDexamethasoneCereblonMCLIL-6/STAT3 1.,Non-OADS,/arxiv_data1/oa_pdf/37/26/main.PMC5478233.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.04.037 2352-3964/© 2017 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/37/26/main.PMC5478233.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/37/26/main.PMC5478233.pdf
2012:523842. http://dx.doi.org/10.1155/2012/523842 .,Non-OADS,/arxiv_data1/oa_pdf/37/26/main.PMC5478233.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.05.0162352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/16/85/main.PMC5478234.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/16/85/main.PMC5478234.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/16/85/main.PMC5478234.pdf
"Interestingly, a HFD induces de novo oscillation of Ldlrexpression in the liver, mostly likely a necessary adaptation to such nutrient insult(http://circadiomics.igb.uci.edu ).",Non-OADS,/arxiv_data1/oa_pdf/f8/1e/main.PMC5478239.pdf
"With new studies revealing the impor- tance of peripheral signals in regulating circadian behavior and clock function in the CNS ( Chavan et al., 2016 ), the authors may have discov- ered a unique role for cholesterol in maintaining this important circadi- an crosstalk between tissues and thereby implicating LDLR as a protective mechanism for the clock under nutrient challenge conditions.EBioMedicine 20 (2017) 5 –6 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2017.04.034 .",Non-OADS,/arxiv_data1/oa_pdf/f8/1e/main.PMC5478239.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.05.021 2352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f8/1e/main.PMC5478239.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/1e/main.PMC5478239.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: ProbioticMicrobiome Premature infant Necrotizing enterocolitis 1.,Non-OADS,/arxiv_data1/oa_pdf/e6/0e/main.PMC5478240.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.05.019 2352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e6/0e/main.PMC5478240.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e6/0e/main.PMC5478240.pdf
http://dx.doi.org/ 10.3390/ijms17050649 .,Non-OADS,/arxiv_data1/oa_pdf/e6/0e/main.PMC5478240.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/e6/0e/main.PMC5478240.pdf
http://dx.doi.org/10.7717/peerj.2928 .,Non-OADS,/arxiv_data1/oa_pdf/e6/0e/main.PMC5478240.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Ovarian stimulationIntelligence quotientOffspringAssisted reproductive technologiesEstradiol 1.,Non-OADS,/arxiv_data1/oa_pdf/cd/f7/main.PMC5478241.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.05.020 2352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/cd/f7/main.PMC5478241.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cd/f7/main.PMC5478241.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: p53TranscriptomeRadiationKeratinization 1.,Non-OADS,/arxiv_data1/oa_pdf/f6/33/main.PMC5478243.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.05.017 2352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f6/33/main.PMC5478243.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f6/33/main.PMC5478243.pdf
The raw data obtain- ed in this study can be accessible in DDBJ database ( http://www.ddbj.,OADS,/arxiv_data1/oa_pdf/f6/33/main.PMC5478243.pdf
Other Bioinformatics Analysis KEGG pathway analyses and GO term analyses were performed using DAVID ( https://david.ncifcrf.gov /).,OADS,/arxiv_data1/oa_pdf/f6/33/main.PMC5478243.pdf
irb.hr /) and Cytoscape version 3.2.1 ( http://www.cytoscape.org /).,Non-OADS,/arxiv_data1/oa_pdf/f6/33/main.PMC5478243.pdf
TCGA (The Cancer Genome Atlas) Data Gene expression data and p53mutation status in clinical samples were obtained from the TCGA data portal ( https://tcga-data.nci.nih.,OADS,/arxiv_data1/oa_pdf/f6/33/main.PMC5478243.pdf
"MeSH Keywords:  Receptors, Opioid – History • Opium – History • Papaver – Drug Effects • Morphine – History •   Morphine – Therapeutic Use • Opium – Therapeutic Use • Receptors, Opioid – Therapeutic Use  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/905167Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Psychiatry, Charles University First Faculty of Medicine and  General Teaching Hospital, Center for Cognitive Molecular Neuroscience, Prague,  Czech Republic 2 Warsaw Medical University, Public Central Teaching Hospital, Warsaw, Polande-ISSN 1643-3750 © Med Sci Monit, 2017; 23: 2890-2896 DOI: 10.12659/MSM.905167 2890 Indexed in: [Current Contents/Clinical Medicine] [SCI Expanded] [ISI Alerting System]   [ISI Journals Master List] [Index Medicus/MEDLINE] [EMBASE/Excerpta Medica]   [Chemical Abstracts/CAS] [Index Copernicus]REVIEW ARTICLES This work is licensed under Creative Common Attribution- NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)",Non-OADS,/arxiv_data1/oa_pdf/be/c7/medscimonit-23-2890.PMC5478244.pdf
"MeSH Keywords:  Fractures, Stress • Kyphoplasty • Vertebroplasty  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/904802Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection GDepartment of Orthopaedic Surgery, The First Affiliated Hospital of Soochow  University, Suzhou, Jiangsu, P.R.",Non-OADS,/arxiv_data1/oa_pdf/04/8b/medscimonit-23-2879.PMC5478245.pdf
"Collectively, these efforts are hoped to drive smarter healthcare diagnostics.EBioMedicine 20 (2017) 1 –2 http://dx.doi.org/10.1016/j.ebiom.2017.06.006 2352-3964/© 2017 Published by Elsevier B.V.",Non-OADS,/arxiv_data1/oa_pdf/97/95/main.PMC5478248.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/97/95/main.PMC5478248.pdf
therefore highlight the need to reappraise lung function and pathology in a variety of diseases stemming from iron overload.EBioMedicine 20 (2017) 13 –14 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2017.04.036 .,Non-OADS,/arxiv_data1/oa_pdf/27/7c/main.PMC5478249.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.05.023 2352-3964/© 2017 The Author.,Non-OADS,/arxiv_data1/oa_pdf/27/7c/main.PMC5478249.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/27/7c/main.PMC5478249.pdf
This  is  an  open  access article under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e3/6e/main.PMC5478250.pdf
"Upasani).nal people  living  in  synchronization  with  nature  to  develop  a system of  knowledge  about  plants,  which  play  several  impor- tant  functions  in  human  life.1–3The  result  of  human  interface and  assortment  of  the  most  desirable,  inﬂuential,  and  success- ful  plant  species  found  in  the  immediate  environment  during speciﬁc events  is  attributable  to  the  indigenous  knowledge http://dx.doi.org/10.1016/j.imr.2017.03.001 2213-4220/©  2017  Korea  Institute  of  Oriental  Medicine.",Non-OADS,/arxiv_data1/oa_pdf/e3/6e/main.PMC5478250.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e3/6e/main.PMC5478250.pdf
This is an ope n access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: BCL11bCancer immune-therapyCD147Trans-differentiation Thymocyte development 1.,Non-OADS,/arxiv_data1/oa_pdf/4e/e9/main.PMC5478251.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.05.022 2352-3964/© 2017 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/4e/e9/main.PMC5478251.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/e9/main.PMC5478251.pdf
http://dx.doi.org/10.1016/j.imr.2016.12.003 2213-4220/©  2017  Korea  Institute  of  Oriental  Medicine.,Non-OADS,/arxiv_data1/oa_pdf/b7/21/main.PMC5478252.pdf
This  is  an  open  access  article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/21/main.PMC5478252.pdf
This  is  an  open  access article under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/21/main.PMC5478252.pdf
Available  from: http://www.indianmedicine.nic.in .,Non-OADS,/arxiv_data1/oa_pdf/b7/21/main.PMC5478252.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Sodium glucose cotransporter-2 inhibitorObesityEnergy metabolism Brown adipose tissue Inﬂammation Macrophage 1.,Non-OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.05.028 2352-3964/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.org/10.1038/nm.3828 .,Non-OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.org/10.1038/nature14115 .,Non-OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.org/10.1016/j.cell.2013.12.021 .,OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.org/10.1038/nrendo.,OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.org/10.1172/ JCI72227 .,Non-OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.org/10.2337/db15-1356 .,Non-OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.org/10.1101/gad.177857.111 .,Non-OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.org/10.1016/j.cmet.,OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
14 (1):83 –90.http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.org/10.1016/j.cmet.2014.09.013 .,OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.org/10.1016/ j.tcb.2015.10.013 .,OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.org/10.1038/nature05485 .,Non-OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.org/10.1016/j.cmet.2007.05.003 .,OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.org/10.1177/1479164114559852 .,Non-OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.org/10.2337/db11-1506/-/DC1 .,Non-OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.org/10.1172/JCI70704 .,Non-OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.org/10.2337/ db14-0393 .,Non-OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.org/10.1210/en.2014-1776 .,Non-OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.org/10.1038/nm.1964 .,OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.org/10.1210/en.2015-1588 .,Non-OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.org/10.1038/ nature05894 .,Non-OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.org/10.1172/JCI32752 .,Non-OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.org/10.1016/j.cmet.2008.08.015 .148 L. Xu et al.,OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
7:104. http://dx.doi.org/10.1186/s13098- 015-0102-8 .,Non-OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.org/10.1172/JCI112981 .,Non-OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.org/10.1038/nrendo.2012.114 .,Non-OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.org/10.1016/j.ejphar.2013.05.014 .,OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
14 (1):94 –96.http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.org/10.1002/hep.26607 .,Non-OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.org/10.1172/JCI19246 .,Non-OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.org/ 10.1038/ijo.2008.233 .,OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
727:66 –74.http://dx.doi.org/10.1016/j.ejphar.2014.01.,OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.org/10.2337/db16-0317 .149 L. Xu et al.,OADS,/arxiv_data1/oa_pdf/13/4b/main.PMC5478253.pdf
http://dx.doi.org/10.1016/j.imr.2017.01.007 2213-4220/©  2017  Korea  Institute  of  Oriental  Medicine.,Non-OADS,/arxiv_data1/oa_pdf/37/ea/main.PMC5478254.pdf
This  is  an  open  access  article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/37/ea/main.PMC5478254.pdf
This  is  an  open  access article under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/37/ea/main.PMC5478254.pdf
This  is  an  open  access article under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d0/3d/main.PMC5478255.pdf
http://dx.doi.org/10.1016/j.imr.2017.01.006 2213-4220/©  2017  Korea  Institute  of  Oriental  Medicine.,Non-OADS,/arxiv_data1/oa_pdf/d0/3d/main.PMC5478255.pdf
This  is  an  open  access  article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d0/3d/main.PMC5478255.pdf
This  is  an  open  access article under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a4/d9/main.PMC5478256.pdf
http://dx.doi.org/10.1016/j.imr.2017.02.002 2213-4220/©  2017  Korea  Institute  of  Oriental  Medicine.,Non-OADS,/arxiv_data1/oa_pdf/a4/d9/main.PMC5478256.pdf
This  is  an  open  access  article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a4/d9/main.PMC5478256.pdf
https://en.wikipedia.org/wiki/Animation .,Non-OADS,/arxiv_data1/oa_pdf/a4/d9/main.PMC5478256.pdf
https://en.wikipedia.org/wiki/List ofPororo the  Little Penguin characters .,Non-OADS,/arxiv_data1/oa_pdf/a4/d9/main.PMC5478256.pdf
http://home.ebs.co.kr/pororo/etc/1/cast .,Non-OADS,/arxiv_data1/oa_pdf/a4/d9/main.PMC5478256.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Ep-CAM Expression CRCPrognosisDiagnosisBiomarker 1.,Non-OADS,/arxiv_data1/oa_pdf/8d/54/main.PMC5478257.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.05.0252352-3964/© 2017 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/8d/54/main.PMC5478257.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8d/54/main.PMC5478257.pdf
http://dx.doi.org/10.1016/j.imr.2017.03.003 2213-4220/©  2017  Korea  Institute  of  Oriental  Medicine.,Non-OADS,/arxiv_data1/oa_pdf/00/2f/main.PMC5478258.pdf
This  is  an  open  access  article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/2f/main.PMC5478258.pdf
This  is  an  open  access article under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/2f/main.PMC5478258.pdf
This  is  an  open  access article under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/22/c3/main.PMC5478259.pdf
http://dx.doi.org/10.1016/j.imr.2017.03.002 2213-4220/©  2017  Korea  Institute  of  Oriental  Medicine.,Non-OADS,/arxiv_data1/oa_pdf/22/c3/main.PMC5478259.pdf
This  is  an  open  access  article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/22/c3/main.PMC5478259.pdf
"gories used  for  analyses  were  “biological  process,”  “molecular function,”  and  “cellular  component.”  Biological  pathway  infor- mation was obtained  from  the  GSEA  (Gene  Set  Enrichment Analysis)  database  (http://software.broadinstitute.org/gsea ), which contains  the  BIOCRATA,  KEGG  (Kyoto  Encyclopedia  of Genes  and  Genomes),  and  REACTOME  pathways.39Disease phenotypes were obtained  from  the  Menche  et  al40dataset containing OMIM  (Online  Mendelian  Inheritance  in  Man)  dis- ease  and  GWAS  (genome-wide  association  study)  information.",OADS,/arxiv_data1/oa_pdf/22/c3/main.PMC5478259.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be found,  in  the  online  version,  at  http://dx.doi.org/10.1016/ j.imr.2017.03.002 .",OADS,/arxiv_data1/oa_pdf/22/c3/main.PMC5478259.pdf
http://www.bioinformatics.,Non-OADS,/arxiv_data1/oa_pdf/22/c3/main.PMC5478259.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Antimicrobial susceptibility testing (AST)MIC testing Antibiotic resistance Multidrug-resistant pathogensAntimicrobial therapy 1.,Non-OADS,/arxiv_data1/oa_pdf/da/bd/main.PMC5478264.pdf
http://dx.doi.org/10.1016/j.ebiom.2017.05.026 2352-3964/© 2017 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/da/bd/main.PMC5478264.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/da/bd/main.PMC5478264.pdf
Reprints and permissions information is available online at http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/da/bd/main.PMC5478264.pdf
http://www.srga.org/ Eucastwt/eucastde ﬁnitions.htm .,Non-OADS,/arxiv_data1/oa_pdf/da/bd/main.PMC5478264.pdf
http://www.mayomedicallaboratories.,Non-OADS,/arxiv_data1/oa_pdf/da/bd/main.PMC5478264.pdf
This  is  an  open  access article under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/61/main.PMC5478266.pdf
http://dx.doi.org/10.1016/j.imr.2017.02.001 2213-4220/©  2017  Korea  Institute  of  Oriental  Medicine.,Non-OADS,/arxiv_data1/oa_pdf/11/61/main.PMC5478266.pdf
This  is  an  open  access  article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/61/main.PMC5478266.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4f/2c/ndt-13-1559.PMC5478272.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 1559–1567Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1559OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S13221 4 Risk factors for the existence of attention deficit  hyperactivity disorder symptoms in children with  autism spectrum disorders anna linda lamanna Francesco craig emilia Matera Marta simone Maura Buttiglione lucia Margari child Neuropsychiatry Unit,   Department of Basic Medical  sciences, Neuroscience and sense  Organs, University of Bari “ aldo  Moro”, Bari, italyAbstract:  Over the years, several authors have reported symptoms of attention deficit  hyperactivity disorder (ADHD) in patients with autism spectrum disorders (ASD); however,  studies on the risk factors of ADHD symptoms in children with ASD are lacking.",Non-OADS,/arxiv_data1/oa_pdf/4f/2c/ndt-13-1559.PMC5478272.pdf
"Studies that have assessed some clinical features,  such as executive control and aggression, in samples of children with ASD and ADHD,  indicated a shared behavioral alteration in the two disorders.6–8 Lundström et al9 showed that there is a correlation between autistic traits and  traits of other disorders, and that the correlation between them is largely mediated by correspondence: lucia Margari child Neuropsychiatry Unit, Department  of Basic Medical sciences, Neuroscience  and sense Organs, University of Bari  “aldo Moro”, Piazza giulio cesare 11,  70124 Bari, italy Tel +39 80 559 2829 Fax +39 80 559 5260 email lucia.margari@uniba.i t Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Lamanna et al Running head recto: Factors associated with ADHD symptoms in ASD DOI: http://dx.doi.org/10.2147/NDT.S132214",Non-OADS,/arxiv_data1/oa_pdf/4f/2c/ndt-13-1559.PMC5478272.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/4f/2c/ndt-13-1559.PMC5478272.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4f/2c/ndt-13-1559.PMC5478272.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7b/18/ndt-13-1541.PMC5478273.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 1541–1549Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1541OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S13647 7 Intelligence profiles of Chinese school-aged boys  with high-functioning ASD and ADHD gaizhi li,1,* Wenqing Jiang,2,*   Yasong Du,2 Kathryn  Rossbach3 1shanghai Mental health center,   shanghai Jiao Tong University school  of Medicine, Shanghai, People’s  Republic of China; 2Department  of Child & Adolescent Psychiatry,   shanghai Mental health center,   shanghai Jiao Tong University school  of Medicine, Shanghai, People’s  Republic of China; 3emory autism  Center, Emory University School of  Medicine, atlanta, ga, Usa *These authors contributed equally  to this workPurpose:  This study aimed to explore the intelligence profiles of Chinese school-aged boys  with high-functioning autism spectrum disorder (HFASD) and attention-deficit/hyperactivity  disorder (ADHD).",Non-OADS,/arxiv_data1/oa_pdf/7b/18/ndt-13-1541.PMC5478273.pdf
"Introduction According to the Diagnostic and Statistical Manual of Mental Disorders , Fifth  Edition (DSM-5), autism spectrum disorder (ASD) is characterized by an impair - ment in social communication as well as displaying restrictive or repetitive patterns correspondence: Yasong Du Department of Child & Adolescent  Psychiatry, Shanghai Mental Health  center, shanghai Jiao Tong University  School of Medicine, No 600 Wanping  Nan road, Xuhui, shanghai 200030,  People’s Republic of China Tel +86 216 438 7250 Ext 3420 Fax +86 216 438 7986 email yasongdu@163.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Li et al Running head recto: Intellectual functioning within boys with HFASD and ADHD DOI: http://dx.doi.org/10.2147/NDT.S136477 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/7b/18/ndt-13-1541.PMC5478273.pdf
Or use: http://youtu.be/x40ydnm_E3 wVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/7b/18/ndt-13-1541.PMC5478273.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/7b/18/ndt-13-1541.PMC5478273.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7b/18/ndt-13-1541.PMC5478273.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b5/ae/ndt-13-1533.PMC5478274.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 1533–1540Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1533OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S13318 1 Burnout and compassion fatigue: prevalence and  associations among israeli burn clinicians Josef haik1–3 stav Brown1,2 alon liran1 Denis Visentin4 amit sokolov2 isaac Zilinsky1,2 rachel Kornhaber1,4 1Department of Plastic and  reconstruction surgery, The National  Burns center, sheba Medical center,   T el hashomer, 2sackler Faculty of  Medicine, T el aviv University, T el aviv,   3Talpiot Medical leadership Program,   sheba Medical center, T el hashomer,   israel; 4school of health sciences,   Faculty of health, University of  Tasmania, sydney, N sW, australiaAbstract:  Acute health  care environments can be stressful settings with clinicians experiencing  deleterious effects of burnout and compassion fatigue affecting their mental health.",Non-OADS,/arxiv_data1/oa_pdf/b5/ae/ndt-13-1533.PMC5478274.pdf
"Keywords:  burnout, compassion fatigue, professional quality of life scale, resilience, burns, health  personnel, emotional intelligence, psychological stress Introduction Occupational burnout remains a global phenomenon related to the quality of the  working environment, workload, relationships, and conflict.1 Subsequently, a growing  body of literature is emerging concerning clinicians’ quality of life (QoL) encompass - ing compassion fatigue and burnout in the field of trauma.2 Research suggests that  clinicians working in the health care professions are at greater risk of adverse psy - chological implications resulting from direct patient interactions.3 Repeated exposure  to traumatic injuries has the propensity to increase the risk of burnout, compassion  fatigue, and secondary traumatic stress in health care professionals.4 Consequently, the  concept of vicarious trauma has gained interest in professions related to the domain  of trauma.5 Within the health care setting, burnout in clinicians can be defined as a  psychological syndrome of emotional exhaustion, patient depersonalization, negative  views of patients, and diminished feelings of both personal and work accomplishments.6 correspondence: Josef haik Department of Plastic and reconstruction  surgery, The National Burns center,  sheba Medical center, Tel hashomer,  emek haela st 1, ramat gan, israel email josef.haik@sheba.health.gov.i l Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Haik et al Running head recto: Burnout and compassion fatigue DOI: http://dx.doi.org/10.2147/NDT.S133181",Non-OADS,/arxiv_data1/oa_pdf/b5/ae/ndt-13-1533.PMC5478274.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/b5/ae/ndt-13-1533.PMC5478274.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b5/ae/ndt-13-1533.PMC5478274.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ca/a7/ndt-13-1527.PMC5478275.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 1527–1531Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1527OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/NDT .S13907 5 relapse and hospitalization in patients with  schizophrenia and bipolar disorder at the  st amanuel Mental specialized hospital, addis  ababa, ethiopia: a comparative quantitative  cross-sectional study getnet ayano1 Bereket Duko2 1research and Training Department,  st amanuel Mental specialized  hospital, addis ababa, 2school of  Nursing and Midwifery, college  of Medicine and health sciences,   hawassa University, hawassa, ethiopiaBackground:  Relapse and hospital admission are common among, and carry a heavy burden  in, patients with schizophrenia and bipolar disorder.",Non-OADS,/arxiv_data1/oa_pdf/ca/a7/ndt-13-1527.PMC5478275.pdf
"Keywords:  relapse, hospitalization, schizophrenia, bipolar disorder Background Severe mental disorders (SMDs), including schizophrenia, bipolar disorder,  schizoaffective disorder and depressive psychosis, have a relatively low prevalence  (1%–2%), and they are associated with increased risk of relapse and hospitalizations.1,2 correspondence: Bereket Duko school of Nursing and Midwifery,  college of Medicine and health sciences,  hawassa University, PO Box 1560,  hawassa, ethiopia Tel +251 91 197 5900 email berkole.dad@gmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Ayano and Duko Running head recto: Relapse and hospitalization in schizophrenia and bipolar disorder DOI: http://dx.doi.org/10.2147/NDT.S139075",Non-OADS,/arxiv_data1/oa_pdf/ca/a7/ndt-13-1527.PMC5478275.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/ca/a7/ndt-13-1527.PMC5478275.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ca/a7/ndt-13-1527.PMC5478275.pdf
"Available from: http://www.hcup-us.ahrq.gov/reports/statbriefs/ sb175-Hospital-Cost-Utilization-Projections-2013.pd f. Accessed  March 13, 2015.",OADS,/arxiv_data1/oa_pdf/ca/a7/ndt-13-1527.PMC5478275.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/54/75/ndt-13-1551.PMC5478276.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 1551–1557Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1551OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S13931 6 De ritis ratio (asT/al T) as an independent  predictor of poor outcome in patients with  acute ischemic stroke Fan gao1 chen chen2 Jun lu1 Jie Zheng1 Xian-cang Ma1,3 Xing-Yun Yuan2 Kang huo2 Jian-Feng han2 1clinical research center,   2Department of Neurology,   3Department of Psychiatry, The First  affiliated hospital of Xi’an Jiaotong  University, Xi’an, shaanxi, chinaPurpose:  The aspartate transaminase/alanine transaminase ratio (De Ritis ratio, AAR) was  reported to be associated with patients’ prognosis in certain diseases recently.",Non-OADS,/arxiv_data1/oa_pdf/54/75/ndt-13-1551.PMC5478276.pdf
"Lowering of the blood glutamate level according to the AST and ALT levels could  therefore result in the transfer of glutamate from the brain into the peripheral blood  (following the concentration gradient) and thereby exert a neuroprotective effect in AIS correspondence: Jian-Feng han Department of Neurology, The First  Affiliated Hospital of Xi’an Jiaotong  University, 277 Yanta West road, Xi’an  710061, shaanxi, china Tel +86 29 8532 3614 email hanjianfeng_xjtu@163.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Gao et al Running head recto: De Ritis ratio and acute ischemic stroke outcome DOI: http://dx.doi.org/10.2147/NDT.S139316",Non-OADS,/arxiv_data1/oa_pdf/54/75/ndt-13-1551.PMC5478276.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/54/75/ndt-13-1551.PMC5478276.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/54/75/ndt-13-1551.PMC5478276.pdf
This  is  an  open  access article under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/3d/main.PMC5478282.pdf
http://dx.doi.org/10.1016/j.imr.2017.04.002 2213-4220/©  2017  Korea  Institute  of  Oriental  Medicine.,Non-OADS,/arxiv_data1/oa_pdf/86/3d/main.PMC5478282.pdf
This  is  an  open  access  article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/3d/main.PMC5478282.pdf
http://nccam.nih.gov/health/whatiscam .,Non-OADS,/arxiv_data1/oa_pdf/86/3d/main.PMC5478282.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9d/8d/main.PMC5478283.pdf
http://dx.doi.org/10.1016/j.sjbs.2016.12.009 1319-562X/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9d/8d/main.PMC5478283.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding author at: Department of Arid Land Agriculture, College of Agriculture and Food Sciences, King Faisal University, Al-Ahsa, Saudi Arabia.",Non-OADS,/arxiv_data1/oa_pdf/9d/8d/main.PMC5478283.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f9/80/main.PMC5478284.pdf
"In central Saudi Arabia, environmental conditions are character- http://dx.doi.org/10.1016/j.sjbs.2016.12.006 1319-562X/ /C2112016 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/f9/80/main.PMC5478284.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/f9/80/main.PMC5478284.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f9/80/main.PMC5478284.pdf
http://dx.doi.org/10.1127/0941-2948/2010/0430 .,Non-OADS,/arxiv_data1/oa_pdf/f9/80/main.PMC5478284.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8a/97/main.PMC5478285.pdf
"The length polymorphism of tRNA leu-COII region of mtDNA, due to the absence/presence of P element and different copy num- bers of Q element, which correlates with their evolutionary lin- http://dx.doi.org/10.1016/j.sjbs.2016.12.008 1319-562X/ /C2112016 The Authors.",OADS,/arxiv_data1/oa_pdf/8a/97/main.PMC5478285.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/8a/97/main.PMC5478285.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.sjbs.2016.12.008 .",OADS,/arxiv_data1/oa_pdf/8a/97/main.PMC5478285.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/a8/main.PMC5478286.pdf
"The typical bulk composition of propolis is vegetation resin and balsam (gum) (50%), wax (30%), http://dx.doi.org/10.1016/j.sjbs.2016.12.012 1319-562X/ /C2112016 The Authors.",OADS,/arxiv_data1/oa_pdf/f8/a8/main.PMC5478286.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding author at: 2951 SE Midvale Dr., Corvallis, OR 97333 USA.",Non-OADS,/arxiv_data1/oa_pdf/f8/a8/main.PMC5478286.pdf
This  is  an  open  access article under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a7/3e/main.PMC5478287.pdf
http://dx.doi.org/10.1016/j.imr.2017.03.005 2213-4220/©  2017  Korea  Institute  of  Oriental  Medicine.,Non-OADS,/arxiv_data1/oa_pdf/a7/3e/main.PMC5478287.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a7/3e/main.PMC5478287.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/b8/main.PMC5478288.pdf
"Alternative therapies such as antimicrobial combination therapy or new antimicrobial agents from natural resources, e.g., insect ( Hirai et al., 1979 ), amphibian (Park et al., 1998 ), and mammalian ( Lee et al., 1989 ), have been http://dx.doi.org/10.1016/j.sjbs.2016.12.013 1319-562X/ /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/b1/b8/main.PMC5478288.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/b8/main.PMC5478288.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/be/69/main.PMC5478289.pdf
Each colony consisted of http://dx.doi.org/10.1016/j.sjbs.2016.12.018 1319-562X/ /C2112016 The Authors.,OADS,/arxiv_data1/oa_pdf/be/69/main.PMC5478289.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/be/69/main.PMC5478289.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/69/main.PMC5478289.pdf
"https://doi.org/10.1177/1177932217712241Bioinformatics and Biology Insights Volume 11:  1–14 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1177932217712241 Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Introduction Homeostasis with respect to the proportions of cells in differ- ent states is crucial for the functioning of multicellular organ-isms, and its regulation enables organisms to stay in a healthy state.",Non-OADS,/arxiv_data1/oa_pdf/b1/aa/10.1177_1177932217712241.PMC5478290.pdf
"We provide an implementation of CellTrans in R, freely available via GitHub (https://github.com/tbuder/CellTrans).",OADS,/arxiv_data1/oa_pdf/b1/aa/10.1177_1177932217712241.PMC5478290.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b6/17/main.PMC5478291.pdf
"Both internal and external factors affect haemocyte counts depending on age, instar, sex, size and method of detection in different organs and systems depending upon their mode and http://dx.doi.org/10.1016/j.sjbs.2016.12.011 1319-562X/ /C2112016 The Authors.",OADS,/arxiv_data1/oa_pdf/b6/17/main.PMC5478291.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding author at: Apartment No.,Non-OADS,/arxiv_data1/oa_pdf/b6/17/main.PMC5478291.pdf
This  is  an  open  access article under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/82/main.PMC5478292.pdf
"Since  then,  OY  prescriptions  can  be  found  in  several http://dx.doi.org/10.1016/j.imr.2017.03.006 2213-4220/©  2017  Korea  Institute  of  Oriental  Medicine.",Non-OADS,/arxiv_data1/oa_pdf/a1/82/main.PMC5478292.pdf
This  is  an  open  access  article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/82/main.PMC5478292.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/75/1b/main.PMC5478293.pdf
"The global production of honey is approximately 1.20 million tons per annum ( Bogdanov et al., http://dx.doi.org/10.1016/j.sjbs.2016.12.010 1319-562X/ /C2112017 The Authors.",OADS,/arxiv_data1/oa_pdf/75/1b/main.PMC5478293.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding author at: Department of Physiology (29), College of Medicine, King Saud University, P.O.",Non-OADS,/arxiv_data1/oa_pdf/75/1b/main.PMC5478293.pdf
http://dx.doi.org/10.1002/jsfa.7729 [Epub ahead of print].,Non-OADS,/arxiv_data1/oa_pdf/75/1b/main.PMC5478293.pdf
"Types of Honey: Available at: < http://www.honeyo.com/types.shtml >, (cited date Feb 2, 2016).",OADS,/arxiv_data1/oa_pdf/75/1b/main.PMC5478293.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/52/32/main.PMC5478294.pdf
"Interleukin-6 (IL- 6) is a multifunctional cytokine synthesized in response to stimuli such as inﬂammation and trauma ( Abbas et al., 2007 ) by a variety of cells such as macrophages, neutrophils, keratinocytes, ﬁbrob- http://dx.doi.org/10.1016/j.sjbs.2016.12.019 1319-562X/ /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/52/32/main.PMC5478294.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/52/32/main.PMC5478294.pdf
<http://www.apitherapie.ch/ﬁles/ﬁles/Propolis/PropolisBookReview.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/52/32/main.PMC5478294.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/df/fa/main.PMC5478295.pdf
Fungal spores present on all surfaces within http://dx.doi.org/10.1016/j.sjbs.2016.04.016 1319-562X/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/df/fa/main.PMC5478295.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/df/fa/main.PMC5478295.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b0/56/main.PMC5478296.pdf
"Furthermore, honey contains amino acids, vitamin B, Vitamin B6, Vitamin C, niacin, folic acid, minerals, iron, zinc and http://dx.doi.org/10.1016/j.sjbs.2016.12.020 1319-562X/ /C2112017 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/b0/56/main.PMC5478296.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding author at: Department of Physiology (29), College of Medicine, King Saud University, P.O.",Non-OADS,/arxiv_data1/oa_pdf/b0/56/main.PMC5478296.pdf
"5, 232. http://dx.doi.org/10.4172/2161- 1017.1000232 .",Non-OADS,/arxiv_data1/oa_pdf/b0/56/main.PMC5478296.pdf
http://dx.doi.org/10.1002/jsfa.7729 .,Non-OADS,/arxiv_data1/oa_pdf/b0/56/main.PMC5478296.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b6/a7/main.PMC5478297.pdf
"In a study carried ( Husain et al., 2014 ) out to determine the effect insecticides on three species of A.mellifera and their ability to survive and calculate the value of LT 50, there were found differ- http://dx.doi.org/10.1016/j.sjbs.2016.12.007 1319-562X/ /C2112016 The Author.",OADS,/arxiv_data1/oa_pdf/b6/a7/main.PMC5478297.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).E-mail address: daljedani@kau.edu.sa Peer review under responsibility of King Saud University.,Non-OADS,/arxiv_data1/oa_pdf/b6/a7/main.PMC5478297.pdf
"PLoS ONE 9 (3), 91180. http://dx.doi.org/10.1371/journal.pone.0091180 .",Non-OADS,/arxiv_data1/oa_pdf/b6/a7/main.PMC5478297.pdf
http://dx.doi.org/10.1007/s13592-013-0199-4 .,Non-OADS,/arxiv_data1/oa_pdf/b6/a7/main.PMC5478297.pdf
"PLoS ONE 6 (4), 18491. http://dx.doi.org/ 10.1371/ journal .",Non-OADS,/arxiv_data1/oa_pdf/b6/a7/main.PMC5478297.pdf
http://dx.doi.org/10.1016/j.imr.2017.03.004 2213-4220/©  2017  Korea  Institute  of  Oriental  Medicine.,Non-OADS,/arxiv_data1/oa_pdf/e7/d5/main.PMC5478298.pdf
This  is  an  open  access  article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e7/d5/main.PMC5478298.pdf
This  is  an  open  access article under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e7/d5/main.PMC5478298.pdf
"Supplementary  data Supplementary  data  associated  with  this  arti- cle can  be  found,  in  the  online  version,  at http://dx.doi.org/10.1016/j.imr.2017.03.004 .",OADS,/arxiv_data1/oa_pdf/e7/d5/main.PMC5478298.pdf
"MeSH Keywords:  Fracture Fixation, Intramedullary • Recovery of Function • Tibial Fractures  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/902261Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection GDepartment of Trauma Surgery and Joint Surgery, East Hospital Affiliated to Tongji  University, Shanghai, P.R.",Non-OADS,/arxiv_data1/oa_pdf/e9/cc/medscimonit-23-2871.PMC5478299.pdf
Medicine (2017) 96:24(e6580)Received: 1 November 2016 / Received in ﬁnal form: 13 March 2017 / Accepted: 18 March 2017 http://dx.doi.org/10.1097/MD.0000000000006580Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/a2/6d/medi-96-e6580.PMC5478300.pdf
"However,the number of CHB patients with a high viral load (HBV DNA > 2000IU/mL) —and hence being treated with an antiviral agent — was only slightly higher in the matched control group than in thepatients treated with 12.45g of BCAAs (see Table, supplemental data, http://links.lww.com/MD/B640 which shows the number of CHB patients with a high viral load and their treatment).",Non-OADS,/arxiv_data1/oa_pdf/a2/6d/medi-96-e6580.PMC5478300.pdf
Medicine (2017) 96:24(e6656)Received: 25 January 2017 / Received in ﬁnal form: 25 March 2017 / Accepted: 30 March 2017 http://dx.doi.org/10.1097/MD.0000000000006656Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/5b/a8/medi-96-e6656.PMC5478301.pdf
Medicine (2017) 96:24(e6817)Received: 15 March 2017 / Received in ﬁnal form: 12 April 2017 / Accepted: 13 April 2017 http://dx.doi.org/10.1097/MD.0000000000006817Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/2a/b6/medi-96-e6817.PMC5478302.pdf
Medicine (2017) 96:24(e6855)Received: 17 January 2016 / Received in ﬁnal form: 18 January 2017 / Accepted: 17 April 2017 http://dx.doi.org/10.1097/MD.0000000000006855Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/0f/f9/medi-96-e6855.PMC5478303.pdf
Medicine (2017) 96:24(e6884)Received: 11 January 2017 / Received in ﬁnal form: 15 March 2017 / Accepted: 9 April 2017 http://dx.doi.org/10.1097/MD.0000000000006884Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/bf/d3/medi-96-e6884.PMC5478304.pdf
"Fourth, there was publication bias in those publications enrolled into this systematic review and meta-analysis as evidenced by funnel plot(Supplement Figure 1, http://links.lww.com/MD/B727).",Non-OADS,/arxiv_data1/oa_pdf/bf/d3/medi-96-e6884.PMC5478304.pdf
"Available at: http://www.nccn.org., Accessed 2014.",Non-OADS,/arxiv_data1/oa_pdf/bf/d3/medi-96-e6884.PMC5478304.pdf
Medicine (2017) 96:24(e6934)Received: 26 September 2016 / Received in ﬁnal form: 11 April 2017 / Accepted: 21 April 2017 http://dx.doi.org/10.1097/MD.0000000000006934Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/22/d6/medi-96-e6934.PMC5478305.pdf
Medicine (2017) 96:24(e7010)Received: 16 November 2016 / Received in ﬁnal form: 3 May 2017 / Accepted: 3 May 2017 http://dx.doi.org/10.1097/MD.0000000000007010Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/96/bc/medi-96-e7010.PMC5478307.pdf
"All variants identi ﬁed by NGS and deemed as pathogenic were veri ﬁed by Sanger sequencing, using primers designed from Primer 3 online software (http://bioinfo.ut.ee/primer3 –0.4.0/primer3/input.htm).",OADS,/arxiv_data1/oa_pdf/96/bc/medi-96-e7010.PMC5478307.pdf
Medicine (2017) 96:24(e7070)Received: 25 August 2016 / Received in ﬁnal form: 2 April 2017 / Accepted: 6 May 2017 http://dx.doi.org/10.1097/MD.0000000000007070Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/0d/ed/medi-96-e7070.PMC5478309.pdf
Medicine (2017) 96:24(e7086)Received: 2 January 2017 / Received in ﬁnal form: 27 March 2017 / Accepted: 23 April 2017 http://dx.doi.org/10.1097/MD.0000000000007086Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/dc/05/medi-96-e7086.PMC5478310.pdf
Medicine (2017) 96:24(e7095)Received: 23 December 2016 / Received in ﬁnal form: 3 May 2017 / Accepted: 16 May 2017 http://dx.doi.org/10.1097/MD.0000000000007095Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/d8/b5/medi-96-e7095.PMC5478311.pdf
"”The detailed search strategies can be seen in Supplement S1, http://links.lww.com/ MD/B748.",Non-OADS,/arxiv_data1/oa_pdf/d8/b5/medi-96-e7095.PMC5478311.pdf
"Subgroup analysis results are presented in Supplement S2, http://links.lww.com/MD/B748.Results indicated that a TXA dose of 1g or 3g can decrease totalYu et al.",Non-OADS,/arxiv_data1/oa_pdf/d8/b5/medi-96-e7095.PMC5478311.pdf
"Available at: http://www.cochrane-handbook.org, Accessed 2011.",OADS,/arxiv_data1/oa_pdf/d8/b5/medi-96-e7095.PMC5478311.pdf
Medicine (2017) 96:24(e7099)Received: 18 January 2017 / Received in ﬁnal form: 15 May 2017 / Accepted: 16 May 2017 http://dx.doi.org/10.1097/MD.0000000000007099Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/a7/44/medi-96-e7099.PMC5478313.pdf
Medicine (2017) 96:24(e7105)Received: 26 July 2016 / Received in ﬁnal form: 9 May 2017 / Accepted: 16 May 2017 http://dx.doi.org/10.1097/MD.0000000000007105Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ee/20/medi-96-e7105.PMC5478314.pdf
Medicine (2017) 96:24(e7109)Received: 14 December 2016 / Received in ﬁnal form: 28 April 2017 / Accepted: 14 May 2017 http://dx.doi.org/10.1097/MD.0000000000007109Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/af/e7/medi-96-e7109.PMC5478315.pdf
Medicine (2017) 96:24(e7116)Received: 3 February 2017 / Received in ﬁnal form: 23 March 2017 / Accepted: 19 April 2017 http://dx.doi.org/10.1097/MD.0000000000007116Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/c4/9a/medi-96-e7116.PMC5478316.pdf
Available at: http://www.ons.gov.uk/ons/rel/pop-estimate/population-Liang et al.,OADS,/arxiv_data1/oa_pdf/c4/9a/medi-96-e7116.PMC5478316.pdf
"Available at: http://support.sas.com/resources/papers/proceedings12/335-2012.pdf.Accessed May 25, 2017.",Non-OADS,/arxiv_data1/oa_pdf/c4/9a/medi-96-e7116.PMC5478316.pdf
Medicine (2017) 96:24(e7126)Received: 13 April 2017 / Received in ﬁnal form: 9 May 2017 / Accepted: 10 May 2017 http://dx.doi.org/10.1097/MD.0000000000007126Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/87/2b/medi-96-e7126.PMC5478317.pdf
Medicine (2017) 96:24(e7127)Received: 17 April 2017 / Received in ﬁnal form: 10 May 2017 / Accepted: 12 May 2017 http://dx.doi.org/10.1097/MD.0000000000007127Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/4e/cb/medi-96-e7127.PMC5478318.pdf
Medicine (2017) 96:24(e7129)Received: 22 February 2017 / Received in ﬁnal form: 11 May 2017 / Accepted: 14 May 2017 http://dx.doi.org/10.1097/MD.0000000000007129Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/0d/20/medi-96-e7129.PMC5478320.pdf
Available at: https://www.nccn.org/professio nals/physician_gls/pdf/nscl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0d/20/medi-96-e7129.PMC5478320.pdf
Medicine (2017) 96:24(e7134)Received: 4 August 2016 / Received in ﬁnal form: 21 May 2017 / Accepted: 22 May 2017 http://dx.doi.org/10.1097/MD.0000000000007134Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/78/f6/medi-96-e7134.PMC5478322.pdf
2011; [ http://www.cochrane-handbook.org].,OADS,/arxiv_data1/oa_pdf/78/f6/medi-96-e7134.PMC5478322.pdf
Medicine (2017) 96:24(e7138)Received: 1 November 2016 / Received in ﬁnal form: 22 May 2017 / Accepted: 23 May 2017 http://dx.doi.org/10.1097/MD.0000000000007138Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/70/ab/medi-96-e7138.PMC5478323.pdf
Data on UNC5D orthologous genes were downloaded from the homologene database (http://www.ncbi.nlm.nih.gov/homo logene).,OADS,/arxiv_data1/oa_pdf/70/ab/medi-96-e7138.PMC5478323.pdf
Multiple-sequence alignment was carried out using theClustalW software (http://www.ebi.ac.uk/Tools/msa/clustalw2/).,OADS,/arxiv_data1/oa_pdf/70/ab/medi-96-e7138.PMC5478323.pdf
"The other4 candidate SNVs under the dominant model were genotyped in all 18 members by Sanger sequencing, only the novel mutation in the UNC5D gene (c.1297C >T, p.R433C) were con ﬁrmed to be consistent with the genetic relationship between family members (Supplemental Table 2, http://links.lww.com/MD/B737).",Non-OADS,/arxiv_data1/oa_pdf/70/ab/medi-96-e7138.PMC5478323.pdf
"The c.1297C >T, p.R433C mutation was a novel mutation compare to the Exome Aggregation Consortium(ExAC) database (http://exac.broadinstitute.org/), which spanned 60,706 unrelated individuals sequenced as part of various disease-speci ﬁc and population genetic studies.",OADS,/arxiv_data1/oa_pdf/70/ab/medi-96-e7138.PMC5478323.pdf
"From the structure model of UNC5D, p.R433 is in a hydrophilicenvironment, and the mutation resulting in a larger hydrophobic residue might subtly affect the interactions with other amino acid sites or ligands (Supplemental Figure 1, http://links.lww.com/MD/B737); thus, these genetic results indicated the UNC5D gene might be involved in the pathogenesis of anisometropia.",Non-OADS,/arxiv_data1/oa_pdf/70/ab/medi-96-e7138.PMC5478323.pdf
Medicine (2017) 96:24(e7142)Received: 3 January 2017 / Received in ﬁnal form: 16 May 2017 / Accepted: 24 May 2017 http://dx.doi.org/10.1097/MD.0000000000007142Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/9b/fa/medi-96-e7142.PMC5478326.pdf
Medicine (2017) 96:24(e7143)Received: 8 December 2016 / Received in ﬁnal form: 8 May 2017 / Accepted: 24 May 2017 http://dx.doi.org/10.1097/MD.0000000000007143Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/73/34/medi-96-e7143.PMC5478327.pdf
Medicine (2017) 96:24(e7144)Received: 20 December 2016 / Received in ﬁnal form: 23 May 2017 / Accepted: 25 May 2017 http://dx.doi.org/10.1097/MD.0000000000007144Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/a8/c9/medi-96-e7144.PMC5478328.pdf
Medicine (2017) 96:24(e7147)Received: 14 December 2016 / Received in ﬁnal form: 8 May 2017 / Accepted: 16 May 2017 http://dx.doi.org/10.1097/MD.0000000000007147Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/2b/b1/medi-96-e7147.PMC5478329.pdf
Available at: http://www.ers.usda.gov/data-products/rural-urban-continuum-codes.aspx.,Non-OADS,/arxiv_data1/oa_pdf/2b/b1/medi-96-e7147.PMC5478329.pdf
Available at: http://bhpr.hrsa.gov/shortage/hpsas/ designationcriteria/primarycarehpsaoverview.html.,Non-OADS,/arxiv_data1/oa_pdf/2b/b1/medi-96-e7147.PMC5478329.pdf
Available at: https://healthcaredelivery.cancer.gov/seermedicare/considerations/calculation.html.,Non-OADS,/arxiv_data1/oa_pdf/2b/b1/medi-96-e7147.PMC5478329.pdf
Available at: http://www.cancer.org/cancer/breastcancer/detailedguide/breast-cancer-risk-factors.,Non-OADS,/arxiv_data1/oa_pdf/2b/b1/medi-96-e7147.PMC5478329.pdf
Available at: http://www.nashp.org/sites/default/ ﬁles/Disparities_and_HCR_IB.,Non-OADS,/arxiv_data1/oa_pdf/2b/b1/medi-96-e7147.PMC5478329.pdf
Medicine (2017) 96:24(e7152)Received: 6 January 2017 / Received in ﬁnal form: 21 May 2017 / Accepted: 23 May 2017 http://dx.doi.org/10.1097/MD.0000000000007152Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/1d/43/medi-96-e7152.PMC5478330.pdf
Medicine (2017) 96:24(e7153)Received: 16 January 2017 / Received in ﬁnal form: 21 April 2017 / Accepted: 21 May 2017 http://dx.doi.org/10.1097/MD.0000000000007153Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/89/98/medi-96-e7153.PMC5478331.pdf
Medicine (2017) 96:24(e7157)Received: 17 February 2017 / Received in ﬁnal form: 22 May 2017 / Accepted: 24 May 2017 http://dx.doi.org/10.1097/MD.0000000000007157Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/60/9f/medi-96-e7157.PMC5478333.pdf
Medicine (2017) 96:24(e7161)Received: 19 April 2017 / Received in ﬁnal form: 22 May 2017 / Accepted: 23 May 2017 http://dx.doi.org/10.1097/MD.0000000000007161Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/a4/f9/medi-96-e7161.PMC5478334.pdf
"R Foundation for Statistical Computing, Vienna, Austria; 2014. http://www.R-project.org/.",Non-OADS,/arxiv_data1/oa_pdf/a4/f9/medi-96-e7161.PMC5478334.pdf
Available at: https://www.jstatsoft.org/article/view/v036i03.,Non-OADS,/arxiv_data1/oa_pdf/a4/f9/medi-96-e7161.PMC5478334.pdf
Available at: https://rdrr.io/cran/forestplot/.,Non-OADS,/arxiv_data1/oa_pdf/a4/f9/medi-96-e7161.PMC5478334.pdf
Medicine (2017) 96:24(e7166)Received: 15 May 2016 / Received in ﬁnal form: 30 April 2017 / Accepted: 24 May 2017 http://dx.doi.org/10.1097/MD.0000000000007166Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/f0/eb/medi-96-e7166.PMC5478336.pdf
Medicine (2017) 96:24(e7167)Received: 1 February 2017 / Received in ﬁnal form: 16 May 2017 / Accepted: 24 May 2017 http://dx.doi.org/10.1097/MD.0000000000007167Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ac/73/medi-96-e7167.PMC5478337.pdf
Medicine (2017) 96:24(e7168)Received: 9 February 2017 / Received in ﬁnal form: 16 May 2017 / Accepted: 24 May 2017 http://dx.doi.org/10.1097/MD.0000000000007168Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/6e/81/medi-96-e7168.PMC5478338.pdf
"And a few studies[16,42,45]reported that they performed an adequate allocation but did not report the sequence(item 24) (see Supplemental Table 1, http://links.lww.com/MD/B740, which demonstrates full scoring results).",Non-OADS,/arxiv_data1/oa_pdf/6e/81/medi-96-e7168.PMC5478338.pdf
"Begg test ( P=.921, see Supplemental Figure 1, http:// links.lww.com/MD/B740, which shows the Begg funnel plot) andEgger test (SE =0.63, P=.880, see Supplemental Figure 2, http://links.lww.com/MD/B740, which demonstrates the Egger publi- cation bias plot) for funnel plot asymmetry were not statistically signiﬁcant, indicating weak evidence of publication bias for the ﬁrst peak EKAM.Table 2 Demographics of included studies.",Non-OADS,/arxiv_data1/oa_pdf/6e/81/medi-96-e7168.PMC5478338.pdf
"Begg test ( P=.764, see Supplemental Figure 3, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/6e/81/medi-96-e7168.PMC5478338.pdf
"Begg test (P=.602, see Supplemental Figure 5, http://links.lww.com/MD/ B740, which demonstrates the Begg funnel plot) and Egger test(SE=0.87, P=0.779, see Supplemental Figure 6, http://links.",Non-OADS,/arxiv_data1/oa_pdf/6e/81/medi-96-e7168.PMC5478338.pdf
Medicine (2017) 96:24(e7169)Received: 7 November 2016 / Received in ﬁnal form: 16 May 2017 / Accepted: 24 May 2017 http://dx.doi.org/10.1097/MD.0000000000007169Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/c0/a9/medi-96-e7169.PMC5478339.pdf
"R software, version 3.0 (http://www.R-project.org/),was used to perform all statistical analyses.",OADS,/arxiv_data1/oa_pdf/c0/a9/medi-96-e7169.PMC5478339.pdf
Medicine (2017) 96:24(e7173)Received: 5 April 2017 / Received in ﬁnal form: 16 May 2017 / Accepted: 20 May 2017 http://dx.doi.org/10.1097/MD.0000000000007173Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/69/32/medi-96-e7173.PMC5478340.pdf
Medicine (2017) 96:24(e7179)Received: 17 March 2017 / Received in ﬁnal form: 23 May 2017 / Accepted: 24 May 2017 http://dx.doi.org/10.1097/MD.0000000000007179Meta-Analysis of Observational Studies in Epidemiology Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/0f/a7/medi-96-e7179.PMC5478341.pdf
Medicine (2017) 96:24(e7185)Received: 31 October 2016 / Received in ﬁnal form: 25 April 2017 / Accepted: 24 May 2017 http://dx.doi.org/10.1097/MD.0000000000007185Quality Improvement Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/c3/3f/medi-96-e7185.PMC5478342.pdf
Available at: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#site.,Non-OADS,/arxiv_data1/oa_pdf/c3/3f/medi-96-e7185.PMC5478342.pdf
Medicine (2017) 96:24(e7187)Received: 14 March 2017 / Received in ﬁnal form: 15 May 2017 / Accepted: 16 May 2017 http://dx.doi.org/10.1097/MD.0000000000007187Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/57/bb/medi-96-e7187.PMC5478343.pdf
Medicine (2017) 96:24(e7188)Received: 22 March 2017 / Received in ﬁnal form: 17 May 2017 / Accepted: 21 May 2017 http://dx.doi.org/10.1097/MD.0000000000007188Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/cd/b7/medi-96-e7188.PMC5478344.pdf
Medicine (2017) 96:24(e7189)Received: 4 March 2017 / Received in ﬁnal form: 17 May 2017 / Accepted: 18 May 2017 http://dx.doi.org/10.1097/MD.0000000000007189Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/e2/af/medi-96-e7189.PMC5478345.pdf
"Furthermore, there was also no difference in platelets composi-tion (Supplementary Table 1, http://links.lww.com/MD/B735).",Non-OADS,/arxiv_data1/oa_pdf/e2/af/medi-96-e7189.PMC5478345.pdf
Medicine (2017) 96:24(e7191)Received: 28 March 2017 / Received in ﬁnal form: 17 May 2017 / Accepted: 23 May 2017 http://dx.doi.org/10.1097/MD.0000000000007191Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ec/00/medi-96-e7191.PMC5478346.pdf
Statistical analysis HWE of the control group was evaluated using an online tool (available at https://ihg.gsf.de/cgi-bin/hw/hwa1.pl) for eachstudy.,OADS,/arxiv_data1/oa_pdf/ec/00/medi-96-e7191.PMC5478346.pdf
"We re-tested all genetic models excluding each study in turn as well as excluding the studythat deviated from HWE in the control group, and found that the pooled estimates did not change, which demonstrates the results of our meta-analysis were stable (Supplemental Figures S1 and S2,http://links.lww.com/MD/B736).",Non-OADS,/arxiv_data1/oa_pdf/ec/00/medi-96-e7191.PMC5478346.pdf
Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm.,Non-OADS,/arxiv_data1/oa_pdf/ec/00/medi-96-e7191.PMC5478346.pdf
Medicine (2017) 96:24(e7193)Received: 25 March 2017 / Received in ﬁnal form: 14 May 2017 / Accepted: 18 May 2017 http://dx.doi.org/10.1097/MD.0000000000007193Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/f9/a8/medi-96-e7193.PMC5478347.pdf
Medicine (2017) 96:24(e7199)Received: 19 December 2016 / Received in ﬁnal form: 9 May 2017 / Accepted: 20 May 2017 http://dx.doi.org/10.1097/MD.0000000000007199Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/d4/99/medi-96-e7199.PMC5478348.pdf
Medicine (2017) 96:24(e7200)Received: 20 November 2016 / Received in ﬁnal form: 7 April 2017 / Accepted: 24 May 2017 http://dx.doi.org/10.1097/MD.0000000000007200Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/22/b1/medi-96-e7200.PMC5478349.pdf
"The example video of 2-FPS and 4-FPS setting during trans-septalpuncture was presented in a movie ﬁle (see Video, Supplemental Digital Content 1, http://links.lww.com/MD/B742 —comparison of the real-time frame rates between 2-FPS and 4-FPS duringtrans-septal catheterization).",Non-OADS,/arxiv_data1/oa_pdf/22/b1/medi-96-e7200.PMC5478349.pdf
Medicine (2017) 96:24(e7202)Received: 1 December 2016 / Received in ﬁnal form: 25 April 2017 / Accepted: 21 May 2017 http://dx.doi.org/10.1097/MD.0000000000007202Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/94/13/medi-96-e7202.PMC5478350.pdf
Medicine (2017) 96:24(e7209)Received: 22 December 2016 / Received in ﬁnal form: 21 March 2017 / Accepted: 18 May 2017 http://dx.doi.org/10.1097/MD.0000000000007209Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/12/ff/medi-96-e7209.PMC5478352.pdf
"Multivariate regression analysis When we conducted a multivariate regression analysis, utilizing the variables found to be signi ﬁcantly different in our regional bivariate analysis comparing regions 4 and 6 versus other regions (hospital inclusion, AMC inclusion, number of bene ﬁciaries, and total Medicare per capita cost), only the total Medicare per capita cost remained signi ﬁcant in predicting the ability of an ACO to earn a shared savings payment ( P<.001) (see Table, Supplemen- tal Content, http://links.lww.com/MD/B753, which displays the output of the regression analysis).",Non-OADS,/arxiv_data1/oa_pdf/12/ff/medi-96-e7209.PMC5478352.pdf
Available from: http://www.hhs.gov/about/news/2016/01/11/new-hospitals-and-health-care-providers-join-successful-cutting-edge-federal-initiative.html.,Non-OADS,/arxiv_data1/oa_pdf/12/ff/medi-96-e7209.PMC5478352.pdf
Available from: https://www.cms.gov/Newsroom/MediaReleaseDatabase/Press-releases/2015-Press-releases-items/2015-08-25.html.,Non-OADS,/arxiv_data1/oa_pdf/12/ff/medi-96-e7209.PMC5478352.pdf
Availablefrom: https://www.cms.gov/Newsroom/MediaReleaseDatabase/Fact-sheets/2015-Fact-sheets-items/2015-08-25.html.,Non-OADS,/arxiv_data1/oa_pdf/12/ff/medi-96-e7209.PMC5478352.pdf
Available from: http://healthaffairs.org/blog/2015/01/22/early-evidence-on-medicare-acos-and-next-steps-for-the-medicare-aco-program/.,Non-OADS,/arxiv_data1/oa_pdf/12/ff/medi-96-e7209.PMC5478352.pdf
Available from: http://healthaffairs.org/blog/2015/01/22/unpacking-the-medicare-shared-savings-proposed-rule-geography-and-policy/.,Non-OADS,/arxiv_data1/oa_pdf/12/ff/medi-96-e7209.PMC5478352.pdf
Available from:http://healthaffairs.org/blog/2014/12/18/aco-quality-results-good-but-not-great/.,Non-OADS,/arxiv_data1/oa_pdf/12/ff/medi-96-e7209.PMC5478352.pdf
Available from: https://www.cms.gov/ Newsroom/MediaReleaseDatabase/Fact-sheets/2016-Fact-sheets-items/2016-06-06.html.,Non-OADS,/arxiv_data1/oa_pdf/12/ff/medi-96-e7209.PMC5478352.pdf
Available from: https://data.cms.gov/ACO/Medicare-Shared-Savings- Program-Accountable-Care-O/yuq5-65xt.,OADS,/arxiv_data1/oa_pdf/12/ff/medi-96-e7209.PMC5478352.pdf
"Baltimore (MD):Centers for Medicare and Medicaid Services; [updated August, 2015].Available from: https://data.cms.gov/ACO/Medicare-Shared-Savings-Program-Accountable-Care-O/ucce-hhpu.",OADS,/arxiv_data1/oa_pdf/12/ff/medi-96-e7209.PMC5478352.pdf
Available from: https://data.cms.gov/ACO/Medicare-Shared-Savings- Program-Accountable-Care-O/ay8x-m5k6.,Non-OADS,/arxiv_data1/oa_pdf/12/ff/medi-96-e7209.PMC5478352.pdf
Available from: https://www.cms.gov/About-CMS/Agency-Information/RegionalOf ﬁces/RegionalMap.html.,OADS,/arxiv_data1/oa_pdf/12/ff/medi-96-e7209.PMC5478352.pdf
Available from: https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Dashboard/GeoVar-State/GeoVar_State.html.,OADS,/arxiv_data1/oa_pdf/12/ff/medi-96-e7209.PMC5478352.pdf
Medicine (2017) 96:24(e7211)Received: 12 January 2017 / Received in ﬁnal form: 13 May 2017 / Accepted: 16 May 2017 http://dx.doi.org/10.1097/MD.0000000000007211Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/fa/77/medi-96-e7211.PMC5478353.pdf
Medicine (2017) 96:24(e7214)Received: 28 February 2017 / Received in ﬁnal form: 27 April 2017 / Accepted: 19 May 2017 http://dx.doi.org/10.1097/MD.0000000000007214Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/a1/f9/medi-96-e7214.PMC5478354.pdf
Medicine (2017) 96:24(e7215)Received: 9 February 2017 / Received in ﬁnal form: 23 May 2017 / Accepted: 24 May 2017 http://dx.doi.org/10.1097/MD.0000000000007215Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/d8/cd/medi-96-e7215.PMC5478355.pdf
E-mail address :aalkhazim1@gmail.com (A. Al-Ghamdi) http://dx.doi.org/10.1016/j.sjbs.2017.06.007 1319-562X/ /C2112017 Production and hosting by Elsevier B.V. on behalf of King Saud University.,Non-OADS,/arxiv_data1/oa_pdf/19/34/main.PMC5478364.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Peer review under responsibility of King Saud University.,Non-OADS,/arxiv_data1/oa_pdf/19/34/main.PMC5478364.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5478365.pdf
"The decline of honeybees seems to be due to multiple causes including the occur- rence of epidemiological factors affecting honeybee health, com- prising disease and parasites, the degradation and fragmentation http://dx.doi.org/10.1016/j.sjbs.2017.01.062 1319-562X/ /C2112017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5478365.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5478365.pdf
Factors Data Source URL Temperature Temperature data ARSAC http://arsac.calabria.it/ (available upon request) Road Road network CISIS DBPrior 10 k project http://www.centrointerregionale-gis.it/ Water needs Hydrographic network CISIS DBPrior 10 k project http://www.centrointerregionale-gis.it/ Altitude Digital elevation model ISPRA http://www.isprambiente.gov.it Land use CLC IV level 2012P.,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5478365.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.sjbs.2017.01.062 .",OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5478365.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/48/d4/main.PMC5478366.pdf
"Origi- nally, N. apis and N. ceranae were reported in European honey bees (A. mellifera ) and Asian honey bees ( Apis cerana ), respectively, and http://dx.doi.org/10.1016/j.sjbs.2017.01.010 1319-562X/ /C2112017 The Authors.",OADS,/arxiv_data1/oa_pdf/48/d4/main.PMC5478366.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/48/d4/main.PMC5478366.pdf
"However, the same measures are not needed in cases of N. ceranae infected apiaries (see http://www.sivempveneto.it/leggi-tutte-le-notizie/ 3664-parere-ministero-misure-polizia-veterinaria-solo-nei-casi- di-nosema-apis-clinicamente-manifesta ).",Non-OADS,/arxiv_data1/oa_pdf/48/d4/main.PMC5478366.pdf
51: doi: http://dx.doi.org/10.3896/IBRA.1.52.1.14 (accessed 14.02.14).,Non-OADS,/arxiv_data1/oa_pdf/48/d4/main.PMC5478366.pdf
Available online: < http://articles.extension.org/pages/60674/effects-of-nosema-on- honey-bee-behavior-and-physiology > (accessed 14.02.14).,Non-OADS,/arxiv_data1/oa_pdf/48/d4/main.PMC5478366.pdf
http://dx.doi.org/10.1371/journal.ppat.1000489 .,Non-OADS,/arxiv_data1/oa_pdf/48/d4/main.PMC5478366.pdf
http://dx.doi.org/10.1371/journal.pone.0020656 .,Non-OADS,/arxiv_data1/oa_pdf/48/d4/main.PMC5478366.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/48/d4/main.PMC5478366.pdf
http://dx.doi.org/10.1371/journal.pone.0006481 .,Non-OADS,/arxiv_data1/oa_pdf/48/d4/main.PMC5478366.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/42/a7/main.PMC5478367.pdf
"Several causes of these large-scale losses have been reported, including honey bee parasites ( Varroa destructor ,Acarapis http://dx.doi.org/10.1016/j.sjbs.2017.01.054 1319-562X/ /C2112017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/42/a7/main.PMC5478367.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/42/a7/main.PMC5478367.pdf
"Partial 16S rRNA gene sequences of the iso- lates were compared with 16S rRNA gene sequences available by the BLAST search ( Altschul et al., 1990 ), in the National Centre for Biotechnology Information (NCBI) database ( http://www.ncbi.",OADS,/arxiv_data1/oa_pdf/42/a7/main.PMC5478367.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/42/a7/main.PMC5478367.pdf
http://dx.doi.org/10.1016/j.sjbs.2016.10.012 .,OADS,/arxiv_data1/oa_pdf/42/a7/main.PMC5478367.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/42/a7/main.PMC5478367.pdf
URL http://www.oie.int/en/animal-health-in-the-world/oie- listeddiseases-2013 .,Non-OADS,/arxiv_data1/oa_pdf/42/a7/main.PMC5478367.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/41/22/main.PMC5478368.pdf
These conditions force many beekeepers to move their http://dx.doi.org/10.1016/j.sjbs.2017.01.009 1319-562X/ /C2112017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/41/22/main.PMC5478368.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/41/22/main.PMC5478368.pdf
http://dx.doi.org/10.1046/j.1365-2311.2003.00548.x .,Non-OADS,/arxiv_data1/oa_pdf/41/22/main.PMC5478368.pdf
http://dx.doi.org/ 10.1111/j.1365-2311.1993.tb01089.x .,Non-OADS,/arxiv_data1/oa_pdf/41/22/main.PMC5478368.pdf
< http://faculty.ksu.edu.,Non-OADS,/arxiv_data1/oa_pdf/41/22/main.PMC5478368.pdf
http://dx.doi.org/10.2307/1939214 .,Non-OADS,/arxiv_data1/oa_pdf/41/22/main.PMC5478368.pdf
http://dx.doi.org/10.1890/ 1051-0761(2000) 010[1861: RSOVPS]2.0.CO;2 .,Non-OADS,/arxiv_data1/oa_pdf/41/22/main.PMC5478368.pdf
http://dx.doi.org/10.1046/j.1442-9993.2000.01010.x .,OADS,/arxiv_data1/oa_pdf/41/22/main.PMC5478368.pdf
http://dx.doi.org/ 10.2478/v10289-012-0023-9 .,Non-OADS,/arxiv_data1/oa_pdf/41/22/main.PMC5478368.pdf
http://dx.doi.org/10.1111/ j.1469-8137.2003.01003.x .,Non-OADS,/arxiv_data1/oa_pdf/41/22/main.PMC5478368.pdf
http://dx.doi.org/10.1016/j.chb.2013.06.025 .,OADS,/arxiv_data1/oa_pdf/41/22/main.PMC5478368.pdf
http://dx.doi.org/10.1093/jpe/rtm005 .1044 N. Adgaba et al.,OADS,/arxiv_data1/oa_pdf/41/22/main.PMC5478368.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c4/cc/main.PMC5478369.pdf
http://dx.doi.org/10.1016/j.sjbs.2017.01.055 1319-562X/ /C2112017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/cc/main.PMC5478369.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/c4/cc/main.PMC5478369.pdf
Closely related partial 16S rRNA sequences were retrieved from the National Cen- ter for Biotechnology Information (NCBI) database by BLAST-N (https://blast.ncbi.nlm.nih.gov ).,OADS,/arxiv_data1/oa_pdf/c4/cc/main.PMC5478369.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.sjbs.2017.01.055 .",OADS,/arxiv_data1/oa_pdf/c4/cc/main.PMC5478369.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/cc/main.PMC5478369.pdf
http://bioinfogp.cnb.csic.es/tools/venny/index.html (accessed: 02.12.2016).,OADS,/arxiv_data1/oa_pdf/c4/cc/main.PMC5478369.pdf
"14, 129. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c4/cc/main.PMC5478369.pdf
"Guest Editor Prof. Ahmad Al-Ghamdi Co-Guest Editor Dr. Mohammad Javed Ansari E-mail addresses :aalkhazim1@gmail.com (A. Al-Ghamdi), mjavedansari@gmail.com (M. Javed Ansari) http://dx.doi.org/10.1016/j.sjbs.2017.06.008 1319-562X/ /C2112017 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/69/9d/main.PMC5478370.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Peer review under responsibility of King Saud University.,Non-OADS,/arxiv_data1/oa_pdf/69/9d/main.PMC5478370.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c4/31/main.PMC5478371.pdf
http://dx.doi.org/10.1016/j.sjbs.2017.01.007 1319-562X/ /C2112017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/31/main.PMC5478371.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/c4/31/main.PMC5478371.pdf
http://dx.doi.org/10.5897/JAERD14.0592 .,Non-OADS,/arxiv_data1/oa_pdf/c4/31/main.PMC5478371.pdf
(MSc Thesis) University of Gulf.PP 81. http://www.uoguelph.,Non-OADS,/arxiv_data1/oa_pdf/c4/31/main.PMC5478371.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/31/main.PMC5478371.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/c8/main.PMC5478372.pdf
http://dx.doi.org/10.1016/j.sjbs.2017.01.008 1319-562X/ /C2112017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a6/c8/main.PMC5478372.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/a6/c8/main.PMC5478372.pdf
http://dx.doi.org/10.3896/IBRA.1.52.3.03 .,Non-OADS,/arxiv_data1/oa_pdf/a6/c8/main.PMC5478372.pdf
http://dx.doi.org/ 10.1016/j.sjbs.2013.10.007 .,OADS,/arxiv_data1/oa_pdf/a6/c8/main.PMC5478372.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/c8/main.PMC5478372.pdf
http://dx.doi.org/10.1007/s13592-012-0138-9 .,Non-OADS,/arxiv_data1/oa_pdf/a6/c8/main.PMC5478372.pdf
"56 (1), 147– 158. http://dx.doi.org/10.2478/v10289-012-0015-9 .",Non-OADS,/arxiv_data1/oa_pdf/a6/c8/main.PMC5478372.pdf
http://dx.doi.org/ 10.3896/IBRA.1.49.2.04 .,Non-OADS,/arxiv_data1/oa_pdf/a6/c8/main.PMC5478372.pdf
http://dx.doi.org/ 10.3896/IBRA.1.53.2.05 .,Non-OADS,/arxiv_data1/oa_pdf/a6/c8/main.PMC5478372.pdf
http://dx.doi.org/10.1051/apido:19660402 .,Non-OADS,/arxiv_data1/oa_pdf/a6/c8/main.PMC5478372.pdf
http://dx.doi.org/10.3896/IBRA.1.53.2.01 .,Non-OADS,/arxiv_data1/oa_pdf/a6/c8/main.PMC5478372.pdf
http://dx.doi.org/10.1051/ apido:2007012 .A.A.,OADS,/arxiv_data1/oa_pdf/a6/c8/main.PMC5478372.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0d/19/main.PMC5478373.pdf
We hypothesize that A. barba-jovis could be a pivotal source of pol- len and nectar for Apoidea in arid coastal areas of the Mediter- http://dx.doi.org/10.1016/j.sjbs.2017.01.018 1319-562X/ /C2112017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0d/19/main.PMC5478373.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/0d/19/main.PMC5478373.pdf
http://dx.doi.org/10.1007/s10876-016-1143-3 .,Non-OADS,/arxiv_data1/oa_pdf/0d/19/main.PMC5478373.pdf
http://dx.doi.org/10.1007/s11829-016- 9488-y .,Non-OADS,/arxiv_data1/oa_pdf/0d/19/main.PMC5478373.pdf
http://dx.doi.org/10.1016/j.agee.2012.06.020 .,OADS,/arxiv_data1/oa_pdf/0d/19/main.PMC5478373.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/f2/main.PMC5478387.pdf
"Furthermore, wide attention has been drawn to the fact that traces of these pesticides have been found http://dx.doi.org/10.1016/j.sjbs.2017.01.052 1319-562X/ /C2112017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/83/f2/main.PMC5478387.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/83/f2/main.PMC5478387.pdf
"Developmental Cognitive Neuroscience  25  (2017)  58–68 Contents  lists  available  at  ScienceDirect Developmental  Cognitive  Neuroscience jo  ur  nal  ho  me  pag  e:  http://www.elsevier.com/locate/dcn Children’s  head motion during  fMRI  tasks  is  heritable  and  stable  over time Laura  E.  Engelhardta,∗,  Mary  Abbe  Roea,  Jenifer  Juranekb,  Dana  DeMasterb, K. Paige  Hardena,c,  Elliot  M.  Tucker-Droba,c,  Jessica  A.  Churcha,d aDepartment  of  Psychology,  The  University  of  Texas  at  Austin,  United  States bThe Children’s Learning  Institute,  The  University  of  Texas  Health  Science  Center  at  Houston,  United  States cPopulation  Research  Center,  The  University  of  Texas  at  Austin,  United  States dImaging  Research  Center,  The  University  of  Texas  at  Austin,  United  States a  r  t  i  c  l  e  i  n  f  o Article history: Received  27  September  2016 Received  in  revised  form 21  November  2016 Accepted  30  January  2017 Available  online 1 February 2017 Keywords:Head motion fMRITwin study Repeated  measures Individual  differencesa  b  s  t  r  a  c  t Head  motion  during  fMRI  scans  negatively  impacts  data  quality,  and  as  post-acquisition  techniques  for addressing motion  become  increasingly  stringent,  data  retention  decreases.",Non-OADS,/arxiv_data1/oa_pdf/60/f6/main.PMC5478437.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/60/f6/main.PMC5478437.pdf
https://doi.org/10.1016/j.dcn.2017.01.011 1878-9293/© 2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/60/f6/main.PMC5478437.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.,Non-OADS,/arxiv_data1/oa_pdf/60/f6/main.PMC5478437.pdf
"21  (1),  93–111,  http://dx.doi.org/10.1207/S15326942DN2101  5.",Non-OADS,/arxiv_data1/oa_pdf/60/f6/main.PMC5478437.pdf
"11  (1),  e1001462, http://dx.doi.org/10.1371/journal.pbio.1001462 .",Non-OADS,/arxiv_data1/oa_pdf/60/f6/main.PMC5478437.pdf
"31  (6),  852–862,  http://dx.doi.org/10.1002/hbm.21036 .",Non-OADS,/arxiv_data1/oa_pdf/60/f6/main.PMC5478437.pdf
"23  (1), 33–45,  http://dx.doi.org/10.1016/j.euroneuro.2012.10.015 .",Non-OADS,/arxiv_data1/oa_pdf/60/f6/main.PMC5478437.pdf
"PLoS  One  11  (1), e0146271  http://dx.doi.org/10.1371/journal.pone.0146271 .Diedenhofen,  B.,  Musch,  J.,  2015.  cocor:  a  comprehensive  solution  for  the  statistical comparison  of  correlations.",OADS,/arxiv_data1/oa_pdf/60/f6/main.PMC5478437.pdf
"PLoS  One  10  (4),  http://dx.doi.org/10.1371/journal.",Non-OADS,/arxiv_data1/oa_pdf/60/f6/main.PMC5478437.pdf
"9  (631),  http://dx.doi.org/10.3389/fnhum.2015.00631 .",Non-OADS,/arxiv_data1/oa_pdf/60/f6/main.PMC5478437.pdf
"155  (1), 75–82, http://dx.doi.org/10.1016/j.pscychresns.2006.12.009 .",OADS,/arxiv_data1/oa_pdf/60/f6/main.PMC5478437.pdf
"PLoS One  5  (4), e10110, http://dx.doi.org/10.1371/journal.pone.",Non-OADS,/arxiv_data1/oa_pdf/60/f6/main.PMC5478437.pdf
"18,  101–112,  http://dx.doi.org/10.1016/j.dcn.2015.12.005 .",OADS,/arxiv_data1/oa_pdf/60/f6/main.PMC5478437.pdf
"16  (1),  385–390,  http://dx.doi.org/10.1017/thg.2012.97 .",Non-OADS,/arxiv_data1/oa_pdf/60/f6/main.PMC5478437.pdf
"Cortex  19  (3),  640–657,  http://dx.doi.org/ 10.1093/cercor/bhn117 .",OADS,/arxiv_data1/oa_pdf/60/f6/main.PMC5478437.pdf
"Cortex,  http://dx.doi.",OADS,/arxiv_data1/oa_pdf/60/f6/main.PMC5478437.pdf
"Cortex  17  (5), 1047–1054,  http://dx.doi.org/10.1093/cercor/bhl014 .",OADS,/arxiv_data1/oa_pdf/60/f6/main.PMC5478437.pdf
1–128  (Retrieved from) http://CRAN.R-project.org/package=nlme .,Non-OADS,/arxiv_data1/oa_pdf/60/f6/main.PMC5478437.pdf
"Neuroimage  59  (3),  2142–2154,  http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/60/f6/main.PMC5478437.pdf
"Neuroimage  84  (0),  320–341,  http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/60/f6/main.PMC5478437.pdf
"Neuroimage  105,  536–551, http://dx.doi.org/10.1016/j.neuroimage.2014.10.044 .",OADS,/arxiv_data1/oa_pdf/60/f6/main.PMC5478437.pdf
"Neuroimage  60  (1),  623–632,  http://dx.doi.org/10.1016/j.neuroimage.2012.08.",OADS,/arxiv_data1/oa_pdf/60/f6/main.PMC5478437.pdf
"Neuroimage  64,  240–256,  http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/60/f6/main.PMC5478437.pdf
"35 (5),  1981–1996,  http://dx.doi.org/10.1002/hbm.22307 .",Non-OADS,/arxiv_data1/oa_pdf/60/f6/main.PMC5478437.pdf
"Cortex,  http://dx.doi.org/10.1093/cercor/ bhw253 ,  in  press.",OADS,/arxiv_data1/oa_pdf/60/f6/main.PMC5478437.pdf
"Package,  Version  2.38, Retrieved from  http://CRAN.R-project.org/package=survival .",Non-OADS,/arxiv_data1/oa_pdf/60/f6/main.PMC5478437.pdf
"Neuroimage  122,  222–232,  http://dx.doi.org/10.1016/j.neuroimage.",OADS,/arxiv_data1/oa_pdf/60/f6/main.PMC5478437.pdf
"Neuroimage  76,  183–201, http://dx.doi.org/10.1016/j.neuroimage.2013.03.004 .",OADS,/arxiv_data1/oa_pdf/60/f6/main.PMC5478437.pdf
"Developmental Cognitive Neuroscience  25  (2017)  145–159 Contents  lists  available  at  ScienceDirect Developmental  Cognitive  Neuroscience j  o  ur  nal  ho  me  pa  ge:  http://www.elsevier.com/locate/dcn Early  life adversity during  the  infant  sensitive  period  for  attachment: Programming  of behavioral neurobiology of  threat  processing  and social  behavior Maya  Opendaka,b,∗,  Elizabeth  Gouldc,  Regina  Sullivana,b aEmotional  Brain  Institute,  Nathan  Kline  Institute  for  Psychiatric  Research,  Orangeburg,  NY,  USA bChild  Study  Center,  Child  &  Adolescent  Psychiatry,  New  York  University  School  of  Medicine,  New  York,  USA cDepartment of Psychology, Princeton University, Princeton, NJ,  USA a  r  t  i  c  l  e  i  n  f  o Article  history: Received  30  April  2016 Received  in  revised  form  3  January  2017 Accepted  4  February  2017 Available  online 16 February 2017 Keywords:DevelopmentThreatAmygdalaSocial behavior Dominance  hierarchya  b  s  t  r  a  c  t Animals,  including  humans,  require  a  highly  coordinated  and  ﬂexible  system  of  social  behavior  and  threat evaluation.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
https://doi.org/10.1016/j.dcn.2017.02.002 1878-9293/© 2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.,Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Neural  Circuits  6,  8,  http://dx.doi.org/10.3389/fncir.",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"935  (1),  107–117,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"6  (2),  196–202,  http://dx.doi.org/10.1038/ nn1001 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"30  (1),  97–117,  http://dx.doi.org/10.1016/j.neubiorev.2005.07.002 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"92 (3),  292–300,  http://dx.doi.org/10.1016/j.nlm.2009.03.004 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"16  (6),  332–344,  http://dx.doi.org/10.1038/ nrn3818 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"130  (1),  107–152,  http://dx.doi.org/10.1111/j.1096-3642.1958.tb00565.x .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"12  (11),  1367–1369,  http://dx.doi.org/10.1038/nn.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"120  (4), 749–760, http://dx.doi.org/10.1037/0735-7044.120.4.749 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Neuroscience  279,  187–219,  http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"65,  187–207,  http://dx.doi.org/10.1146/ annurev-psych-010213-115202 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"125 (6),  848–858,  http://dx.doi.org/10.1037/a0025757 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"8,  11,  http://dx.doi.org/10.3389/fnins.2014.00011 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"1125  (1),  9–16,  http://dx.doi.org/10.1016/j.brainres.",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"56  (8),  1635–1650,  http://dx.doi.org/10.1002/dev.21260 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"53,  128–137,  http://dx.doi.org/10.1016/j.chiabu.2015.11.010 .",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"9 (3),  104–110,  http://dx.doi.org/10.1016/j.tics.2005.01.011 .",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"520 (9), 1965–1984, http://dx.doi.org/10.1002/cne.23023 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"520  (16),  3745–3763, http://dx.doi.org/10.1002/cne.23132 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"33  (4),  573–585,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"10  (4),  248–258,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Endocrinology 141  (5),  1590–1592, http://dx.doi.org/10.1210/endo.141.5.7527 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"17,  http://dx.doi.org/10.1016/ 0166-2236(94)90106-6 .",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"77,  182–192,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"19),  4819–4838,  http://dx.doi.org/10.1113/ jphysiol.2012.237453 .Elzinga,  B.M.,  Schmahl,  C.G.,  Vermetten,  E.,  van  Dyck,  R.,  Bremner,  J.D.,  2003.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Neuropsychopharmacology  28  (9),  1656–1665,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"23  (2),  200–224,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"11  (2), 327–336,  http://dx.doi.org/10.1093/scan/nsv116 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"502  (6),  1109–1122,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Psychiatry  57  (10), 1154–1164,  http://dx.doi.org/10.1111/jcpp.12630 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"18,  57–69,  http://dx.doi.org/10.1016/j.dcn.2015.08.009 .",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"176  (1),  75–93,  http://dx.doi.org/10.1016/j.bbr.2006.09.020 .",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"12,  12–39,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"18,  12–25,  http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"55  (8),  849–859,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Psychiatry  57  (10), 1135–1144, http://dx.doi.org/10.1111/jcpp.12578 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Cell 157 (7),  1535–1551, http://dx.doi.org/10.1016/j.cell.2014.05.017 .",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"58,  145–173,  http://dx.doi.org/10.1146/annurev.psych.58.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"167,  137–149,  http://dx.doi.org/10.1016/ S0079-6123(07)67010-1 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Psychiatry 57  (10),  1183–1193,  http://dx.doi.org/10.1111/jcpp.12622 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"233  (1),  102–111,  http://dx.doi.org/ 10.1016/j.expneurol.2011.10.032 .",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"30  (4),  470–482, http://dx.doi.org/10.1016/j.yfrne.2009.06.001 .",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"57  (1),  50–62,  http://dx.doi.org/10.1002/dev.21256 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"14  (2),  148–155,  http://dx.doi.org/10.1016/ j.conb.2004.03.007 .",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"140  (1),  256–282,  http://dx.doi.org/10.1037/a0032671 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"18  (2),  281–297,  http://dx.doi.org/10.1111/desc.12195 .Houston,  S.M.,  Herting,  M.M.,  Sowell,  E.R.,  2014.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"16,  3–17,  http://dx.doi.org/10.1007/7854  2013  265 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"132  (1),  135–165,  http://dx.doi.org/10.1002/ cne.901320108 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Neuropsychopharmacology 40 (1), 154–170,  http://dx.doi.org/10.1038/npp.2014.165 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Psychiatry  57  (10),  1174–1182, http://dx.doi.org/10.1111/jcpp.12607 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"3,  38–44,  http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Psychiatry  57  (10),  1194–1202,  http://dx.doi.org/10.1111/jcpp.12623 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Neuroscience  159  (1),  335–343,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Psychiatry  57  (10),  1113–1125, http://dx.doi.org/10.1111/jcpp.12576 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"118  (4),  798–804, http://dx.doi.org/10.1037/0735-7044.118.4.798 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"16  (8),  1412–1425,  http://dx.doi.org/10.1162/ 0898929042304796 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"11  (8),  889–893,  http://dx.doi.org/10.1203/00006450- 197708000-00007 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"254,  8–21,  http://dx.doi.org/10.1016/j.bbr.2013.02.007 .",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Psychiatry  57  (10),  1126–1134,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"1156, 152–167,  http://dx.doi.org/10.1016/j.brainres.2007.04.042 .",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"18  (3),  618–646,  http://dx.doi.org/10.1111/j.1467-9507.2008.00500.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Psychiatry  54  (2),  108–115,  http://dx.doi.org/10.1016/j.jaac.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Psychoneuroendocrinology  30  (10),  939–946,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"22  (21),  1998–2007,  http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"10  (6), 434–445,  http://dx.doi.org/10.1038/nrn2639 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"34  (1),  29–35,  http://dx.doi.org/10.1002/(sici)1098-2302(199901) .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"124  (6),  742–760,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"77  (2),  169–189,  http://dx.doi.org/10.1002/dneu.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Psychiatry  3,  e216,  http://dx.doi.org/10.1038/tp.2012.144 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"55  (4),  538–547, http://dx.doi.org/10.1016/j.yhbeh.2009.01.009 .",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"9  (3),  149–154,  http://dx.doi.org/ 10.1002/mrdd.10074 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Psychoneuroendocrinology  33  (9),  1198–1210,  http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"24  (5),  1182–1189,  http://dx.doi.org/10.1523/JNEUROSCI.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"29  (50),  15745–15755,  http://dx.doi.org/10.1523/JNEUROSCI.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"20  (4), 405–414,  http://dx.doi.org/10.1002/dev.420200405 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Trauma  Violence  Abuse  10  (4),  389–410,  http://dx.doi.org/ 10.1177/1524838009339758 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"18  (2),  99–108, http://dx.doi.org/10.1016/j.tics.2013.11.003 .",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"77,  98–112,  http://dx.doi.org/10.1016/j.yhbeh.2015.05.015 .",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"1),  S175–S181,  http://dx.doi.org/ 10.1016/j.amepre.2006.07.005 .",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"19  (3),  151–161,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"7  (31279),  http://dx.doi.org/10.3402/ejpt.v7.31276 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Psychoneuroendocrinology  74,  149–157,  http://dx.doi.org/10.1016/ j.psyneuen.2016.08.028 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"109  (40),  16318–16323,  http://dx.doi.org/10.1073/ pnas.1206834109 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Neuroimage  97, 236–244,  http://dx.doi.org/10.1016/j.neuroimage.2014.04.",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"15  (4),  349–355,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Neuroscience  268, 10–20,  http://dx.doi.org/10.1016/j.neuroscience.2014.02.044 .",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"56  (8),  1626–1634, http://dx.doi.org/10.1002/dev.21219 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Neuron  48  (2),  175–187, http://dx.doi.org/10.1016/j.neuron.2005.09.025 .",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"J.  Psychiatry  162  (2), 291–296, http://dx.doi.org/10.1176/appi.ajp.162.2.291 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Psychiatry  57  (10),  1165–1173,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"16  (2),  114–121,  http://dx.doi.org/10.1101/ lm.977909 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Hippocampus  20  (9),  1037–1046,  http://dx.doi.org/10.1002/hipo.20702 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"32 (22),  7758–7765,  http://dx.doi.org/10.1523/JNEUROSCI.5843-11.2012 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Neuropsychopharmacology 40  (4),  906–914,  http://dx.doi.org/10.1038/npp.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"56  (8),  1711–1722, http://dx.doi.org/10.1002/dev.21234 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"10  (9), 1116–1124,  http://dx.doi.org/10.1038/nn1944 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Psychiatry  57  (10),  1103–1112,  http://dx.doi.org/10.1111/jcpp.12621 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"104 (4),  632–640,  http://dx.doi.org/10.1016/j.physbeh.2011.04.008 .",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"(Lausanne)  5,  33,  http://dx.doi.org/10.3389/ fendo.2014.00033 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"127–128,  64–90,  http://dx.doi.org/10.1016/j.pneurobio.2015.",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Psychiatry  57  (8),  823–831,  http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"48  (1),  71–78, http://dx.doi.org/10.1002/dev.20107 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"12  (7),  673–680,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"56  (8), 1755–1763,  http://dx.doi.org/10.1002/dev.21218 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"50  (4),  623–631,  http://dx.doi.org/ 10.1016/j.yhbeh.2006.06.012 .",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"77 (2),  158–168,  http://dx.doi.org/10.1002/dneu.22449 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Science 308  (5722),  648–652,  http://dx.doi.org/10.1126/science.1106477 .Sarro,  E.C.,  Sullivan,  R.M.,  Barr,  G.,  2014a.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Neuroscience  258,  147–161,  http://dx.doi.org/10.1016/j.neuroscience.",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"24  (14),  1664–1669,  http://dx.doi.org/10.1016/j.cub.2014.06.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"33  (5),  699–771, http://dx.doi.org/10.1016/j.neubiorev.2009.01.004 .",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"1  (1),  77–87,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Psychiatry  79  (3),  194–202,  http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"52  (3), 391–400,  http://dx.doi.org/10.1016/j.yhbeh.2007.06.004 .",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"J.  Psychiatry  166  (9), 1011–1024,  http://dx.doi.org/10.1176/appi.ajp.2009.08121760 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"217  (3),  202–209,  http://dx.doi.org/10.1016/j.psychres.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"PLoS  One  10  (7),  e0134509,  http://dx.doi.org/10.1371/journal.pone.0134509 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"34  (6), 835–844,  http://dx.doi.org/10.1016/j.neubiorev.2009.11.010 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"10  (5), 500–511,  http://dx.doi.org/10.1080/17470919.2015.1087425 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"38 (4),  643–655, http://dx.doi.org/10.1016/j.clp.2011.08.011 .",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"1008 (1), 132–139,  http://dx.doi.org/10.1196/ annals.1301.014 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"240,  46–51,  http://dx.doi.org/10.1016/j.bbr.2012.11.017 .",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"35  (2),  245–251,  http://dx.doi.org/10.1016/j.yfrne.2013.11.",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"17  (10),  652–666,  http://dx.doi.org/10.1038/nrn.2016.111 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Neuropsychopharmacology  36  (11),  2349–2356,  http://dx.doi.org/10.1038/ npp.2011.125 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"3,  68,  http://dx.doi.org/10.3389/neuro.09.068.2009 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"54  (6),  598–611,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Psychiatry  57 (10),  1145–1153,  http://dx.doi.org/10.1111/jcpp.12604 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"19  (9), 761–768,  http://dx.doi.org/10.1111/j.1365-2982.2007.00955.x .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"30,  411–429,  http://dx.doi.org/10.1007/7854  2015  430 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"PLoS  One  7  (10),  e46970, http://dx.doi.org/10.1371/journal.pone.0046970 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"44,  55–64,  http://dx.doi.org/10.1016/j.ijdevneu.2015.05.006 .",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"45  (3),  125–133,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"9,  154,  http://dx.doi.org/10.3389/fnins.2015.00154 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"61  (1),  91–99,  http://dx.doi.org/10.1016/j.yhbeh.2011.10.",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"114 (1–2),  1–22,  http://dx.doi.org/ 10.1016/j.applanim.2008.06.006 .",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"66,  173–196, http://dx.doi.org/10.1146/ annurev-psych-010814-015104 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Neuroscience  76  (1), 261–272,  http://dx.doi.org/10.1016/S0306-4522(96)00369-7 .",OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"26  (5),  593–604,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"7  (6),  413–421,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"87  (6), 3156–3159,  http://dx.doi.org/10.1152/jn.00917.2001 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"13  (1), 25–37, http://dx.doi.org/10.1111/gbb.12104 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Hippocampus  23  (9),  745–750, http://dx.doi.org/10.1002/hipo.22139 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Psychiatry  56  (3),  207–222,  http://dx.doi.org/10.1111/jcpp.",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"Psychiatry  57  (10), 1099–1102, http://dx.doi.org/10.1111/jcpp.12642 .",Non-OADS,/arxiv_data1/oa_pdf/27/41/main.PMC5478471.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Drosos I Georgios, MD, PhD, Associate  Professor of Orthopaedics, Department of Orthopaedic Surgery,  Medical School, Democritus University of Thrace, University  General Hospital of Alexandroupolis, St. Niarhos Street 1, Dragana,  68100 Ale xandroupolis, Greece.",Non-OADS,/arxiv_data1/oa_pdf/d6/bd/WJO-8-441.PMC5478486.pdf
"Our objective is to review any blood saving  method/strategy into the preoperative, intraoperative  and postoperative period and analyze their possible Submit a Manuscript: http://www.f6publishing.com DOI: 10.5312/wjo.v8.i6.441World J Orthop  2017 June 18; 8(6): 441-454 ISSN 2218-5836 (online)",Non-OADS,/arxiv_data1/oa_pdf/d6/bd/WJO-8-441.PMC5478486.pdf
World J Orthop   2017; 8(6): 441-454  Available from: URL:  http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/d6/bd/WJO-8-441.PMC5478486.pdf
"com/ 2218-5836 /full/v8/i6/441.htm  DOI: http://dx.doi.org/10.5312/ wjo.v8.i6.441 INTRODUCTION Total knee arthroplasty (TKA) is currently the most cost- effective and efficacious way for treating patients with  end-stage knee osteoarthritis who suffer from severe  pain, activity limitation and for whom conservative  treatment is unsuccessful.",Non-OADS,/arxiv_data1/oa_pdf/d6/bd/WJO-8-441.PMC5478486.pdf
"Available from: URL:  http://www.who.int/vmnis/indicators/haemoglobin/en/ 13 Goodnough LT , Vizmeg K, Sobecks R, Schwarz A, Soegiarso W.  Prevalence and classification of anemia in elective orthopedic surgery  patients: implications for blood conservation programs.",Non-OADS,/arxiv_data1/oa_pdf/d6/bd/WJO-8-441.PMC5478486.pdf
"Available from: URL: https://www.ncbi.nlm.nih.gov/books/ NBK327570/ 39 Deutsch A , Spaulding J, Marcus RE.",Non-OADS,/arxiv_data1/oa_pdf/d6/bd/WJO-8-441.PMC5478486.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/d6/bd/WJO-8-441.PMC5478486.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Unsolicited manuscript Correspondence to: Robert Pearse Piggott, Orthopaedic  Specialist Registrar, Department of Trauma and Orthopaedic  Surgery, Galway University Hospitals, the West/North West  Hospitals Group, HSE, Newcastle Road, Galway H91 YR71,  Ireland.",Non-OADS,/arxiv_data1/oa_pdf/2b/98/WJO-8-455.PMC5478487.pdf
"Piggott RP, Curtin M, Munigangaiah S, Jadaan M, McCabe JP,  Devitt A. Sternal metastasis - the forgotten column and its effect Submit a Manuscript: http://www.f6publishing.com DOI: 10.5312/wjo.v8.i6.455World J Orthop  2017 June 18; 8(6): 455-460 ISSN 2218-5836 (online)",Non-OADS,/arxiv_data1/oa_pdf/2b/98/WJO-8-455.PMC5478487.pdf
"World J Orthop  2017; 8(6): 455-460   Available from: URL:  http://www.wjgnet.com/ 2218-5836 /full/ v8/i6/455.htm  DOI: http://dx.doi.org/10.5312/wjo.v8.i6.455 INTRODUCTION Cancer remains the second leading cause of death in the  United States, with 589430 cancer related deaths each  year[1].",Non-OADS,/arxiv_data1/oa_pdf/2b/98/WJO-8-455.PMC5478487.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/2b/98/WJO-8-455.PMC5478487.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to:  Vasileios S Nikolaou, MD, PhD, MSc,  Orthopaedic Surgeon, Assistant Professor  of Orthopaedics,  2nd Department of Orthopaedics, Agia Olga Hospital, National  and Kapodistrian University of Athens, School of Medicine, 21  Dimitriou Ralli Str, 11527 Athens, Greece.",Non-OADS,/arxiv_data1/oa_pdf/06/1e/WJO-8-461.PMC5478488.pdf
"In th e case of arthritis, clinical studies have shown Submit a Manuscript: http://www.f6publishing.com DOI: 10.5312/wjo.v8.i6.461World J Orthop  2017 June 18; 8(6): 461-464 ISSN 2218-5836 (online)",Non-OADS,/arxiv_data1/oa_pdf/06/1e/WJO-8-461.PMC5478488.pdf
wjgnet.com/ 2218-5836 /full/v8/i6/461.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/06/1e/WJO-8-461.PMC5478488.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/06/1e/WJO-8-461.PMC5478488.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscriptCorrespondence to: Federico P Girardi, MD, Spine Service,  Hospital for Special Surgery, 535 East 70th Street, New York, NY  10021, United States.",Non-OADS,/arxiv_data1/oa_pdf/1d/09/WJO-8-465.PMC5478489.pdf
One patient  was diagnosed with a compressive hematoma which Submit a Manuscript: http://www.f6publishing.com DOI: 10.5312/wjo.v8.i6.465World J Orthop  2017 June 18; 8(6): 465-470 ISSN 2218-5836 (online) Retrospective Study,Non-OADS,/arxiv_data1/oa_pdf/1d/09/WJO-8-465.PMC5478489.pdf
World J Orthop  2017; 8(6): 465-470   Available from: URL:  http://www.wjgnet.com/ 2218-5836 /full/ v8/i6/465.htm  DOI: http://dx.doi.org/10.5312/wjo.v8.i6.465 INTRODUCTION Degenerative conditions of the cervical spine result from  disk degeneration and the subsequent osteophytic bone  formation extending along the affected vertebrae[1-3].,Non-OADS,/arxiv_data1/oa_pdf/1d/09/WJO-8-465.PMC5478489.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/1d/09/WJO-8-465.PMC5478489.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Fabrizio Perna, MD, Istituto Ortopedico  Rizzoli, Via G. C. Pupilli 1, 40136 Bologna,  Italy.",Non-OADS,/arxiv_data1/oa_pdf/e3/51/WJO-8-471.PMC5478490.pdf
Cultures on intraoperative samples were Submit a Manuscript: http://www.f6publishing.com DOI: 10.5312/wjo.v8.i6.471World J Orthop  2017 June 18; 8(6): 471-477 ISSN 2218-5836 (online) Retrospective Study,Non-OADS,/arxiv_data1/oa_pdf/e3/51/WJO-8-471.PMC5478490.pdf
"World J Orthop  2017; 8(6): 471-477  Available from: URL:   http://www.wjgnet.com/ 2218-5836 /full/v8/i6/471.htm  DOI:  http://dx.doi.org/10.5312/wjo.v8.i6.471 INTRODUCTION Septic non-union are defined as the absence of evidence  of fracture healing and persistence of infection at the  fracture site for 6 to 8 mo[1,2].",Non-OADS,/arxiv_data1/oa_pdf/e3/51/WJO-8-471.PMC5478490.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/e3/51/WJO-8-471.PMC5478490.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/Manuscript source:  Invited manuscript Correspondence to: Eleni Jelastopulu, MD, PhD, Professor  of Public Health, Department of Public Health, Medical School,  University of Patras, Hippokrates Avenue, 26500 Patras,  Greece.",Non-OADS,/arxiv_data1/oa_pdf/8d/e5/WJO-8-478.PMC5478491.pdf
Submit a Manuscript: http://www.f6publishing.com DOI: 10.5312/wjo.v8.i6.478World J Orthop  2017 June 18; 8(6): 478-483 ISSN 2218-5836 (online) Observational Study,Non-OADS,/arxiv_data1/oa_pdf/8d/e5/WJO-8-478.PMC5478491.pdf
"World J Orthop  2017; 8(6): 478-483  Available from: URL:   http://www.wjgnet.com/ 2218-5836 /full/v8/i6/478.htm  DOI:  http://dx.doi.org/10.5312/wjo.v8.i6.478 INTRODUCTION Working in the heavy industry sector can cause the  manifestation of occupational diseases and injuries,  having a direct impact on the employee, the employer  and the state’s economy.",Non-OADS,/arxiv_data1/oa_pdf/8d/e5/WJO-8-478.PMC5478491.pdf
"Available from: URL: http://www.bls.gov/iif/ oshbulletin2006.htm 3 Descatha A , Roquelaure Y , Chastang JF, Evanoff B, Cyr D, Leclerc A.",Non-OADS,/arxiv_data1/oa_pdf/8d/e5/WJO-8-478.PMC5478491.pdf
Available from: URL: http://www.dash.iwh.,Non-OADS,/arxiv_data1/oa_pdf/8d/e5/WJO-8-478.PMC5478491.pdf
Available from: URL: http://www.rand.,Non-OADS,/arxiv_data1/oa_pdf/8d/e5/WJO-8-478.PMC5478491.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/8d/e5/WJO-8-478.PMC5478491.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Kiminori Yukata, MD, PhD, Department  of Orthopedic Surgery, Yamaguchi University Graduate School  of Medicine, 1-1-1 Minami-Kogushi, Ube, Yamaguchi 755-8505,  Japan.",Non-OADS,/arxiv_data1/oa_pdf/1e/d0/WJO-8-484.PMC5478492.pdf
"CONCLUSION We found that MRI showed three different localizations  of medial tibial plateau stress fractures, which were  associated with tibial posterior slope at the medial tibial  plateau.Submit a Manuscript: http://www.f6publishing.com DOI: 10.5312/wjo.v8.i6.484World J Orthop  2017 June 18; 8(6): 484-490 ISSN 2218-5836 (online) Observational Study",Non-OADS,/arxiv_data1/oa_pdf/1e/d0/WJO-8-484.PMC5478492.pdf
World J Orthop   2017; 8(6): 484-490  Available from: URL:  http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/1e/d0/WJO-8-484.PMC5478492.pdf
com/ 2218-5836 /full/v8/i6/484.htm  DOI: http://dx.doi.org/10.5312/ wjo.v8.i6.484 INTRODUCTION Stress fractures of the lower extremity commonly occur  in athletes and military personnel.,Non-OADS,/arxiv_data1/oa_pdf/1e/d0/WJO-8-484.PMC5478492.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/1e/d0/WJO-8-484.PMC5478492.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Frank A Liporace, MD, Chairman,  Division of Orthopedic Surgery, Department of Orthopedic  Surgery, Jersey City Medical Center - RWJ Barnabas Health, 355  Grand Street, Jersey City, NJ 07302,  United States.",Non-OADS,/arxiv_data1/oa_pdf/ad/18/WJO-8-491.PMC5478493.pdf
Enhanced healing Submit a Manuscript: http://www.f6publishing.com DOI: 10.5312/wjo.v8.i6.491World J Orthop  2017 June 18; 8(6): 491-506 ISSN 2218-5836 (online),Non-OADS,/arxiv_data1/oa_pdf/ad/18/WJO-8-491.PMC5478493.pdf
"World J Orthop  2017; 8(6): 491-506   Available from: URL:  http://www.wjgnet.com/ 2218-5836 /full/ v8/i6/491.htm  DOI: http://dx.doi.org/10.5312/wjo.v8.i6.491 INTRODUCTION With the widespread use of orthobiologics in everyday  practice, attention must be directed to substantiate  the evidence for their current use and to direct future  practice guidelines.",Non-OADS,/arxiv_data1/oa_pdf/ad/18/WJO-8-491.PMC5478493.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/ad/18/WJO-8-491.PMC5478493.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Christopher D Smith, Shoulder and  Elbow Consultant, PEOC,  Royal Devon and Exeter Hospital,  Barrack Road, Exeter, Devon EX2 5DW,  United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/3d/29/WJO-8-507.PMC5478494.pdf
Treat - ment is conservative initially with activity avoidance and  if that fails surgical management includes resection of  triceps edge or transposition of the tendon plus or minus Submit a Manuscript: http://www.f6publishing.com DOI: 10.5312/wjo.v8.i6.507World J Orthop  2017 June 18; 8(6): 507-513 ISSN 2218-5836 (online),Non-OADS,/arxiv_data1/oa_pdf/3d/29/WJO-8-507.PMC5478494.pdf
World J Orthop  2017; 8(6): 507-513  Available from: URL:   http://www.wjgnet.com/ 2218-5836 /full/v8/i6/507.htm  DOI:  http://dx.doi.org/10.5312/wjo.v8.i6.507 INTRODUCTION Triceps injuries are relatively rare in comparison to other  tendons around the elbow and found to be present  on 3.8% of elbow magnetic resonance imaging (MRI)  studies following elbow injury[1].,Non-OADS,/arxiv_data1/oa_pdf/3d/29/WJO-8-507.PMC5478494.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/3d/29/WJO-8-507.PMC5478494.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Unsolicited manuscript Correspondence to: Erik Hohmann, FRCS, FRCS (Tr&Orth), MD, PhD, Department of Orthopedic Surgery and Sports  Medicine, Valiant Clinic/Houston Methodist Group, Dubai  414296, United Arab Emirates.",Non-OADS,/arxiv_data1/oa_pdf/46/ce/WJO-8-514.PMC5478495.pdf
"Adjusting GDP/capita, for  publications and IF, C hina, India, and the United States Submit a Manuscript: http://www.f6publishing.com DOI: 10.5312/wjo.v8.i6.514World J Orthop  2017 June 18; 8(6): 514-523 ISSN 2218-5836 (online)",Non-OADS,/arxiv_data1/oa_pdf/46/ce/WJO-8-514.PMC5478495.pdf
World J Orthop  2017; 8(6): 514-523  Available from: URL:  http:// www.wjgnet.com/ 2218-5836 /full/v8/i6/514.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/ce/WJO-8-514.PMC5478495.pdf
Available from: URL: http://data.worldbank.or g  12 The World factbook .,Non-OADS,/arxiv_data1/oa_pdf/46/ce/WJO-8-514.PMC5478495.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/46/ce/WJO-8-514.PMC5478495.pdf
": Relationship between overtime work and decayed teeth  Methods Selection of participants Participants were selected from a pool of people who registered with an online research company called Intage(http://www.intage.co.jp/), who had agreed to participatein oral health-related surveys when they registered.",Non-OADS,/arxiv_data1/oa_pdf/e3/e0/1348-9585-59-280.PMC5478502.pdf
"1]; Available from:URL: http://www.nih.go.jp/niid/en/basic-science/865-iasr/5000-tpc415.html 4) Lawitz E, Poordad FF, Pang PS, et al.",Non-OADS,/arxiv_data1/oa_pdf/fc/ab/1348-9585-59-304.PMC5478506.pdf
1]; Available from: URL: http://www.state.gov/documents/organization/204416.pdf 10) National Institute of Occupati onal Safety and Health.,Non-OADS,/arxiv_data1/oa_pdf/fc/ab/1348-9585-59-304.PMC5478506.pdf
"1]; Available from: URL: https://www.jniosh.go.jp/icpro/jicosh-old/englis h/guideline/2073-906.html 11) Henderson DK, Dembry L, Fishman NO, et al.",Non-OADS,/arxiv_data1/oa_pdf/fc/ab/1348-9585-59-304.PMC5478506.pdf
"1]; Available from: URL: https://www.gov.uk/government/uploads/syste m/uploads/attachment_data/fil e/333018/Management_of_HIV_infected_Healthcare_Workers_guidance_January_2014.pdf 13) Nagao Y, Baba H, Torii K, et al.",Non-OADS,/arxiv_data1/oa_pdf/fc/ab/1348-9585-59-304.PMC5478506.pdf
1]; Available from: URL: http://www.ilo.org/dyn/normlex/en/f?p=NORMLEXPUB:12100:0::NO::P12100_ILO_CODE:R200 17) Morikane K. Infection Control in Healthcare Settings in Japan.,Non-OADS,/arxiv_data1/oa_pdf/fc/ab/1348-9585-59-304.PMC5478506.pdf
"[cited 2016 Oct. 26]; Available from: URL:http://monographs.iarc.fr/ENG/ Monographs/vol99/mono99-1 3.pdf 2) Fritschi L, Driscoll T. Cancer due to occupation in Australia.",Non-OADS,/arxiv_data1/oa_pdf/c6/6d/1348-9585-59-296.PMC5478508.pdf
[cited 2016 Oct. 26]; Available from:URL: http://www.safeworkaustralia.gov.au/sites/swa/about/publications/pages/awes-carcinogen-exposures-manufacturing-industry 12) OSHA Method 71.,Non-OADS,/arxiv_data1/oa_pdf/c6/6d/1348-9585-59-296.PMC5478508.pdf
"1989[cited 2016 Oct. 26]; Availablefrom: URL: https://www.osha.gov/dts/sltc/methods/organic/org071/org071.html 13) Skarping G, Renman L, Smith BEF.",OADS,/arxiv_data1/oa_pdf/c6/6d/1348-9585-59-296.PMC5478508.pdf
26]; Available from: URL: http://www.safeworkaustralia.gov.au/sites/swa/about/publica tions/pages/workplace-exposur e-standards 15) State of California.,Non-OADS,/arxiv_data1/oa_pdf/c6/6d/1348-9585-59-296.PMC5478508.pdf
"26]; Available from: URL: http://www.dir.ca.gov/title8/5215.html 16) Kromhout H, Vermeulen R. Tem poral, personal and spatial variability in dermal exposure.",OADS,/arxiv_data1/oa_pdf/c6/6d/1348-9585-59-296.PMC5478508.pdf
4]; Available from: URL: http://www.mhlw.go.jp/stf/houdou/0000126365.html.,Non-OADS,/arxiv_data1/oa_pdf/ad/93/1348-9585-59-237.PMC5478509.pdf
"[cited 2014]; Avail- able from: URL: http://www.euroqol.org/about-eq-5d/valuation-of-eq-5d/eq-5d-5l-value-sets.html 27) Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Tor- rance GW.",OADS,/arxiv_data1/oa_pdf/18/f4/1348-9585-59-267.PMC5478510.pdf
2012[cited 2012 Sep. 2012]; Available from: URL: http://www.fk.cvz.nl/ 30) Zorginstituut N. Drug costs in the Netherlands.,Non-OADS,/arxiv_data1/oa_pdf/18/f4/1348-9585-59-267.PMC5478510.pdf
2014 [cited 2014 Aug. 2014]; Available from: URL: http://www.medicijnkosten.nl/ 31) Zorginstituut N. Medical aids categories.,OADS,/arxiv_data1/oa_pdf/18/f4/1348-9585-59-267.PMC5478510.pdf
"[cited 2014]; Available from: URL: http://statline.cbs.nl/StatWeb/publication/?VW=T&DM=SLNL&PA=80857NED&LA=NL 36) Lambeek LC, van Mechelen W, Knol DL, Loisel P, Anema JR. Randomised controlled trial of integrated care to reducedisability from chronic low back pain in working and privatelife.",Non-OADS,/arxiv_data1/oa_pdf/18/f4/1348-9585-59-267.PMC5478510.pdf
Available from: URL: http://www.gender.go.jp/about_da njo/law/pdf/brilliant_wome n02.pdf (Japanese).,OADS,/arxiv_data1/oa_pdf/7b/d1/1348-9585-59-286.PMC5478511.pdf
Available from:URL: http://hirougakkai.com/guideline.pdf (Japanese).,Non-OADS,/arxiv_data1/oa_pdf/7b/d1/1348-9585-59-286.PMC5478511.pdf
Methods: Available from: URL: http://www.eurofound.europe.eu/surveys/ewcs/2010/sampling.htm 2013.,OADS,/arxiv_data1/oa_pdf/ce/fe/1348-9585-59-177.PMC5478515.pdf
[cited 2016 Sep.14]; Available from :URL :http://law.e-gov.go.jp/htmldata/S3 5/S35HO030.html (in Japanese).,OADS,/arxiv_data1/oa_pdf/6e/15/1348-9585-59-91.PMC5478517.pdf
[cited 2016 Sep. 14];Available from :URL :http://law.e-gov.go.jp/htmldata/S35/S3 5F04101000006.html (in Japanese).,OADS,/arxiv_data1/oa_pdf/6e/15/1348-9585-59-91.PMC5478517.pdf
14]; Available from :URL :http://law.e-gov.go.jp/htmldat a/S47/S47HO057.html (in Japanese).,OADS,/arxiv_data1/oa_pdf/6e/15/1348-9585-59-91.PMC5478517.pdf
[cited 2016 Sep. 14];Available from :URL :http://law.e-gov.go.jp/htmldata/S54/S5 4F04101000018.html (in Japanese).,OADS,/arxiv_data1/oa_pdf/6e/15/1348-9585-59-91.PMC5478517.pdf
1979[cited 2016 Sep. 14]; Available from : URL :http://www.mhlw.go.jp/shingi/2010/04/dl/s0420-5b.pdf (in Japanese).,OADS,/arxiv_data1/oa_pdf/6e/15/1348-9585-59-91.PMC5478517.pdf
"[cited 2016 Sep. 14];Available from :URL :http://www.erca.go.jp/erca/english/activ ities/ac_09.html 10) Ministry of Health, Labour and Welfare.",Non-OADS,/arxiv_data1/oa_pdf/6e/15/1348-9585-59-91.PMC5478517.pdf
[cited 2016 Sep. 14]; Available from : URL :http://www.ilo.org/dyn/natlex/docs/ELECTRONIC/293 20/69506/F1079186294/JPN29320.pdf 12) ILO.,OADS,/arxiv_data1/oa_pdf/6e/15/1348-9585-59-91.PMC5478517.pdf
2001[cited 2016 Sep.14]; Available from :URL :http://www.jrs.or.jp/modules/guide lines/index.php?content_id=12 (in Japanese).,OADS,/arxiv_data1/oa_pdf/6e/15/1348-9585-59-91.PMC5478517.pdf
[cited 2016 Sep. 14]; Available from :URL :http://www.mhlw.go.jp/shingi/200 2/11/s1118-5d.html (in Japanese).,OADS,/arxiv_data1/oa_pdf/6e/15/1348-9585-59-91.PMC5478517.pdf
[cited 2016 Sep. 14]; Available from : URL :http://www.mhlw.go.jp/new-info/kobetu/roudou/sekime n/iryo/ (in Japanese).,OADS,/arxiv_data1/oa_pdf/6e/15/1348-9585-59-91.PMC5478517.pdf
2001[cited2016 Sep. 14]; Available from :URL :http://anzeninfo.mhlw.g o.jp/anzen/hor/hombun/hor1- 42/hor1-42-47-1-0.htm (in Japa- nese).,OADS,/arxiv_data1/oa_pdf/6e/15/1348-9585-59-91.PMC5478517.pdf
2007[cited 2016 Sep. 14];Available from :URL :http://anzeninfo.mhlw.go.jp/anzen/hor/ hombun/hor1-48/hor1-48-58-1-0.htm (in Japanese).,OADS,/arxiv_data1/oa_pdf/6e/15/1348-9585-59-91.PMC5478517.pdf
"[cited 2016 Sep. 14];Available from :URL :http://www.cdc.gov/niosh/docs/2008-1 39/pdfs/manuscript-suganum a-imageparameters.pdf 27) Ministry of Health, Labour and Welfare.",Non-OADS,/arxiv_data1/oa_pdf/6e/15/1348-9585-59-91.PMC5478517.pdf
[cited 2016 Sep. 14]; Available from :URL :http://www.mhlw.,OADS,/arxiv_data1/oa_pdf/6e/15/1348-9585-59-91.PMC5478517.pdf
2011[cited 2016 Oct. 17];Available from :URL :http://www.jniosh.go.jp/publication/srr.,OADS,/arxiv_data1/oa_pdf/6e/15/1348-9585-59-91.PMC5478517.pdf
"2010[cited 2016 Sep. 14]; Availablefrom :URL :http://www.mhlw.go.jp/bunya/roudoukijun/anzen eisei42/dl/03.pdf 53) Ministry of Health, Labour, and Welfare.",Non-OADS,/arxiv_data1/oa_pdf/6e/15/1348-9585-59-91.PMC5478517.pdf
2013 [cited 2016 Sep. 14]; Available from :URL :http://www.mhlw.,OADS,/arxiv_data1/oa_pdf/6e/15/1348-9585-59-91.PMC5478517.pdf
"2014[cited 2015 Feb. 1]; Availablefrom: URL: http://www.oae.go.th 2) Hauser S. Corn or maize, essential crop for millions of Thai farmers.",Non-OADS,/arxiv_data1/oa_pdf/cf/73/1348-9585-59-165.PMC5478518.pdf
"2014[cited 2015 Feb. 1]; Available from:URL: http://www.sjonhauser.nl 3) Ray DE, Richards PG.",Non-OADS,/arxiv_data1/oa_pdf/cf/73/1348-9585-59-165.PMC5478518.pdf
"2012[cited 2015 Dec. 2]; Available from:URL: http://www.mhlw.go.jp/toukei/list/h24-46-50.html 2) Development, O.f.E.C.-O.A.",Non-OADS,/arxiv_data1/oa_pdf/09/81/1348-9585-59-139.PMC5478520.pdf
"2012[cited 2015 Dec. 2]; Avail-able from: URL: http://stats.oec d.org/Index.aspx?DataSetCode =ANHRS 3) Development, O. f. E. C. -O.",OADS,/arxiv_data1/oa_pdf/09/81/1348-9585-59-139.PMC5478520.pdf
"2012[cited 2015 Dec. 2]; Availablefrom: URL: http://www.oecd.org/gender/data/balancingpaidworkunpaidworkandleisure.htm 4) Spiegelhalder K, Regen W, Nanovska S, Baglioni C, Riemann D. Comorbid sleep disorders in neuropsychiatric disordersacross the life cycle.",OADS,/arxiv_data1/oa_pdf/09/81/1348-9585-59-139.PMC5478520.pdf
"7]; Available from: URL: http://www.oecd.org/chemicalsafety/nanosafety/testing-programme-manufactured-nanomaterials.htm 2) Reasor MJ, Antonini JM.",Non-OADS,/arxiv_data1/oa_pdf/13/c2/1348-9585-59-112.PMC5478522.pdf
[cited 2016 Nov. 2]; Availablefrom: URL: http://www.pref.miyagi.jp/soshiki/toukei/suikei-top.html 18) National Police Agency.,OADS,/arxiv_data1/oa_pdf/27/9d/1348-9585-59-156.PMC5478523.pdf
"[Online].2016[cited 2016 Nov. 2]; Available from: URL: http://www.npa.go.jp/archive/keibi/biki/higaijokyo.pdf 19) Maslach C, Jackson SE, Leiter MP, Schaufeli WB, Schwab RL.",OADS,/arxiv_data1/oa_pdf/27/9d/1348-9585-59-156.PMC5478523.pdf
[cited 2011]; Available from: URL: http://www.cdc.gov/niosh/ncpc/ 2) National Institute for Occupational Safety and Health.,OADS,/arxiv_data1/oa_pdf/1c/d0/1348-9585-59-131.PMC5478526.pdf
[cited 2010 Feb]; Available from: URL: http://www.osha.gov/SLTC/de rmalexposure/index.html 5) CEH Marketing Research Report.,OADS,/arxiv_data1/oa_pdf/1c/d0/1348-9585-59-131.PMC5478526.pdf
"[cited 2005]; Availablefrom: URL: http://www.cnn.com/2005/TECH/science/01/28/plastics.from.oranges/ 17) Mikatavage M, Que Hee S.S, Ayer H.E.",OADS,/arxiv_data1/oa_pdf/1c/d0/1348-9585-59-131.PMC5478526.pdf
"2002; Available from: URL: http://www.surgin.com/clear-flow 3) West LG, Bandenhop AF, McLaughlin JL.",Non-OADS,/arxiv_data1/oa_pdf/dc/bc/1348-9585-59-104.PMC5478528.pdf
"The 10 minutes lunch fitness ⡴ program was created by the Society of 10 Minutes LunchFitness ( http://10mlf.com) w ith the aim of preventing metabolic and locomotive syndromes, and promoting anopportunity for individuals to develop exercise habit 9).",Non-OADS,/arxiv_data1/oa_pdf/d4/7e/1348-9585-59-122.PMC5478529.pdf
"[cited 2016 Aug. 18]; Available from: URL: http://www.soumu.go.jp/johotsusintoke i/whitepaper/eng/WP2015/201 5-index.html 4) Ohta M, Mizoue T, Mishima N, Ikeda M. Effect of the physi- cal activities in leisure time and commuting to work on mentalhealth.",OADS,/arxiv_data1/oa_pdf/d4/7e/1348-9585-59-122.PMC5478529.pdf
"Available from: URL: http://10mlf.com 10) Kumahara H, Schutz Y, Ayabe M, et al.",OADS,/arxiv_data1/oa_pdf/d4/7e/1348-9585-59-122.PMC5478529.pdf
"MeSH Keywords:  Delivery of Health Care, Integrated • Economics • Pulmonary Disease, Chronic Obstructive  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/901982Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Public Health and Social Medicine, Medical University of Gdańsk,  Gdańsk, Poland 2 Department of Allergology, Medical University of Gdańsk, Gdańsk, Poland 3 National Health Fund, Warsaw, Poland 4 Coordination Center, University Clinical Center in Gdańsk, Gdańsk, Polande-ISSN 1643-3750 © Med Sci Monit, 2017; 23: 2850-2862 DOI: 10.12659/MSM.901982 2850 Indexed in: [Current Contents/Clinical Medicine] [SCI Expanded] [ISI Alerting System]   [ISI Journals Master List] [Index Medicus/MEDLINE] [EMBASE/Excerpta Medica]   [Chemical Abstracts/CAS] [Index Copernicus]CLINICAL RESEARCH This work is licensed under Creative Common Attribution- NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)",Non-OADS,/arxiv_data1/oa_pdf/cf/b2/medscimonit-23-2850.PMC5478556.pdf
[cited 2016 Oct 3]; Available from: http://www.who.int/nmh/ publications/ncd-status-report-2014/en/  2.,OADS,/arxiv_data1/oa_pdf/cf/b2/medscimonit-23-2850.PMC5478556.pdf
Available from:  http://www.goldcopd.org/uploads/users/files/GOLD_Report_2015.pdf  5.,OADS,/arxiv_data1/oa_pdf/cf/b2/medscimonit-23-2850.PMC5478556.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/94/50/1349-7235-56-0993.PMC5478557.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/94/50/1349-7235-56-0993.PMC5478557.pdf
[cited 2015 March 11] Available from: http://CRAN.R-project.org/package=rms.,Non-OADS,/arxiv_data1/oa_pdf/5e/e3/1349-7235-56-1001.PMC5478558.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/5e/e3/1349-7235-56-1001.PMC5478558.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/5e/e3/1349-7235-56-1001.PMC5478558.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/b5/30/1349-7235-56-1009.PMC5478559.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/b5/30/1349-7235-56-1009.PMC5478559.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/7e/57/1349-7235-56-1015.PMC5478560.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/7e/57/1349-7235-56-1015.PMC5478560.pdf
Avail- able from: http://www.stat.go.j p/data/jyuta ku/2008/nihon/2_1.htm 5.Yoneda R. A guideline and diagnostic criteria for hypersensitivity pneumonitis.,Non-OADS,/arxiv_data1/oa_pdf/da/d4/1349-7235-56-1023.PMC5478561.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/da/d4/1349-7235-56-1023.PMC5478561.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/da/d4/1349-7235-56-1023.PMC5478561.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/8c/ed/1349-7235-56-1029.PMC5478562.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/8c/ed/1349-7235-56-1029.PMC5478562.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/05/5d/1349-7235-56-1037.PMC5478563.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/05/5d/1349-7235-56-1037.PMC5478563.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/fe/ee/1349-7235-56-1041.PMC5478564.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/fe/ee/1349-7235-56-1041.PMC5478564.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/f2/05/1349-7235-56-1049.PMC5478565.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/f2/05/1349-7235-56-1049.PMC5478565.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/aa/1d/1349-7235-56-1053.PMC5478566.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/aa/1d/1349-7235-56-1053.PMC5478566.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/4f/ca/1349-7235-56-1057.PMC5478567.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/4f/ca/1349-7235-56-1057.PMC5478567.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/86/99/1349-7235-56-1061.PMC5478568.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/86/99/1349-7235-56-1061.PMC5478568.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/bb/f0/1349-7235-56-1067.PMC5478569.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/bb/f0/1349-7235-56-1067.PMC5478569.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/a6/b7/1349-7235-56-1071.PMC5478570.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/a6/b7/1349-7235-56-1071.PMC5478570.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/19/ec/1349-7235-56-1079.PMC5478571.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/19/ec/1349-7235-56-1079.PMC5478571.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/d7/e8/1349-7235-56-1085.PMC5478572.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/d7/e8/1349-7235-56-1085.PMC5478572.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/ca/ea/1349-7235-56-1089.PMC5478573.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/ca/ea/1349-7235-56-1089.PMC5478573.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/ee/e5/1349-7235-56-1095.PMC5478574.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/ee/e5/1349-7235-56-1095.PMC5478574.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/53/e1/1349-7235-56-1101.PMC5478575.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/53/e1/1349-7235-56-1101.PMC5478575.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/60/87/1349-7235-56-1107.PMC5478576.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/60/87/1349-7235-56-1107.PMC5478576.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/19/7c/1349-7235-56-1113.PMC5478577.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/19/7c/1349-7235-56-1113.PMC5478577.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/af/de/1349-7235-56-1115.PMC5478578.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/af/de/1349-7235-56-1115.PMC5478578.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/6e/a6/1349-7235-56-1117.PMC5478579.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/6e/a6/1349-7235-56-1117.PMC5478579.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/40/0e/1349-7235-56-1119.PMC5478580.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/40/0e/1349-7235-56-1119.PMC5478580.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/42/75/1349-7235-56-1121.PMC5478581.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/42/75/1349-7235-56-1121.PMC5478581.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/33/2c/1349-7235-56-1123.PMC5478582.pdf
"Department of Pathology, Microbiology and Immunol ogy, Vanderbilt University Medical Center, USA Received for publication July 29, 2016; Accepted for publication August 31, 2016Correspondence to Dr. Takashi Shinha, takashi.shinha@vanderbilt.edu⡥2017 The Japanese Society of Internal Medicine Journal W ebsite: http://www.naika.or.jp/imonline/index.html",Non-OADS,/arxiv_data1/oa_pdf/33/2c/1349-7235-56-1123.PMC5478582.pdf
"To view the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/ec/22/1349-7235-56-1125.PMC5478583.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/ec/22/1349-7235-56-1125.PMC5478583.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/20/02/1349-7235-56-1127.PMC5478584.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/20/02/1349-7235-56-1127.PMC5478584.pdf
"2, 2017G&I    Genomics & InformaticseISSN 2234-0742 Genomics Inform  2017;15(2):55 https://doi.org/10.5808/GI.2017.15.2.55 EDITORIAL *Corresponding author:  Tel: +82-2-2258-7343, Fax: +82-2-537-0572, E-mail: yejun@catholic.ac.kr Copyright © 2017 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).Editor’s Introduction to This Issue (G&I 15:2, 2017) Yeun-Jun Chung* IRCGP , College of Medicine, The Catholic University of Korea, Seoul 06591, Korea In this issue, Dr. Jong-Il Kim’s group (Seoul National  University, Korea) reports gene expression profile data in  human dermal fibroblasts treated with COX inhibitors.",Non-OADS,/arxiv_data1/oa_pdf/3e/55/gni-15-55.PMC5478707.pdf
"For further details, please visit the G&I homepage  (https://www.genominfo.org/).",Non-OADS,/arxiv_data1/oa_pdf/3e/55/gni-15-55.PMC5478707.pdf
"G&I    Genomics & InformaticseISSN 2234-0742 Genomics Inform  2017;15(2):56-64 https://doi.org/10.5808/GI.2017.15.2.56 ORIGINAL ARTICLE Received March 31, 2017; Revised May 2, 2017; Accepted May 4, 2017 *Corresponding author:  Tel: +82-33-250-8832, Fax: +82-33-250-8807, E-mail: gshja@kangwon.ac.kr **Corresponding author:  Tel: +82-2-740-8251, Fax: +82-2-744-4534, E-mail: jongil@snu.ac.kr Copyright © 2017 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).Analysis of Gene Expression in Human Dermal Fibroblasts  Treated with Senescence-Modulating COX Inhibitors Jeong A. Han1*, Jong-Il Kim2,3,4** 1Department of Biochemistry and Molecular Biology, Kangwon Nati onal University School of Medicine, Chuncheon 24341, Korea,  2Department of Biochemistry and Molecular Biology, Seoul Nati onal University College of Medicine, Seoul 03080, Korea,  3Cancer Research Institute, Seoul National University College of Medicine, Seoul 03080, Korea,  4Department of Biomedical Sciences, Seoul National  University Graduate School, Seoul 03080, Korea We have previously reported that NS-398, a cyclooxygenase-2 (COX-2) –selective inhibitor, inhi bited replicative cellular  senescence in human dermal fibroblasts and skin aging in  hairless mice.",Non-OADS,/arxiv_data1/oa_pdf/37/30/gni-15-56.PMC5478708.pdf
Supplementary materials Supplementary data including 22 tables and two figures  can be found with this article online http://www.genominfo.,OADS,/arxiv_data1/oa_pdf/37/30/gni-15-56.PMC5478708.pdf
"SUPPLEMENTARY INFORMATION Analysis of Gene Expression in  Human Dermal Fibroblasts  Treated with Senescence-Modulating COX Inhibitors Jeong A. Han1*, Jong-Il Kim2,3,4** 1Department of Biochemistry and Molecular Biology,  Kangwon National Univer sity School of Medicine,  Chuncheon 24341, Korea, 2Department of Biochemistry and Molecu lar Biology, Seoul National University  College of Medicine, Seoul 03080, Korea, 3Cancer Research Institute, Seoul National University College of  Medicine, Seoul 03080, Korea, 4Department of Biomedical Sciences,  Seoul National University Grad uate School, Seoul 03080, Korea http://www.genominfo.org/src/sm/gni-15-56-s001.pdf",Non-OADS,/arxiv_data1/oa_pdf/37/30/gni-15-56.PMC5478708.pdf
"G&I    Genomics & InformaticseISSN 2234-0742 Genomics Inform  2017;15(2):65-68 https://doi.org/10.5808/GI.2017.15.2.65 ORIGINAL ARTICLE Received April 28, 2017; Revised May 9, 2017; Accepted May 9, 2017 *Corresponding author:  Tel: +82-2-2258-7343, Fax: +82-2-537-0572, E-mail: yejun@catholic.ac.kr Copyright © 2017 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).A Variant in RUNX3  Is Associated with the Risk of  Ankylosing Spondylitis in Koreans Sung-Min Cho1,2,3, Seung-Hyun Jung3,4, Yeun-Jun Chung1,2,3* 1Department of Microbiology, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea,  2Precision Medicine Research Center, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea,  3Integrated Research Center for Genome Polymorphism, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea,  4Cancer Evolution Research Center, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea Ankylosing spondylitis (AS) is a chronic au toinflammatory disease that affects the sp ine and sacroiliac joints.",Non-OADS,/arxiv_data1/oa_pdf/24/14/gni-15-65.PMC5478709.pdf
"G&I    Genomics & InformaticseISSN 2234-0742 Genomics Inform  2017;15(2):69-80 https://doi.org/10.5808/GI.2017.15.2.69 ORIGINAL ARTICLE Received April 28, 2017; Revised May 9, 2017; Accepted May 9, 2017 *Corresponding author:  Tel: +98-21-66953311-20, Fax: +98-21-66492619, E-mail: manaoloomi@yahoo.com Copyright © 2017 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).In Silico  Signature Prediction Modeling in Cytolethal  Distending Toxin-Producing Escherichia coli  Strains Maryam Javadi, Mana Oloomi*, Saeid Bouzari Department of Molecular Biology, Pasteur Institute of Iran, Tehran 13164, Iran In this study, cytolethal distending to xin (CDT) producer isolates genome were co mpared with genome of pathogenic and  commensal Escherichia coli  strains.",Non-OADS,/arxiv_data1/oa_pdf/7b/11/gni-15-69.PMC5478710.pdf
"To facilitate sub- sequent analysis steps, the overlapping fragments were assembled using DNA Dragon software, version 1.6.0  (http://www.dna-dragon.com/).",OADS,/arxiv_data1/oa_pdf/7b/11/gni-15-69.PMC5478710.pdf
The results were confirmed using the Uni- ProtKB Bank BLASTX program (http://www.uniprot.,Non-OADS,/arxiv_data1/oa_pdf/7b/11/gni-15-69.PMC5478710.pdf
"SUPPLEMENTARY INFORMATION In Silico  Signature Prediction Modeling in Cytolethal Distending  Toxin-Producing Escherichia coli  Strains Maryam Javadi, Mana Oloomi*, Saeid Bouzari Department of Molecular Biology, Pasteur Institute of Iran, Tehran 13164, Iran http://www.genominfo.org/src/sm/gni-15-69-s001.pdf",Non-OADS,/arxiv_data1/oa_pdf/7b/11/gni-15-69.PMC5478710.pdf
Available at: http://userpage.fu-berlin.,Non-OADS,/arxiv_data1/oa_pdf/d2/dc/IJCBNM-5-231.PMC5478743.pdf
[Cited 5 September  2016] Available from: http://www.un .org/ esa/socdev/ngo/outreachmaterials/ empowerment-booklet.pdf .,Non-OADS,/arxiv_data1/oa_pdf/37/ad/IJCBNM-5-248.PMC5478745.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.EDITORIAL pISSN 1598-9100  • eISSN 2288-1956 https://doi.org/10.5217/ir.2017.15.3.263Intest Res 2017;15(3):263-265 Received March 13, 2017.",Non-OADS,/arxiv_data1/oa_pdf/d0/04/ir-15-263.PMC5478752.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 265 www.irjournal.orghttps://doi.org/10.5217/ir.2017.15.3.263 • Intest Res 2017;15(3):263-265 8.,Non-OADS,/arxiv_data1/oa_pdf/d0/04/ir-15-263.PMC5478752.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.REVIEW pISSN 1598-9100  • eISSN 2288-1956 https://doi.org/10.5217/ir.2017.15.3.266Intest Res 2017;15(3):266-284 Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease Shu-Chen Wei1, Ting-An Chang2, Te-Hsin Chao3, Jinn-Shiun Chen4, Jen-Wei Chou5, Yenn-Hwei Chou6,  Chiao-Hsiung Chuang7, Wen-Hung Hsu8, Tien‐Yu Huang9, Tzu-Chi Hsu10, Chun-Chi Lin11, Hung-Hsin  Lin11,12, Jen-Kou Lin11, Wei-Chen Lin13, Yen-Hsuan Ni14, Ming-Jium Shieh15, I-Lun Shih16, Chia-Tung Shun17,  Yuk-Ming Tsang18, Cheng- Yi Wang1, Horng- Yuan Wang19,20,21, Meng-Tzu Weng22, Deng-Chyang Wu23,24,  Wen-Chieh Wu25, Hsu-Heng Yen26, Jau-Min Wong1 1Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, 2Department  of Pathology, Taipei City Hospital Renai Branch, Taipei, 3Division of Colorectal Surgery, Department of Surgery, Taichung Veterans General  Hospital, Taichung, 4Division of Colorectal Surgery, Chang Gung Memorial Hospital at Linkou, Taoyuan, 5Division of Gastroenterology and  Hepatology, Department of Internal Medicine, China Medical University Hospital, Taichung, 6Division of General Surgery, Department of  Surgery, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, 7Department of Internal Medicine, National Cheng Kung University Hospital,  National Cheng Kung University College of Medicine, Tainan, 8Division of Gastroenterology, Department of Internal Medicine, Kaohsiung  Municipal Hsiaokang Hospital, Kaohsiung, 9Division of Gastroenterology, Department of Internal Medicine, Tri-Service General Hospital,  National Defense Medical Center, Taipei, 10Division of Colon and Rectal Surgery, Department of Surgery, Mackay Memorial Hospital, Taipei,  11Division of Colon and Rectal Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, 12Department of Surgery, National  Yang-Ming University, Taipei, 13Department of Internal Medicine, Mackay Memorial Hospital, Taipei, 14Department of Pediatrics, National  Taiwan University Hospital, Taipei, Departments of 15Oncology, 16Medical Imaging, and 17Pathology and Forensic Medicine, National Taiwan  University Hospital, National Taiwan University College of Medicine, Taipei, 18Division of Medical Imaging, Department of Radiology, Far  Eastern Memorial Hospital, New Taipei City, 19Division of Gastroenterology, Department of Internal Medicine, MacKay Memorial Hospital,  Taipei, 20MacKay Junior College of Medicine, Nursing, and Management, Taipei, 21MacKay Medical College, New Taipei City, 22Department  of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, 23Division of Gastroenterology, Department of Internal Medicine,  Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, 24Department of Internal Medicine, Kaohsiung Municipal  Ta-Tung Hospital, Kaohsiung, 25Division of Gastroenterology, Department of Medicine, Taipei City Hospital Renai Branch, Taipei, 26Division of  Gastroenterology, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan Ulcerative colitis (UC) is an inflammatory bowel disease characterized by chronic mucosal inflammation of the colon, and the prevalence and incidence of UC have been steadily increasing in Taiwan.",Non-OADS,/arxiv_data1/oa_pdf/39/d4/ir-15-266.PMC5478753.pdf
"https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 267 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.266 • Intest Res 2017;15(3):266-284 INTRODUCTION Ulcerative colitis (UC), a form of IBD, is an immune- mediated disorder characterized by chronic mucosal inflam- mation of the colon and alternating periods of active disease and remission.",Non-OADS,/arxiv_data1/oa_pdf/39/d4/ir-15-266.PMC5478753.pdf
"https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 269 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.266 • Intest Res 2017;15(3):266-284 Statement 2.3 Symptoms of UC are dependent upon extent and severity of dis- ease, and most commonly include diarrhea, bloody mucoid stool,  rectal bleeding, and/or rectal urgency.",Non-OADS,/arxiv_data1/oa_pdf/39/d4/ir-15-266.PMC5478753.pdf
"https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 271 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.266 • Intest Res 2017;15(3):266-284 In studies assessing outcome of HBV infection in patients  with IBD, 25% to 36% of patients who were HBsAg-positive  experienced liver dysfunction.58,59 In HBV-infected patients,  most cases of HBV reactivation have been observed in those treated with 2 or more immunomodulators for a long period of time, were positive for HBV DNA, and/or had not received prophylactic antiviral treatment.",Non-OADS,/arxiv_data1/oa_pdf/39/d4/ir-15-266.PMC5478753.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 273 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.266 • Intest Res 2017;15(3):266-284 2.,Non-OADS,/arxiv_data1/oa_pdf/39/d4/ir-15-266.PMC5478753.pdf
"https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 275 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.266 • Intest Res 2017;15(3):266-284 agent with evidence specifically in support of its efficacy in  steroid-refractory acute severe UC.99,100 A biologic of a differ - ent mechanistic class is vedolizumab, an anti- α4β7-integrin  agent which inhibits lymphocyte recruitment to the inflamed gut.",Non-OADS,/arxiv_data1/oa_pdf/39/d4/ir-15-266.PMC5478753.pdf
"https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 277 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.266 • Intest Res 2017;15(3):266-284 Delay in surgical treatment in indicated UC patients is as - sociated with high morbidity and mortality.12,136 Restorative  proctocolectomy with ileal pouch anal anastomosis (IP AA)  is one of the elective surgical procedures for UC.",Non-OADS,/arxiv_data1/oa_pdf/39/d4/ir-15-266.PMC5478753.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 279 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.266 • Intest Res 2017;15(3):266-284 11.,Non-OADS,/arxiv_data1/oa_pdf/39/d4/ir-15-266.PMC5478753.pdf
http://www.cdc.gov.tw/professional/info.aspx?treeid=beac9c103df952c4&nowtreeid=6744c19c09435458&tid=B02B73C3D6F15437.,OADS,/arxiv_data1/oa_pdf/39/d4/ir-15-266.PMC5478753.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 281 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.266 • Intest Res 2017;15(3):266-284 65.,Non-OADS,/arxiv_data1/oa_pdf/39/d4/ir-15-266.PMC5478753.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 283 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.266 • Intest Res 2017;15(3):266-284 119.,Non-OADS,/arxiv_data1/oa_pdf/39/d4/ir-15-266.PMC5478753.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.REVIEW pISSN 1598-9100  • eISSN 2288-1956 https://doi.org/10.5217/ir.2017.15.3.285Intest Res 2017;15(3):285-310 Management of Crohn’s disease in Taiwan:  consensus guideline of the Taiwan Society of Inflammatory Bowel Disease Shu-Chen Wei1, Ting-An Chang2, Te-Hsin Chao3, Jinn-Shiun Chen4, Jen-Wei Chou5, Yenn-Hwei Chou6,  Chiao-Hsiung Chuang7, Wen-Hung Hsu8, Tien‐Yu Huang9, Tzu-Chi Hsu10, Chun-Chi Lin11,   Hung-Hsin Lin11,12, Jen-Kou Lin11, Wei-Chen Lin13, Yen-Hsuan Ni14, Ming-Jium Shieh15, I-Lun Shih16,   Chia-Tung Shun17, Yuk-Ming Tsang18, Cheng- Yi Wang1, Horng- Yuan Wang19,20,21, Meng-Tzu Weng22,   Deng-Chyang Wu23,24, Wen-Chieh Wu25, Hsu-Heng Yen26, Jau-Min Wong1 1Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, 2Department  of Pathology, Taipei City Hospital Renai Branch, Taipei, 3Division of Colorectal Surgery, Department of Surgery, Taichung Veterans General  Hospital, Taichung, 4Division of Colorectal Surgery, Chang Gung Memorial Hospital at Linkou, Taoyuan, 5Division of Gastroenterology and  Hepatology, Department of Internal Medicine, China Medical University Hospital, Taichung, 6Division of General Surgery, Department of  Surgery, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, 7Department of Internal Medicine, National Cheng Kung University Hospital,  National Cheng Kung University College of Medicine, Tainan, 8Division of Gastroenterology, Department of Internal Medicine, Kaohsiung  Municipal Hsiaokang Hospital, Kaohsiung, 9Division of Gastroenterology, Department of Internal Medicine, Tri-Service General Hospital,  National Defense Medical Center, Taipei, 10Division of Colon and Rectal Surgery, Department of Surgery, Mackay Memorial Hospital, Taipei,  11Division of Colon and Rectal Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, 12Department of Surgery, National  Yang-Ming University, Taipei, 13Department of Internal Medicine, Mackay Memorial Hospital, Taipei, 14Department of Pediatrics, National  Taiwan University Hospital, Taipei, Departments of 15Oncology, 16Medical Imaging, and 17Pathology and Forensic Medicine, National Taiwan  University Hospital, National Taiwan University College of Medicine, Taipei, 18Division of Medical Imaging, Department of Radiology, Far  Eastern Memorial Hospital, New Taipei City, 19Division of Gastroenterology, Department of Internal Medicine, MacKay Memorial Hospital,  Taipei, 20MacKay Junior College of Medicine, Nursing, and Management, Taipei, 21MacKay Medical College, New Taipei City, 22Department  of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, 23Division of Gastroenterology, Department of Internal Medicine,  Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, 24Department of Internal Medicine, Kaohsiung Municipal  Ta-Tung Hospital, Kaohsiung, 25Division of Gastroenterology, Department of Medicine, Taipei City Hospital Renai Branch, Taipei, 26Division of  Gastroenterology, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan Crohn’s disease (CD) is a chronic relapsing and remitting inflammatory disease of the gastrointestinal tract.",Non-OADS,/arxiv_data1/oa_pdf/e3/c6/ir-15-285.PMC5478754.pdf
"https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 287 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.285 • Intest Res 2017;15(3):285-310 (95% CI, 0.138–0.321), respectively, in 2000 to 1.949 (95% CI,  1.705–2.219) and 0.883 (95% CI, 0.723–1.067), respectively, in 2010.",Non-OADS,/arxiv_data1/oa_pdf/e3/c6/ir-15-285.PMC5478754.pdf
"https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 289 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.285 • Intest Res 2017;15(3):285-310 tomatic patients is debatable, nevertheless, it can clarify the  location of involvement, particularly in patients with undif - ferentiated IBD by ileocolonoscopy, and can provide further details for use in Montreal classification.",Non-OADS,/arxiv_data1/oa_pdf/e3/c6/ir-15-285.PMC5478754.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 291 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.285 • Intest Res 2017;15(3):285-310 antiviral prophylaxis is recommended in patients with de- tectable HBV DNA.,Non-OADS,/arxiv_data1/oa_pdf/e3/c6/ir-15-285.PMC5478754.pdf
"https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 293 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.285 • Intest Res 2017;15(3):285-310 budesonide (36% mesalamine group vs. 62% budesonide  group, P<0.001).101 Compared with conventional steroids,  budesonide was less effective for induction of remission in a meta-analysis of 8 trials (RR, 0.85; 95% CI, 0.75–0.97), but significantly fewer side effects occurred in those treated with budesonide compared to conventional steroids (RR, 0.64; 95% CI, 0.54–0.76).",Non-OADS,/arxiv_data1/oa_pdf/e3/c6/ir-15-285.PMC5478754.pdf
"https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 295 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.285 • Intest Res 2017;15(3):285-310 In CD, mucosal healing is associated with longer relapse- free survival, higher steroid-free remission rates, and fewer  disease-related hospitalizations and surgeries.127,128 Mucosal  healing is a critical component of outcome measurement in trials evaluating CD treatment, and has been commonly defined as the absence of mucosal ulceration or a CDEIS or SES-CD score of 0.",Non-OADS,/arxiv_data1/oa_pdf/e3/c6/ir-15-285.PMC5478754.pdf
"https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 297 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.285 • Intest Res 2017;15(3):285-310 Percutaneous drainage and delayed resection is recom- mended for patients with active small bowel CD with a con- comitant abdominal abscess and obstructive symptoms.125  Although randomized trials are lacking, results from retro-spective studies have shown that antibiotic treatment with percutaneous drainage is successful in 74% to 100% of pa-tients and may allow avoidance of surgery.",Non-OADS,/arxiv_data1/oa_pdf/e3/c6/ir-15-285.PMC5478754.pdf
"https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 299 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.285 • Intest Res 2017;15(3):285-310 Fistula-associated adenocarcinomas can develop in pa- tients with chronic perianal CD.207,208 The incidence is very  rare, however, and was reported at 0.2/1,000 patient-years in  CD patient in a meta-analysis of 20 clinical studies published from 1965 to 2008.",Non-OADS,/arxiv_data1/oa_pdf/e3/c6/ir-15-285.PMC5478754.pdf
"https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 301 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.285 • Intest Res 2017;15(3):285-310 CONCLUSIONS These statements on the diagnosis and management of  CD in Taiwan were developed through consensus of an ex - pert panel established by TSIBD with consideration of avail- able evidence, expert opinion, and factors specific to Taiwan, including endemic diseases, availability of treatments, and treatment coverage by NHI.",Non-OADS,/arxiv_data1/oa_pdf/e3/c6/ir-15-285.PMC5478754.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 303 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.285 • Intest Res 2017;15(3):285-310 46.,Non-OADS,/arxiv_data1/oa_pdf/e3/c6/ir-15-285.PMC5478754.pdf
(Taiwan) Web site http://www.cdc.gov.tw/professional/info.aspx?treeid=beac9c103df952c4&nowtreeid=6744c19c09435458&tid=B02B73C3D6F15437.,OADS,/arxiv_data1/oa_pdf/e3/c6/ir-15-285.PMC5478754.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 305 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.285 • Intest Res 2017;15(3):285-310 100.,Non-OADS,/arxiv_data1/oa_pdf/e3/c6/ir-15-285.PMC5478754.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 307 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.285 • Intest Res 2017;15(3):285-310 151.,Non-OADS,/arxiv_data1/oa_pdf/e3/c6/ir-15-285.PMC5478754.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 309 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.285 • Intest Res 2017;15(3):285-310 205.,Non-OADS,/arxiv_data1/oa_pdf/e3/c6/ir-15-285.PMC5478754.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.FOCUSED REVIEW: INTESTINAL BEHÇET’S DISEASE pISSN 1598-9100  • eISSN 2288-1956 https://doi.org/10.5217/ir.2017.15.3.311Intest Res 2017;15(3):311-317 Optimal diagnosis and disease activity monitoring of intestinal Behçet’s disease Hyun Jung Lee*, Jae Hee Cheon* Department of Internal Medicine and Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea Intestinal Behçet’s disease (BD), generally accepted as a type of inflammatory bowel disease (IBD), could be diagnosed when patients with BD have objectively documented gastrointestinal symptoms and intestinal ulcerations.",Non-OADS,/arxiv_data1/oa_pdf/e6/bf/ir-15-311.PMC5478755.pdf
"https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 313 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.311 • Intest Res 2017;15(3):311-317 perianal lesions, stricture, and fistula formations are more  frequent in CD.11,22 Endoscopically, longitudinal ulcers with  a cobblestone appearance are frequently observed in CD, whereas intestinal lesions in intestinal BD tend to appear as few round-shaped, punched-out, deep ulcers with discrete margins, which are more prone to perforate.",Non-OADS,/arxiv_data1/oa_pdf/e6/bf/ir-15-311.PMC5478755.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 315 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.311 • Intest Res 2017;15(3):311-317 involved in Th17 differentiation were significantly correlated  with clinical and endoscopic activities of intestinal BD impli-cating its potential role as a biomarker.,Non-OADS,/arxiv_data1/oa_pdf/e6/bf/ir-15-311.PMC5478755.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 317 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.311 • Intest Res 2017;15(3):311-317 29.,Non-OADS,/arxiv_data1/oa_pdf/e6/bf/ir-15-311.PMC5478755.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.FOCUSED REVIEW: INTESTINAL BEHÇET’S DISEASE pISSN 1598-9100  • eISSN 2288-1956 https://doi.org/10.5217/ir.2017.15.3.318Intest Res 2017;15(3):318-327 Treatment and outcomes: medical and surgical treatment for intestinal Behçet’s disease Tadakazu Hisamatsu, Mari Hayashida The Third Department of Internal Medicine, K yorin University School of Medicine, Tokyo, Japan Behçet’s disease (BD) is a chronic relapsing disease involving multiple organ systems.",Non-OADS,/arxiv_data1/oa_pdf/a0/68/ir-15-318.PMC5478756.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 319 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.318 • Intest Res 2017;15(3):318-327 index for intestinal Behçet’s disease (DAIBD) score (≥60)  were associated with a poor response to 5-ASA therapy.,Non-OADS,/arxiv_data1/oa_pdf/a0/68/ir-15-318.PMC5478756.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 321 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.318 • Intest Res 2017;15(3):318-327 tients who received thiopurines than in patients treated with  5-ASA ( P=0.050).,Non-OADS,/arxiv_data1/oa_pdf/a0/68/ir-15-318.PMC5478756.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 323 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.318 • Intest Res 2017;15(3):318-327 IFX (5 mg/kg) every 8 weeks for 6 years.,Non-OADS,/arxiv_data1/oa_pdf/a0/68/ir-15-318.PMC5478756.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 325 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.318 • Intest Res 2017;15(3):318-327 anti-TNF- α mAbs therapy in intestinal BD patients.,Non-OADS,/arxiv_data1/oa_pdf/a0/68/ir-15-318.PMC5478756.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 327 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.318 • Intest Res 2017;15(3):318-327 50.,Non-OADS,/arxiv_data1/oa_pdf/a0/68/ir-15-318.PMC5478756.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ORIGINAL ARTICLE pISSN 1598-9100  • eISSN 2288-1956 https://doi.org/10.5217/ir.2017.15.3.328Intest Res 2017;15(3):328-337 NUDT15 , FTO , and RUNX1  genetic variants and  thiopurine intolerance among Japanese patients with inflammatory bowel diseases Toshiyuki Sato1*, Tetsuya Takagawa1,2*, Yoichi Kakuta3, Akihiro Nishio1, Mikio Kawai1, Koji Kamikozuru1,  Yoko Yokoyama1, Yuko Kita1, Takako Miyazaki1, Masaki Iimuro1, Nobuyuki Hida1, Kazutoshi Hori1,2,   Hiroki Ikeuchi4, Shiro Nakamura1,2 1Division of Internal Medicine, Department of Inflammatory Bowel Disease, 2Department of Intestinal Inflammation Research, Hyogo  College of Medicine, Nishinomiya, 3Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, 4Department of  Inflammatory Bowel Disease Surgery, Hyogo College of Medicine, Nishinomiya, Japan Background/Aims: Recent genome-wide analyses have provided strong evidence concerning adverse events caused by thiopurine drugs such as azathioprine (AZA) and 6-mercaptopurine.",Non-OADS,/arxiv_data1/oa_pdf/be/17/ir-15-328.PMC5478757.pdf
"https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 329 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.328 • Intest Res 2017;15(3):328-337 IBD (either UC or CD), thiopurines are used together with  5-aminosalicylic acid or the anti-tumor necrosis factor α an- tibodies infliximab and adalimumab to induce or maintain remission.",Non-OADS,/arxiv_data1/oa_pdf/be/17/ir-15-328.PMC5478757.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 331 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.328 • Intest Res 2017;15(3):328-337 each genotype.,Non-OADS,/arxiv_data1/oa_pdf/be/17/ir-15-328.PMC5478757.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 333 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.328 • Intest Res 2017;15(3):328-337 3.,Non-OADS,/arxiv_data1/oa_pdf/be/17/ir-15-328.PMC5478757.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 335 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.328 • Intest Res 2017;15(3):328-337 mal region of RUNX1  (rs2834826) with thiopurine-induced  leukopenia and severe hair loss among Japanese patients  with IBD.,Non-OADS,/arxiv_data1/oa_pdf/be/17/ir-15-328.PMC5478757.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 337 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.328 • Intest Res 2017;15(3):328-337 13.,Non-OADS,/arxiv_data1/oa_pdf/be/17/ir-15-328.PMC5478757.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ORIGINAL ARTICLE pISSN 1598-9100  • eISSN 2288-1956 https://doi.org/10.5217/ir.2017.15.3.338Intest Res 2017;15(3):338-344 Impact of inflammatory bowel disease on daily life: an online survey by the Korean Association for the Study of Intestinal Diseases Young Sun Kim1, Sung-Ae Jung2, Kang-Moon Lee3, Soo Jung Park4, Tae Oh Kim5, Chang Hwan Choi6,   Hyun Gun Kim7, Won Moon8, Chang Mo Moon2, Hye K young Song2, Soo- Young Na9, Suk-K yun Yang10,  Korean Association for the Study of Intestinal Diseases (KASID) 1Department of Internal Medicine, Seoul National University Healthcare System Gangnam Center, Seoul, 2Department of Internal Medicine,  Ewha Womans University School of Medicine, Seoul, 3Department of Internal Medicine, St. Vincent’s Hospital, The Catholic University of Korea  College of Medicine, Suwon, 4Department of Internal Medicine, Yonsei University College of Medicine, Seoul, 5Department of Internal Medicine,  Haeundae Paik Hospital, Inje University College of Medicine, Busan, 6Department of Internal Medicine, Chung-Ang University College of  Medicine, Seoul, 7Department of Internal Medicine, Soonchunhyang University College of Medicine, Seoul, 8Department of Internal Medicine,  Kosin University College of Medicine, Busan, 9Department of Internal Medicine, Jeju National University School of Medicine, Jeju, 10Department  of Internal Medicine, University of Ulsan College of Medicine, Seoul, Korea Background/Aims: Inflammatory bowel disease (IBD) is a chronic disabling gastrointestinal disorder that diminishes the quality of life of the affected individuals.",Non-OADS,/arxiv_data1/oa_pdf/5d/6a/ir-15-338.PMC5478758.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 339 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.338 • Intest Res 2017;15(3):338-344 IBD mainly consists of UC and CD.,Non-OADS,/arxiv_data1/oa_pdf/5d/6a/ir-15-338.PMC5478758.pdf
"https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 341 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.338 • Intest Res 2017;15(3):338-344 percent of the patients had experienced side effects from  corticosteroids, and 87% of the patients were concerned about the long-term effects of corticosteroids.",Non-OADS,/arxiv_data1/oa_pdf/5d/6a/ir-15-338.PMC5478758.pdf
"https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 343 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.338 • Intest Res 2017;15(3):338-344 in Korea, thereby delaying hospital visit or referral to IBD  specialists.7,17,18 In the IMP ACT survey, only 54% of the 4,670  patients received a final diagnosis within 1 year after notic - ing the first symptoms.",Non-OADS,/arxiv_data1/oa_pdf/5d/6a/ir-15-338.PMC5478758.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ORIGINAL ARTICLE pISSN 1598-9100  • eISSN 2288-1956 https://doi.org/10.5217/ir.2017.15.3.345Intest Res 2017;15(3):345-351 Japanese physicians’ attitudes towards enteral nutrition treatment for pediatric patients with Crohn’s disease: a questionnaire survey Takashi Ishige1, Takeshi Tomomasa2, Hitoshi Tajiri3, Atsushi Yoden4, on behalf of the Japanese Study  Group for Pediatric Crohn’s Disease 1Department of Pediatrics, Gunma University Graduate School of Medicine, Maebashi, 2PAL Children’s Clinic, Isesaki,   3Department of Pediatrics, Osaka General Medical Center, Osaka, 4Department of Pediatrics, Osaka Medical College, Takatsuki, Japan Background/Aims: Enteral nutrition (EN) is recommended for the treatment of pediatric Crohn’s disease (CD) in Japan.",Non-OADS,/arxiv_data1/oa_pdf/f4/f6/ir-15-345.PMC5478759.pdf
"https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 347 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.345 • Intest Res 2017;15(3):345-351 Japan, Tokyo, Japan; and Racol®, Otsuka Pharmaceutical for  polymeric diet) were listed in the questionnaire.",Non-OADS,/arxiv_data1/oa_pdf/f4/f6/ir-15-345.PMC5478759.pdf
"https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 349 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.345 • Intest Res 2017;15(3):345-351 (ESPGHAN), as well as in previous Japanese pediatric CD  guidelines.13,14 EEN has also been recommended for use in  adult patients with CD in Japan.15 However, a number of fac - tors determine whether EEN is administered to pediatric patients.",Non-OADS,/arxiv_data1/oa_pdf/f4/f6/ir-15-345.PMC5478759.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 351 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.345 • Intest Res 2017;15(3):345-351 14.,Non-OADS,/arxiv_data1/oa_pdf/f4/f6/ir-15-345.PMC5478759.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ORIGINAL ARTICLE pISSN 1598-9100  • eISSN 2288-1956 https://doi.org/10.5217/ir.2017.15.3.352Intest Res 2017;15(3):352-357 Changes in serum levels of lipopolysaccharides and CD26 in patients with Crohn’s disease Daniéla Oliveira Magro1, Paulo Gustavo Kotze2, Carlos Augusto Real Martinez1, Michel Gardere Camargo1,  Dioze Guadagnini3, Antonio Ramos Calixto4, Ana Carolina Junqueira Vasques4,5, Maria de Lourdes  Setsuko Ayrizono1, Bruno Geloneze4, José Carlos Pareja1, Mario José Saad3, Claudio Saddy Rodrigues Coy1 1Department of Surgery, Faculty of Medical Sciences, State University of Campinas, Campinas, 2Colorectal Surgery Unit,   Cajuru University Hospital, Catholic University of Paraná, Curitiba, 3Department of Internal Medicine, Faculty of Medical Sciences,   4Research Laboratory of Metabolism and Diabetes, Gastrocentro, and 5Faculty of Applied Sciences, State University of Campinas, Campinas, Brazil Background/Aims: Lipopolysaccharide (LPS) is a molecule formed by lipids and polysaccharides and is the major cell wall component of gram-negative bacteria.",Non-OADS,/arxiv_data1/oa_pdf/40/09/ir-15-352.PMC5478760.pdf
"https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 353 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.352 • Intest Res 2017;15(3):352-357 high fat content, leading to increased activation of inflamma- tory pathways and impaired insulin signaling.1 CD is characterized by an autoimmune transmural bowel  inflammatory process based on increased production of inflammatory cytokines, such as interleukins and TNF- α.",Non-OADS,/arxiv_data1/oa_pdf/40/09/ir-15-352.PMC5478760.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 355 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.352 • Intest Res 2017;15(3):352-357 elevated in CD groups compared to levels in the control group  (P<0.010).,Non-OADS,/arxiv_data1/oa_pdf/40/09/ir-15-352.PMC5478760.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 357 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.352 • Intest Res 2017;15(3):352-357 15.,Non-OADS,/arxiv_data1/oa_pdf/40/09/ir-15-352.PMC5478760.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-9100  • eISSN 2288-1956 https://doi.org/10.5217/ir.2017.15.3.358Intest Res 2017;15(3):358-367ORIGINAL ARTICLE Comparison of efficacies of once-daily dose multimatrix mesalazine and multiple-dose mesalazine for the maintenance of remission in ulcerative colitis:  a randomized, double-blind study Haruhiko Ogata1, Akihiro Ohori2, Haruo Nishino3, Seiichi Mizushima4, Atsushi Hagino4, Toshifumi Hibi5 1Center for Diagnostic and Therapeutic Endoscopy, Keio University Hospital, Tokyo, 2Inogashiradori Proctology and Gastroenterology Clinic,  Tokyo, 3Matsushima Clinic, Kanagawa, 4Clinical Development Department, Mochida Pharmaceutical Co., Ltd., Tokyo, 5Center for Advanced  IBD Research and Treatment, Kitasato Institute Hospital, Kitasato University, Tokyo, Japan Background/Aims: This study compared the efficacy of once-daily administration of multimatrix mesalazine 2.4 g/day with multiple-dose mesalazine for the maintenance of remission.",Non-OADS,/arxiv_data1/oa_pdf/bf/7f/ir-15-358.PMC5478761.pdf
"https://doi.org/10.5217/ir.2017.15.3.358 • Intest Res 2017;15(3):358-367 359 www.irjournal.org tions of oral 5-aminosalicylic acid (5-ASA; mesalazine) in the  maintenance of remission in UC.5 Multimatrix mesalazine (Lialda® in the United States;  MezavantTM XL in the United Kingdom, Ireland, and Malta;  MezavantTM elsewhere in the European Union) is approved  in Europe and the United States for once-daily (QD) use in the induction and maintenance of remission of mild-to-moderate UC.",Non-OADS,/arxiv_data1/oa_pdf/bf/7f/ir-15-358.PMC5478761.pdf
Clini-cal laboratory tests were also evaluated at week 4. AEs were summarized by preferred terms of the Medical Dictionary for Regulatory Activities version 15.0 (http://www.meddra.org/).,OADS,/arxiv_data1/oa_pdf/bf/7f/ir-15-358.PMC5478761.pdf
https://doi.org/10.5217/ir.2017.15.3.358 • Intest Res 2017;15(3):358-367 361 www.irjournal.org ratio of the time to occurrence of rectal bleeding for the Mul- timatrix-2.4 g/day group compared with the Time-2.25 g/day group and the two-sided 95% CI were calculated.,OADS,/arxiv_data1/oa_pdf/bf/7f/ir-15-358.PMC5478761.pdf
"https://doi.org/10.5217/ir.2017.15.3.358 • Intest Res 2017;15(3):358-367 363 www.irjournal.org ed the noninferiority margin (−10%), thus demonstrating the  noninferiority of Multimatrix-2.4 g/day QD to Time-2.25 g/day TID.",OADS,/arxiv_data1/oa_pdf/bf/7f/ir-15-358.PMC5478761.pdf
https://doi.org/10.5217/ir.2017.15.3.358 • Intest Res 2017;15(3):358-367 365 www.irjournal.org DISCUSSION The efficacy of QD dosing compared with that of multiple  dosing of the same formulation of mesalazine has been  investigated in several previous studies.,Non-OADS,/arxiv_data1/oa_pdf/bf/7f/ir-15-358.PMC5478761.pdf
https://doi.org/10.5217/ir.2017.15.3.358 • Intest Res 2017;15(3):358-367 367 www.irjournal.org 5.,Non-OADS,/arxiv_data1/oa_pdf/bf/7f/ir-15-358.PMC5478761.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ORIGINAL ARTICLE pISSN 1598-9100  • eISSN 2288-1956 https://doi.org/10.5217/ir.2017.15.3.368Intest Res 2017;15(3):368-379 Comparison of efficacy of multimatrix mesalazine 4.8 g/day once-daily with other high-dose mesalazine in active ulcerative colitis: a randomized, double-blind study Haruhiko Ogata1, Nobuo Aoyama2, Seiichi Mizushima3, Atsushi Hagino3, Toshifumi Hibi4 1Center for Diagnostic and Therapeutic Endoscopy, Keio University Hospital, Tokyo, 2Gastrointestinal Endoscopy and Inflammatory Bowel  Disease Center, Aoyama Medical Clinic, Hyogo, 3Clinical Development Department, Mochida Pharmaceutical Co., Ltd., Tokyo, 4Center for  Advanced IBD Research and Treatment, Kitasato Institute Hospital, Kitasato University, Tokyo, Japan Background/Aims: This study assessed the efficacy and safety of high-dose multimatrix mesalazine once-daily (QD) com-pared to another form of high-dose mesalazine.",Non-OADS,/arxiv_data1/oa_pdf/9f/5b/ir-15-368.PMC5478762.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 369 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.368 • Intest Res 2017;15(3):368-379 ent formulations of high-dose mesalazine at doses exceed- ing 3.0 g/day.,Non-OADS,/arxiv_data1/oa_pdf/9f/5b/ir-15-368.PMC5478762.pdf
AEs were summarized by the preferred term using the Medical Dictionary for Regulatory Activities version 18.0 (http://www.meddra.org/).,OADS,/arxiv_data1/oa_pdf/9f/5b/ir-15-368.PMC5478762.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 371 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.368 • Intest Res 2017;15(3):368-379 6.,Non-OADS,/arxiv_data1/oa_pdf/9f/5b/ir-15-368.PMC5478762.pdf
"https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 373 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.368 • Intest Res 2017;15(3):368-379 2) Secondary Endpoints The proportions of patients who achieved remission, clini- cal remission, endoscopic remission, and improvement are shown in Fig.",Non-OADS,/arxiv_data1/oa_pdf/9f/5b/ir-15-368.PMC5478762.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 375 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.368 • Intest Res 2017;15(3):368-379 3.,Non-OADS,/arxiv_data1/oa_pdf/9f/5b/ir-15-368.PMC5478762.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 377 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.368 • Intest Res 2017;15(3):368-379 change in each variable of the UC-DAI) supported the result  obtained for the primary endpoint.,Non-OADS,/arxiv_data1/oa_pdf/9f/5b/ir-15-368.PMC5478762.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 379 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.368 • Intest Res 2017;15(3):368-379 13.,Non-OADS,/arxiv_data1/oa_pdf/9f/5b/ir-15-368.PMC5478762.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ORIGINAL ARTICLE  pISSN 1598-9100  • eISSN 2288-1956 https://doi.org/10.5217/ir.2017.15.3.380Intest Res 2017;15(3):380-387 Ophthalmologic manifestations in patients with inflammatory bowel disease Hye Jin Lee1, Hyun Joo Song2, Jin Ho Jeong1, Heung Up Kim2, Sun-Jin Boo2, Soo- Young Na2  Departments of 1Ophthalmology and 2Internal Medicine, Jeju National University School of Medicine, Jeju, Korea Background/Aims: Inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), has been reported to have various ophthalmologic manifestations.",Non-OADS,/arxiv_data1/oa_pdf/22/ab/ir-15-380.PMC5478763.pdf
"https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 381 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.380 • Intest Res 2017;15(3):380-387 itis in 11.5% of cases, retinal pigment epithelial detachment  in 11.5% of cases and optic neuritis in 3.8% of cases.6 Coinci- dental DES was found in 50.0% of cases, steroid induced cat - aract in 30.7% of cases, and conjunctivitis in 3.8% of cases.6 However, the above reports are the result of research in  Western countries and, to our knowledge, this study is the first study of its type with Korean patients.",Non-OADS,/arxiv_data1/oa_pdf/22/ab/ir-15-380.PMC5478763.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 383 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.380 • Intest Res 2017;15(3):380-387 patients (23.0%) were mild and 11 patients (18.0%) were  moderate to severe.,Non-OADS,/arxiv_data1/oa_pdf/22/ab/ir-15-380.PMC5478763.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 385 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.380 • Intest Res 2017;15(3):380-387 because of its cross-sectional nature.,Non-OADS,/arxiv_data1/oa_pdf/22/ab/ir-15-380.PMC5478763.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 387 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.380 • Intest Res 2017;15(3):380-387 16.,Non-OADS,/arxiv_data1/oa_pdf/22/ab/ir-15-380.PMC5478763.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ORIGINAL ARTICLE pISSN 1598-9100  • eISSN 2288-1956 https://doi.org/10.5217/ir.2017.15.3.388Intest Res 2017;15(3):388-394 Familial aggregation of inflammatory bowel disease in patients with ulcerative colitis  Akshita Gupta, Sawan Bopanna, Saurabh Kedia, Dawesh Prakash Yadav, Sandeep Goyal, Saransh Jain, Govind Makharia, Vineet Ahuja Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India Background/Aims: Familial occurrence of inflammatory bowel disease (IBD) is well documented.",Non-OADS,/arxiv_data1/oa_pdf/c7/52/ir-15-388.PMC5478764.pdf
"https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 389 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.388 • Intest Res 2017;15(3):388-394 found to be less than that in the Western population.14,15 There are currently no available data from India on the  prevalence of family history in patients with UC.",Non-OADS,/arxiv_data1/oa_pdf/c7/52/ir-15-388.PMC5478764.pdf
"https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 391 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.388 • Intest Res 2017;15(3):388-394 ous type or a single episode of UC, respectively.",Non-OADS,/arxiv_data1/oa_pdf/c7/52/ir-15-388.PMC5478764.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 393 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.388 • Intest Res 2017;15(3):388-394 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/c7/52/ir-15-388.PMC5478764.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ORIGINAL ARTICLE pISSN 1598-9100  • eISSN 2288-1956 https://doi.org/10.5217/ir.2017.15.3.395Intest Res 2017;15(3):395-401 Long-term safety and efficacy of adalimumab for intestinal Behçet’s disease in the open label study following a phase 3 clinical trial  Nagamu Inoue1, Kiyonori Kobayashi2, Makoto Naganuma3, Fumihito Hirai4, Morio Ozawa5, Dilek Arikan6,  Bidan Huang6, Anne M. Robinson6, Roopal B. Thakkar6, Toshifumi Hibi7 1Center for Preventive Medicine, Keio University Hospital, Tokyo, 2Department of Gastroenterology, Kitasato University Hospital, Kanagawa,  3Division of Gastroenterology & Hepatology, Department of Internal Medicine, Keio University School of Medicine, 4IBD Center, Fukuoka  University Chikushi Hospital, Fukuoka, 5AbbVie GK, Tokyo, Japan, 6AbbVie Inc., North Chicago, IL, USA, 7Center for Advanced IBD Research  and Treatment, Kitasato Institute Hospital, Kitasato University, Tokyo, Japan Background/Aims: Intestinal Behçet’s disease (BD) is an immune-mediated inflammatory disorder.",Non-OADS,/arxiv_data1/oa_pdf/6a/07/ir-15-395.PMC5478765.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 397 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.395 • Intest Res 2017;15(3):395-401 study.,Non-OADS,/arxiv_data1/oa_pdf/6a/07/ir-15-395.PMC5478765.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 399 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.395 • Intest Res 2017;15(3):395-401 Table 4.,Non-OADS,/arxiv_data1/oa_pdf/6a/07/ir-15-395.PMC5478765.pdf
"https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 401 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.395 • Intest Res 2017;15(3):395-401 tive cohort studies of IFX treatment.13,14 In conclusion, it has been demonstrated that approximate- ly 2 years of long-term treatment for intestinal BD with adali- mumab was well tolerated without any unexpected AEs.",Non-OADS,/arxiv_data1/oa_pdf/6a/07/ir-15-395.PMC5478765.pdf
http://www.mhlw.go.jp/file/06-Seisakujouhou-10900000-Kenkoukyoku/0000089968.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6a/07/ir-15-395.PMC5478765.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ORIGINAL ARTICLE pISSN 1598-9100  • eISSN 2288-1956 https://doi.org/10.5217/ir.2017.15.3.402Intest Res 2017;15(3):402-410 Clinical characteristics of patients with serrated polyposis syndrome in Korea: comparison with Western patients Eun Ran Kim*, Jaryong Jeon*, Jin Hee Lee, Yoon Jung Lee, Sung Noh Hong, Dong K yung Chang, Young-Ho Kim Division of Gastroenterology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Background/Aims: Serrated polyposis syndrome (SPS) has been shown to increase the risk of colorectal cancer (CRC).",Non-OADS,/arxiv_data1/oa_pdf/79/df/ir-15-402.PMC5478766.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 403 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.402 • Intest Res 2017;15(3):402-410 included in previous studies.,Non-OADS,/arxiv_data1/oa_pdf/79/df/ir-15-402.PMC5478766.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 405 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.402 • Intest Res 2017;15(3):402-410 2.,Non-OADS,/arxiv_data1/oa_pdf/79/df/ir-15-402.PMC5478766.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 407 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.402 • Intest Res 2017;15(3):402-410Table 4.,Non-OADS,/arxiv_data1/oa_pdf/79/df/ir-15-402.PMC5478766.pdf
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 409 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.402 • Intest Res 2017;15(3):402-410 patients with SPS.,Non-OADS,/arxiv_data1/oa_pdf/79/df/ir-15-402.PMC5478766.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ORIGINAL ARTICLE pISSN 1598-9100  • eISSN 2288-1956 https://doi.org/10.5217/ir.2017.15.3.411Intest Res 2017;15(3):411-418 Miss rate of colorectal neoplastic polyps and risk factors for missed polyps in consecutive colonoscopies Nam Hee Kim*, Yoon Suk Jung*, Woo Shin Jeong, Hyo-Joon Yang, Soo-K yung Park, K yuyong Choi, Dong Il Park Division of Gastroenterology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea Background/Aims: Colonoscopic polypectomy is the best diagnostic and therapeutic tool to detect and prevent colorectal neoplasms.",Non-OADS,/arxiv_data1/oa_pdf/9d/25/ir-15-411.PMC5478767.pdf
"https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 413 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.411 • Intest Res 2017;15(3):411-418 enomas; tubular, villous, or tubulovillous adenomas; and car - cinomas.",Non-OADS,/arxiv_data1/oa_pdf/9d/25/ir-15-411.PMC5478767.pdf
"https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 415 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.411 • Intest Res 2017;15(3):411-418 DISCUSSION In this quality-adjusted, consecutive colonoscopy study,  we found that the miss rate for adenomas was 24.1% and  that for advanced adenomas was 1.2%.",Non-OADS,/arxiv_data1/oa_pdf/9d/25/ir-15-411.PMC5478767.pdf
"https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년> 417 www.irjournal.org https://doi.org/10.5217/ir.2017.15.3.411 • Intest Res 2017;15(3):411-418 In our study, smaller neoplastic polyps (<10 mm, espe- cially ≤5 mm) were more frequently missed than large neo- plastic polyps (≥10 mm).",Non-OADS,/arxiv_data1/oa_pdf/9d/25/ir-15-411.PMC5478767.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-9100  • eISSN 2288-1956 https://doi.org/10.5217/ir.2017.15.3.419Intest Res 2017;15(3):419-421CASE REPORT Telmisartan-induced sprue-like enteropathy: a case report and a review of patients using non-olmesartan angiotensin receptor blockers Harshal Surendra Mandavdhare1, Vishal Sharma1, Kaushal K Prasad1, Amit Kumar1, Manish Rathi2,  Surinder S Rana1  Departments of 1Gastroenterology and 2Nephrology, Postgraduate Institute of Medical Education and Research, Chandigarh, India  Recent studies have identified sprue-like illness associated with the use of the antihypertensive agent olmesartan medoxomil.",Non-OADS,/arxiv_data1/oa_pdf/d8/3e/ir-15-419.PMC5478768.pdf
"https://doi.org/10.5217/ir.2017.15.3.419 • Intest Res 2017;15(3):419-421 421 www.irjournal.org DISCUSSION Several recent studies have reported olmesartan-induced  sprue-like enteropathy.1-4 A systematic review of 54 cases  of olmesartan-induced sprue-like enteropathy showed that  64% patients were human leukocyte antigen (HLA) DQ2/DQ8 positive, whereas the incidence of HLA DQ2/DQ8-positive individuals is 40% among the general population; therefore, the involvement of the HLA system in this disease cannot be ruled out.",Non-OADS,/arxiv_data1/oa_pdf/d8/3e/ir-15-419.PMC5478768.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-9100  • eISSN 2288-1956 https://doi.org/10.5217/ir.2017.15.3.422Intest Res 2017;15(3):422-428CASE REPORT Behçet’s disease with multiple splenic abscesses in a child K yung In Lim, Dong Hwa Yang, Eell Ryoo Department of Pediatrics, Gachon University Gil Hospital, Incheon, Korea We report the case of a 5-year-old male patient with multiple aseptic splenic abscesses associated with Behçet’s disease.",Non-OADS,/arxiv_data1/oa_pdf/42/be/ir-15-422.PMC5478769.pdf
"https://doi.org/10.5217/ir.2017.15.3.422 • Intest Res 2017;15(3):422-428 423 www.irjournal.org CASE REPORT A 5-year-old boy visited the hospital with a 6-day history  of fever and abdominal pain, and a 2-year history of inter - mittent abdominal pain and diarrhea.",Non-OADS,/arxiv_data1/oa_pdf/42/be/ir-15-422.PMC5478769.pdf
"https://doi.org/10.5217/ir.2017.15.3.422 • Intest Res 2017;15(3):422-428 425 www.irjournal.org initial infliximab dose, the second 5 mg/kg dose was admin- istered 2 weeks later, and the third dose 4 weeks after that.",Non-OADS,/arxiv_data1/oa_pdf/42/be/ir-15-422.PMC5478769.pdf
"https://doi.org/10.5217/ir.2017.15.3.422 • Intest Res 2017;15(3):422-428 427 www.irjournal.org Therefore, his condition was considered incomplete BD with  probable intestinal BD.",Non-OADS,/arxiv_data1/oa_pdf/42/be/ir-15-422.PMC5478769.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.IMAGES OF THE ISSUE pISSN 1598-9100  • eISSN 2288-1956 https://doi.org/10.5217/ir.2017.15.3.429Intest Res 2017;15(3):429-430 Asymptomatic multiple cystic lesions filled with gas in the colon Ki Bae Kim, Soon Man Yoon Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Korea Received May 1, 2017.",Non-OADS,/arxiv_data1/oa_pdf/d3/bf/ir-15-429.PMC5478770.pdf
"Using bi oinformatics tools  TargetScan (http://www.targetscan.org), IRS1 and  IRS2 could be putative targets of miR -570 based on  multiple complementary binding sites (Figure 4A).",OADS,/arxiv_data1/oa_pdf/b9/45/IJBMS-20-481.PMC5478775.pdf
"@ERSpublications Tuberculosis control, and the where and why of artificial intelligence http://ow.ly/GwuY30bCXkJ Cite this article as: Doshi R, Falzon D, Thomas BV, et al.",Non-OADS,/arxiv_data1/oa_pdf/ad/ca/00056-2017.PMC5478795.pdf
ERJ Open Res 2017; 3: 00056-2017 [https://doi.org/10.1183/ 23120541.00056-2017].,Non-OADS,/arxiv_data1/oa_pdf/ad/ca/00056-2017.PMC5478795.pdf
https://doi.org/10.1183/23120541.00056-2017 ERJ Open Res 2017; 3: 00056-2017 REVIEW TUBERCULOSIS,Non-OADS,/arxiv_data1/oa_pdf/ad/ca/00056-2017.PMC5478795.pdf
Such a personalised approach to care is bound to challenge https://doi.org/10.1183/23120541.00056-2017 2TUBERCULOSIS | R. DOSHI ET AL.,Non-OADS,/arxiv_data1/oa_pdf/ad/ca/00056-2017.PMC5478795.pdf
Many of the healthcare processes streamlined by https://doi.org/10.1183/23120541.00056-2017 3TUBERCULOSIS | R. DOSHI ET AL.,Non-OADS,/arxiv_data1/oa_pdf/ad/ca/00056-2017.PMC5478795.pdf
"https://aicure.com/wp-content/uploads/2016/12/Shafner_et_ al_Vancouver_Feb_2017.pdf Date last accessed: May 26, 2017.",Non-OADS,/arxiv_data1/oa_pdf/ad/ca/00056-2017.PMC5478795.pdf
2015: Article 12. https://doi.org/10.1183/23120541.00056-2017 4TUBERCULOSIS | R. DOSHI ET AL.,Non-OADS,/arxiv_data1/oa_pdf/ad/ca/00056-2017.PMC5478795.pdf
"http://nikshay.gov.in/AboutNikshay.htm Date last accessed: May 26, 2017.",Non-OADS,/arxiv_data1/oa_pdf/ad/ca/00056-2017.PMC5478795.pdf
https://doi.org/10.1183/23120541.00056-2017 5TUBERCULOSIS | R. DOSHI ET AL.,Non-OADS,/arxiv_data1/oa_pdf/ad/ca/00056-2017.PMC5478795.pdf
"@ERSpublications Iatrogenic bleeding during flexible bronchoscopy http://ow.ly/w9Fy30bsoe5 Cite this article as: Bernasconi M, Koegelenberg CFN, Koutsokera A, et al .",Non-OADS,/arxiv_data1/oa_pdf/fc/30/00084-2016.PMC5478796.pdf
ERJ Open Res 2017; 3: 00084-2016 [https://doi.org/10.1183/23120541.00084-2016].,Non-OADS,/arxiv_data1/oa_pdf/fc/30/00084-2016.PMC5478796.pdf
https://doi.org/10.1183/23120541.00084-2016 ERJ Open Res 2017; 3: 00084-2016 REVIEW BRONCHOSCOPY,Non-OADS,/arxiv_data1/oa_pdf/fc/30/00084-2016.PMC5478796.pdf
https://doi.org/10.1183/23120541.00084-2016 2BRONCHOSCOPY | M. BERNASCONI ET AL.,Non-OADS,/arxiv_data1/oa_pdf/fc/30/00084-2016.PMC5478796.pdf
https://doi.org/10.1183/23120541.00084-2016 3BRONCHOSCOPY | M. BERNASCONI ET AL.,Non-OADS,/arxiv_data1/oa_pdf/fc/30/00084-2016.PMC5478796.pdf
Resuscitation equipment and additional staffnecessary for emergency resuscitation should be readily available should an unexpected life-threatening https://doi.org/10.1183/23120541.00084-2016 4BRONCHOSCOPY | M. BERNASCONI ET AL.,Non-OADS,/arxiv_data1/oa_pdf/fc/30/00084-2016.PMC5478796.pdf
https://doi.org/10.1183/23120541.00084-2016 5BRONCHOSCOPY | M. BERNASCONI ET AL.,Non-OADS,/arxiv_data1/oa_pdf/fc/30/00084-2016.PMC5478796.pdf
"Differently, continuous suction should be applied where visibility has been lost, in https://doi.org/10.1183/23120541.00084-2016 6BRONCHOSCOPY | M. BERNASCONI ET AL.",Non-OADS,/arxiv_data1/oa_pdf/fc/30/00084-2016.PMC5478796.pdf
https://doi.org/10.1183/23120541.00084-2016 7BRONCHOSCOPY | M. BERNASCONI ET AL.,Non-OADS,/arxiv_data1/oa_pdf/fc/30/00084-2016.PMC5478796.pdf
https://doi.org/10.1183/23120541.00084-2016 8BRONCHOSCOPY | M. BERNASCONI ET AL.,Non-OADS,/arxiv_data1/oa_pdf/fc/30/00084-2016.PMC5478796.pdf
https://doi.org/10.1183/23120541.00084-2016 9BRONCHOSCOPY | M. BERNASCONI ET AL.,Non-OADS,/arxiv_data1/oa_pdf/fc/30/00084-2016.PMC5478796.pdf
https://doi.org/10.1183/23120541.00084-2016 10BRONCHOSCOPY | M. BERNASCONI ET AL.,Non-OADS,/arxiv_data1/oa_pdf/fc/30/00084-2016.PMC5478796.pdf
https://doi.org/10.1183/23120541.00084-2016 11BRONCHOSCOPY | M. BERNASCONI ET AL.,Non-OADS,/arxiv_data1/oa_pdf/fc/30/00084-2016.PMC5478796.pdf
"Available from: HYPERLINK ""http://www.choosemyplate.",Non-OADS,/arxiv_data1/oa_pdf/29/11/OSP4-3-134.PMC5478801.pdf
"URL http://www.who.int/gho/en/ (accessed Sep 25, 2016).",OADS,/arxiv_data1/oa_pdf/0b/9f/OSP4-3-162.PMC5478803.pdf
Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes_05_06/CV.pdf.,OADS,/arxiv_data1/oa_pdf/12/6c/OSP4-3-153.PMC5478808.pdf
Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes_03_04/Anthropometric_Procedures_Manual.pdf.,OADS,/arxiv_data1/oa_pdf/12/6c/OSP4-3-153.PMC5478808.pdf
Am J Lifestyle Med 2016https://doi.org/10.1177/1559827615624417.160 Fitness and racial disparities in obesity S. McDonald et al.,Non-OADS,/arxiv_data1/oa_pdf/12/6c/OSP4-3-153.PMC5478808.pdf
"@ERSpublications Prescribing antibiotics for patients presenting to their GP with COPD exacerbations was found to be cost-effective http://ow.ly/F7Pe30bYBEs Cite this article as: Ronaldson SJ, Raghunath A, Torgerson DJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/12/43/00085-2016.PMC5478862.pdf
ERJ Open Res 2017; 3: 00085-2016 [https://doi.org/10.1183/23120541.00085-2016].,Non-OADS,/arxiv_data1/oa_pdf/12/43/00085-2016.PMC5478862.pdf
Conflict of interest: Disclosures can be found alongside this article at openres.ersjournals.com https://doi.org/10.1183/23120541.00085-2016 ERJ Open Res 2017; 3: 00085-2016 ORIGINAL ARTICLE COPD,Non-OADS,/arxiv_data1/oa_pdf/12/43/00085-2016.PMC5478862.pdf
"In the base case, the time horizon of the evaluation was 4 weeks after the index visit for the https://doi.org/10.1183/23120541.00085-2016 2COPD | S.J.",Non-OADS,/arxiv_data1/oa_pdf/12/43/00085-2016.PMC5478862.pdf
https://doi.org/10.1183/23120541.00085-2016 3COPD | S.J.,Non-OADS,/arxiv_data1/oa_pdf/12/43/00085-2016.PMC5478862.pdf
https://doi.org/10.1183/23120541.00085-2016 4COPD | S.J.,Non-OADS,/arxiv_data1/oa_pdf/12/43/00085-2016.PMC5478862.pdf
https://doi.org/10.1183/23120541.00085-2016 5COPD | S.J.,Non-OADS,/arxiv_data1/oa_pdf/12/43/00085-2016.PMC5478862.pdf
https://doi.org/10.1183/23120541.00085-2016 6COPD | S.J.,Non-OADS,/arxiv_data1/oa_pdf/12/43/00085-2016.PMC5478862.pdf
https://doi.org/10.1183/23120541.00085-2016 7COPD | S.J.,Non-OADS,/arxiv_data1/oa_pdf/12/43/00085-2016.PMC5478862.pdf
2013. https://www.slideshare.net/NHSImprovement/managing-exacerbations-in-chronic-obstructive-pulmonary-disease-copd-a-secondary-care-toolkit-the-ingredients-for-successDate last accessed: March 21 2017.,Non-OADS,/arxiv_data1/oa_pdf/12/43/00085-2016.PMC5478862.pdf
"NHS Reference Costs: Financial Year 2011 to 2012. https://www.gov.uk/government/ publications/nhs-reference-costs-financial-year-2011-to-2012 Date last accessed: March 21, 2017.",Non-OADS,/arxiv_data1/oa_pdf/12/43/00085-2016.PMC5478862.pdf
"https://amr-review.org/sites/default/files/160525_Final%20paper_with%20cover.pdf Date last accessed: March 21, 2017.",Non-OADS,/arxiv_data1/oa_pdf/12/43/00085-2016.PMC5478862.pdf
"https://www.pcc-cic.org.uk/sites/ default/files/articles/attachments/spirometry_e-guide_1-5-13_0.pdf Date last accessed: March 21, 2017. https://doi.org/10.1183/23120541.00085-2016 8COPD | S.J.",Non-OADS,/arxiv_data1/oa_pdf/12/43/00085-2016.PMC5478862.pdf
"@ERSpublications An increase in blood glucose marks severity of community-acquired pneumonia in patientswithout diabetes mellitus http://ow.ly/3omE30c0whm Cite this article as: Jensen AV, Egelund GB, Andersen SB, et al.",Non-OADS,/arxiv_data1/oa_pdf/22/81/00114-2016.PMC5478863.pdf
ERJ Open Res 2017; 3: 00114-2016 [https://doi.org/10.1183/23120541.00114-2016].,Non-OADS,/arxiv_data1/oa_pdf/22/81/00114-2016.PMC5478863.pdf
Conflict of interest: Disclosures can be found alongside this article at openres.ersjournals.com https://doi.org/10.1183/23120541.00114-2016 ERJ Open Res 2017; 3: 00114-2016 ORIGINAL ARTICLE PNEUMONIA,Non-OADS,/arxiv_data1/oa_pdf/22/81/00114-2016.PMC5478863.pdf
"TABLE 1 Inclusion and exclusion criteria Inclusion criteria Exclusion criteria Age⩾18 years New infiltrate on chest radiography (confirmed by radiologist) At least one of the following symptoms of lower respiratory tract infection Cough Purulent expectoration Fever ⩾38.3 °C (rectal) or ⩾37.8 °C (ear) Pathological lung auscultationHospital admission within the last 28 days prior to admission due to pneumonia Active tuberculosis Missing information on prior medical history Immunosuppression, defined as Treatment with corticosteroids ( ⩾20 mg prednisolone-equivalent/day >14 days) HIV infection Received cancer chemotherapy within the last 28 days and had neutropenia (neutrophil granulocytes <1000 µL−1) Immunosuppression after organ or bone marrow transplantation https://doi.org/10.1183/23120541.00114-2016 2PNEUMONIA | A.V.",Non-OADS,/arxiv_data1/oa_pdf/22/81/00114-2016.PMC5478863.pdf
https://doi.org/10.1183/23120541.00114-2016 3PNEUMONIA | A.V.,Non-OADS,/arxiv_data1/oa_pdf/22/81/00114-2016.PMC5478863.pdf
https://doi.org/10.1183/23120541.00114-2016 4PNEUMONIA | A.V.,Non-OADS,/arxiv_data1/oa_pdf/22/81/00114-2016.PMC5478863.pdf
https://doi.org/10.1183/23120541.00114-2016 5PNEUMONIA | A.V.,Non-OADS,/arxiv_data1/oa_pdf/22/81/00114-2016.PMC5478863.pdf
https://doi.org/10.1183/23120541.00114-2016 6PNEUMONIA | A.V.,Non-OADS,/arxiv_data1/oa_pdf/22/81/00114-2016.PMC5478863.pdf
https://doi.org/10.1183/23120541.00114-2016 7PNEUMONIA | A.V.,Non-OADS,/arxiv_data1/oa_pdf/22/81/00114-2016.PMC5478863.pdf
https://doi.org/10.1183/23120541.00114-2016 8PNEUMONIA | A.V.,Non-OADS,/arxiv_data1/oa_pdf/22/81/00114-2016.PMC5478863.pdf
"@ERSpublications TLR2 activation by mucoid Pseudomonas increases corticosteroid-resistant inflammation in airway epithelial cells http://ow.ly/lR3d30bsRrr Cite this article as: Mizutani M, Bérubé J, Ahlgren HG, et al.",Non-OADS,/arxiv_data1/oa_pdf/e9/7f/00144-2016.PMC5478864.pdf
Conflict of interest: Disclosures can be found alongside this article at openres.ersjournals.com https://doi.org/10.1183/23120541.00144-2016 ERJ Open Res 2017; 3: 00144-2016 ORIGINAL ARTICLE CYSTIC FIBROSIS,Non-OADS,/arxiv_data1/oa_pdf/e9/7f/00144-2016.PMC5478864.pdf
https://doi.org/10.1183/23120541.00144-2016 2CYSTIC FIBROSIS | M. MIZUTANI ET AL.,Non-OADS,/arxiv_data1/oa_pdf/e9/7f/00144-2016.PMC5478864.pdf
https://doi.org/10.1183/23120541.00144-2016 3CYSTIC FIBROSIS | M. MIZUTANI ET AL.,Non-OADS,/arxiv_data1/oa_pdf/e9/7f/00144-2016.PMC5478864.pdf
https://doi.org/10.1183/23120541.00144-2016 4CYSTIC FIBROSIS | M. MIZUTANI ET AL.,Non-OADS,/arxiv_data1/oa_pdf/e9/7f/00144-2016.PMC5478864.pdf
https://doi.org/10.1183/23120541.00144-2016 5CYSTIC FIBROSIS | M. MIZUTANI ET AL.,Non-OADS,/arxiv_data1/oa_pdf/e9/7f/00144-2016.PMC5478864.pdf
https://doi.org/10.1183/23120541.00144-2016 6CYSTIC FIBROSIS | M. MIZUTANI ET AL.,Non-OADS,/arxiv_data1/oa_pdf/e9/7f/00144-2016.PMC5478864.pdf
https://doi.org/10.1183/23120541.00144-2016 7CYSTIC FIBROSIS | M. MIZUTANI ET AL.,Non-OADS,/arxiv_data1/oa_pdf/e9/7f/00144-2016.PMC5478864.pdf
http://dx.doi.org/10.1016/j.celrep.2017.05.053,OADS,/arxiv_data1/oa_pdf/02/de/main.PMC5478878.pdf
"La Thangue1,4,* 1Laboratory of Cancer Biology, Medical Sciences Division, Department of Oncology, University of Oxford, Old Road Campus Research Building, Old Road Campus, Oxford OX3 7DQ, UK 2Nufﬁeld Orthopaedic Centre, Nufﬁeld Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Windmill Road, Oxford OX3 7HE, UK 3Target Discovery Institute, Nufﬁeld Department of Medicine, University of Oxford, Roosevelt Drive, Oxford OX3 7FZ, UK 4Lead Contact *Correspondence: nick.lathangue@oncology.ox.ac.uk http://dx.doi.org/10.1016/j.celrep.2017.05.053 SUMMARY The retinoblastoma tumor suppressor protein pRb is a master regulator of cellular proliferation, principallythrough interaction with E2F and regulation of E2Ftarget genes.",Non-OADS,/arxiv_data1/oa_pdf/02/de/main.PMC5478878.pdf
2193 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/02/de/main.PMC5478878.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures and four ﬁgures and can be found with this article online at http://dx.doi.org/ 10.1016/j.celrep.2017.05.053 .,Non-OADS,/arxiv_data1/oa_pdf/02/de/main.PMC5478878.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/2f/main.PMC5478910.pdf
"Contents lists available at ScienceDirect Indian Pacing and Electrophysiology Journal journal homepage: www.elsevier.com /locate/IPEJ http://dx.doi.org/10.1016/j.ipej.2017.03.003 0972-6292/Copyright ©2017, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/83/2f/main.PMC5478910.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/18/main.PMC5478911.pdf
"Contents lists available at ScienceDirect Indian Pacing and Electrophysiology Journal journal homepage: www.elsevier.com/locate/IPEJ Indian Pacing and Electrophysiology Journal 17 (2017) 89 http://dx.doi.org/10.1016/j.ipej.2017.03.001 0972-6292/Copyright ©2017, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/b8/18/main.PMC5478911.pdf
"Contents lists available at ScienceDirect Indian Pacing and Electrophysiology Journal journal homepage: www.elsevier.com /locate/IPEJ Indian Pacing and Electrophysiology Journal 17 (2017) 70 e71 http://dx.doi.org/10.1016/j.ipej.2017.05.003 0972-6292/Copyright ©2017, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/51/48/main.PMC5478912.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4c/c3/main.PMC5478914.pdf
"Contents lists available at ScienceDirect Indian Pacing and Electrophysiology Journal journal homepage: www.elsevier.com /locate/IPEJ http://dx.doi.org/10.1016/j.ipej.2017.05.001 0972-6292/Copyright ©2017, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/4c/c3/main.PMC5478914.pdf
Retrieved from http://data.worldbank.org/ .,OADS,/arxiv_data1/oa_pdf/4c/c3/main.PMC5478914.pdf
"Contents lists available at ScienceDirect Indian Pacing and Electrophysiology Journal journal homepage: www.elsevier.com/locate/IPEJ http://dx.doi.org/10.1016/j.ipej.2017.03.002 0972-6292/Copyright ©2017, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/df/c1/main.PMC5478915.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/f9/main.PMC5478916.pdf
"Contents lists available at ScienceDirect Indian Pacing and Electrophysiology Journal journal homepage: www.elsevier.com/locate/IPEJ http://dx.doi.org/10.1016/j.ipej.2017.01.003 0972-6292/Copyright ©2017, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/5e/f9/main.PMC5478916.pdf
"Contents lists available at ScienceDirect Indian Pacing and Electrophysiology Journal journal homepage: www.elsevier.com/locate/IPEJ Indian Pacing and Electrophysiology Journal 17 (2017) 63 e64 http://dx.doi.org/10.1016/j.ipej.2017.06.001 0972-6292/Copyright ©2017, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/0c/b8/main.PMC5478938.pdf
http://dx.doi.org/10.1016/ j.jacep.2016.09.002 .,OADS,/arxiv_data1/oa_pdf/0c/b8/main.PMC5478938.pdf
"Contents lists available at ScienceDirect Indian Pacing and Electrophysiology Journal journal homepage: www.elsevier.com/locate/IPEJ http://dx.doi.org/10.1016/j.ipej.2017.05.004 0972-6292/Copyright ©2017, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/77/a0/main.PMC5478945.pdf
http://www.treat-nmd.eu (accessed 10/01/2014).,Non-OADS,/arxiv_data1/oa_pdf/78/2d/1128-2460-36-19.PMC5479104.pdf
http://www.salute.gov.it/ (accessed 15/01/2014).,Non-OADS,/arxiv_data1/oa_pdf/78/2d/1128-2460-36-19.PMC5479104.pdf
"14       http://www.medsci.org  515  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2017;  14(6):  515-522.  doi: 10.7150/ ijms.19368   Research Paper   Nuclear Expression of GS28 Protein: A Novel  Biomarker that Predicts Prognosis in Colorectal  Cancers   Sung Hak Lee1, Hyung Jae Yoo2, Do Eun Rim2, Yinji Cui3, Ahwon Lee1, Eun Sun Jung1, Seung Taek Oh4, Jun  Gi Kim4, Oh- Joo Kwon2, Su Young Kim3, Seong -Whan Jeong2  1.",Non-OADS,/arxiv_data1/oa_pdf/da/c9/ijmsv14p0515.PMC5479119.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/da/c9/ijmsv14p0515.PMC5479119.pdf
See http://ivyspring.com/terms  for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/da/c9/ijmsv14p0515.PMC5479119.pdf
14     http://www.medsci.org  516  progression is an intricate process associated with  cumulative genomic changes  [4].,Non-OADS,/arxiv_data1/oa_pdf/da/c9/ijmsv14p0515.PMC5479119.pdf
"14     http://www.medsci.org  517  KRAS  mutation test    Genomic DNA was isolated from  formalin -fixed, paraffin -embedded tissue sections at a  thickness of 10 μm, containing a representative  tumour -rich area, with the QIAamp DNA Mini Kit  (Qiagen, Hilden, Germany).",Non-OADS,/arxiv_data1/oa_pdf/da/c9/ijmsv14p0515.PMC5479119.pdf
14       http://www.medsci.org  518     Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/da/c9/ijmsv14p0515.PMC5479119.pdf
14       http://www.medsci.org  519  Table 2.,Non-OADS,/arxiv_data1/oa_pdf/da/c9/ijmsv14p0515.PMC5479119.pdf
14       http://www.medsci.org  520    Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/da/c9/ijmsv14p0515.PMC5479119.pdf
14     http://www.medsci.org  521  and a significant association between the high nuclear  expression of GS28 and the advanced T stage tumors   [14].,Non-OADS,/arxiv_data1/oa_pdf/da/c9/ijmsv14p0515.PMC5479119.pdf
14     http://www.medsci.org  522  7.,Non-OADS,/arxiv_data1/oa_pdf/da/c9/ijmsv14p0515.PMC5479119.pdf
"1 4      http://www.medsci.org  523  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2017;  14(6):  523-529.  doi: 10.7150/ ijms.19033   Research Paper   Synergistic Antitumor Effect of Sorafenib in  Combination with ATM Inhibitor in Hepatocellular  Carcinoma Cells  Jianhua Liu1, Yahui Liu1, Lingyu Meng1, Bai Ji1, Daqing Yang2  1.",Non-OADS,/arxiv_data1/oa_pdf/0f/bb/ijmsv14p0523.PMC5479120.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0f/bb/ijmsv14p0523.PMC5479120.pdf
See http://ivyspring.com/terms  for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/0f/bb/ijmsv14p0523.PMC5479120.pdf
"1 4    http://www.medsci.org  524  dysregulation in HCC and its key  role in regulating  cell proliferation, migration, survival and  angiogenesis [ 6, 7].",Non-OADS,/arxiv_data1/oa_pdf/0f/bb/ijmsv14p0523.PMC5479120.pdf
1 4    http://www.medsci.org  525  compare difference of multiple groups.,Non-OADS,/arxiv_data1/oa_pdf/0f/bb/ijmsv14p0523.PMC5479120.pdf
1 4    http://www.medsci.org  526  Scratch wou nd healing assay   Cell scratch assay was used to analyze whether  KU-55933 and sorafenib inhibit the migration of HCC  cells.,OADS,/arxiv_data1/oa_pdf/0f/bb/ijmsv14p0523.PMC5479120.pdf
"1 4      http://www.medsci.org  527  33 and sorafenib reverse EMT phenotype  change induced by TGF-β 1 in HCC cell lines   TGF treatment alone led to phenotype change  from epithelium -like morphology to mesenchymal  phenotype and grew separately in a more aggressive  manner, which demonstrates that cells present metastatic and invasive characteristics.",Non-OADS,/arxiv_data1/oa_pdf/0f/bb/ijmsv14p0523.PMC5479120.pdf
1 4    http://www.medsci.org  528    Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/0f/bb/ijmsv14p0523.PMC5479120.pdf
"1 4    http://www.medsci.org  529  Conclusion    In conclusion, the results of this study  demonstrate that combining sorafenib and KU-55933  shows a synergistic effect in HCC cell lines.",Non-OADS,/arxiv_data1/oa_pdf/0f/bb/ijmsv14p0523.PMC5479120.pdf
"1 4      http://www.medsci.org  530  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2017;  14(6):  530-535.  doi: 10.7150/ ijms.19024   Research Paper   KLF6 inhibited oral cancer migration and invasion via   downregulation of mesenchymal markers and inhibition  of MMP -9 activities   Li-Sung Hsu1, 2*, Ren- Hung Huang3*, Hung -Wen Lai4, 5, Hui -Ting Hsu3, 6, 7, 8,Wen -Wei Sung6, 7, 8, 9, Ming -Ju  Hsieh10, 11, Chong -Yu Wu1, Yueh- Min Lin3, 8, Mu -Kuan Chen7, 12, Yu-Sheng Lo10, Chih- Jung Chen3, 7, 8  1.",Non-OADS,/arxiv_data1/oa_pdf/dd/1b/ijmsv14p0530.PMC5479121.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/1b/ijmsv14p0530.PMC5479121.pdf
See http://ivyspring.com/terms  for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/dd/1b/ijmsv14p0530.PMC5479121.pdf
1 4    http://www.medsci.org  531  forced KLF6 expression in lung cancer cell lines can  trigger cells to undergo apoptosis and reduce colony formation ability [6] .,Non-OADS,/arxiv_data1/oa_pdf/dd/1b/ijmsv14p0530.PMC5479121.pdf
1 4    http://www.medsci.org  532  Migration and invasion assay   Plasmids such as pLenti -C-mGFP and  pLenti -C-mGFP -KLF6 were purchased from Origene.,Non-OADS,/arxiv_data1/oa_pdf/dd/1b/ijmsv14p0530.PMC5479121.pdf
1 4      http://www.medsci.org  533    Figure  2.,Non-OADS,/arxiv_data1/oa_pdf/dd/1b/ijmsv14p0530.PMC5479121.pdf
1 4      http://www.medsci.org  534    Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/dd/1b/ijmsv14p0530.PMC5479121.pdf
1 4    http://www.medsci.org  535  Competing  Interest s  The authors have declared that no competing  interest exists.,Non-OADS,/arxiv_data1/oa_pdf/dd/1b/ijmsv14p0530.PMC5479121.pdf
"1 4      http://www.medsci.org  536  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2017;  14(6):  536-542.  doi: 10.7150/ ijms.18926   Research Paper   Clinical insomnia and associated factors in failed back  surgery syndrome : a retrospective cross- sectional study   Soon Young Yun, Do Heon Kim, Hae Yoon Do , and Shin Hyung  Kim  Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Insti tute, Yonsei University College of Medicine, Seoul, Republic of Korea     Corresponding author : Shin Hyung Kim  MD, PhD ., Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute,  Yonsei  University College of Medicine,  50 Yonsei -ro, Seodaemun -gu, Seoul 120- 752, Republic of Korea  Tel: 82 -2-2228 -7500, Fax: 82 -2-364-2951, E-mail: tessar@yuhs.ac   © Ivyspring International Publisher.",Non-OADS,/arxiv_data1/oa_pdf/80/0c/ijmsv14p0536.PMC5479122.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (C C BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/80/0c/ijmsv14p0536.PMC5479122.pdf
See http://ivyspring.com/terms  for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/80/0c/ijmsv14p0536.PMC5479122.pdf
1 4    http://www.medsci.org  537  clinicians educate patients and will facilitate the  formulation of more effective treatment plans.,Non-OADS,/arxiv_data1/oa_pdf/80/0c/ijmsv14p0536.PMC5479122.pdf
1 4    http://www.medsci.org  538  considered to be 3 0 [7].,Non-OADS,/arxiv_data1/oa_pdf/80/0c/ijmsv14p0536.PMC5479122.pdf
1 4      http://www.medsci.org  539  Table 1 shows patient demographics and clinical  characteristics.,Non-OADS,/arxiv_data1/oa_pdf/80/0c/ijmsv14p0536.PMC5479122.pdf
1 4    http://www.medsci.org  540   Yes 44 14 (31.8)  1.425 (0.683 – 2.972)      Fusion surgery     0.114      No 117 26 (22.2)  1.000       Yes 77 25 (32.4)  1.683 (0.882 – 3.211)       Comorbid musculoskeletal pain  (except back and legs)     0.688      No 160 43 (26.8)  1.000       Yes 34 8 (23.5)  0.837 (0.352 – 1.991)      Neuropathic pain components     0.478      No 41 9 (21.9)  1.000       Yes 153 42 (27.4)  1.345 (0.592 – 3.056)      Compensation/legal claims     < 0.001   0.121    No 178 42 (23.5)  1.000   1.000     Yes 16 9 (56.2)  4.163 (1.462 – 11.856)   2.950 (0.751 – 11.583)    Psychological factors         Pain catastrophizing     < 0.001   0.002    ＜30 PCS   144 19 (13.1)  1.000   1.000     ≥30 PCS  50 32 (64.0)  11.696 (5.511 – 24.824)   4.185 (1.697 – 10.324)    Anxiety     < 0.001   0.143    ＜8 HADS -A 140 20 (14.2)  1.000   1.000     ≥8 HADS -A 54 31 (57.4)  8.087 (3.946 – 16.575)   2.204 (0.766 – 6.336)    Depression     < 0.001   0.030    ＜8 HADS -D 143 20 (13.9)  1.000   1.000     ≥8 HADS -D 51 31 (60.7)  9.532 (4.574 – 19.867)   3.330 (1.127 – 9.837)    Significant variables ( P < 0.05) in univariate  analysis were selected for multivariate analysis.,Non-OADS,/arxiv_data1/oa_pdf/80/0c/ijmsv14p0536.PMC5479122.pdf
"1 4    http://www.medsci.org  541  Diagnostic and Statistical Manual of Mental  Disorders, insomnia is a defining symptom of major depressive disorder [27].",Non-OADS,/arxiv_data1/oa_pdf/80/0c/ijmsv14p0536.PMC5479122.pdf
1 4    http://www.medsci.org  542  sleep as studied by muscimol microinjections in the cat.,Non-OADS,/arxiv_data1/oa_pdf/80/0c/ijmsv14p0536.PMC5479122.pdf
"1 4      http://www.medsci.org  543  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2017; 14(6): 543-553. doi: 10.7150/ ijms.18988  Research Paper   Existence of a Strong Correlation of Biomarkers and  miRNA in Females with Metabolic Syndrome and  Obesity in a Population of West Virginia   Perrine Goguet -Rubio1*, Rebecca L. Klug2*, Dana L. Sharma1, Krithika Srikanthan1, Nitin Puri3, Vishal H  Lakhani1, Alexandra Nichols1, Kathleen M. O’Hanlon4, Nader G. Abraham5, Joseph I. Shapiro1 and Komal  Sodhi2  1.",Non-OADS,/arxiv_data1/oa_pdf/0a/55/ijmsv14p0543.PMC5479123.pdf
This is an open access article di stributed under the terms of the Creative Commons Attribution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0a/55/ijmsv14p0543.PMC5479123.pdf
See http://ivyspring.com/terms  for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/0a/55/ijmsv14p0543.PMC5479123.pdf
"1 4    http://www.medsci.org  544  disease management, prevention, and early  intervention are vital component s for combatting this  disease [9].",Non-OADS,/arxiv_data1/oa_pdf/0a/55/ijmsv14p0543.PMC5479123.pdf
"1 4    http://www.medsci.org  545  Biomarker Quantification   Enzyme -linked immunosorbent assays (ELISA)  were used to determine levels of leptin (EMD  Millipore Corporation, Billerica, MA), HMW  adiponectin (Abcam plc, Cambridge, UK), IL- 6 (R&D  Systems, Inc., Minneapolis, MN).",OADS,/arxiv_data1/oa_pdf/0a/55/ijmsv14p0543.PMC5479123.pdf
"1 4      http://www.medsci.org  546  Serum cytokine biomarkers   Adipokines, leptin and adiponectin, are  bioactive substances released by adipocytes that  control appetite, promote effective glucose use, and  enhance insulin sensitivity.",Non-OADS,/arxiv_data1/oa_pdf/0a/55/ijmsv14p0543.PMC5479123.pdf
1 4    http://www.medsci.org  547    Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/0a/55/ijmsv14p0543.PMC5479123.pdf
1 4    http://www.medsci.org  548  Table 2.,Non-OADS,/arxiv_data1/oa_pdf/0a/55/ijmsv14p0543.PMC5479123.pdf
1 4    http://www.medsci.org  549    Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/0a/55/ijmsv14p0543.PMC5479123.pdf
1 4      http://www.medsci.org  550    Figure 7.,Non-OADS,/arxiv_data1/oa_pdf/0a/55/ijmsv14p0543.PMC5479123.pdf
"1 4    http://www.medsci.org  551  oxygen species are formed from high levels of lipid  oxidation, which precipitates systemic stress and the  release of inflammatory cytokines [38].",Non-OADS,/arxiv_data1/oa_pdf/0a/55/ijmsv14p0543.PMC5479123.pdf
1 4    http://www.medsci.org  552  irreversible complications.,Non-OADS,/arxiv_data1/oa_pdf/0a/55/ijmsv14p0543.PMC5479123.pdf
1 4    http://www.medsci.org  553  30.,Non-OADS,/arxiv_data1/oa_pdf/0a/55/ijmsv14p0543.PMC5479123.pdf
"1 4      http://www.medsci.org  554  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2017; 14(6): 554-559. doi: 10.7150/ ijms.17890  Review  ProEx  C as Diagnostic Marker for Detection of  Urothelial Carcinoma in Urinary Samples : A Review   Gerardo Botti1, Maria Gabriella Malzone1, 2, Elvira La Mantia1, 2, Micaela Montanari2, 3, Daniela Vanacore2,  Sabrina Rossetti2, 4, Vincenzo Quagliariello2, 4, Carla Cavaliere2, 5, Rossella Di Franco2, 6, Luigi Castaldo2, 7 ,  Gianluca Ametrano2, 6, Francesca Cappuccio2, 8, Francesco Jacopo Romano2, Raffaele Piscitelli2, 9, Maria  Filomena Pepe1, 2, Carmine D’Aniello2, 10 and Gaetano Facchini 4  1.",Non-OADS,/arxiv_data1/oa_pdf/f8/87/ijmsv14p0554.PMC5479124.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY -NC) license  (https://creativecommons.org /licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f8/87/ijmsv14p0554.PMC5479124.pdf
See http://ivyspring.com/terms  for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/f8/87/ijmsv14p0554.PMC5479124.pdf
1 4    http://www.medsci.org  555  are the current approaches for the initial detection and  follow -up of UCs.,Non-OADS,/arxiv_data1/oa_pdf/f8/87/ijmsv14p0554.PMC5479124.pdf
1 4    http://www.medsci.org  556  microglandular hyperplasia and reactive endocervix  [45].,Non-OADS,/arxiv_data1/oa_pdf/f8/87/ijmsv14p0554.PMC5479124.pdf
1 4    http://www.medsci.org  557    Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/f8/87/ijmsv14p0554.PMC5479124.pdf
"1 4    http://www.medsci.org  558  regarding low -grade versus high grade UC, but it is  not a  useful marker in identifying metastatic UC,   being also expressed in colon, stomach, breast and  lung carcinomas.",Non-OADS,/arxiv_data1/oa_pdf/f8/87/ijmsv14p0554.PMC5479124.pdf
1 4    http://www.medsci.org  559  45.,Non-OADS,/arxiv_data1/oa_pdf/f8/87/ijmsv14p0554.PMC5479124.pdf
"1 4      http://www.medsci.org  560  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2017; 14(6): 560-569. doi: 10.7150/ ijms.18702  Research Paper   Bioactivities of ethanol  extract from the Antarctic   freshwater microalga, Chloromonas sp.",Non-OADS,/arxiv_data1/oa_pdf/20/3f/ijmsv14p0560.PMC5479125.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/3f/ijmsv14p0560.PMC5479125.pdf
See http://ivyspring.com/terms  for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/20/3f/ijmsv14p0560.PMC5479125.pdf
"1 4    http://www.medsci.org  561  different types of cancers such as prostate, breast,  lung and colon cancers.",Non-OADS,/arxiv_data1/oa_pdf/20/3f/ijmsv14p0560.PMC5479125.pdf
1 4    http://www.medsci.org  562  ABTS radical scavenging assay   The scavenging activity was measured as  described in previous  work  [27] with slight  modifications.,Non-OADS,/arxiv_data1/oa_pdf/20/3f/ijmsv14p0560.PMC5479125.pdf
1 4    http://www.medsci.org  563  nm in a plate reader.,Non-OADS,/arxiv_data1/oa_pdf/20/3f/ijmsv14p0560.PMC5479125.pdf
1 4    http://www.medsci.org  564    Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/20/3f/ijmsv14p0560.PMC5479125.pdf
1 4    http://www.medsci.org  565    Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/20/3f/ijmsv14p0560.PMC5479125.pdf
1 4    http://www.medsci.org  566  regulators of apoptosis signaling.,Non-OADS,/arxiv_data1/oa_pdf/20/3f/ijmsv14p0560.PMC5479125.pdf
1 4      http://www.medsci.org  567  Discussion   Increasing evidence from cancer studies  indicates bioactive compounds derived from the  natural sources may act as potentially promising  therapeutic agents in the treatment of human cancer  [20-22].,Non-OADS,/arxiv_data1/oa_pdf/20/3f/ijmsv14p0560.PMC5479125.pdf
1 4      http://www.medsci.org  568    Figure 6.,Non-OADS,/arxiv_data1/oa_pdf/20/3f/ijmsv14p0560.PMC5479125.pdf
1 4    http://www.medsci.org  569  22.,Non-OADS,/arxiv_data1/oa_pdf/20/3f/ijmsv14p0560.PMC5479125.pdf
"1 4      http://www.medsci.org  570  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2017; 14(6): 570-577. doi: 10.7150/ ijms.19021  Research Paper   The Effect of Nefopam Infusion during Laparascopic  Cholecystectomy on Postoperative Pain   Eun Mi Kim, Joo Hyun Jeon , Mi Hwa Chung, Eun Mi Choi, Seung Hwa Baek, Pil Hyun Jeon, Mi Hyeon  Lee  Department of Anesthesiology and Pain Medicine, Kangnam Sacred Heart Hospital, Hallym University College o f Medicine, Seoul, Republic of Korea    Corresponding author : Mi Hyeon Lee , M.D., Ph.D., Department of Anesthesiology and Pain Medicine, Kangnam Sacred Heart Hospital, Hallym University  College of Medicine, 948 -1, Daerim 1 -dong, Yeongdeungpo -gu, Seoul, 150- 950, Korea.",Non-OADS,/arxiv_data1/oa_pdf/6a/66/ijmsv14p0570.PMC5479126.pdf
See http://ivyspring.com/terms  for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/6a/66/ijmsv14p0570.PMC5479126.pdf
1 4    http://www.medsci.org  571  receptors.,Non-OADS,/arxiv_data1/oa_pdf/6a/66/ijmsv14p0570.PMC5479126.pdf
"1 4    http://www.medsci.org  572  more than 20% of the baseline value, intravenous  ephedrine (4 mg) was administered; intravenous  atropine (0.5 mg) was utilized to treat heart rates less  than 45 beats per minute (bpm).",Non-OADS,/arxiv_data1/oa_pdf/6a/66/ijmsv14p0570.PMC5479126.pdf
1 4    http://www.medsci.org  573  Results   There were 60 patients who participated in this  study; no one was excluded (Figure 1).,Non-OADS,/arxiv_data1/oa_pdf/6a/66/ijmsv14p0570.PMC5479126.pdf
"1 4      http://www.medsci.org  574  During surgery, there was  no significant  difference in blood pressure, heart rate, and oxygen  saturation between groups .",Non-OADS,/arxiv_data1/oa_pdf/6a/66/ijmsv14p0570.PMC5479126.pdf
1 4    http://www.medsci.org  575      Figure 3 .,Non-OADS,/arxiv_data1/oa_pdf/6a/66/ijmsv14p0570.PMC5479126.pdf
"1 4    http://www.medsci.org  576  In our present study, nefopam and ketamine  equally reduced VAS and the need for fentanyl  during the acute postoperative period.",Non-OADS,/arxiv_data1/oa_pdf/6a/66/ijmsv14p0570.PMC5479126.pdf
1 4    http://www.medsci.org  577  12.,Non-OADS,/arxiv_data1/oa_pdf/6a/66/ijmsv14p0570.PMC5479126.pdf
"1 4      http://www.medsci.org  578  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2017; 14(6): 578-584. doi: 10.7150/ ijms.15699  Research Paper   Hypoxia- regulated MicroRNA -210 Overexpression is  Associated with Tumor Development and Progression  in Upper Tract Urothelial Carcinoma   Hung -Lung Ke1,2,3, Wei-Ming Li1,2,3,4, Hui -Hui Lin2,3, Wei -Chi Hsu1,2,3, Ya-Ling Hsu1, Lin -Li Chang1,6,  Chun -Nung Huang1,2,3, Ching -Chia Li2,3,5, Hsin- Ping Chang2,3, Hsin -Chih Yeh1,2,3, Chien -Feng Li7,8,9,  Wen -Jeng Wu1,2,3,5  1.",Non-OADS,/arxiv_data1/oa_pdf/ff/f0/ijmsv14p0578.PMC5479127.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/f0/ijmsv14p0578.PMC5479127.pdf
See http://ivyspring.com/terms  for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/ff/f0/ijmsv14p0578.PMC5479127.pdf
"1 4    http://www.medsci.org  579  nephroureterecto my [1, 2] .",Non-OADS,/arxiv_data1/oa_pdf/ff/f0/ijmsv14p0578.PMC5479127.pdf
"1 4    http://www.medsci.org  580  According to this miRNA expression profile, we  found miR -210 to be the most promising candidate  and consequently our further studies focused only on  miR-210.",Non-OADS,/arxiv_data1/oa_pdf/ff/f0/ijmsv14p0578.PMC5479127.pdf
1 4      http://www.medsci.org  581  Table 1.,Non-OADS,/arxiv_data1/oa_pdf/ff/f0/ijmsv14p0578.PMC5479127.pdf
1 4    http://www.medsci.org  582    Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/ff/f0/ijmsv14p0578.PMC5479127.pdf
1 4    http://www.medsci.org  583  regulation of hypoxia -induced pathogenesis is  well -documented; it is known to be mediated by  HIF-1α through the hypoxia -responsive element  located on the proximal promoter of the  miR-210-coding DNA [22] .,Non-OADS,/arxiv_data1/oa_pdf/ff/f0/ijmsv14p0578.PMC5479127.pdf
1 4    http://www.medsci.org  584  nephroureterectomy for primary upper urinary tract urothelial carcinoma.,Non-OADS,/arxiv_data1/oa_pdf/ff/f0/ijmsv14p0578.PMC5479127.pdf
"1 4      http://www.medsci.org  585  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2017; 14(6): 585-594. doi: 10.7150/ ijms.18706  Research Paper   The Application of Dehydroepiandrosterone on  Improving Mitochondrial Function and Reducing  Apoptosis of Cumulus Cells in Poor Ovarian  Responders  Li-Te Lin1, 2, 3, Peng -Hui Wang3, 4, 5, 6, 7, Zhi-Hong Wen8, Chia -Jung Li9, San -Nung Chen2, Eing -Mei Tsai10, 11,  Jiin-Tsuey Cheng1, Kuan -Hao Tsui1, 2, 3, 12  1.",Non-OADS,/arxiv_data1/oa_pdf/fe/0a/ijmsv14p0585.PMC5479128.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/fe/0a/ijmsv14p0585.PMC5479128.pdf
See http://ivyspring.com/terms  for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/fe/0a/ijmsv14p0585.PMC5479128.pdf
"1 4      http://www.medsci.org  586  Introduction   Poor ovarian responders (PORs), characterized  by a poor response to controlled ovarian stimulation  (COS), pose a great obstacle for in vitro  fertilization  (IVF).",Non-OADS,/arxiv_data1/oa_pdf/fe/0a/ijmsv14p0585.PMC5479128.pdf
1 4    http://www.medsci.org  587  consent was obtained from all individual participants  included in the study.,Non-OADS,/arxiv_data1/oa_pdf/fe/0a/ijmsv14p0585.PMC5479128.pdf
1 4    http://www.medsci.org  588  Situ Apoptosis Detection Kit (Millipore Co.).,Non-OADS,/arxiv_data1/oa_pdf/fe/0a/ijmsv14p0585.PMC5479128.pdf
"1 4    http://www.medsci.org  589  respectively, p < 0.05) we re significantly greater .",Non-OADS,/arxiv_data1/oa_pdf/fe/0a/ijmsv14p0585.PMC5479128.pdf
"1 4      http://www.medsci.org  590  DHEA supplementation suppressed apoptosis  in cumulus cells   The mRNA levels  of BAX, BAD , caspase -3,  caspase -9 and cytochrome c significantly decreased in  the CCs from the POR/DHEA group compared with  those from the POR group ( Fig.",Non-OADS,/arxiv_data1/oa_pdf/fe/0a/ijmsv14p0585.PMC5479128.pdf
1 4      http://www.medsci.org  591  Effects of DHEA supplementation on the  mitochondria in cumulus cells   As shown in Fig.,Non-OADS,/arxiv_data1/oa_pdf/fe/0a/ijmsv14p0585.PMC5479128.pdf
"1 4      http://www.medsci.org  592  Discussion   This prospective cohort study demonstrated that  PORs following DHEA supplementation significantly  improved the prop ortion of grade 3 COC and mean  COC grade and markedly increased the number of  top-quality embryos at day 3, transferred embryos  and fertilization rate compared to PORs without   DHEA supplementation .",Non-OADS,/arxiv_data1/oa_pdf/fe/0a/ijmsv14p0585.PMC5479128.pdf
"1 4    http://www.medsci.org  593  and pregnancy outcomes [26, 42- 44].",Non-OADS,/arxiv_data1/oa_pdf/fe/0a/ijmsv14p0585.PMC5479128.pdf
http://www.medsci.org/v14p0585s1.pdf   Acknowledgements   This work was generously supported by grants  VGHKS105- G06-01 from Kaohsiung Veterans General  Hospital.,Non-OADS,/arxiv_data1/oa_pdf/fe/0a/ijmsv14p0585.PMC5479128.pdf
1 4    http://www.medsci.org  594  9.,Non-OADS,/arxiv_data1/oa_pdf/fe/0a/ijmsv14p0585.PMC5479128.pdf
"1 4      http://www.medsci.org  595  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2017; 14(6): 595-601. doi: 10.7150/ ijms.18996  Research Paper   Gastric Juice -Based Real -Time PCR for Tailored  Helicobacter Pylori Treatment: A Practical Approach   Xianhui Peng1, Zhiqiang Song2, Lihua He1, Sanren Lin2, Yanan Gong1, Lu Sun1, Fei Zhao1, Yixin Gu1,  Yuanhai You1, Liya Zhou2, Jianzhong  Zhang1  1.",Non-OADS,/arxiv_data1/oa_pdf/c3/f7/ijmsv14p0595.PMC5479129.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c3/f7/ijmsv14p0595.PMC5479129.pdf
See http://ivyspring.com/terms  for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/c3/f7/ijmsv14p0595.PMC5479129.pdf
1 4    http://www.medsci.org  596  therapy.,Non-OADS,/arxiv_data1/oa_pdf/c3/f7/ijmsv14p0595.PMC5479129.pdf
"1 4    http://www.medsci.org  597  Sample DNA ex traction, H. pylori isolation and  E-test  One piece of a gastric biopsy sample was  homogenized using a sterile glass homogenizer.",Non-OADS,/arxiv_data1/oa_pdf/c3/f7/ijmsv14p0595.PMC5479129.pdf
"1 4      http://www.medsci.org  598  Real-time PCR   Five primers and nine matching Taqman probes  targeting the H. pylori cagH  and 23S rRNA  genes and  the human RnaseP , CYP2C19*2  and CYP2C19*3  genes  were designed for this assay.",OADS,/arxiv_data1/oa_pdf/c3/f7/ijmsv14p0595.PMC5479129.pdf
All sequences obtained  from NCBI Entrez Nucleotide Database  (http://www.ncbi.nlm.nih.gov/nuccore) were  aligned using Vector NTI alignment so ftware  (http://www.lifetechnologies.com/cn/zh/home/life -science/cloning/vector -nti-software.html).,OADS,/arxiv_data1/oa_pdf/c3/f7/ijmsv14p0595.PMC5479129.pdf
1 4      http://www.medsci.org  599  Table 3.,Non-OADS,/arxiv_data1/oa_pdf/c3/f7/ijmsv14p0595.PMC5479129.pdf
1 4    http://www.medsci.org  600  and gastric juice -based real -time PCR provided  identical results regarding CYP2C19*2 and  CYP2C19*3 mutations.,Non-OADS,/arxiv_data1/oa_pdf/c3/f7/ijmsv14p0595.PMC5479129.pdf
1 4    http://www.medsci.org  601  gastric biopsy- based PCR.,Non-OADS,/arxiv_data1/oa_pdf/c3/f7/ijmsv14p0595.PMC5479129.pdf
"14       http://www.medsci.org  602  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2017; 14(6): 602-614. doi: 10.7150/ ijms.19058  Research Paper   Titanium Dioxide Nanoparticles as Radiosensitisers: An  In vitro  and Phantom -Based Study   Esho Qasho Youkhana1, Bryce Feltis2, Anton Blencowe3, Moshi Geso1  1.",Non-OADS,/arxiv_data1/oa_pdf/e3/a1/ijmsv14p0602.PMC5479130.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e3/a1/ijmsv14p0602.PMC5479130.pdf
See http://ivyspring.com/terms  for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/e3/a1/ijmsv14p0602.PMC5479130.pdf
"14     http://www.medsci.org  603  interaction is mainly due to the increas ed  photoelectric effect’s probability of occurrence (PE),  but only significantly with low energy X -rays, where  the probability of PEs are high.",Non-OADS,/arxiv_data1/oa_pdf/e3/a1/ijmsv14p0602.PMC5479130.pdf
"14     http://www.medsci.org  604  (2000 rcf, 30 s) and then resuspended in isopropanol  (40 mL).",Non-OADS,/arxiv_data1/oa_pdf/e3/a1/ijmsv14p0602.PMC5479130.pdf
14       http://www.medsci.org  605    Figure 1 .,Non-OADS,/arxiv_data1/oa_pdf/e3/a1/ijmsv14p0602.PMC5479130.pdf
14     http://www.medsci.org  606  medium was removed and 300 μL of culture medium  and 60 μL of CellTiter 96® AQueous One Solution Cell   Proliferation Assay reagent were  added.,Non-OADS,/arxiv_data1/oa_pdf/e3/a1/ijmsv14p0602.PMC5479130.pdf
14     http://www.medsci.org  607    Figure 2 .,Non-OADS,/arxiv_data1/oa_pdf/e3/a1/ijmsv14p0602.PMC5479130.pdf
14       http://www.medsci.org  608    Figure 4 .,Non-OADS,/arxiv_data1/oa_pdf/e3/a1/ijmsv14p0602.PMC5479130.pdf
"14     http://www.medsci.org  609  Cytotoxicity of TiO 2-NPs   HaCaT and DU145 cell lines were exposed to  amine functionalised TiO 2-NPs at concentrations  ranging from 1 to 8 mM for 24, 48 and 72 h to  investigate the kinetic tolerance of these cell lines to  TiO 2-NPs.",Non-OADS,/arxiv_data1/oa_pdf/e3/a1/ijmsv14p0602.PMC5479130.pdf
14     http://www.medsci.org  610    Figure 7 .,Non-OADS,/arxiv_data1/oa_pdf/e3/a1/ijmsv14p0602.PMC5479130.pdf
"14     http://www.medsci.org  611  High Energy “MV” X -Ray Irradiation   The methods described in the previous section  (kV X -Ray Irradiat ion), were repeated to measure the  radiosensitivity of TiO 2-NPs in vitro  and in phantom  with 6 MV X -ray beams.",OADS,/arxiv_data1/oa_pdf/e3/a1/ijmsv14p0602.PMC5479130.pdf
14       http://www.medsci.org  612    Figure 9 .,Non-OADS,/arxiv_data1/oa_pdf/e3/a1/ijmsv14p0602.PMC5479130.pdf
14     http://www.medsci.org  613  number of TiO 2 is 18.49 and that of tissue is about 7.4.,OADS,/arxiv_data1/oa_pdf/e3/a1/ijmsv14p0602.PMC5479130.pdf
14     http://www.medsci.org  614  Abbreviations   TiO 2: Titanium Dioxide; NPs: Nanoparticles;  HaCaT: Human Keratinocyte cell line; DU145:  Prostate cancer cell line; ROS: Reactive Oxygen  Species; •OH: Hydroxyl Radicals; PE: Photoelectric  Effect; APTS: AminoPropyl TrimethoxySilane;  PEGTS: Poly (Ethylene Glycol) TrimethoxySilane;  LMG: Leucomalachite Green; DBTDL: Dibutyltin Dilaurate; SXRT: Superficial X -Ray Therapy ; ΔOD:  changes in optical density; DCFDA:  Dichlorofluorescin Diacetate ; DEF: Dose  Enhancement Factor.,Non-OADS,/arxiv_data1/oa_pdf/e3/a1/ijmsv14p0602.PMC5479130.pdf
"2664 Biophysical Journal 112, 2664–2671, June 20, 2017http://dx.doi.org/10.1016/j.bpj.2017.05.014 /C2112017 Biophysical Society.",OADS,/arxiv_data1/oa_pdf/08/a4/main.PMC5479142.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/38/hnw030.001.PMC5479158.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9d/21/hnw030.PMC5479181.pdf
"8      http://www.jcancer .org 1324  JJoouurrnnaall  ooff  CCaanncceerr   2017; 8(8): 1324- 1329.  doi: 10.7150/ jca.18086  Research Paper   Association of MAGE A1 -6 Expression with Lung  Cancer Progression   Eunjue Yi1#*, Ji-Eun Chang1*, Chosun Leem2, Chang -Ho Jeon3, and Sanghoon Jheon1, 4  1.",Non-OADS,/arxiv_data1/oa_pdf/30/95/jcav08p1324.PMC5479236.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/30/95/jcav08p1324.PMC5479236.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/30/95/jcav08p1324.PMC5479236.pdf
"8    http://www.jcancer .org 1325  normal tissues, t he MAGE -I group , especially  MAGE -A subfamily, is rarely expressed in normal  tissue except for the testis , but is highly expressed in  various cancer cells  [8].",Non-OADS,/arxiv_data1/oa_pdf/30/95/jcav08p1324.PMC5479236.pdf
8    http://www.jcancer .org 1326  Table 1.,Non-OADS,/arxiv_data1/oa_pdf/30/95/jcav08p1324.PMC5479236.pdf
"8    http://www.jcancer .org 1327  showed loco- regional recurrence, and no patient had   distant metastasis (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/30/95/jcav08p1324.PMC5479236.pdf
"8    http://www.jcancer .org 1328    Most investigators use d microarray analysis [25],  RT-PCR  [26], and RNA in situ hybridization  [27] for  detection of MAGE expression.",Non-OADS,/arxiv_data1/oa_pdf/30/95/jcav08p1324.PMC5479236.pdf
8    http://www.jcancer .org 1329  15.,Non-OADS,/arxiv_data1/oa_pdf/30/95/jcav08p1324.PMC5479236.pdf
"8    http://www.jcancer .org 1330  JJoouurrnnaall  ooff  CCaanncceerr   2017; 8(8): 1330-1337.  doi: 10.7150/ jca.18274  Research Paper   Overexpression of Transcobalamin  1 is an Independent  Negative Prognosticator in Rectal Cancers Receiving  Concurrent Chemoradiotherapy   Yi-Ying Lee1, 2, Yu-Ching Wei3, Yu-Feng Tian4, 5, Ding -Ping Sun4, 6, Ming -Jen Sheu7, Ching -Chieh Yang8,  Li-Ching Lin8, Chen -Yi Lin7, Chung -Hsi Hsing9, Wan -Shan Li10, Chien -Feng Li10, 11, 12, 13, Pei-Ling Hsieh14,  Ching -Yih Lin7, 15  1.",Non-OADS,/arxiv_data1/oa_pdf/ec/f9/jcav08p1330.PMC5479237.pdf
This is an open access  article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ec/f9/jcav08p1330.PMC5479237.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/ec/f9/jcav08p1330.PMC5479237.pdf
8    http://www.jcancer .org 1331  Introduction   Colorectal cancer (CRC) ranks as the third most  frequent cancer in men and second in women  worldwide [1].,Non-OADS,/arxiv_data1/oa_pdf/ec/f9/jcav08p1330.PMC5479237.pdf
"8    http://www.jcancer .org 1332  the American Joint Committee on Cancer (AJCC)  staging manual, 7th edition [29].",Non-OADS,/arxiv_data1/oa_pdf/ec/f9/jcav08p1330.PMC5479237.pdf
8    http://www.jcancer .org 1333  Table 1.,Non-OADS,/arxiv_data1/oa_pdf/ec/f9/jcav08p1330.PMC5479237.pdf
"8    http://www.jcancer .org 1334  Prognostic impact of TCN1 expression in  rectal cancer   In addition, we analyzed the prognostic  significance of TCN1 expression in patients with  rectal cancer.",Non-OADS,/arxiv_data1/oa_pdf/ec/f9/jcav08p1330.PMC5479237.pdf
8    http://www.jcancer .org 1335  Table 3.,Non-OADS,/arxiv_data1/oa_pdf/ec/f9/jcav08p1330.PMC5479237.pdf
"8    http://www.jcancer .org 1336  its production by tumor cells themselves or to an  increase of hypergranulocytosis [17, 36, 38].",Non-OADS,/arxiv_data1/oa_pdf/ec/f9/jcav08p1330.PMC5479237.pdf
8    http://www.jcancer .org 1337  3.,Non-OADS,/arxiv_data1/oa_pdf/ec/f9/jcav08p1330.PMC5479237.pdf
"8      http://www.jcancer .org 1338  JJoouurrnnaall  ooff  CCaanncceerr   2017; 8(8): 1338- 1346.  doi: 10.7150/ jca.18030  Research Paper   Serum Ig G4:IgG Ratio Predicts Recurrence of Patients  with Hepatocellular Carcinoma a fter Curative  Resection   Jiong Wu1*, Xiao -Lu Ma1*, Lu Tian1, Chun -Yan Zhang1, Bei -Li Wang1, Yu-Yi Hu1, Xin g-Hui Gao1, Yan  Zhou1, Min -Na Shen1, Yin -Fei Peng1, Bai -Shen Pan1, Jian Zhou2, Jia Fan2, Xin -Rong Yang2, Wei Guo1  1.",Non-OADS,/arxiv_data1/oa_pdf/4a/b2/jcav08p1338.PMC5479238.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/4a/b2/jcav08p1338.PMC5479238.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/4a/b2/jcav08p1338.PMC5479238.pdf
8    http://www.jcancer .org 1339  Recent evidence demonstrates that the immune  microenvironment plays an important role in  regulating tumor progression and metastasis.,Non-OADS,/arxiv_data1/oa_pdf/4a/b2/jcav08p1338.PMC5479238.pdf
"8    http://www.jcancer .org 1340  Diagnostics, Germany) , which based on the scattering  immunoturbidimetric assay,  were used to determine  serum IgG4 and total IgG concentrations for each  patient using the BNII ins trument according to the  manufacturer’s instructions.",Non-OADS,/arxiv_data1/oa_pdf/4a/b2/jcav08p1338.PMC5479238.pdf
8    http://www.jcancer .org 1341    Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/4a/b2/jcav08p1338.PMC5479238.pdf
8    http://www.jcancer .org 1342  cm were also independent indicators of TTR  (Table  2).,OADS,/arxiv_data1/oa_pdf/4a/b2/jcav08p1338.PMC5479238.pdf
8    http://www.jcancer .org 1343    Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/4a/b2/jcav08p1338.PMC5479238.pdf
8    http://www.jcancer .org 1344  P<0.01; Figure 3A –D).,Non-OADS,/arxiv_data1/oa_pdf/4a/b2/jcav08p1338.PMC5479238.pdf
8    http://www.jcancer .org 1345  predict by conventional indexes.,Non-OADS,/arxiv_data1/oa_pdf/4a/b2/jcav08p1338.PMC5479238.pdf
8    http://www.jcancer .org 1346  optimized negative enrichment and qRT -PCR -based platform.,Non-OADS,/arxiv_data1/oa_pdf/4a/b2/jcav08p1338.PMC5479238.pdf
"8      http://www.jcancer .org 1347  JJoouurrnnaall  ooff  CCaanncceerr   2017; 8(8): 1347- 1354.  doi: 10.7150/ jca.18450  Research Paper   Ratio of Autoantibodies of Tumor Suppressor AIMP2  and Its Oncogenic Variant Is Associated with  Clinical  Outcome in Lung Cancer   Ji Ye Jung1, Eun Young Kim1, Arum Kim2, Joon Chang1, Nam Hoon Kwon3, Youngji  Moon3, Eun Joo Kang3,  Jun Sik Sung3, Hyunbo Shim4, Sunghoon Kim3, 5, Yoon Soo Chang2  1.",Non-OADS,/arxiv_data1/oa_pdf/b7/45/jcav08p1347.PMC5479239.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b7/45/jcav08p1347.PMC5479239.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/b7/45/jcav08p1347.PMC5479239.pdf
"8    http://www.jcancer .org 1348  anti-proliferative and cell death -promoting activity  through multiple pathways such as tumor -derived  growth factor (TGF) -β, p53, tumor necrosis factor  (TNF) -α signaling and Wnt signaling.",Non-OADS,/arxiv_data1/oa_pdf/b7/45/jcav08p1347.PMC5479239.pdf
"For mouse lung cancer tissues, LSL -Kras G12D  and LSL -Kras G12D:p53fl/fl mice  (http://mouse.ncifcrf.gov/) inhaled 5 × 107 PFU  AdCre particles at 8 weeks of age and sacrificed at 8 and 24 weeks after inhalation, respectively.",Non-OADS,/arxiv_data1/oa_pdf/b7/45/jcav08p1347.PMC5479239.pdf
The  expression level of each protein was measured using  Image J ( http://rsbweb.nih.gov/ij/ ) and quantif ied  relative to that of β -actin.,OADS,/arxiv_data1/oa_pdf/b7/45/jcav08p1347.PMC5479239.pdf
"8    http://www.jcancer .org 1349  as 0 (<10%), 1 (10– 50%), 2 (51 –80%), and 3 (>80%) ( Fig.",Non-OADS,/arxiv_data1/oa_pdf/b7/45/jcav08p1347.PMC5479239.pdf
8    http://www.jcancer .org 1350  smoking habits were not different between lung  cancer (n = 80) and control patients (n = 80) (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/b7/45/jcav08p1347.PMC5479239.pdf
"8    http://www.jcancer .org 1351  AIMP2 -DX2 autoantibody levels are  related  with tumor size   AIMP2 -DX2 and AIMP2 autoantibody levels  were measured in 165 lung cancer patients, and the  AIMP2 -DX2/AIMP2 autoantibody ratio was  calculated.",OADS,/arxiv_data1/oa_pdf/b7/45/jcav08p1347.PMC5479239.pdf
"8    http://www.jcancer .org 1352  Elevated AIMP2 -DX2/AIMP2 autoantibody  ratio is related with poor clinical outcome in  lung cancer   To evaluate the prognostic value of AIMP2 -DX2,  AIMP2, and AIMP2- DX2/AIMP2 autoantibody ratio   in lung cancer , OS and PFS were compared using  Kaplan –Meier estimators (Fig.",OADS,/arxiv_data1/oa_pdf/b7/45/jcav08p1347.PMC5479239.pdf
8    http://www.jcancer .org 1353  Table 4.,Non-OADS,/arxiv_data1/oa_pdf/b7/45/jcav08p1347.PMC5479239.pdf
8    http://www.jcancer .org 1354  Abbreviations   AIMP2 : aminoacyl t -RNA synthetase -interacting  multi -functional protein 2; AIMP2 -DX2 : aminoacyl  t-RNA synthetase -interacting multi -functional protein  2–exon 2 deletion; ARS : aminoacyl t -RNA synthetase;  CEA : carcinoembryonic antigen; CI : confidence  interval; FBP:  FUSE -binding protein; IHC :  immunohistochemistry; ELISA : enzyme -linked  immunosorbent assay; OS : overall survival; PFS :  progression/recurrence- free survival; TGF :  tumor -derived growth factor; TNF : tumor necrosis  factor; TRAF2 : TNF rece ptor -associated factor 2 .,Non-OADS,/arxiv_data1/oa_pdf/b7/45/jcav08p1347.PMC5479239.pdf
"8      http://www.jcancer .org 1355  JJoouurrnnaall  ooff  CCaanncceerr   2017; 8(8): 1355- 1361.  doi: 10.7150/ jca.18014  Research Paper   Plasma Mesothelin as a Novel Diagnostic and Prognostic  Biomarker in Colorectal Cancer   Shuwei Li1, 2*, Lisheng Xie1, 2*, Lei He3*, Zhimin Fan4, Junhua Xu4, Kaili Xu1, 2, Lingjun Zhu5, Gaoxiang Ma1, 2,  Mulong Du1, 2, Haiyan Chu1, 2, Zhengdong Zhang1, 2, Min Ni4, Meilin Wang1, 2  1.",Non-OADS,/arxiv_data1/oa_pdf/43/d5/jcav08p1355.PMC5479240.pdf
This is an open access article distributed under the terms of the Cre ative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/43/d5/jcav08p1355.PMC5479240.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/43/d5/jcav08p1355.PMC5479240.pdf
"8    http://www.jcancer .org 1356  identify new potential biomarkers, especially in  plasma or serum, for the diagnosis of colorectal cancer  and prediction of therapy.",Non-OADS,/arxiv_data1/oa_pdf/43/d5/jcav08p1355.PMC5479240.pdf
8    http://www.jcancer .org 1357  Table 1.,Non-OADS,/arxiv_data1/oa_pdf/43/d5/jcav08p1355.PMC5479240.pdf
8    http://www.jcancer .org 1358  Table 2.,Non-OADS,/arxiv_data1/oa_pdf/43/d5/jcav08p1355.PMC5479240.pdf
8    http://www.jcancer .org 1359  Table 4.,Non-OADS,/arxiv_data1/oa_pdf/43/d5/jcav08p1355.PMC5479240.pdf
8    http://www.jcancer .org 1360  unclear.,Non-OADS,/arxiv_data1/oa_pdf/43/d5/jcav08p1355.PMC5479240.pdf
8    http://www.jcancer .org 1361  14.,Non-OADS,/arxiv_data1/oa_pdf/43/d5/jcav08p1355.PMC5479240.pdf
"8      http://www.jcancer .org 1362  JJoouurrnnaall  ooff  CCaanncceerr   2017; 8(8): 1362- 1370.  doi: 10.7150/ jca.18031  Research Paper   Osteopontin is Critical for Hyperactive mTOR -Induced   Tumorigenesis in Oral Squamous Cell Carcinoma   Ning Gan1, 2, 3, 4, Sihai Zou1, 2, 3, Wenming Hang1, 2, 3, Deqin Yang1, 2, 3, Xuemei Zhang4, Yibing Yin4  1.",Non-OADS,/arxiv_data1/oa_pdf/18/1a/jcav08p1362.PMC5479241.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/18/1a/jcav08p1362.PMC5479241.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/18/1a/jcav08p1362.PMC5479241.pdf
8    http://www.jcancer .org 1363  Materials and Metho ds  Reagents and antibodies   Rapamycin  and XCT -790 were purchased from  Sigma ; Lipofectamine 2000 and 4 -12% Bis -Tris  Nu-PAGE gels were obtained from Life Technologies .,Non-OADS,/arxiv_data1/oa_pdf/18/1a/jcav08p1362.PMC5479241.pdf
8    http://www.jcancer .org 1364  according to the manufacturer’s protocol.,Non-OADS,/arxiv_data1/oa_pdf/18/1a/jcav08p1362.PMC5479241.pdf
"8    http://www.jcancer .org 1365  Raptor with siRNA s dramatically decreased the  expression level of OPN  in Tca8113 cells , whereas  the  level of OPN  in cells transfect ed with Rictor siRNAs  was no change with that in the control  (Figure 2B).",Non-OADS,/arxiv_data1/oa_pdf/18/1a/jcav08p1362.PMC5479241.pdf
8    http://www.jcancer .org 1366    Figure 2. mTORC1  positively regulates  OPN  expression.,Non-OADS,/arxiv_data1/oa_pdf/18/1a/jcav08p1362.PMC5479241.pdf
8    http://www.jcancer .org 1367      Figure 3. mTORC1 up -regulates OPN through activation of ERR α signaling.,Non-OADS,/arxiv_data1/oa_pdf/18/1a/jcav08p1362.PMC5479241.pdf
8    http://www.jcancer .org 1368      Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/18/1a/jcav08p1362.PMC5479241.pdf
8    http://www.jcancer .org 1369  Discussion   The underlying mechanisms of OSCC mediated  by hyperactivated mTOR  remain largely elusive.,Non-OADS,/arxiv_data1/oa_pdf/18/1a/jcav08p1362.PMC5479241.pdf
8    http://www.jcancer .org 1370  10.,Non-OADS,/arxiv_data1/oa_pdf/18/1a/jcav08p1362.PMC5479241.pdf
"8      http://www.jcancer .org 1371  JJoouurrnnaall  ooff  CCaanncceerr   2017; 8(8): 1371- 1377.  doi: 10.7150/ jca.17102  Research Paper   Antiemetic Effectiveness and  Cost-Saving of Aprepitant  plus Granisetron Is Superior to Palonosetron in  Gastrointestinal Cancer Patients Who Received  Moderately Emetogenic Chemotherapy   Haruka Toda1*, Hitoshi Kawazoe1*, Akiko Yano1, Yuji Yamamoto2, Yuji Watanabe2, Yasunori Yamamoto3,  Yoichi Hiasa4, Yoshihiro Yakushijin5, Akihiro Tanaka1, and Hiroaki Araki1  1.",Non-OADS,/arxiv_data1/oa_pdf/e5/ed/jcav08p1371.PMC5479242.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY -NC) licen se  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e5/ed/jcav08p1371.PMC5479242.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/e5/ed/jcav08p1371.PMC5479242.pdf
8    http://www.jcancer .org 1372  can reduce patients ’ quality of life.,Non-OADS,/arxiv_data1/oa_pdf/e5/ed/jcav08p1371.PMC5479242.pdf
"8    http://www.jcancer .org 1373  Subjects meeting any of the following criteria  were excluded from this study: 1) complications that  induced nausea and/or emesis (e.g., symptomatic  brain metastases, ulcerative diseases, and severe hepatic dysfunction); 2) administration of drugs  which cause nausea and/or emesis during the  investigation period, except for antiemetics (e.g.,  major or minor tranquilizers , or corticosteroids for  any other reason); 3) concomitant radiotherapy at an  esophageal site during the investigation period; and  4) administration of total parenteral nutrition.",Non-OADS,/arxiv_data1/oa_pdf/e5/ed/jcav08p1371.PMC5479242.pdf
"8    http://www.jcancer .org 1374  complete response than the control group in the  overall, acute phase, and delayed phase during all  courses , wh ereas the control group had significantly  higher percentages of no nausea and no nausea and vomiting than t he study group in the overall, acute  phase, and delayed phase during all courses.",Non-OADS,/arxiv_data1/oa_pdf/e5/ed/jcav08p1371.PMC5479242.pdf
"8    http://www.jcancer .org 1375  generic granisetron , and  dexamethasone  was superior  to that of a two -drug combination  of palonosetron  plus dexamethasone .",Non-OADS,/arxiv_data1/oa_pdf/e5/ed/jcav08p1371.PMC5479242.pdf
8    http://www.jcancer .org 1376  The present study demonstrates that the true  endpoint and the surrogate endpoint of  a three- drug  combination was significantly superior to that of a  two-drug combination.,Non-OADS,/arxiv_data1/oa_pdf/e5/ed/jcav08p1371.PMC5479242.pdf
8    http://www.jcancer .org 1377  study.,Non-OADS,/arxiv_data1/oa_pdf/e5/ed/jcav08p1371.PMC5479242.pdf
Antiemetic Guidelines  Version 1.1 -  Updated March 2016. http://www.mascc.org/   antiemetic -guidelines.,Non-OADS,/arxiv_data1/oa_pdf/e5/ed/jcav08p1371.PMC5479242.pdf
2016.  https://www.nccn.org/professionals/physician_gls/pdf/antiemesis.,Non-OADS,/arxiv_data1/oa_pdf/e5/ed/jcav08p1371.PMC5479242.pdf
http://evs.nci.nih.gov/ftp1/CTCAE/About.html.,OADS,/arxiv_data1/oa_pdf/e5/ed/jcav08p1371.PMC5479242.pdf
"8      http://www.jcancer .org 1378  JJoouurrnnaall  ooff  CCaanncceerr   2017; 8(8): 1378- 1394.  doi: 10.7150/ jca.17478  Research Paper   Targeting TPX2 S uppresses the T umorigenesis of  Hepatocellular Carcinoma Cells Resulting in Arrested   Mitotic Phase  Progression  and Increased Genomic  Instability   Chao -Wen Hsu1, 5, Yu-Chia Chen2, Hsing -Hao Su3, Guan -Jin Huang4, Chih -Wen Shu6, Tony Tong- Lin  Wu2,5, Hung -Wei Pan6  1.",Non-OADS,/arxiv_data1/oa_pdf/b5/1f/jcav08p1378.PMC5479243.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b5/1f/jcav08p1378.PMC5479243.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/b5/1f/jcav08p1378.PMC5479243.pdf
"8    http://www.jcancer .org 1379  the time of diagnosis, and the associated viral  hepatitis- induced  cirrhosis [4].",Non-OADS,/arxiv_data1/oa_pdf/b5/1f/jcav08p1378.PMC5479243.pdf
"8    http://www.jcancer .org 1380  (Sigma -Aldrich Corp, St. Louis, MO, USA), followed  by HRP -conjugated  secondary antibody, to observe  the TPX2 protein expression level in both t umor and  normal cells  by using t he mouse/r abbit probe HRP  labeling kit (BioTnA, Kaohsiung, Taiwan).",Non-OADS,/arxiv_data1/oa_pdf/b5/1f/jcav08p1378.PMC5479243.pdf
8    http://www.jcancer .org 1381  the procedure.,Non-OADS,/arxiv_data1/oa_pdf/b5/1f/jcav08p1378.PMC5479243.pdf
"8    http://www.jcancer .org 1382  (SA-β-gal), a widely used marker for identifying  senescent cells, was  done as described manufacturer’s  protocols (Senescence Cells Histochemical Staining  Kit, SIGMA).",Non-OADS,/arxiv_data1/oa_pdf/b5/1f/jcav08p1378.PMC5479243.pdf
"8    http://www.jcancer .org 1383  (Figure  5C), we found that knockdown of TPX2  protein expression (Figure  5A) potently inhibited  anchorage -dependent cell growth in Ha22T and  SkHep -1 liver cance r cells.",Non-OADS,/arxiv_data1/oa_pdf/b5/1f/jcav08p1378.PMC5479243.pdf
8    http://www.jcancer .org 1384    Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/b5/1f/jcav08p1378.PMC5479243.pdf
8    http://www.jcancer .org 1385    Figure  4.,Non-OADS,/arxiv_data1/oa_pdf/b5/1f/jcav08p1378.PMC5479243.pdf
8    http://www.jcancer .org 1386    Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/b5/1f/jcav08p1378.PMC5479243.pdf
8    http://www.jcancer .org 1387  both cell  lines.,Non-OADS,/arxiv_data1/oa_pdf/b5/1f/jcav08p1378.PMC5479243.pdf
8    http://www.jcancer .org 1388    Figure 7.,Non-OADS,/arxiv_data1/oa_pdf/b5/1f/jcav08p1378.PMC5479243.pdf
8    http://www.jcancer .org 1389    Figure 8.,Non-OADS,/arxiv_data1/oa_pdf/b5/1f/jcav08p1378.PMC5479243.pdf
"8    http://www.jcancer .org 1390  TPX2 depletion increases genomic instability  resulting in multinucleation and DNA damage  in liver cancer cells   Since TPX2 silencing cause d the G2/M transition  and mitotic error and increased the DNA content, this  finding indicated that the cell nucle i were vari ed.",OADS,/arxiv_data1/oa_pdf/b5/1f/jcav08p1378.PMC5479243.pdf
8    http://www.jcancer .org 1391    Figure 9.,Non-OADS,/arxiv_data1/oa_pdf/b5/1f/jcav08p1378.PMC5479243.pdf
8    http://www.jcancer .org 1392    Figure 10.,Non-OADS,/arxiv_data1/oa_pdf/b5/1f/jcav08p1378.PMC5479243.pdf
"8    http://www.jcancer .org 1393  structural studies indicate that Aurora -A is activated  fully and localized properly during mitosis through  interaction with the spindle regulator TPX2 [37] ,  which protects Aurora -A from degradation during  interphase and mitosis in human cells.",Non-OADS,/arxiv_data1/oa_pdf/b5/1f/jcav08p1378.PMC5479243.pdf
8    http://www.jcancer .org 1394  7.,Non-OADS,/arxiv_data1/oa_pdf/b5/1f/jcav08p1378.PMC5479243.pdf
"8      http://www.jcancer .org 1395  JJoouurrnnaall  ooff  CCaanncceerr   2017; 8(8): 1395- 1399.  doi: 10.7150/ jca.17898  Research Paper   The Clinical Impact of c -MET Over -Expression in  Advanced Biliary Tract Cancer (BTC)   Mi Hwa Heo1, Hee Kyung Kim1, Hansang Lee1, Kyoung -Mee Kim2, Jeeyun Lee1, Se Hoon Park1, Joon Oh  Park1, Ho Yeong Lim1, Won Ki Kang1, Young Suk Park1, and Seung Tae Kim1  1.",Non-OADS,/arxiv_data1/oa_pdf/71/fb/jcav08p1395.PMC5479244.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/71/fb/jcav08p1395.PMC5479244.pdf
See http://ivyspring.com/terms for full ter ms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/71/fb/jcav08p1395.PMC5479244.pdf
"8    http://www.jcancer .org 1396  especially with the emergence of advanced genomic  techniques  [3, 4] .",Non-OADS,/arxiv_data1/oa_pdf/71/fb/jcav08p1395.PMC5479244.pdf
8    http://www.jcancer .org 1397  Table 1.,Non-OADS,/arxiv_data1/oa_pdf/71/fb/jcav08p1395.PMC5479244.pdf
"8    http://www.jcancer .org 1398  c-MET overexpression as a prognostic factor   The median OS was 14.4 months (95% CI,  11.9- 16.9 months).",Non-OADS,/arxiv_data1/oa_pdf/71/fb/jcav08p1395.PMC5479244.pdf
"8    http://www.jcancer .org 1399  The present study has some limitations,  including a small sample size, retrospective nature  and heterogeneous patient population.",Non-OADS,/arxiv_data1/oa_pdf/71/fb/jcav08p1395.PMC5479244.pdf
"8      http://www.jcancer .org 1400  JJoouurrnnaall  ooff  CCaanncceerr   2017; 8(8): 1400- 1409.  doi: 10.7150/ jca.18170  Research Paper   Downregulation of Mitochondrial Single Stranded DNA  Binding Protein (SSBP1) Induces Mitochondrial  Dysfunction and Increases the Radiosensitivity in  Non-Small Cell Lung Cancer Cells   You Wang1, 2*, Liu Hu1, 3*, Ximei Zhang1, Hong Zhao1, Hui Xu1, 2, Yuehua We i1, Huangang Jiang1, 2,  Conghua Xie1, 2, Yunfeng Zhou1, 2, Fuxiang Zhou1, 2  1.",Non-OADS,/arxiv_data1/oa_pdf/f8/26/jcav08p1400.PMC5479245.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f8/26/jcav08p1400.PMC5479245.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/f8/26/jcav08p1400.PMC5479245.pdf
"8    http://www.jcancer .org 1401  factors involved in DNA damage response (DDR),  single -stranded DNA -binding proteins (SSBs) play  essential roles in DNA metabolic processes, including  replication, repair and recomb ination [8, 9] .",Non-OADS,/arxiv_data1/oa_pdf/f8/26/jcav08p1400.PMC5479245.pdf
"8    http://www.jcancer .org 1402  After blocking with 5% skim milk in TBST, the  membranes were incubated with primary antibodies,  against human SSBP1 (1:500 dilution; proteintech  12212- 1-AP), G APDH (1:10000 dilution; proteintech  60004- 1-Ig), HIF -1α (1:500 dilution; proteintech  20960- 1-AP), PDK1 (1:500 dilution; BBI D153265),  HK2 (1:500 dilution; BBI D22185), PKM2 (1:500 dilution; BBI D120008), Chk1 (1:1000 dilution; Cell Signaling Technology #23 60), p -Chk1 (1:1000 dilution;  Cell Signaling Technology #2341), Bax (1:1000 dilution; proteintech 50599 -2-Ig), Bcl -2 (1:1000  dilution; proteintech 12789 -1-AP), Ku70 (1:1000  dilution; proteintech 10723 -1-AP), Ku80 (1:1000  dilution; proteintech 16389 -1-AP), Rad51 (1:300  dilution; proteintech 14961 -1-AP), BRCA2 (1:300  dilution; proteintech 19791 -1-AP), γH2Ax (1:1000  dilution; abcam ab37168) at 4 °C overnight, followed by incubation with Horseradish  peroxidase -conjugated secondary antibody diluted at  1:20,000.",Non-OADS,/arxiv_data1/oa_pdf/f8/26/jcav08p1400.PMC5479245.pdf
8    http://www.jcancer .org 1403    Figure 1. shRNA against SSBP1 decreased SSBP1 mRNA and protein levels.,Non-OADS,/arxiv_data1/oa_pdf/f8/26/jcav08p1400.PMC5479245.pdf
8    http://www.jcancer .org 1404  number and then induce the alteration in  mitochondrial morphology and function.,Non-OADS,/arxiv_data1/oa_pdf/f8/26/jcav08p1400.PMC5479245.pdf
"8    http://www.jcancer .org 1405  SSBP1 downregulation decreased the  proportion of cells in the S phase, but  increased the proportion of cells in the G2/M  phase and IR -induced G2/M phase arrest in  H1299 cells   As cell cycle distribution is one of the key factors  affecting radiosensitivity, we next investigated the  SSBP1 knockdown -media ted effect on the cell cycle  distribution with  flow cytometry.",Non-OADS,/arxiv_data1/oa_pdf/f8/26/jcav08p1400.PMC5479245.pdf
8    http://www.jcancer .org 1406    Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/f8/26/jcav08p1400.PMC5479245.pdf
"8    http://www.jcancer .org 1407  Moreover, mtDNA depletion was revealed to impair  the ATP synthase activity [23]  and to cause more ROS  produc tion [24, 25] .",Non-OADS,/arxiv_data1/oa_pdf/f8/26/jcav08p1400.PMC5479245.pdf
8    http://www.jcancer .org 1408  Classical radiation biology suggests that the  changes in the cell cycle distribution are one of the key  factors regulating radioresistance.,Non-OADS,/arxiv_data1/oa_pdf/f8/26/jcav08p1400.PMC5479245.pdf
8    http://www.jcancer .org 1409  5.,Non-OADS,/arxiv_data1/oa_pdf/f8/26/jcav08p1400.PMC5479245.pdf
"8      http://www.jcancer .org 1410  JJoouurrnnaall  ooff  CCaanncceerr   2017; 8(8): 1410- 1416.  doi: 10.7150/ jca.1832 5  Research Paper   The Prognostic and Predictive Value of Carbohydrate  Antigen 19-9 in Metastatic Colorectal Cancer Patients  with First Line Bevacizumab Containing Chemotherapy   Chang  Jiang1, 2, 3*, Shousheng Liu1, 2, 3*, Wenzhuo He1, 2, 3, Bei Zhang1, 2, 3, Liangping Xia1, 2, 3  1.",Non-OADS,/arxiv_data1/oa_pdf/c6/66/jcav08p1410.PMC5479246.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c6/66/jcav08p1410.PMC5479246.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/c6/66/jcav08p1410.PMC5479246.pdf
8    http://www.jcancer .org 1411  prognosis.,Non-OADS,/arxiv_data1/oa_pdf/c6/66/jcav08p1410.PMC5479246.pdf
"8    http://www.jcancer .org 1412  patients with low NLR was 10.8 and 32.6 compared to  8.2 and 22.4 months for patients with high NLR ( P =  0.002 and P  = 0.001) (Figure 4A, B).",Non-OADS,/arxiv_data1/oa_pdf/c6/66/jcav08p1410.PMC5479246.pdf
8    http://www.jcancer .org 1413    Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/c6/66/jcav08p1410.PMC5479246.pdf
8    http://www.jcancer .org 1414    Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/c6/66/jcav08p1410.PMC5479246.pdf
"8    http://www.jcancer .org 1415  Discussion   Bevacizumab, the classical anti- angiogenesis  drug, had been widely applied in various cancers [18].",Non-OADS,/arxiv_data1/oa_pdf/c6/66/jcav08p1410.PMC5479246.pdf
8    http://www.jcancer .org 1416  9.,Non-OADS,/arxiv_data1/oa_pdf/c6/66/jcav08p1410.PMC5479246.pdf
"8      http://www.jcancer .org 1417  JJoouurrnnaall  ooff  CCaanncceerr   2017; 8(8): 1417- 1424.  doi: 10.7150/ jca.18339  Research Paper   Temozolomide and Bevacizumab Induction before  Chemoradiotherapy in Patients with Bulky Glioblastoma  and/or  with Severe Neurological Impairment  Ilan Darmon1, Mony Chenda Morisse2, Alexandre Coutte1, Marie Blonski3, Emilie Le Rhun4, Luc  Taillandier3, Diana Bello Roufai2, Christine Desenclos5, Stéphanie Trudel6, Jean -Christophe Faivre7, 8,  Nicolas Blanchard9, Bruno Chauffert 2, Mathieu Boone2  1.",Non-OADS,/arxiv_data1/oa_pdf/94/c8/jcav08p1417.PMC5479247.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/94/c8/jcav08p1417.PMC5479247.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/94/c8/jcav08p1417.PMC5479247.pdf
8    http://www.jcancer .org 1418  Introduction   Glioblastoma (GB; WHO grade IV gliomas) is the  most common malignant primitive brain tumor.,Non-OADS,/arxiv_data1/oa_pdf/94/c8/jcav08p1417.PMC5479247.pdf
8    http://www.jcancer .org 1419  (Europe an Organization for Research and Treatment  of Cancer) guidelines [10] .,Non-OADS,/arxiv_data1/oa_pdf/94/c8/jcav08p1417.PMC5479247.pdf
8    http://www.jcancer .org 1420  therapy had to be stopped due to disease progression.,Non-OADS,/arxiv_data1/oa_pdf/94/c8/jcav08p1417.PMC5479247.pdf
"8    http://www.jcancer .org 1421  (3 thrombocytopenia, 1 neutropenia).",Non-OADS,/arxiv_data1/oa_pdf/94/c8/jcav08p1417.PMC5479247.pdf
8    http://www.jcancer .org 1422  Table 5.,Non-OADS,/arxiv_data1/oa_pdf/94/c8/jcav08p1417.PMC5479247.pdf
8    http://www.jcancer .org 1423  Upfront BEV and TMZ treatment is feasible with   a good tolerance in most patients and provides a  rapid and sometimes prolonged clinical benefit in  some patients.,Non-OADS,/arxiv_data1/oa_pdf/94/c8/jcav08p1417.PMC5479247.pdf
8    http://www.jcancer .org 1424  radiochemotherapy in ord er to alleviate the initial  neurological impairment and/or to reduce the tumor  volume.,Non-OADS,/arxiv_data1/oa_pdf/94/c8/jcav08p1417.PMC5479247.pdf
"8      http://www.jcancer .org 1425  JJoouurrnnaall  ooff  CCaanncceerr   2017; 8(8): 1425- 1432. doi: 10.7150/ jca.18371  Research Paper   Upregulation of Coxsackie Adenovirus Receptor  Sensitizes Cisplatin -Resistant Lung Cancer Cells to  CRAd -Induced Inhibition  Ali Sakhawat1*, Yanan Liu2*, Ling Ma1, Tahir Muhammad1, Shensen Wang1, Lina Zhang1, Xianling Cong3  and Yinghui Huang1  1.",Non-OADS,/arxiv_data1/oa_pdf/5c/d5/jcav08p1425.PMC5479248.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5c/d5/jcav08p1425.PMC5479248.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/5c/d5/jcav08p1425.PMC5479248.pdf
"8    http://www.jcancer .org 1426  cancer, but its clinical applications are affected by  severe chemotoxic  side effects and increasing drug  resistance issues [1, 2] .",Non-OADS,/arxiv_data1/oa_pdf/5c/d5/jcav08p1425.PMC5479248.pdf
8    http://www.jcancer .org 1427  region was deleted.,Non-OADS,/arxiv_data1/oa_pdf/5c/d5/jcav08p1425.PMC5479248.pdf
"8    http://www.jcancer .org 1428  22 % tumor inhibition is achieved in A549 cell line  while in cisplatin resistant cell line A549 -DDPR, the  inhibition rate was almost 2.5 folds higher (55 %).",Non-OADS,/arxiv_data1/oa_pdf/5c/d5/jcav08p1425.PMC5479248.pdf
8    http://www.jcancer .org 1429  (internal control) were employed for PCR  amplifications.,Non-OADS,/arxiv_data1/oa_pdf/5c/d5/jcav08p1425.PMC5479248.pdf
8    http://www.jcancer .org 1430  adducts to damage DNA and the activation of  apoptosis which culminate in cancer cell killing [2].,Non-OADS,/arxiv_data1/oa_pdf/5c/d5/jcav08p1425.PMC5479248.pdf
8    http://www.jcancer .org 1431  than the monotherapies of respective treatments.,Non-OADS,/arxiv_data1/oa_pdf/5c/d5/jcav08p1425.PMC5479248.pdf
8    http://www.jcancer .org 1432  selec tive cytotoxic for prostate -specific antigen -positive prostate cancer cells.,Non-OADS,/arxiv_data1/oa_pdf/5c/d5/jcav08p1425.PMC5479248.pdf
"8      http://www.jcancer .org 1433  JJoouurrnnaall  ooff  CCaanncceerr   2017; 8(8): 1433- 1440.  doi: 10.7150/ jca.18435  Research Paper   Anti-Metastatic Effect of Semi- Purified  Nuphar Lutea Leaf  Extracts   Janet  Ozer1, Daniel Fishman2, Brit Eilam1, Avi  Golan -Goldhirsh4* and Jacob  Gopas1, 3*  1.",Non-OADS,/arxiv_data1/oa_pdf/34/67/jcav08p1433.PMC5479249.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/34/67/jcav08p1433.PMC5479249.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/34/67/jcav08p1433.PMC5479249.pdf
"8    http://www.jcancer .org 1434  NF-κB is a family of transcription factors  (composed of five sub -units, p50, p65, p52, Rel -B and  c-Rel, that form dimmers) that is involved in many  biological and pathological processes and  can both  induce and repress gene expression by binding to  discrete DNA sequences, known as κB sites  [4].",Non-OADS,/arxiv_data1/oa_pdf/34/67/jcav08p1433.PMC5479249.pdf
"8    http://www.jcancer .org 1435  106 cells per sample, were prepared with the  NucBuster kit (Novagen).",OADS,/arxiv_data1/oa_pdf/34/67/jcav08p1433.PMC5479249.pdf
8    http://www.jcancer .org 1436    Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/34/67/jcav08p1433.PMC5479249.pdf
8    http://www.jcancer .org 1437    Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/34/67/jcav08p1433.PMC5479249.pdf
"8    http://www.jcancer .org 1438  demonstrated that in rat cardiomyocytes, IL -10  treatment activated  ERK 1/2 which in turn blocked  NF-κB activation.",Non-OADS,/arxiv_data1/oa_pdf/34/67/jcav08p1433.PMC5479249.pdf
"8    http://www.jcancer .org 1439  Furthermore, our in vivo  experiments  demonstrated that mice  treated with NUP only  slightly reduced the metastatic load while cisplatin  was significantly effective as compared to those  treated only with vehicle.",Non-OADS,/arxiv_data1/oa_pdf/34/67/jcav08p1433.PMC5479249.pdf
8    http://www.jcancer .org 1440  molecule -1 expression by inhibitors of I kappa B -alpha phosphorylation.,Non-OADS,/arxiv_data1/oa_pdf/34/67/jcav08p1433.PMC5479249.pdf
"8      http://www.jcancer .org 1441  JJoouurrnnaall  ooff  CCaanncceerr   2017; 8(8): 1441- 1452. doi: 10.7150/ jca.1845 5  Research Paper   Towards Prognostic Profiling of  Non-Small Cell Lung  Cancer: New Perspectives on the Relevance of  Polo-Like Kinase 1 Expression, the TP53 Mutation Status  and Hypoxia   Jolien Van den Bossche1, Christophe Deben1, 2, Ken Op de Beeck1, 3, Vanessa Deschoolmeester1, 2,  Christophe Hermans1, 2, Ines De Pauw1, Julie Jacobs1, 2, Paul Van Schil4, Jan Baptist Vermorken1, 5, Patrick  Pauwels1, 2, Marc Peeters1, 5, Filip Lardon1*, An Wouters1*  1.",Non-OADS,/arxiv_data1/oa_pdf/0b/78/jcav08p1441.PMC5479250.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/0b/78/jcav08p1441.PMC5479250.pdf
"8      http://www.jcancer .org 1442  Introduction   Non- small cell lung cancer (NSCLC), accounting  for an estimated 75 -85% of all lung neoplasms, is the  leading cause of cancer -related death worldwide [1].",Non-OADS,/arxiv_data1/oa_pdf/0b/78/jcav08p1441.PMC5479250.pdf
8    http://www.jcancer .org 1443  are summarized in Table 1 .,Non-OADS,/arxiv_data1/oa_pdf/0b/78/jcav08p1441.PMC5479250.pdf
"8    http://www.jcancer .org 1444  percentage positive tu mor cells was scored 0 to 4 (0%,  1-5%, 6 -29%, 30- 59% and > 60% of tumor cells  stained).",Non-OADS,/arxiv_data1/oa_pdf/0b/78/jcav08p1441.PMC5479250.pdf
8    http://www.jcancer .org 1445  smokers versus non -smokers (P = 0.001).,Non-OADS,/arxiv_data1/oa_pdf/0b/78/jcav08p1441.PMC5479250.pdf
8    http://www.jcancer .org 1446      Figure 1 .,Non-OADS,/arxiv_data1/oa_pdf/0b/78/jcav08p1441.PMC5479250.pdf
8    http://www.jcancer .org 1447  Table 3.,Non-OADS,/arxiv_data1/oa_pdf/0b/78/jcav08p1441.PMC5479250.pdf
8    http://www.jcancer .org 1448  4).,Non-OADS,/arxiv_data1/oa_pdf/0b/78/jcav08p1441.PMC5479250.pdf
8    http://www.jcancer .org 1449  Table 4.,Non-OADS,/arxiv_data1/oa_pdf/0b/78/jcav08p1441.PMC5479250.pdf
"8    http://www.jcancer .org 1450  molecular biomarkers, might further improve  prediction of prognosis.",Non-OADS,/arxiv_data1/oa_pdf/0b/78/jcav08p1441.PMC5479250.pdf
8    http://www.jcancer .org 1451  presence of a TP53  mutation.,Non-OADS,/arxiv_data1/oa_pdf/0b/78/jcav08p1441.PMC5479250.pdf
"111063 (C. Deben) and 120822 (J. Jacobs ),  IWT (http://www.iwt.be).",Non-OADS,/arxiv_data1/oa_pdf/0b/78/jcav08p1441.PMC5479250.pdf
8    http://www.jcancer .org 1452  23.,Non-OADS,/arxiv_data1/oa_pdf/0b/78/jcav08p1441.PMC5479250.pdf
"8      http://www.jcancer .org 1453  JJoouurrnnaall  ooff  CCaanncceerr   2017; 8(8): 1453- 1459. doi: 10.7150/ jca.18762  Hypothesis   ZEB1 Mediates Drug Resistance and EMT in  p300- Deficient CRC   Darina  Lazarova, Michael Bordonaro  Department of Basic Sciences, Geisinger Commonwealth School of Medicine, 525 Pine Street, Scranton, PA 18509, USA     Corresponding author : Geisinger Commonwealth School of Medicine, 525 Pine Street , Scranton, PA 18509.",Non-OADS,/arxiv_data1/oa_pdf/f5/d9/jcav08p1453.PMC5479251.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f5/d9/jcav08p1453.PMC5479251.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/f5/d9/jcav08p1453.PMC5479251.pdf
8    http://www.jcancer .org 1454  The histone acetylases (HATs) CBP and p300  associate with the Wnt signaling factor beta -catenin  and mediate the transcriptional activity of the Wnt  pathway.,Non-OADS,/arxiv_data1/oa_pdf/f5/d9/jcav08p1453.PMC5479251.pdf
"8    http://www.jcancer .org 1455  to cancer stem cells (CSCs), resistance to therapy, and  HDACis [59 -65].",Non-OADS,/arxiv_data1/oa_pdf/f5/d9/jcav08p1453.PMC5479251.pdf
"8    http://www.jcancer .org 1456  propose that there is reciprocal repression between  ZEB1 and the miR -200 family of miRNA s, particularly  miR-200c, and this modulation of expression  influences EMT [79].",Non-OADS,/arxiv_data1/oa_pdf/f5/d9/jcav08p1453.PMC5479251.pdf
8    http://www.jcancer .org 1457    Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/f5/d9/jcav08p1453.PMC5479251.pdf
8    http://www.jcancer .org 1458  7.,Non-OADS,/arxiv_data1/oa_pdf/f5/d9/jcav08p1453.PMC5479251.pdf
8    http://www.jcancer .org 1459  71.,Non-OADS,/arxiv_data1/oa_pdf/f5/d9/jcav08p1453.PMC5479251.pdf
"8      http://www.jcancer .org 1460  JJoouurrnnaall  ooff  CCaanncceerr   2017; 8(8): 1460- 1465.  doi: 10.7150/ jca.18470  Review  Current Status of I mmune Checkpoint Inhibitor s in  Gastrointestinal Cancer s  Bum Jun Kim, Hyun Joo Jang, Hyeong Su Kim, Jung Han Kim  Division of Hemato -Oncology, Department of Internal Medicine, Kangnam Sacred -Heart Hospital, Hallym University Medical Center, Hallym University  College of Medicine, Seoul 07441, Republic of K orea     Corresponding author : Department of Internal Medicine, Kangnam Sacred -Heart Hospital, Hallym University Medical Center, Hallym University College of  Medicine, Seoul 07441, Republic of Korea  Tel: +82 -10-5392 -5419, Fax: +82- 2-3010- 6961, E -mail: harricil@hallym.or.kr, harricil@hotmail.com   © Ivyspring International Publisher.",Non-OADS,/arxiv_data1/oa_pdf/e8/b5/jcav08p1460.PMC5479252.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/b5/jcav08p1460.PMC5479252.pdf
"8    http://www.jcancer .org 1461  hardly retain immunogeni c nature  [6-8, 10].",Non-OADS,/arxiv_data1/oa_pdf/e8/b5/jcav08p1460.PMC5479252.pdf
8    http://www.jcancer .org 1462  Table 2.,Non-OADS,/arxiv_data1/oa_pdf/e8/b5/jcav08p1460.PMC5479252.pdf
"8    http://www.jcancer .org 1463  Hepatocellular carcinoma   Hepatocellular carcinoma (HCC) is typically an  inflammation -associated cancer and, thus, is often  immunogenic  [19].",Non-OADS,/arxiv_data1/oa_pdf/e8/b5/jcav08p1460.PMC5479252.pdf
8    http://www.jcancer .org 1464  mg/kg)  combination arm (26%) than the nivolumab  monotherapy arm (14%) or  the nivolumab (3 mg/kg )  plus ipilimumab ( 1 mg/kg ) combination arm (10%).,Non-OADS,/arxiv_data1/oa_pdf/e8/b5/jcav08p1460.PMC5479252.pdf
"8    http://www.jcancer .org 1465  efficacy  of immune checkpoint inhibitor s in GI  cancers, we should build more profound  understanding of tumor immune system and  microenvironment .",Non-OADS,/arxiv_data1/oa_pdf/e8/b5/jcav08p1460.PMC5479252.pdf
"8      http://www.jcancer .org 1466  JJoouurrnnaall  ooff  CCaanncceerr   2017; 8(8): 1466- 1476.  doi: 10.7150/ jca.18466  Research Paper   Reorganized Collagen in the Tumor Microenvironment  of Gastric Cancer and Its Association with Prognos is  Zhi-Hua Zhou1, 2, Cheng -Dong Ji1, 2, Hua -Liang Xiao3, Hai -Bin Zhao4, You -Hong Cui1, 2, Xiu-Wu Bian1, 2  1.",Non-OADS,/arxiv_data1/oa_pdf/da/0d/jcav08p1466.PMC5479253.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/da/0d/jcav08p1466.PMC5479253.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/da/0d/jcav08p1466.PMC5479253.pdf
8    http://www.jcancer .org 1467  a 5-year survival rate of only 29.6% [9].,Non-OADS,/arxiv_data1/oa_pdf/da/0d/jcav08p1466.PMC5479253.pdf
"8    http://www.jcancer .org 1468  IHC in tissue microarrays was evaluated  according to staining area, and the positive  percentage was determined as a percentage of  positive area relative to the entire tumor area using  Image  J (version 1.48v, NIH, Bethesda USA).",OADS,/arxiv_data1/oa_pdf/da/0d/jcav08p1466.PMC5479253.pdf
"The other collagen  parameters (alignment, length, straightness, and  width) were assayed using CT -FIRE, an open- source  software package specifica lly designed for automatic  quantification of collagen fibers within SHG images  (http://loci.wisc.edu/software/ctfire) [18].",OADS,/arxiv_data1/oa_pdf/da/0d/jcav08p1466.PMC5479253.pdf
8    http://www.jcancer .org 1469    Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/da/0d/jcav08p1466.PMC5479253.pdf
8    http://www.jcancer .org 1470  morphological changes.,Non-OADS,/arxiv_data1/oa_pdf/da/0d/jcav08p1466.PMC5479253.pdf
8    http://www.jcancer .org 1471    Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/da/0d/jcav08p1466.PMC5479253.pdf
"8    http://www.jcancer .org 1472  Then, we divided all the 225 cases (cohort 1) into a  wide collagen group (93 cases) and a thin collagen  group (132 cases) according to the collagen width  (cutoff value: 4.02).",Non-OADS,/arxiv_data1/oa_pdf/da/0d/jcav08p1466.PMC5479253.pdf
8    http://www.jcancer .org 1473    Figure 6.,Non-OADS,/arxiv_data1/oa_pdf/da/0d/jcav08p1466.PMC5479253.pdf
8    http://www.jcancer .org 1474    Table 4.,Non-OADS,/arxiv_data1/oa_pdf/da/0d/jcav08p1466.PMC5479253.pdf
"8    http://www.jcancer .org 1475  collagen fibers in cancer stroma were similar to those  in non- neoplastic mucosa, but the linearization or  (and) density of collagen fibers were increased; when strongly changed, the content, thickness and  eosinophilia were signif icantly altered.",Non-OADS,/arxiv_data1/oa_pdf/da/0d/jcav08p1466.PMC5479253.pdf
8    http://www.jcancer .org 1476  References   1.,Non-OADS,/arxiv_data1/oa_pdf/da/0d/jcav08p1466.PMC5479253.pdf
http://globocan.iarc.fr.Default.aspx .,Non-OADS,/arxiv_data1/oa_pdf/da/0d/jcav08p1466.PMC5479253.pdf
"8      http://www.jcancer .org 1477  JJoouurrnnaall  ooff  CCaanncceerr   2017; 8(8): 1477- 1483.  doi: 10.7150/ jca.18487  Research Paper   Deficiency of hMLH1 and hMSH2 expression is a poor  prognostic factor in Early Gastric Cancer  (EGC)   Xueru Zhu1, Yiwei Wang1, Hongjia Li2, Wenji Xue1, Ruifen Wang3, Lifeng Wang3, Meiling Zhu1, Leizhen  Zheng1  1.",Non-OADS,/arxiv_data1/oa_pdf/a6/e8/jcav08p1477.PMC5479254.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a6/e8/jcav08p1477.PMC5479254.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/a6/e8/jcav08p1477.PMC5479254.pdf
8    http://www.jcancer .org 1478  oncogenesis  and this mutation is associated with  prognosis and  specific clinicopathological  characteristics in col orectal cancer [5].,Non-OADS,/arxiv_data1/oa_pdf/a6/e8/jcav08p1477.PMC5479254.pdf
"8    http://www.jcancer .org 1479  Results   Of the 160 early gastric cancer samples,  89  (55.6%) and 45 (28.1%) were judged negative  for  hMLH1 and hMSH2, respectively, while  71 (44.4%)  and 1 15 (71.9%)  were negative for hMLH1 and  hMSH2, respectively.",Non-OADS,/arxiv_data1/oa_pdf/a6/e8/jcav08p1477.PMC5479254.pdf
8    http://www.jcancer .org 1480  Table 2.,Non-OADS,/arxiv_data1/oa_pdf/a6/e8/jcav08p1477.PMC5479254.pdf
8    http://www.jcancer .org 1481    Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/a6/e8/jcav08p1477.PMC5479254.pdf
"8    http://www.jcancer .org 1482  colorectal cancer (HNPCC),  sporadic colorectal  cancer, GC and endometrial  cancer [18, 19].",Non-OADS,/arxiv_data1/oa_pdf/a6/e8/jcav08p1477.PMC5479254.pdf
8    http://www.jcancer .org 1483  2.,Non-OADS,/arxiv_data1/oa_pdf/a6/e8/jcav08p1477.PMC5479254.pdf
"8      http://www.jcancer .org 1484  JJoouurrnnaall  ooff  CCaanncceerr   2017; 8(8): 1484- 1491.  doi: 10.7150/ jca.18553  Research Paper   Overexpression  of PAK1 Correlates with Aberrant  Expression of EMT Markers and Poor Prognosis in  Non-Small Cell Lung Cancer   Zhiying Yang1*, Heran Wang2*, Longzheng Xia2, Linda Oyang2, Yujuan Zhou2, Baihua Zhang2, Xiaoyan  Chen2, Xia Luo2, Qianjin Liao2, Jianping Liang2  1.",Non-OADS,/arxiv_data1/oa_pdf/16/5a/jcav08p1484.PMC5479255.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/16/5a/jcav08p1484.PMC5479255.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/16/5a/jcav08p1484.PMC5479255.pdf
8    http://www.jcancer .org 1485  mortality due to the metastatic spread[3].,Non-OADS,/arxiv_data1/oa_pdf/16/5a/jcav08p1484.PMC5479255.pdf
8    http://www.jcancer .org 1486  Table 1.,Non-OADS,/arxiv_data1/oa_pdf/16/5a/jcav08p1484.PMC5479255.pdf
8    http://www.jcancer .org 1487    Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/16/5a/jcav08p1484.PMC5479255.pdf
8    http://www.jcancer .org 1488  Table 2.,Non-OADS,/arxiv_data1/oa_pdf/16/5a/jcav08p1484.PMC5479255.pdf
8    http://www.jcancer .org 1489  Table 3.,Non-OADS,/arxiv_data1/oa_pdf/16/5a/jcav08p1484.PMC5479255.pdf
8    http://www.jcancer .org 1490  Several other studies suggested that metastasis is  one of the most decisive factors influencing the  patient prognosis.,Non-OADS,/arxiv_data1/oa_pdf/16/5a/jcav08p1484.PMC5479255.pdf
8    http://www.jcancer .org 1491  4.,Non-OADS,/arxiv_data1/oa_pdf/16/5a/jcav08p1484.PMC5479255.pdf
"8      http://www.jcancer .org 1492  JJoouurrnnaall  ooff  CCaanncceerr   2017; 8(8): 1492- 1497.  doi: 10.7150/ jca.18615  Research Paper   Prediction of Lymph Node Metastases in Gastric Cancer  by Serum  APE1 Expression  Xi Wei1*, Yi-bo Li3*, Ying Li2, Ben-cheng Lin8, Xiao -Min Shen4, Ran-Liang Cui5, Ya-Jun Gu6, Ming Gao7,  Yue-Guo Li5, Sheng Zhang1  1.",Non-OADS,/arxiv_data1/oa_pdf/53/80/jcav08p1492.PMC5479256.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/53/80/jcav08p1492.PMC5479256.pdf
8    http://www.jcancer .org 1493  prognosis of non- small cell lung cancer and enhanced  epithel ial-Mesenchymal Transition (EMT)  of lung  cancer cell in vitro  and in vivo [2].,Non-OADS,/arxiv_data1/oa_pdf/53/80/jcav08p1492.PMC5479256.pdf
8    http://www.jcancer .org 1494  USA).,Non-OADS,/arxiv_data1/oa_pdf/53/80/jcav08p1492.PMC5479256.pdf
8    http://www.jcancer .org 1495    Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/53/80/jcav08p1492.PMC5479256.pdf
8    http://www.jcancer .org 1496    Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/53/80/jcav08p1492.PMC5479256.pdf
"8    http://www.jcancer .org 1497  Using immunohistorchemistry (IHC) to detect  APE1 expression, multiple studies reported that APE1  positive expression associated with poor prog nosis in  various cancers.",Non-OADS,/arxiv_data1/oa_pdf/53/80/jcav08p1492.PMC5479256.pdf
"8      http://www.jcancer .org 1498  JJoouurrnnaall  ooff  CCaanncceerr   2017; 8(8): 1498- 1506.  doi: 10.7150/ jca.18626  Research Paper   Long Noncoding RNA  CCAT2 as a Potential Novel  Biomarker to Predict the Clinical Outcome of Cancer  Patients: A Meta -Analysis   Juan Tan*, Yi-Chao Hou*, Lin -Na Fu, Yun -Qian Wang, Qian -Qian Liu, Hua Xiong, Ying -Xuan Chen,  Jing-Yuan Fang   Division of Gastroenterology and Hepatology, Key Lab oratory of Gastroenterology and Hepatology, Ministry of Health, State Key Laboratory for Oncogenes  and Related Genes, Renji Hospital, School of Medicine, Shanghai Jiao Tong University; Shanghai Institute of Digestive Disease;  145 Middle Shandong Road,  Shan ghai 200001, China.",Non-OADS,/arxiv_data1/oa_pdf/6d/c4/jcav08p1498.PMC5479257.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/6d/c4/jcav08p1498.PMC5479257.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/6d/c4/jcav08p1498.PMC5479257.pdf
8    http://www.jcancer .org 1499  Growing evidence ha s revealed that lncRNAs may  play a role in the development and progression of  cancer  [4-6].,Non-OADS,/arxiv_data1/oa_pdf/6d/c4/jcav08p1498.PMC5479257.pdf
8    http://www.jcancer .org 1500  by Tierney et al .,Non-OADS,/arxiv_data1/oa_pdf/6d/c4/jcav08p1498.PMC5479257.pdf
8    http://www.jcancer .org 1501  Table 1.,Non-OADS,/arxiv_data1/oa_pdf/6d/c4/jcav08p1498.PMC5479257.pdf
8    http://www.jcancer .org 1502  Table 2.,Non-OADS,/arxiv_data1/oa_pdf/6d/c4/jcav08p1498.PMC5479257.pdf
"8    http://www.jcancer .org 1503  1.67- 8.03, P < 0.01).",Non-OADS,/arxiv_data1/oa_pdf/6d/c4/jcav08p1498.PMC5479257.pdf
8    http://www.jcancer .org 1504    Figure 7.,Non-OADS,/arxiv_data1/oa_pdf/6d/c4/jcav08p1498.PMC5479257.pdf
8    http://www.jcancer .org 1505  demonstrated an unfavorable impact of CCAT2  abnormality on clinical metastasis.,Non-OADS,/arxiv_data1/oa_pdf/6d/c4/jcav08p1498.PMC5479257.pdf
8    http://www.jcancer .org 1506  Table S2.,Non-OADS,/arxiv_data1/oa_pdf/6d/c4/jcav08p1498.PMC5479257.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b7/04/ijnrd-10-153.PMC5479258.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b7/04/ijnrd-10-153.PMC5479258.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of Nephrology and Renovascular Disease 2017:10 153–158International Journal of Nephrology and Renovascular Disease Dovepress submit your manuscript | www.dovepress.com Dovepress 153 ORIg INal ReseaRch open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJNRD.S135899 sodium–glucose cotransporter-2 inhibition and  acidosis in patients with type 2 diabetes: a review  of Us FD a data and possible conclusions John a D’elia1 alissa R segal1,2 george P Bayliss3 larry a Weinrauch1 1Kidney and hypertension section,   Joslin Diabetes center, harvard  Medical school, 2Department of  Pharmacy Practice, M cPhs University,   Boston, M a, 3Division of Kidney  Diseases and hypertension, Rhode  Island hospital, alpert Medical school,   Brown University, Providence, RI, UsaObjective: To evaluate whether adverse event reports to the US Food and Drug Administra- tion on incidents of ketoacidosis from use of sodium glucose cotransport inhibitors (SGLT2  inhibitors) provide insight into ways this new class of drugs is being prescribed with other  antihyperglycemic agents; to examine possible mechanisms to explain ketoacidosis.",Non-OADS,/arxiv_data1/oa_pdf/b7/04/ijnrd-10-153.PMC5479258.pdf
"Insulin deficiency due to a decreased secretion or alteration in the dosing of exogenous insulin and lipolysis are two of the predominant hypotheses for the episodes of ketoacidosis that have been correspondence: larry a Weinrauch Kidney and hypertension section,Joslin Diabetes center, harvardMedical school, 521 Mount auburn street, suite 204, Watertown, Ma 02472, Usaemail lweinrauch@hms.harvard.eduJournal name: International Journal of Nephrology and Renovascular Disease Article Designation: Original ResearchY ear: 2017V olume: 10Running head verso: D’Elia et alRunning head recto: Effect of SGLT2 inhibitors on acidosisDOI: http://dx.doi.org/10.2147/IJNRD.S135899",Non-OADS,/arxiv_data1/oa_pdf/b7/04/ijnrd-10-153.PMC5479258.pdf
Available from: https://www.fda.gov/Drugs/DrugSafety/ucm475463.htm.,Non-OADS,/arxiv_data1/oa_pdf/b7/04/ijnrd-10-153.PMC5479258.pdf
Available from: https://www.fda.gov/safety/medwatch/howtoreport/ucm085589.htm.,Non-OADS,/arxiv_data1/oa_pdf/b7/04/ijnrd-10-153.PMC5479258.pdf
Available from: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/206073Orig1s000TOC.cfm.,Non-OADS,/arxiv_data1/oa_pdf/b7/04/ijnrd-10-153.PMC5479258.pdf
Available from: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205649Orig1s000TOC.cfm.,Non-OADS,/arxiv_data1/oa_pdf/b7/04/ijnrd-10-153.PMC5479258.pdf
"International Journal of Nephrology and Renovascular Disease 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journalThe International Journal of Nephrology and Renovascular Disease is   an international, peer-reviewed open access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/b7/04/ijnrd-10-153.PMC5479258.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published   authors.Dovepress 158 D’elia et al,Non-OADS,/arxiv_data1/oa_pdf/b7/04/ijnrd-10-153.PMC5479258.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f2/52/dddt-11-1719.PMC5479259.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 1719–1728Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1719Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S13698 8 lugano 2014 criteria for assessing FDg-PeT/ cT in lymphoma: an operational approach for  clinical trials ronald l Van heertum1 robert scarimbolo1 John g Wolodzko1 Barbara Klencke2 richard Messmann3 Feza T unc4 levi sokol4 rajan agarwal5 James a strafaci1 Michael O’n eal1 1Medical affairs, Bioclinica, inc.,   Princeton, nJ, 2Medical affairs, sierra  Oncology, Brisbane, ca, 3Medical  affairs, apexian Pharmaceuticals,   indianapolis, in, 4radiology, University  radiology at rWJ University hospital,   new Brunswick, nJ, 5radiology,   abington hospital, abington, P a, UsaAbstract:  An operationalized workflow paradigm is presented and validated with pilot subject  data.",Non-OADS,/arxiv_data1/oa_pdf/f2/52/dddt-11-1719.PMC5479259.pdf
"This approach visually  assesses the metabolic activity of lymphoma by three-dimensionally measuring the  uptake distribution post-administration of FDG.4 In addition to identifying the presence  and distribution of disease, FDG-PET imaging, particularly when combined with high  quality computed tomography (CT) imaging (PET/CT), has also been shown to be a  very effective tool for assessing response to treatment.5 Different sub-types of lymphomas exhibit varying degrees of FDG-avidity that  correlate with the aggressiveness of the individual lymphoma.6 Previous investigations  have established that NHL exhibits a varying FDG-avidity range from 40% to 100%,  depending on the lymphoma subtype, while HL exhibits a much narrower FDG-avidity  range of 97% to 100% (Table 1).7 Although the use of FDG-PET/CT for the assessment correspondence: ronald l Van heertum Bioclinica, inc., 100 Overlook center,  Princeton, nJ 08540, Usa Tel +1 609 936 2868 Fax +1 609 514 4964 email ronald.vanheertum@bioclinica.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Van Heertum et al Running head recto: Lugano 2014 criteria operational approach for clinical trials DOI: http://dx.doi.org/10.2147/DDDT.S136988",Non-OADS,/arxiv_data1/oa_pdf/f2/52/dddt-11-1719.PMC5479259.pdf
Available from: https://seer.cancer.gov/statfacts/html/nhl.,Non-OADS,/arxiv_data1/oa_pdf/f2/52/dddt-11-1719.PMC5479259.pdf
Available from: https://seer.cancer.gov/statfacts/html/hodg.,Non-OADS,/arxiv_data1/oa_pdf/f2/52/dddt-11-1719.PMC5479259.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/f2/52/dddt-11-1719.PMC5479259.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/52/dddt-11-1719.PMC5479259.pdf
"Available from: http://www.pub.iaea.org/MTCD/ Publications/PDF/Pub1616_web.pd f. Accessed May 9, 2017.",Non-OADS,/arxiv_data1/oa_pdf/f2/52/dddt-11-1719.PMC5479259.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b0/2a/opth-11-1143.PMC5479261.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 1143–1149Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1143Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S13688 2 Predicting the refractive outcome and accuracy of  IOL power calculation after phacoemulsification  using the srK/T formula with ultrasound  biometry in medium axial lengths Yunus Karabela1 Mustafa eliacik2 Mehmet selim Kocabora3 sevil Karaman erdur3 hakan Baybora4 1Department of Ophthalmology,   istanbul Medipol University, esenler  hospital, esenler, 2Department of  Ophthalmology, istanbul Medipol  University, Kadıkoy Medipol  Hospital, Kadıkoy, 3Department  of Ophthalmology, istanbul  Medipol University, Mega Medipol  hospital, Bagcilar, 4Department  of Ophthalmology, n isa hospital,   Bahcelievler, istanbul, T urkeyPurpose:  To evaluate the accuracy of the SRK/T formula using ultrasound (US) biometry in  predicting a target postoperative refraction of ±1.00D in eyes with medium axial length (AL)  that underwent phacoemulsification.",Non-OADS,/arxiv_data1/oa_pdf/b0/2a/opth-11-1143.PMC5479261.pdf
"Keywords:  axial length, biometry, cataract surgery, IOL power calculation, prediction error,  SRK/T formula Introduction An accurate biometry and appropriate intraocular lens power (IOLp) formula  selection in cataract surgery is very important for postoperative patient satisfaction.1  Measurement, IOL calculation formula, IOL insertion, and lens constant’s errors are  the main sources of postoperative refractive errors.2–13 Forty-three and sixty-seven  percent of large refractive surprises are due to inaccurate preoperative measurement Correspondence: Yunus Karabela Department of Ophthalmology,  istanbul Medipol University, esenler  hospital, Birlik Mahallesi, Bahceler  Caddesi, number 5, esenler 34230,  istanbul, Turkey Tel +90 212 440 1000 Fax +90 212 440 1010 email mrsbela@yahoo.comJournal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Karabela et al Running head recto: IOL power calculation with the SRK/T formula in medium eyes DOI: http://dx.doi.org/10.2147/OPTH.S136882",Non-OADS,/arxiv_data1/oa_pdf/b0/2a/opth-11-1143.PMC5479261.pdf
"Available from: http://www.dukeeyecenter.duke.edu/sites/ dukeeyecenter .duke.edu/files/field/attachments/vann_axial_length_ biometry_svq_2016_0.pd f. Accessed August 1, 2015.",OADS,/arxiv_data1/oa_pdf/b0/2a/opth-11-1143.PMC5479261.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/b0/2a/opth-11-1143.PMC5479261.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/2a/opth-11-1143.PMC5479261.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/a1/1a/jbm-8-067.PMC5479262.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/a1/1a/jbm-8-067.PMC5479262.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Blood Medicine 2017:8 67–73Journal of Blood Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress  67 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JBM.S103796Many factor VIII products available in the  treatment of hemophilia A: an embarrassment of  riches?",Non-OADS,/arxiv_data1/oa_pdf/a1/1a/jbm-8-067.PMC5479262.pdf
"Currently, the standard of care in developed countries is to offer primary prophylactic  Correspondence: Kenneth Lieuw Department of Pediatrics, Walter Reed National Military Medical Center, 8901 Rockville Pike, Bethesda, MD 20889, USA   Tel +1 301 295 1769   Email kenneth.lieuw@usuhs.eduJournal name: Journal of Blood Medicine Article Designation: REVIEWY ear: 2017V olume: 8Running head verso: LieuwRunning head recto: Many FVIII products available in the treatment of HADOI: http://dx.doi.org/10.2147/JBM.S103796",Non-OADS,/arxiv_data1/oa_pdf/a1/1a/jbm-8-067.PMC5479262.pdf
"Journal of Blood Medicine 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Blood Medicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/journal-of-blood-medicine-journalThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects   of all aspect pertaining to blood based medicine including but not limited to:   Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,   and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of blood related medicine; Legal aspects of blood medicine; Historical perspec-tives.",Non-OADS,/arxiv_data1/oa_pdf/a1/1a/jbm-8-067.PMC5479262.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dovepress 73 Many FVIII products available in the treatment of HA 13.,Non-OADS,/arxiv_data1/oa_pdf/a1/1a/jbm-8-067.PMC5479262.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b8/ac/itt-6-039.PMC5479263.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b8/ac/itt-6-039.PMC5479263.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ImmunoTargets and Therapy 2017:6 39–49ImmunoTargets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 39 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/ITT .S131662CD8+ memory T -cell inflation renders  compromised CD4+ T -cell-dependent CD8+  T -cell immunity via naïve T -cell anergy Aizhang Xu1,2 Andrew Freywald3 Yufeng Xie4 Zejun Li5 Jim Xiang1,2 1Cancer Research Cluster,   Saskatchewan Cancer Agency,   2Department of Oncology,   3Department of Pathology, University  of Saskatchewan, Saskatoon, SK,   Canada; 4Department of Oncology,   First Affiliated Hospital, Soochow University, Suzhou,  5Shanghai  Veterinary Research Institute,  Shanghai, ChinaAbstract: Whether inflation of CD8+ memory T (mT) cells, which is often derived from repeated  prime-boost vaccinations or chronic viral infections in the elderly, would affect late CD8+ T -cell  immunity is a long-standing paradox.",Non-OADS,/arxiv_data1/oa_pdf/b8/ac/itt-6-039.PMC5479263.pdf
"The majority (90%–95%) of CD8+ T cells  die of apoptosis in the contraction phase, and the remaining 5%–10% of CTLs become  CD8+ memory T (mT) cells.2 Upon subsequent pathogen encounter, CD8+ mT cells  respond swiftly by rapid proliferation and heightened effector functions.2 In cellular immunity, CD8+ T -cell responses include CD4+ T -cell-dependent and  CD4+ T -cell-independent ones.3 In the former, antigen-presenting cells are required to  be licensed (matured) by CD40L signaling derived from CD4+ T -helper (TH) cells prior  to generating measurable CD8+ T -cell responses to noninflammatory antigens, while in Correspondence: Jim Xiang Cancer Research Cluster, Room 4D30.1, Saskatchewan Cancer Agency, 107 Wiggins Road, Saskatoon, SK S7N 5E5, CanadaTel +1 306 966 7039Fax +1 306 966 7047Email jim.xiang@usask.caJournal name: ImmunoTargets and Therapy  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 6Running head verso: Xu et alRunning head recto: CD8 + memory T -cell inflation induces T -cell anergy DOI: http://dx.doi.org/10.2147/ITT.S131662",Non-OADS,/arxiv_data1/oa_pdf/b8/ac/itt-6-039.PMC5479263.pdf
"ImmunoTargets and Therapy 2017:6submit your manuscript | www.dovepress.com Dovepress Dovepress ImmunoTargets and Therapy Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/immunotargets-and-therapy-journalImmunoTargets and Therapy is an international, peer-reviewed open access journal  focusing on the immunological basis of diseases, potential targets for immune  based therapy and treatment protocols employed to improve patient management.",Non-OADS,/arxiv_data1/oa_pdf/b8/ac/itt-6-039.PMC5479263.pdf
Visit http://www.dovepress.com/testimonials.php to read  real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b8/ac/itt-6-039.PMC5479263.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ee/c5/ijn-12-4455.PMC5479264.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 4455–4466International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4455OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13573 5 Improved lFIas for highly sensitive detection of  BNP at point-of-care Yan gong1–3 Jie hu1,2 Jane ru choi2 Minli Y ou1,2 Yamin Zheng1,2 Bo Xu4 Ting Wen3 Feng Xu1,2 1The Key laboratory of Biomedical  Information engineering of Ministry of  education, Department of Biomedical  engineering, school of life science  and Technology, Xi’an Jiaotong  University, 2Bioinspired engineering  and Biomechanics center (BeBc),   Xi’an Jiaotong University, 3Xi’an  Diandi Biotech company, 4school of  Finance and economics, Xi’an Jiaotong  University, Xi’an, People’s republic  of chinaAbstract:  Heart failure (HF) has become a major cause of morbidity and mortality with a  significant global economic burden.",Non-OADS,/arxiv_data1/oa_pdf/ee/c5/ijn-12-4455.PMC5479264.pdf
"To address the issue, point-of-care (POC) testing of cardiac biomarkers, which is a  promising method for improving disease management,10 holds a significant potential.11 correspondence: Feng Xu The Key laboratory of Biomedical  Information engineering of Ministry of  education, Department of Biomedical  engineering, school of life science and  Technology, Xi’an Jiaotong University,  No 28, Xianning West road, Xi’an  710049, shaanxi, People’s republic  of china Tel +86 29 8266 7486 email fengxu@mail.xjtu.edu.c n  Ting Wen Xi’an Diandi Biotech company,  No 48, Keji road, Xi’an 710049,  shaanxi, People’s republic of china Tel +86 29 8266 5937 email tingwen_impact@sina.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Gong et al Running head recto: Improved LFIAs for highly sensitive detection of BNP at point-of-care DOI: http://dx.doi.org/10.2147/IJN.S135735",Non-OADS,/arxiv_data1/oa_pdf/ee/c5/ijn-12-4455.PMC5479264.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/ee/c5/ijn-12-4455.PMC5479264.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ee/c5/ijn-12-4455.PMC5479264.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/07/88/copd-12-1753.PMC5479265.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 1753–1763International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1753OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S13631 4 Treatment trends in patients with asthma–COPD  overlap syndrome in a COPD cohort: findings  from a real-world survey Bo Ding1 Mark small2 1AstraZeneca Gothenburg, Mölndal,   sweden; 2Adelphi Real World,   Bollington, Macclesfield, UKBackground:  Asthma and chronic obstructive pulmonary disease (COPD) overlap syndrome  (ACOS) is an increasingly recognized phenotype.",Non-OADS,/arxiv_data1/oa_pdf/07/88/copd-12-1753.PMC5479265.pdf
"Asthma  is defined by a history of respiratory symptoms such as wheeze, shortness of breath,  chest tightness, and cough that vary over time and in intensity, together with vari - able expiratory flow volume and reversibility.1 COPD is a common, preventable, and  treatable disease that is characterized by persistent respiratory symptoms and airflow Correspondence: Bo Ding AstraZeneca Gothenburg,  Pepparedsleden 1, SE-431 83 Mölndal,  sweden Tel +46 31 776 2406 email bo.ding@astrazeneca.c om Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Ding and Small Running head recto: Treatment for ACOS: findings from a real-world study DOI: http://dx.doi.org/10.2147/COPD.S136314",Non-OADS,/arxiv_data1/oa_pdf/07/88/copd-12-1753.PMC5479265.pdf
Available from: http://ginasthma.org/ wp-content/uploads/2016/04/wms-GINA-2016-main-report-final.pdf .,Non-OADS,/arxiv_data1/oa_pdf/07/88/copd-12-1753.PMC5479265.pdf
Available from: http://goldcopd.org/ gold-2017-global-strategy-diagnosis-management-prevention-copd /.,Non-OADS,/arxiv_data1/oa_pdf/07/88/copd-12-1753.PMC5479265.pdf
Available from: http://ginasthma.org/asthma-copd-and-asthma-copd- overlap-syndrome-acos /.,Non-OADS,/arxiv_data1/oa_pdf/07/88/copd-12-1753.PMC5479265.pdf
"Available from:  https://www.esomar.org/uploads/public/knowledge-and-standards/ codes-and-guidelines/ICCESOMAR_Code_English_.pd f. Accessed  April 14, 2017.",Non-OADS,/arxiv_data1/oa_pdf/07/88/copd-12-1753.PMC5479265.pdf
"Available from: http://www.hhs.gov/sites/ default/files/privacysummary.pd f. Accessed April 14, 2017.",OADS,/arxiv_data1/oa_pdf/07/88/copd-12-1753.PMC5479265.pdf
"Available  from: http://www.ephmra.org/Code-of-Conduct-Suppor t. Accessed  April 14, 2017.",Non-OADS,/arxiv_data1/oa_pdf/07/88/copd-12-1753.PMC5479265.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/07/88/copd-12-1753.PMC5479265.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/07/88/copd-12-1753.PMC5479265.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/3f/ea/jbm-8-061.PMC5479266.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/3f/ea/jbm-8-061.PMC5479266.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Blood Medicine 2017:8 61–66Journal of Blood Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress  61 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JBM.S136152Prevalence of thrombocytopenia among pregnant  women attending antenatal care service at  Gondar University T eaching Hospital in 2014,  northwest Ethiopia Fikir Asrie   Bamlaku Enawgaw Zegeye Getaneh Department of Hematology and  Immunohematology, School of Biomedical and Laboratory Sciences,  College of Medicine and Health Sciences, University of Gondar,  Gondar, EthiopiaIntroduction: Thrombocytopenia is a common hematologic abnormality during pregnancy.",Non-OADS,/arxiv_data1/oa_pdf/3f/ea/jbm-8-061.PMC5479266.pdf
"Due to hemodilution secondary  to expansion of plasma volume, platelet count  in  normal pregnancies may be decreased by ~10%; most of the decrease in platelet Correspondence: Fikir Asrie Department of Hematology and Immunohematology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, PO Box 196, Gondar, EthiopiaTel +251 91 803 1782Email fikirie2000@gmail.ocmJournal name: Journal of Blood Medicine Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 8Running head verso: Asrie et alRunning head recto: Prevalence of thrombocytopenia among pregnant womenDOI: http://dx.doi.org/10.2147/JBM.S136152",Non-OADS,/arxiv_data1/oa_pdf/3f/ea/jbm-8-061.PMC5479266.pdf
"Journal of Blood Medicine 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Blood Medicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/journal-of-blood-medicine-journalThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects   of all aspect pertaining to blood based medicine including but not limited to:   Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,   and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of blood related medicine; Legal aspects of blood medicine; Historical perspec-tives.",Non-OADS,/arxiv_data1/oa_pdf/3f/ea/jbm-8-061.PMC5479266.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dovepress 66 Asrie et al Disclosure The authors report no conflicts of interest in this work.,Non-OADS,/arxiv_data1/oa_pdf/3f/ea/jbm-8-061.PMC5479266.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6a/91/copd-12-1765.PMC5479267.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 1765–1773International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1765OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/COPD.S13575 2 Dietary beetroot juice – effects on physical  performance in COPD patients: a randomized  controlled crossover trial anne louise Friis1,* Carina Bjørnskov  steenholt1,* anders løkke2 Mette hansen1 1section for sport science,   Department of Public health, aarhus  University, Denmark; 2Department of  Clinical Medicine, aarhus University,   Denmark *These authors contributed equally  to this workBackground and objective:  Dietary beetroot juice (BR) supplementation has been shown to  reduce the oxygen (O2) consumption of standardized exercise and reduce resting blood pressure  (BP) in healthy individuals.",Non-OADS,/arxiv_data1/oa_pdf/6a/91/copd-12-1765.PMC5479267.pdf
"Nitric oxide (NO) mainly facilitates the effects on the mitochondrial respiration9  and is important for smooth muscle cell relaxation in the arterial walls,11 blood Correspondence: Mette hansen section for sport science, Department of  Public health, aarhus University, Dalgas  avenue 4, 8000 aarhus, Denmark email mhan@ph.au.d k Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Friis et al Running head recto: Beetroot juice and physical performance in COPD DOI: http://dx.doi.org/10.2147/COPD.S135752",Non-OADS,/arxiv_data1/oa_pdf/6a/91/copd-12-1765.PMC5479267.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/6a/91/copd-12-1765.PMC5479267.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6a/91/copd-12-1765.PMC5479267.pdf
This is an open  access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/28/82/thnov07p1781.PMC5479268.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/28/82/thnov07p1781.PMC5479268.pdf
"7, Issue 7       http://www.thno .org 1795  TThheerraannoossttiiccss   2017; 7(7): 1795- 1805. doi: 10.7150/ thno .19217  Review  Current and emerging techniques for antibiotic  susceptibility tests   Karan Syal1, Manni Mo1, 3, Hui Yu1, Rafael Iriya1, 3, Wenwen Jing1, Sui Guodong4, Shaopeng Wang1, 2,  Thomas E. Grys5, Shelley E. Haydel6, 7, and Nongjian Tao1,2,3  1.",Non-OADS,/arxiv_data1/oa_pdf/a1/b3/thnov07p1795.PMC5479269.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a1/b3/thnov07p1795.PMC5479269.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/a1/b3/thnov07p1795.PMC5479269.pdf
"7, Issue 7      http://www.thno .org 1796  antibiotic therapy.",Non-OADS,/arxiv_data1/oa_pdf/a1/b3/thnov07p1795.PMC5479269.pdf
"7, Issue 7      http://www.thno .org 1797  rely on measuring bacterial growth in presence of  antibiotics over a few days using methods such as  agar dilution assays (E -test and disk diffusion), broth  dilution assays, and automated systems from various manufacturers.",Non-OADS,/arxiv_data1/oa_pdf/a1/b3/thnov07p1795.PMC5479269.pdf
"7, Issue 7      http://www.thno .org 1798  inoculated by the Sensititre Autoinoculator, and is  capable of handling 64 panels.",Non-OADS,/arxiv_data1/oa_pdf/a1/b3/thnov07p1795.PMC5479269.pdf
"7, Issue 7      http://www.thno .org 1799    Figure 2 .",Non-OADS,/arxiv_data1/oa_pdf/a1/b3/thnov07p1795.PMC5479269.pdf
"7, Issue 7      http://www.thno .org 1800  and luciferase  [30], in bacterial cells are also being  used for rapid AST.",Non-OADS,/arxiv_data1/oa_pdf/a1/b3/thnov07p1795.PMC5479269.pdf
"7, Issue 7      http://www.thno .org 1801  individual microcantilevers.",Non-OADS,/arxiv_data1/oa_pdf/a1/b3/thnov07p1795.PMC5479269.pdf
"7, Issue 7      http://www.thno .org 1802  [23].",Non-OADS,/arxiv_data1/oa_pdf/a1/b3/thnov07p1795.PMC5479269.pdf
"7, Issue 7      http://www.thno .org 1803  Table 1.",Non-OADS,/arxiv_data1/oa_pdf/a1/b3/thnov07p1795.PMC5479269.pdf
"7, Issue 7      http://www.thno .org 1804  Isothermal micro calorimetry (IMC) is a novel  technique that measures cumulative heat and  generates heat cu rves of growing bacterial cells [67].",Non-OADS,/arxiv_data1/oa_pdf/a1/b3/thnov07p1795.PMC5479269.pdf
"Published O nline First: 2013.   http://www.cdc.gov/drugresistance/threat -report -2013/pdf/ar -threats -2013 -508.pdf   2  Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin SA, et al.",OADS,/arxiv_data1/oa_pdf/a1/b3/thnov07p1795.PMC5479269.pdf
"7, Issue 7      http://www.thno .org 1805  24  Sinn I, Albertson T, Kinnunen P, Breslauer DN, McNaughton BH, Burns M a,  et al.",Non-OADS,/arxiv_data1/oa_pdf/a1/b3/thnov07p1795.PMC5479269.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/df/thnov07p1806.PMC5479270.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1d/61/thnov07p1820.PMC5479271.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/1d/61/thnov07p1820.PMC5479271.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/22/5a/thnov07p1835.PMC5479272.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/22/5a/thnov07p1835.PMC5479272.pdf
[Internet] WHO: Clinical management of human infection with avian  influenza A (H5N1) viru s.  http://www.who.int/influenza/resources/documents/clinical_management_h5n1_15_08_2007/en/   3.,Non-OADS,/arxiv_data1/oa_pdf/22/5a/thnov07p1835.PMC5479272.pdf
1997; 46: 1204-7. https://www.cdc.gov/mmwr/preview/mmwrhtml/   00050459.htm   31.,Non-OADS,/arxiv_data1/oa_pdf/22/5a/thnov07p1835.PMC5479272.pdf
2016.  https://www.cdc.gov/flu/avianflu/avian - in-humans.htm   34.,Non-OADS,/arxiv_data1/oa_pdf/22/5a/thnov07p1835.PMC5479272.pdf
This is an open acc ess article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e5/88/thnov07p1847.PMC5479273.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/e5/88/thnov07p1847.PMC5479273.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/b9/thnov07p1863.PMC5479274.pdf
This is an open access article distributed under the  terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/05/thnov07p1875.PMC5479275.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/a9/05/thnov07p1875.PMC5479275.pdf
This is an open access article distributed under the terms of the Creative C ommons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9a/f7/thnov07p1890.PMC5479276.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/9a/f7/thnov07p1890.PMC5479276.pdf
"7, Issue 7       http://www.thno .org 1901  TThheerraannoossttiiccss   2017; 7(7): 1901- 1913. doi: 10.7150/ thno .19168  Research Paper   Therapeutic Inhibition of miR -4260 Suppresses  Colorectal Cancer via Targeting MCC and SMAD4   Junjie Xiao1, Dongc hao Lv1, Jinzhe Zhou2, Yihua Bei1, Ting Chen1, 3, Muren Hu2, Qiulian Zhou1, Siyi Fu1,  Qi Huang2  1.",Non-OADS,/arxiv_data1/oa_pdf/32/96/thnov07p1901.PMC5479277.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/32/96/thnov07p1901.PMC5479277.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/32/96/thnov07p1901.PMC5479277.pdf
"7, Issue 7      http://www.thno .org 1902  reveal s that MCC negatively regulates the G1/S cell  cycle transition and is highly expressed in  well -differentiated cells, indicating its potential role as  a tumor suppressor in both cell growth and differentiation [ 6, 7].",Non-OADS,/arxiv_data1/oa_pdf/32/96/thnov07p1901.PMC5479277.pdf
"Bioinformatics analysis  predicted MCC to be the target of 221 miRNAs in miRDB (http://mirdb.org/miRDB/ index.html), among which only miR -4260 w as confirmed to be  upregulated in our miRNA arrays.",OADS,/arxiv_data1/oa_pdf/32/96/thnov07p1901.PMC5479277.pdf
"7, Issue 7      http://www.thno .org 1903  respectively, supplemented with 1%  penicillin -streptomycin (Gibco) and 10% fetal bovine  serum (FBS, HyClone) at 37 oC with 5% CO 2.",Non-OADS,/arxiv_data1/oa_pdf/32/96/thnov07p1901.PMC5479277.pdf
"7, Issue 7      http://www.thno .org 1904  Table 2.",Non-OADS,/arxiv_data1/oa_pdf/32/96/thnov07p1901.PMC5479277.pdf
"Bioinformatics analysis by searching in the miRDB database (http://mirdb.org/miRDB/  index.html) predicted MCC to be targeted by 221  miRNAs, among which only miR -4260 was identified  by miRNA arrays (Fig.1A) We validated the  upregulati on of miR -4260 in metastatic colorectal  cancer tissues by qRT -PCRs (Fig.",OADS,/arxiv_data1/oa_pdf/32/96/thnov07p1901.PMC5479277.pdf
"7, Issue 7      http://www.thno .org 1905    Figure 1. miR -4260 is increased in human colorectal cancer (A) MCC was predicted to be targeted by 221 miRNAs in miRDB and among them, miR -4260 was identified  to be upregulated in human metastatic colorectal cancer compared to non- metastatic sample.",OADS,/arxiv_data1/oa_pdf/32/96/thnov07p1901.PMC5479277.pdf
"(%)   Age (X±S, years ) 58±10  Sex     Male  27 (64.3% )   Female  15 (35.7% )  Heart rate (X ±S, times/min ) 76±7  BMI (X±S, Kg/m2) 24±3  TNM stage      I 3 (7.1% )   II 18 (42.9% )   III 14 (33.3% )   IV 7 (16.7% )  Tumor location      Colon  26 (61.9%)    Rectum  16 (38.1%)   Comorbidity      Hypertension  11 (26.2%)    Diabetes Mellitus  3 (7.1%)    Coronary heart disease  5 (11.9%)     MCC and SMAD4 A re Identified as Two  Target Genes of miR -4260   MCC is predicted to be directly targeted by  miR-4260 according to the data in miRDB  (http://mirdb.org/miRDB/index.html), As expected,  luciferase assay showed that miR -4260 triggered a  significant reduction in luciferase activity in cells  transfected with the MCC 3’UTR construct.",Non-OADS,/arxiv_data1/oa_pdf/32/96/thnov07p1901.PMC5479277.pdf
"7, Issue 7      http://www.thno .org 1906  while miR -4260 inhibitor increased the protein level of  MCC in HCT116 and HT29 cell lines.",Non-OADS,/arxiv_data1/oa_pdf/32/96/thnov07p1901.PMC5479277.pdf
"7, Issue 7      http://www.thno .org 1907    Figure 3.",Non-OADS,/arxiv_data1/oa_pdf/32/96/thnov07p1901.PMC5479277.pdf
"7, Issue 7      http://www.thno .org 1908    Figure 4.",Non-OADS,/arxiv_data1/oa_pdf/32/96/thnov07p1901.PMC5479277.pdf
"7, Issue 7      http://www.thno .org 1909      Figure 5.",Non-OADS,/arxiv_data1/oa_pdf/32/96/thnov07p1901.PMC5479277.pdf
"7, Issue 7      http://www.thno .org 1910    Figure 6.",Non-OADS,/arxiv_data1/oa_pdf/32/96/thnov07p1901.PMC5479277.pdf
"7, Issue 7      http://www.thno .org 1911    Figure 7.",Non-OADS,/arxiv_data1/oa_pdf/32/96/thnov07p1901.PMC5479277.pdf
"7, Issue 7      http://www.thno .org 1912  for colorectal cancer.",Non-OADS,/arxiv_data1/oa_pdf/32/96/thnov07p1901.PMC5479277.pdf
"7, Issue 7      http://www.thno .org 1913  32.",Non-OADS,/arxiv_data1/oa_pdf/32/96/thnov07p1901.PMC5479277.pdf
"7, Issue 7       http://www.thno .org 1914  TThheerraannoossttiiccss   2017; 7(7): 1914-1927. doi: 10.7150/ thno .17852  Research Paper   Triptolide Inhibits the AR S ignaling Pathway to Suppress  the Proliferation of Enzalutamide  Resistant Prostate  Cancer Cells  Yangyang Han1#, Weiwei Huang1#, Jiakuan Liu2, Dandan Liu3,4, Yangyan Cui2, Ruimin Huang3,4, Jun  Yan2, Ming Lei1,5  1.",Non-OADS,/arxiv_data1/oa_pdf/8e/d4/thnov07p1914.PMC5479278.pdf
This is an open access article  distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8e/d4/thnov07p1914.PMC5479278.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/8e/d4/thnov07p1914.PMC5479278.pdf
"7, Issue 7      http://www.thno .org 1915  AR to translocate into the nucleus and bind DNA.",Non-OADS,/arxiv_data1/oa_pdf/8e/d4/thnov07p1914.PMC5479278.pdf
"7, Issue 7      http://www.thno .org 1916  months  and maintained with  20 μM enzalutamide.",Non-OADS,/arxiv_data1/oa_pdf/8e/d4/thnov07p1914.PMC5479278.pdf
"7, Issue 7      http://www.thno .org 1917  anti-Cleaved- Caspase -3 (Cat #: 9661; 1:3000; Cell  Signal Technologies, Inc), and anti- AR (N -20, Cat #:  sc-27136; 1:1000; Santa Cruz) as primary antibodies  following the standard protocol.",Non-OADS,/arxiv_data1/oa_pdf/8e/d4/thnov07p1914.PMC5479278.pdf
"7, Issue 7      http://www.thno .org 1918  significantly inhibits AR/WT transactivation activity,  whereas AR/S515E abrogates the effect of TPL.",Non-OADS,/arxiv_data1/oa_pdf/8e/d4/thnov07p1914.PMC5479278.pdf
"7, Issue 7      http://www.thno .org 1919    Figure 2.",Non-OADS,/arxiv_data1/oa_pdf/8e/d4/thnov07p1914.PMC5479278.pdf
"7, Issue 7      http://www.thno .org 1920  Figure 4 A, low concentrations of TPL significantly  reduced the R1881 -stimulated growth of LNCaP cells  over a period of 4 days with an IC 50 of 6.25 nM.",Non-OADS,/arxiv_data1/oa_pdf/8e/d4/thnov07p1914.PMC5479278.pdf
"7, Issue 7      http://www.thno .org 1921  Co-treatment also induced higher levels of the cl eaved  products of two markers of apoptosis, Caspase -3 and  PARP, in 22Rv1 and C4- 2R cells (Figure 5 E),  indicating that the combined -treatment is also more  cytotoxic to CRPC cells.",Non-OADS,/arxiv_data1/oa_pdf/8e/d4/thnov07p1914.PMC5479278.pdf
"7, Issue 7      http://www.thno .org 1922  xenograft tumors from the co- treatment group w ere  packed together less tightly than those in the other  groups (Figure 6 E).",Non-OADS,/arxiv_data1/oa_pdf/8e/d4/thnov07p1914.PMC5479278.pdf
"7, Issue 7      http://www.thno .org 1923    Figure 6.",Non-OADS,/arxiv_data1/oa_pdf/8e/d4/thnov07p1914.PMC5479278.pdf
"7, Issue 7      http://www.thno .org 1924  Discussion   As a representative of ‘second generation’ drugs  and as an AR antagonist, enzalutamide has many  favorable effects on mCRPC patients based on data  from some phase I/II/III trials.",Non-OADS,/arxiv_data1/oa_pdf/8e/d4/thnov07p1914.PMC5479278.pdf
"7, Issue 7      http://www.thno .org 1925  phosphory lation of AR at Ser515 in PCa cells.",Non-OADS,/arxiv_data1/oa_pdf/8e/d4/thnov07p1914.PMC5479278.pdf
"7, Issue 7      http://www.thno .org 1926  genes are up -regulated with TPL treatment.",Non-OADS,/arxiv_data1/oa_pdf/8e/d4/thnov07p1914.PMC5479278.pdf
"7, Issue 7      http://www.thno .org 1927  30.",Non-OADS,/arxiv_data1/oa_pdf/8e/d4/thnov07p1914.PMC5479278.pdf
"7, Issue 7       http://www.thno .org 1928  TThheerraannoossttiiccss   2017; 7(7): 1928- 1939. doi: 10.7150/ thno .18719  Research Paper   177Lu-Labeled Phosphoramidate -Based PSMA Inhibitors:  The Effect of an Albumin Binder on Biodistribution and  Therapeutic Efficacy in Prostate Tumor -Bearing Mice   Cindy J. Choy1*, Xiaoxi Ling2*, Jonathan J. Geruntho2, Sophia K. Beyer1, Joseph D. Latoche2, Beatrice  Langton -Webster1, Carol yn J. Anderson2, 3, 4, 5 and Clifford E. Berkman1  1.",Non-OADS,/arxiv_data1/oa_pdf/8b/a7/thnov07p1928.PMC5479279.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8b/a7/thnov07p1928.PMC5479279.pdf
See http://ivyspring.com/terms f or full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/8b/a7/thnov07p1928.PMC5479279.pdf
"7, Issue 7      http://www.thno .org 1929  molecules for imaging and therapeutic agents.",Non-OADS,/arxiv_data1/oa_pdf/8b/a7/thnov07p1928.PMC5479279.pdf
"7, Issue 7      http://www.thno .org 1930    Scheme 1.",Non-OADS,/arxiv_data1/oa_pdf/8b/a7/thnov07p1928.PMC5479279.pdf
"7, Issue 7      http://www.thno .org 1931  Stability Studies in Mouse Serum   Mouse blood was collected via cardiac puncture  of the left ventricle with a 25G needle.",Non-OADS,/arxiv_data1/oa_pdf/8b/a7/thnov07p1928.PMC5479279.pdf
"7, Issue 7      http://www.thno .org 1932  Results   Synthesis and Radiochemistry   The preparation of the precursors CTT1400 and  CTT1402 is fully detailed in the Supplementa l  Material ( Schemes S1 & S2, Figures S1 -S6, Tables  S1-S8).",Non-OADS,/arxiv_data1/oa_pdf/8b/a7/thnov07p1928.PMC5479279.pdf
"7, Issue 7      http://www.thno .org 1933  reaching a maximum of 46 %ID/g at 72 h post  injection.",Non-OADS,/arxiv_data1/oa_pdf/8b/a7/thnov07p1928.PMC5479279.pdf
"7, Issue 7      http://www.thno .org 1934  CTT1401 showed impressive tumor:non -tumor  ratios, with tumor:blood peak ing at 4 h (300 ± 84) and  tumor:muscle reaching 211 ± 52 at 24 h post -injection  (Figure 4A, E ).",Non-OADS,/arxiv_data1/oa_pdf/8b/a7/thnov07p1928.PMC5479279.pdf
"7, Issue 7      http://www.thno .org 1935  Therapeutic Efficacy   Animals were injected with a single dose of 29  MBq CTT1401/CTT1403, or saline (control group)  approximately 7-10 days post -implantation of the  tumor xenografts.",Non-OADS,/arxiv_data1/oa_pdf/8b/a7/thnov07p1928.PMC5479279.pdf
"7, Issue 7      http://www.thno .org 1936  Irrevers ible inhibitors offer persistent target  binding after the drug has been cleared.",Non-OADS,/arxiv_data1/oa_pdf/8b/a7/thnov07p1928.PMC5479279.pdf
"7, Issue 7      http://www.thno .org 1937  previously.",Non-OADS,/arxiv_data1/oa_pdf/8b/a7/thnov07p1928.PMC5479279.pdf
"7, Issue 7      http://www.thno .org 1938  shortly undergo IND -enabling pharmacology studies  to assess dose, regimen, estimated human dosimetry,  and safety studies.",Non-OADS,/arxiv_data1/oa_pdf/8b/a7/thnov07p1928.PMC5479279.pdf
"7, Issue 7      http://www.thno .org 1939  in Patients With Metastatic Castration Resistant Prosta te Cancer.",Non-OADS,/arxiv_data1/oa_pdf/8b/a7/thnov07p1928.PMC5479279.pdf
"7, Issue 7       http://www.thno .org 1940  TThheerraannoossttiiccss   2017; 7(7): 1940- 1941. doi: 10.7150/ thno .20284   Editorial   Should Low Molecular Weight  PSMA Targeted Ligands  Get Bigger and Use Albumin Ligands for PSMA  Targeting?",Non-OADS,/arxiv_data1/oa_pdf/dc/19/thnov07p1940.PMC5479280.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dc/19/thnov07p1940.PMC5479280.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/dc/19/thnov07p1940.PMC5479280.pdf
"7, Issue 7      http://www.thno .org 1941  access tumors through the non- targeted- process of  “enhanced permeability and retention  effect and at  the target site allows enhanced PSMA targeted tumor  uptake and prolonged radioligand retention.”  These  two studies suggest that the addition of an albumin  binding moiety to targeting agents with rapid renal  excretion results in higher tumor  uptake and better  tumor control with no significant increase in host  toxicity (1,8).",Non-OADS,/arxiv_data1/oa_pdf/dc/19/thnov07p1940.PMC5479280.pdf
"7, Issue 7       http://www.thno .org 1942  TThheerraannoossttiiccss   2017; 7(7): 1942- 1952. doi: 10.7150/ thno .16236  Research Paper   Mouse IP -10 Gene Delivered by Folate -modified  Chitosan Nanoparticles and Dendritic/tumor Cells  Fusion Vaccine Effectively Inhibit the Growth of  Hepatocellular Carcinoma in Mice   Zixi Hu1*, Jiaojiao Chen1*, Sufang Zhou1*, Nuo Yang1, Siliang Duan1, Zhenghua Z hang1, Jing Su1, Jian He1,  Zhiyong Zhang1, 2, Xiaoling Lu1, Yongxiang Zhao1  1.",Non-OADS,/arxiv_data1/oa_pdf/09/31/thnov07p1942.PMC5479281.pdf
This is  an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/09/31/thnov07p1942.PMC5479281.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/09/31/thnov07p1942.PMC5479281.pdf
"7, Issue 7      http://www.thno .org 1943  DC isolation and fusion techniques, DC/tumor cell  fusion vaccine has become a key strategy because of  its ability t o induce specific cytotoxic T lymphocytes  (CTLs) for killing tumor cells in vivo.",Non-OADS,/arxiv_data1/oa_pdf/09/31/thnov07p1942.PMC5479281.pdf
"7, Issue 7      http://www.thno .org 1944  Materials and Methods   Materials   Chitosan (deacetylation degree ≥ 90%) was  purchased from Solarbio Company (Beijing, China).",Non-OADS,/arxiv_data1/oa_pdf/09/31/thnov07p1942.PMC5479281.pdf
"7, Issue 7      http://www.thno .org 1945  formula: L1 × (L2)2 × 0.5 (L1: the maximum diameter  of the tumor, L2: the shortest diameter of the tumor).",Non-OADS,/arxiv_data1/oa_pdf/09/31/thnov07p1942.PMC5479281.pdf
"7, Issue 7      http://www.thno .org 1946    Figure 2.",Non-OADS,/arxiv_data1/oa_pdf/09/31/thnov07p1942.PMC5479281.pdf
"7, Issue 7      http://www.thno .org 1947  vaccine than that in the controls.",Non-OADS,/arxiv_data1/oa_pdf/09/31/thnov07p1942.PMC5479281.pdf
"7, Issue 7      http://www.thno .org 1948    Figure 4 .",Non-OADS,/arxiv_data1/oa_pdf/09/31/thnov07p1942.PMC5479281.pdf
"7, Issue 7      http://www.thno .org 1949    Figure 5 .",Non-OADS,/arxiv_data1/oa_pdf/09/31/thnov07p1942.PMC5479281.pdf
"7, Issue 7      http://www.thno .org 1950    Figure 7.",Non-OADS,/arxiv_data1/oa_pdf/09/31/thnov07p1942.PMC5479281.pdf
"7, Issue 7      http://www.thno .org 1951    Figure 9.",Non-OADS,/arxiv_data1/oa_pdf/09/31/thnov07p1942.PMC5479281.pdf
"7, Issue 7      http://www.thno .org 1952  Supplementary Material    Supplementary figures.",Non-OADS,/arxiv_data1/oa_pdf/09/31/thnov07p1942.PMC5479281.pdf
This is an open access article distributed under the terms of the Creative Commons Attribu tion (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/4d/c2/thnov07p1953.PMC5479282.pdf
See http://ivyspring.com/terms for full terms and condit ions.,Non-OADS,/arxiv_data1/oa_pdf/4d/c2/thnov07p1953.PMC5479282.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3e/a9/thnov07p1966.PMC5479283.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/3e/a9/thnov07p1966.PMC5479283.pdf
"7, Issue 7       http://www.thno .org 1976  TThheerraannoossttiiccss   2017; 7(7): 1976- 1989. doi: 10.7150/ thno .17846  Research Paper   Thermoacoustic Imaging and Therapy Guidance based  on Ultra -short Pulsed Microwave Pumped  Thermoelastic Effect I nduced with Superparamagnetic  Iron Oxide Nanoparticles   Liewei Wen1, Sihua Yang1, Junping Zhong1, Quan Zhou2, Da Xing1  1.",OADS,/arxiv_data1/oa_pdf/dd/ae/thnov07p1976.PMC5479284.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY -NC) license  (https://creativecommons.org/lic enses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/ae/thnov07p1976.PMC5479284.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/dd/ae/thnov07p1976.PMC5479284.pdf
"7, Issue 6      http://www.thno .org 1977  cancer diagnostics and therapeutics research.",Non-OADS,/arxiv_data1/oa_pdf/dd/ae/thnov07p1976.PMC5479284.pdf
"7, Issue 6      http://www.thno .org 1978    Schem e 1.",Non-OADS,/arxiv_data1/oa_pdf/dd/ae/thnov07p1976.PMC5479284.pdf
"7, Issue 6      http://www.thno .org 1979    Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/dd/ae/thnov07p1976.PMC5479284.pdf
"7, Issue 6      http://www.thno .org 1980    Figure 2.",Non-OADS,/arxiv_data1/oa_pdf/dd/ae/thnov07p1976.PMC5479284.pdf
"7, Issue 6      http://www.thno .org 1981  tumor, while it also served as TA imaging contrast  agent  to indicate  the TA effect enhancement  in tumor .",Non-OADS,/arxiv_data1/oa_pdf/dd/ae/thnov07p1976.PMC5479284.pdf
"7, Issue 6      http://www.thno .org 1982    Figure 3.",Non-OADS,/arxiv_data1/oa_pdf/dd/ae/thnov07p1976.PMC5479284.pdf
"7, Issue 6      http://www.thno .org 1983  In vivo  TA therapy   Motivated by the tumor accumulation of  HSA -SPIO  and i ts powerful TA effect to  highly -efficient ly kill cancer cells, in vivo  TA therapy  was performed in 4T1 tumor -bearing mice.",Non-OADS,/arxiv_data1/oa_pdf/dd/ae/thnov07p1976.PMC5479284.pdf
"7, Issue 6      http://www.thno .org 1984  TA therapy is a recently proposed therapeutic  technique , which is different from the microwave  thermal therapy.",Non-OADS,/arxiv_data1/oa_pdf/dd/ae/thnov07p1976.PMC5479284.pdf
"7, Issue 6      http://www.thno .org 1985    Figure 7.",Non-OADS,/arxiv_data1/oa_pdf/dd/ae/thnov07p1976.PMC5479284.pdf
"7, Issue 6      http://www.thno .org 1986  [32].",Non-OADS,/arxiv_data1/oa_pdf/dd/ae/thnov07p1976.PMC5479284.pdf
"7, Issue 6      http://www.thno .org 1987  response  [66].",Non-OADS,/arxiv_data1/oa_pdf/dd/ae/thnov07p1976.PMC5479284.pdf
"7, Issue 6      http://www.thno .org 1988  5.",Non-OADS,/arxiv_data1/oa_pdf/dd/ae/thnov07p1976.PMC5479284.pdf
"7, Issue 6      http://www.thno .org 1989  study of the e ffects of microbubbles on simple thermoacoustic targets.",Non-OADS,/arxiv_data1/oa_pdf/dd/ae/thnov07p1976.PMC5479284.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/72/22/thnov07p1990.PMC5479285.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/72/22/thnov07p1990.PMC5479285.pdf
"7, Issue 7       http://www.thno .org 2046  TThheerraannoossttiiccss   2017; 7(7): 2046- 2047.  doi: 10.7150/ thno .20855  Editorial   PSMA -PET for Lymph Node Detection in Recurrent  Prostate Cancer: How do we use the Magic Bullet?",Non-OADS,/arxiv_data1/oa_pdf/1d/0a/thnov07p2046.PMC5479286.pdf
This is an open access article distributed under the terms of the Creative Commons Attribu tion (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1d/0a/thnov07p2046.PMC5479286.pdf
See http://ivyspring.com/terms for full terms and condit ions.,Non-OADS,/arxiv_data1/oa_pdf/1d/0a/thnov07p2046.PMC5479286.pdf
"7, Issue 7      http://www.thno .org 2047  detection of lymph node metastases by this novel  imaging technology.",Non-OADS,/arxiv_data1/oa_pdf/1d/0a/thnov07p2046.PMC5479286.pdf
"7, Issue 7       http://www.thno .org 2065  TThheerraannoossttiiccss   2017; 7(7): 2065- 2066.  doi: 10.7150/ thno .20622  Editorial   In Molecular Pursuit of Bone Metastasis  by Fluciclovine  PET  Liza Lindenberg1,2   1.",Non-OADS,/arxiv_data1/oa_pdf/59/02/thnov07p2065.PMC5479287.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/59/02/thnov07p2065.PMC5479287.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/59/02/thnov07p2065.PMC5479287.pdf
"7, Issue 7      http://www.thno .org 2066  histological analysis was directed not only at the  metastasis but also normal inflammatory cells,  osteoblasts and osteoclasts as well as cells bearing  amino acid transporters.",Non-OADS,/arxiv_data1/oa_pdf/59/02/thnov07p2065.PMC5479287.pdf
"7, Issue 7       http://www.thno .org 2067  TThheerraannoossttiiccss   2017; 7(7): 2067- 2077.  doi: 10.7150/ thno .19427  Review  Current Strategies and Challenges for Purification of  Cardiomyocytes Derived from Human Pluripotent Stem  Cells  Kiwon Ban1, Seongho Bae2, Young -sup Yoon2, 3  1.",Non-OADS,/arxiv_data1/oa_pdf/3b/21/thnov07p2067.PMC5479288.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/21/thnov07p2067.PMC5479288.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/3b/21/thnov07p2067.PMC5479288.pdf
"7, Issue 7      http://www.thno .org 2068  have been tested and varied outcomes were obtained.",Non-OADS,/arxiv_data1/oa_pdf/3b/21/thnov07p2067.PMC5479288.pdf
"7, Issue 7      http://www.thno .org 2069  beneficial for myocardial repair due to improved  electric and mechanical properties  [29].",Non-OADS,/arxiv_data1/oa_pdf/3b/21/thnov07p2067.PMC5479288.pdf
"7, Issue 7      http://www.thno .org 2070  Physical e nrichment   Xu et el.",Non-OADS,/arxiv_data1/oa_pdf/3b/21/thnov07p2067.PMC5479288.pdf
"7, Issue 7      http://www.thno .org 2071  study, the authors us ed NKX2.5/eGFP hESCs to  generate hPSC -CMs, allowing the cells to be sorted by  their NKX2.5 expression .",Non-OADS,/arxiv_data1/oa_pdf/3b/21/thnov07p2067.PMC5479288.pdf
"7, Issue 7      http://www.thno .org 2072  cultured newborn rat CMs and mouse ESCs in media  with lactate, forcing the cells to use the TCA cycle  instead of glucose, and th ey observed that CMs were  the only cells to survive this condition for even 96 hrs.",Non-OADS,/arxiv_data1/oa_pdf/3b/21/thnov07p2067.PMC5479288.pdf
"7, Issue 7      http://www.thno .org 2073  MBs are designed to have the maximum sensitivity  and specificity for the cells of interest, but not others.",Non-OADS,/arxiv_data1/oa_pdf/3b/21/thnov07p2067.PMC5479288.pdf
"7, Issue 7      http://www.thno .org 2074  undifferentiated hiPSCs due to the interaction  between the hiPSCs and the columns, and the  untrapped hiPSC -CMs are eventually separated.",Non-OADS,/arxiv_data1/oa_pdf/3b/21/thnov07p2067.PMC5479288.pdf
"7, Issue 7      http://www.thno .org 2075  Therefore, development of reproducible,  effective, non -mutagenic, scalable, and economical  technologies for purifying hPSC -CMs, independent of  hPSC line s or differentiation protocol s, is a  fundamental requirement for the success of hPSC -CM  applications.",Non-OADS,/arxiv_data1/oa_pdf/3b/21/thnov07p2067.PMC5479288.pdf
"7, Issue 7      http://www.thno .org 2076  19.",Non-OADS,/arxiv_data1/oa_pdf/3b/21/thnov07p2067.PMC5479288.pdf
"7, Issue 7      http://www.thno .org 2077  73.",Non-OADS,/arxiv_data1/oa_pdf/3b/21/thnov07p2067.PMC5479288.pdf
"7, Issue 7      http://www.thno .org 2108  TThheerraannoossttiiccss   2017; 7(7): 2108- 2110.  doi: 10.7150/ thno .20460  Editorial   A Look Inside  of the Complex  Pathogenesis  of  B-RAF(V600E) -Driven  Cancer   Emilia  Caputo   Institute  of Genetics  and Biophysics  –I.G.B., A. Buzzati -Traverso –, CNR,  Via Pietro  Castellino,  111, I-80131 Naples,  Italy.",Non-OADS,/arxiv_data1/oa_pdf/00/57/thnov07p2108.PMC5479289.pdf
This  is an open  access  article  distributed  under  the terms  of the Creative  Commons  Attribution  (CC BY-NC)  license   (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/00/57/thnov07p2108.PMC5479289.pdf
See http://ivyspring.com/terms  for full terms  and conditions.,Non-OADS,/arxiv_data1/oa_pdf/00/57/thnov07p2108.PMC5479289.pdf
"7, Issue 7      http://www.thno .org 2109  is known for shutting  down transcription  and,  thereby , for participating  in the control  of gene   expression  patterns.",Non-OADS,/arxiv_data1/oa_pdf/00/57/thnov07p2108.PMC5479289.pdf
"7, Issue 7      http://www.thno .org 2110  transcriptional  levels,  by direct  binding  to their   regulatory  elements , as well  as at post -transcriptional   level , by repressing  the miR-26a, miR-200b  and  miR-155 expression.",Non-OADS,/arxiv_data1/oa_pdf/00/57/thnov07p2108.PMC5479289.pdf
"7, Issue 7       http://www.thno .org 2111  TThheerraannoossttiiccss   2017; 7(7): 2111- 2133.  doi: 10.7150/ thno .17934  Review  Harnessing Integrative Omics to Facilitate Molecular  Imaging of the Human Epidermal Growth Factor  Receptor Family for Precision Medicine   Martin Pool1*, H. Rudolf de Boer1*, Marjolijn N. Lub -de Hooge2, 3, Marcel A.T.M.",Non-OADS,/arxiv_data1/oa_pdf/fd/e6/thnov07p2111.PMC5479290.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/fd/e6/thnov07p2111.PMC5479290.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/fd/e6/thnov07p2111.PMC5479290.pdf
"7, Issu e 7      http://www.thno .org 2112  failure (5, 6) .",Non-OADS,/arxiv_data1/oa_pdf/fd/e6/thnov07p2111.PMC5479290.pdf
"7, Issu e 7      http://www.thno .org 2113    Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/fd/e6/thnov07p2111.PMC5479290.pdf
"7, Issu e 7      http://www.thno .org 2114  gefitinib or erlotinib are not effective due to the  absence of mutations in EGFR  (10).",Non-OADS,/arxiv_data1/oa_pdf/fd/e6/thnov07p2111.PMC5479290.pdf
"7, Issu e 7      http://www.thno .org 2115  signaling after EGFR blockade (23, 40) .",Non-OADS,/arxiv_data1/oa_pdf/fd/e6/thnov07p2111.PMC5479290.pdf
"7, Issu e 7      http://www.thno .org 2116  sensitivity and the ability to non -invasively acquire  quantitative three -dimensional information of whole  body tracer distribution.",Non-OADS,/arxiv_data1/oa_pdf/fd/e6/thnov07p2111.PMC5479290.pdf
"7, Issu e 7      http://www.thno .org 2117  such as perfusion and vascular permeability might  influence cetuximab -based tracer tumor uptake (64,  65).",Non-OADS,/arxiv_data1/oa_pdf/fd/e6/thnov07p2111.PMC5479290.pdf
"7, Issu e 7      http://www.thno .org 2118    Figure 2.",Non-OADS,/arxiv_data1/oa_pdf/fd/e6/thnov07p2111.PMC5479290.pdf
"7, Issu e 7      http://www.thno .org 2119  Table 1.",Non-OADS,/arxiv_data1/oa_pdf/fd/e6/thnov07p2111.PMC5479290.pdf
"7, Issu e 7      http://www.thno .org 2120  Tracer  Modality  Scaffold  Study type  Target  Remarks  Ref  11C-erlotinib  PET TKI Clinical  mutEGFR  Case report of high 11C-erlotinib uptake in brain metastases of EGFR   exon 19 mutated NSCLC patient which responded to erlotinib  73  18F-afatinib  PET TKI Preclinical  EGFR/HER 2 Higher accumulation in EGFR -wt and EGFR -exon 19 deletion,  compared to EGFR -T790M xenografts  74  89Zr-trastuzumab  PET mAb  Preclinical  HER2  Specific uptake in HER2 -positive xenografts  86, 88   89Zr-trastuzumab  PET mAb  Clinical  HER2  Detection of lesions in HER2 -positive breast cancer patients  94  111In-trastuzumab  SPECT  mAb  Clinical  HER2  Detection of lesions in HER2 -positive breast cancer patients  93  89Zr-pertuzumab  PET mAb  Preclinical  HER2  Specific uptake in HER2 -positive xenografts  79  111In-ABY -002 SPECT  affibody  Clinical  HER2  Detection of lesions in HER2 -positive breast cancer patients  90  68Ga-ABY -002 PET affibody  Clinical  HER2  Detection of lesions in HER2 -positive breast cancer patients  90  68Ga-2Rs15d  PET nanobody  Clinical  HER2  Detection of lesions in HER2 -positive breast cancer patients  91  111In-Fab-PEG 24-HRG  PET Fab/HRG  construct  Preclinical  HER2/  HER3  HER3 and HER2 -mediated uptake in xenografts  100  89Zr-lumretuzumab  PET mAb  Preclinical  HER3  HER3 -specific uptake in xenografts  95  89Zr-lumretuzumab  PET mAb  Clinical  HER3  Tumor uptake in patients with solid tumors, as well as tumor uptake  before and aft er administrating therapeutic doses cold lumretuzumab  102  64Cu-DOTA -HER3 F(ab’) 2 PET f(ab’) 2 Preclinical  HER3  HER3 -specific uptake in xenografts  96  68Ga-HEHEHE -Z08698  PET affibody  Preclinical  HER3  HER3 -specific uptake in xenografts  97   111In-HEHEHE -Z08698  SPECT  affibody  Preclinical  HER3  HER3 -specific uptake in xenografts  98  99mTc-HEHEHE -Z08699  SPECT  affibody  Preclinical  HER3  HER3 -specific uptake in xenografts  99   111In-HEHEHE -Z08699  SPECT  affibody  Preclinical  HER3  HER3 -specific uptake in xenografts  97  64Cu-patritumab  PET mAb  Clinical  HER3  Tumor uptake in patients with solid tumors  101  Accumulation   IRDye 700DX -cetuximab  NIRF  mAb  Preclinical  EGFR  Photoimmunotherapy and detection of lesions  103  89Zr-cetuximab  PET mAb  Preclinical  EGFR  Prediction of accumulation for 88Y- and 177Lu-labeled cetuximab  104  64Cu-MM -302 PET liposome  Preclinical  HER2  Predict deposition, kinetics and efficacy of the parental  doxorubicin -loaded liposome in xenografted mice and primates  105,  106  89Zr-trastuzumab  PET mAb  Clinical  HER2  89Zr-trastuzumab scans to determine intra/interpatient HER2  heterogeneity and (non -)responders to T -DM1 therapy  107  89Zr-trastuzumab  PET mAb  Preclinical  HER2  Increased uptake of 89Zr-trastuzumab after N-acetylcysteine treatment  of MUC4 -expressing xenografts  111  89Zr-pertuzumab  PET mAb  Preclinical  HER2  Enhanced residualization of 89Zr-pertuzumab with concurrent  trastuzumab treatment in xenografted mice  87  89Zr-trastuzumab/  89Zr-Bevacizumab /  89Zr-IgG PET mAb  Preclinical  HER2/  VEGF/  generic  Anti -angiogenic agent bevacizumab decreased general antibody  tracer uptake in xenografts  113  111In-trastuzumab/  125I-trastuzumab/111In-IgG / 125I-IgG SPECT  mAb  Preclinical  HER2/  generic Anti -angiogenic agent B20-4.1 decreased general antibody tracer  uptake in xenografts  112  89Zr-MMOT0530A  PET mAb  Preclinical  mesothelin  Tumor accumulation of naked antibody version of ADC DMOT4039A  108  89Zr-MMOT0530A  PET mAb  Clinical  mesothelin  89Zr-MMOT0530A uptake as predictor for clinical response to the  corresponding ADC DMOT4039A  109  Treatment effects   64Cu-DOTA Cetuximab  F(ab’) 2  PET f(ab’)2  Preclinical  EGFR  EGFR upregulation after PI3K inhibitor GDC -0941 and AKT inhibitor  GDC -0068 treatment  119  89Zr-MEHD7945A  PET mAb  Preclinical  EGFR/  HER3  EGFR and HER3 upregulation after AKT inhibition by GDC -0068  126  89Zr-trastuzumab  PET mAb  Preclinical  HER2  Downregulation of HER2 expression through afatinib treatment  120  89Zr-trastuzumab  PET mAb  Preclinical  HER2  HER2 downregulation after HSP90 inhibition with NVP -AUY -922 122  89Zr-trastuzumab  PET mAb  Preclinical  HER2  HER2 downregulation after HSP90 inhibition with PU -H71 124  89Zr-trastuzumab  PET mAb  Clinical  HER2  HER2 downregulation after HSP90 inhibition with NVP -AUY922 in  HER2 -positive breast cancer patients  125  89Zr-trastuzumab F(ab’) 2  PET f(ab’) 2 Preclinical  HER2  Upregulation and stabilization of HER2 at the plasma membrane after  lapatinib treatment  121  89Zr-trastuzumab F(ab’) 2  PET f(ab’) 2 Preclinical  HER2  HER2 downregulation after HSP90 inhibition with 17AAG  121  AlexaFluor 680 -ZHer2:342  NIRF  affibody  Preclinical  HER2  HER2 downregulation after HSP90 inhibition with 17 -DMAG  123  64Cu-DOTA -HER3 F(ab’) 2  PET f(ab’) 2 Preclinical  HER3  HER3 upregulation after AKT inhibition by GDC -0068  119  89Zr-mAb391  PET mAb  Preclinical  IG1R  IGF1R downregulation after HSP90 inhibition with NVP -AUY -922 115  89Zr-bevacizumab  PET mAb  Preclinical  VEGF  VEGF -A downregulation after heat shock protein -90 inhibition  NVP -AUY922  114,  115  89Zr-bevacizumab  PET mAb  Preclinical  VEGF  Downregulation of VEGF -A through everolimus treatment  116  89Zr-bevacizumab  PET mAb  Clinical  VEGF  Downregulation of VEGF -A through everolimus treatment  117  89Zr-ranibizumab  PET f(ab’) 2 Preclinical  VEGF  Sunitinib treatment -induced changes in VEGF -A tumor levels  118  Intracellular processes   111In-anti-p27kip1-TAT  SPECT  mAb  Preclinical  p27kip1 Upregulation of p27kip1 after trastuzumab treatment  128  111In-anti-γH2AX -TAT  SPECT  mAb  Preclinical  phospho -  H2AX  Detection of DNA breaks induced by chemo and radiotherapy  129  111In-anti-γH2AX -TAT  SPECT  mAb  Preclinical  phospho -  H2AX  Detection of DNA breaks induced during tumorigenesis of breast  cancer in BALB/C  Neu-T mice  131  89Zr-anti-γH2AX -TAT  PET mAb  Preclinical  phospho -  H2AX  Detection of DNA breaks induced by chemo and radiotherapy  130",Non-OADS,/arxiv_data1/oa_pdf/fd/e6/thnov07p2111.PMC5479290.pdf
"7, Issu e 7      http://www.thno .org 2121    HER2 overexpression in breast cancer is  associated with worse prognosis, if not treated with  HER2 -directed therapy (85) .",Non-OADS,/arxiv_data1/oa_pdf/fd/e6/thnov07p2111.PMC5479290.pdf
"7, Issu e 7      http://www.thno .org 2122  89Zr-MMOT0530A uptake and clinical response to the  corresponding ADC DMOT4039A (109) .",Non-OADS,/arxiv_data1/oa_pdf/fd/e6/thnov07p2111.PMC5479290.pdf
"7, Issu e 7      http://www.thno .org 2123  transcription (TAT) peptide, to ensure nuclear  deposition (Figure 2H) (127) .",Non-OADS,/arxiv_data1/oa_pdf/fd/e6/thnov07p2111.PMC5479290.pdf
"7, Issu e 7      http://www.thno .org 2124  protein arrays (RPPA)) (Figure 3) (141) .",OADS,/arxiv_data1/oa_pdf/fd/e6/thnov07p2111.PMC5479290.pdf
